 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  ant_%logit_3.0 if_%logit_3.0 ibr_%logit_2.0 ino_%logit_0.0 ly_%logit_3.0 tic_%logit_0.0  agents_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  CV_%logit_3.0 AD_%logit_3.0 ._%logit_0.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  these_%logit_3.0  agents_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  them_%logit_2.0  to_%logit_3.0  each_%logit_3.0  other_%logit_3.0  in_%logit_2.0  terms_%logit_3.0  of_%logit_3.0  cat_%logit_0.0 heter_%logit_3.0  function_%logit_2.0 ._%logit_0.0  Further_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_1.0  to_%logit_1.0  assess_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_0.0  in_%logit_3.0  reducing_%logit_2.0  CV_%logit_0.0 AD_%logit_0.0  function_%logit_2.0  and_%logit_0.0  the_%logit_3.0  risk_%logit_0.0  of_%logit_3.0  infection_%logit_1.0 ,_%logit_0.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  risks_%logit_3.0  of_%logit_3.0  infection_%logit_1.0  and_%logit_0.0  infection_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  also_%logit_1.0  to_%logit_0.0  compare_%logit_3.0  these_%logit_2.0  drugs_%logit_3.0  with_%logit_3.0  each_%logit_3.0  other_%logit_3.0 ._%logit_2.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  trials_%logit_0.0  are_%logit_2.0  needed_%logit_2.0  to_%logit_3.0  evaluate_%logit_1.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  antim_%logit_3.0 icro_%logit_3.0 b_%logit_2.0 ials_%logit_2.0  in_%logit_0.0  improving_%logit_1.0  CV_%logit_0.0 AD_%logit_0.0  functions_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  draw_%logit_2.0  conclusions_%logit_2.0  about_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  cognitive_%logit_3.0  behavioral_%logit_3.0  therapy_%logit_3.0  for_%logit_3.0  depression_%logit_1.0  in_%logit_3.0  the_%logit_3.0  primary_%logit_3.0  care_%logit_0.0  setting_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  cognitive_%logit_3.0  behavioural_%logit_3.0  therapy_%logit_0.0  in_%logit_3.0  depression_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  cognitive_%logit_2.0  behavioral_%logit_3.0  therapies_%logit_3.0  to_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  psychological_%logit_1.0  therapy_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  cognitive_%logit_3.0  behaviour_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  depressive_%logit_1.0  disorders_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  compare_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  cognitive_%logit_1.0  behavior_%logit_3.0  therapy_%logit_3.0  to_%logit_3.0  other_%logit_1.0  forms_%logit_3.0  of_%logit_3.0  mental_%logit_1.0  health_%logit_3.0  care_%logit_3.0 ,_%logit_3.0  including_%logit_3.0  psychological_%logit_3.0  therapies_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  other_%logit_1.0  psychological_%logit_3.0  therapies_%logit_3.0 ._%logit_3.0
 Ant_%logit_0.0 ib_%logit_0.0 iotic_%logit_2.0  pro_%logit_2.0 ph_%logit_3.0 yl_%logit_0.0 axis_%logit_0.0  is_%logit_2.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_3.0  the_%logit_3.0  incidence_%logit_0.0  of_%logit_0.0  per_%logit_0.0 ist_%logit_3.0 omal_%logit_0.0  infections_%logit_3.0  and_%logit_0.0  reducing_%logit_3.0  the_%logit_0.0  risk_%logit_0.0  of_%logit_3.0  death_%logit_0.0  and_%logit_3.0  infection_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  P_%logit_1.0 EG_%logit_3.0 ._%logit_1.0  Ant_%logit_1.0 ib_%logit_0.0 iotics_%logit_2.0  do_%logit_2.0  not_%logit_2.0  appear_%logit_3.0  to_%logit_2.0  have_%logit_1.0  a_%logit_2.0  significant_%logit_3.0  effect_%logit_2.0  on_%logit_2.0  mortality_%logit_2.0  or_%logit_0.0  infection_%logit_3.0 -_%logit_0.0 related_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  undergoing_%logit_3.0  P_%logit_1.0 EG_%logit_3.0  insertion_%logit_2.0 ._%logit_1.0  However_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotics_%logit_1.0  in_%logit_3.0  treating_%logit_3.0  P_%logit_0.0 EG_%logit_3.0  infections_%logit_1.0  and_%logit_3.0  the_%logit_3.0  risks_%logit_3.0  of_%logit_3.0  bacterial_%logit_1.0  contamination_%logit_3.0  in_%logit_3.0  the_%logit_3.0  early_%logit_0.0  post_%logit_0.0 -_%logit_3.0 trans_%logit_0.0 plant_%logit_0.0  period_%logit_1.0 ._%logit_2.0
 Cognitive_%logit_0.0  memory_%logit_0.0  training_%logit_3.0  appears_%logit_3.0  to_%logit_1.0  be_%logit_1.0  a_%logit_3.0  useful_%logit_3.0  adjunct_%logit_3.0  to_%logit_0.0  cognitive_%logit_0.0  memory_%logit_1.0  training_%logit_1.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  depressive_%logit_1.0  symptoms_%logit_3.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_1.0  it_%logit_0.0  is_%logit_1.0  not_%logit_2.0  clear_%logit_0.0  whether_%logit_2.0  it_%logit_3.0  is_%logit_1.0  a_%logit_1.0  worthwhile_%logit_3.0  adjunct_%logit_3.0  to_%logit_2.0  other_%logit_1.0  cognitive_%logit_1.0  rehabilitation_%logit_3.0  programmes_%logit_1.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  cognitive_%logit_1.0  memory_%logit_1.0 training_%logit_1.0  on_%logit_1.0  depressive_%logit_1.0  symptoms_%logit_3.0  in_%logit_3.0  people_%logit_1.0  with_%logit_3.0  depression_%logit_1.0  and_%logit_3.0  cognitive_%logit_3.0  impairment_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_1.0  on_%logit_2.0  cognitive_%logit_3.0  function_%logit_3.0  and_%logit_3.0  memory_%logit_3.0  training_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_0.0  cognitive_%logit_2.0  memory_%logit_3.0  rehabilitation_%logit_1.0  with_%logit_1.0  other_%logit_3.0  psychological_%logit_3.0  therapies_%logit_3.0 ,_%logit_1.0  including_%logit_1.0  cognitive_%logit_1.0  behavioural_%logit_1.0  rehabilitation_%logit_3.0  programmes_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  cognitive_%logit_1.0  behavioural_%logit_3.0  therapy_%logit_3.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_0.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  cognitive_%logit_1.0 -_%logit_1.0 memory_%logit_1.0  training_%logit_1.0  for_%logit_1.0  depression_%logit_1.0 ,_%logit_3.0  cognitive_%logit_3.0  impairment_%logit_3.0  and_%logit_3.0  memory_%logit_3.0  rehabilitation_%logit_3.0 ._%logit_3.0
 Sodium_%logit_0.0  restriction_%logit_1.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  blood_%logit_0.0  pressure_%logit_3.0  and_%logit_0.0  blood_%logit_3.0  pressure_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_3.0  hypertension_%logit_1.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_3.0  is_%logit_3.0  no_%logit_2.0  evidence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  mortality_%logit_3.0 ,_%logit_3.0  cardiovascular_%logit_3.0  morbid_%logit_3.0 ity_%logit_0.0  or_%logit_1.0  morbid_%logit_3.0 ity_%logit_3.0  between_%logit_0.0  sodium_%logit_3.0  restriction_%logit_3.0  and_%logit_3.0  sodium_%logit_3.0  restriction_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  between_%logit_3.0  sodium_%logit_3.0  and_%logit_3.0  potassium_%logit_3.0  restriction_%logit_3.0 ._%logit_3.0  Sodium_%logit_3.0  restriction_%logit_0.0  does_%logit_3.0  not_%logit_3.0  appear_%logit_3.0  to_%logit_3.0  have_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  impact_%logit_2.0  on_%logit_2.0  blood_%logit_2.0  pressure_%logit_3.0  or_%logit_0.0  blood_%logit_3.0  pressure_%logit_3.0 ,_%logit_0.0  but_%logit_3.0  may_%logit_3.0  have_%logit_3.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_0.0  cardiovascular_%logit_3.0  risk_%logit_3.0  factors_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  cardiovascular_%logit_3.0  disease_%logit_3.0  and_%logit_3.0  diabetes_%logit_3.0  mell_%logit_3.0 itus_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  on_%logit_3.0  mortality_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  defer_%logit_3.0 ox_%logit_3.0 amine_%logit_1.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  iron_%logit_3.0  overload_%logit_0.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_3.0  iron_%logit_0.0  overload_%logit_3.0 ._%logit_2.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_0.0 ,_%logit_0.0  duration_%logit_1.0  and_%logit_0.0  timing_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  the_%logit_3.0  best_%logit_3.0  way_%logit_0.0  to_%logit_3.0  deliver_%logit_1.0  defer_%logit_2.0 ox_%logit_3.0 amines_%logit_0.0  to_%logit_2.0  iron_%logit_0.0  overload_%logit_0.0  patients_%logit_2.0 ,_%logit_2.0  and_%logit_2.0  to_%logit_3.0  evaluate_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  other_%logit_1.0  iron_%logit_3.0  overload_%logit_3.0  conditions_%logit_2.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_1.0  the_%logit_2.0  optimal_%logit_3.0  dosage_%logit_3.0 ,_%logit_0.0  timing_%logit_1.0  and_%logit_3.0  duration_%logit_1.0 ,_%logit_0.0  the_%logit_1.0  best_%logit_1.0  dose_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  defer_%logit_1.0 oxide_%logit_3.0 amine_%logit_1.0  for_%logit_2.0  iron_%logit_3.0  overload_%logit_0.0  and_%logit_2.0  iron_%logit_1.0  overload_%logit_3.0  is_%logit_3.0  needed_%logit_3.0 ._%logit_1.0  The_%logit_2.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  should_%logit_2.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_0.0  caution_%logit_1.0 ,_%logit_3.0  as_%logit_2.0  the_%logit_3.0  conclusions_%logit_3.0  of_%logit_0.0  the_%logit_2.0  review_%logit_0.0  were_%logit_0.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_0.0  number_%logit_3.0  of_%logit_0.0  patients_%logit_0.0 ,_%logit_0.0  with_%logit_2.0  a_%logit_3.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  bias_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  prog_%logit_3.0 est_%logit_3.0 ogen_%logit_0.0  as_%logit_3.0  a_%logit_3.0  supplement_%logit_0.0  to_%logit_0.0  LH_%logit_0.0 H_%logit_3.0  in_%logit_1.0  IV_%logit_3.0 F_%logit_3.0  cycles_%logit_0.0 ._%logit_1.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_0.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  whether_%logit_2.0  prog_%logit_3.0 est_%logit_1.0 ogens_%logit_0.0  are_%logit_3.0  beneficial_%logit_1.0  or_%logit_3.0  harmful_%logit_3.0  for_%logit_0.0  LH_%logit_3.0 H_%logit_3.0  or_%logit_1.0  LH_%logit_3.0 H_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  pregnancy_%logit_1.0  rate_%logit_3.0  and_%logit_3.0  reproduction_%logit_3.0  rates_%logit_3.0  in_%logit_3.0  LH_%logit_1.0 H_%logit_0.0  and_%logit_1.0  LH_%logit_3.0 H_%logit_3.0  cycles_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_1.0 term_%logit_3.0  data_%logit_0.0  are_%logit_3.0  required_%logit_2.0  to_%logit_3.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  gon_%logit_1.0 ad_%logit_3.0 ot_%logit_2.0 roph_%logit_0.0 ins_%logit_1.0  on_%logit_2.0  pregnancy_%logit_3.0  rates_%logit_3.0  and_%logit_3.0  fertility_%logit_1.0  rates_%logit_3.0  in_%logit_3.0  RH_%logit_0.0 H_%logit_0.0  cycles_%logit_1.0 ,_%logit_3.0  and_%logit_2.0  also_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  LH_%logit_2.0 H_%logit_3.0  as_%logit_1.0  a_%logit_3.0  complement_%logit_3.0  to_%logit_1.0  LH_%logit_0.0 RH_%logit_3.0 ._%logit_1.0
 Weight_%logit_0.0  loss_%logit_3.0  is_%logit_0.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  weight_%logit_0.0  gain_%logit_3.0 ._%logit_3.0  Weight_%logit_3.0  loss_%logit_0.0  appears_%logit_1.0  to_%logit_3.0  be_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  an_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  depressive_%logit_1.0  symptoms_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  no_%logit_2.0  clear_%logit_3.0  evidence_%logit_3.0  of_%logit_3.0  an_%logit_3.0  effect_%logit_3.0  on_%logit_3.0  weight_%logit_3.0  loss_%logit_3.0  in_%logit_3.0  the_%logit_3.0  short_%logit_3.0 -_%logit_3.0 term_%logit_3.0  or_%logit_1.0  longer_%logit_3.0  term_%logit_3.0 ._%logit_3.0  Weight_%logit_3.0  gain_%logit_0.0  appears_%logit_3.0  to_%logit_3.0  have_%logit_3.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  depressive_%logit_3.0  symptoms_%logit_3.0  and_%logit_3.0  on_%logit_3.0  self_%logit_3.0 -_%logit_3.0 reported_%logit_1.0  depressive_%logit_1.0  symptoms_%logit_3.0 ._%logit_3.0  However_%logit_1.0 ,_%logit_0.0  weight_%logit_0.0  loss_%logit_3.0  is_%logit_3.0  not_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  issue_%logit_2.0  for_%logit_2.0  people_%logit_2.0  with_%logit_3.0  borderline_%logit_3.0  personality_%logit_3.0  disorder_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  there_%logit_3.0  is_%logit_3.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0  studies_%logit_2.0  to_%logit_2.0  evaluate_%logit_1.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  weight_%logit_1.0  loss_%logit_0.0  on_%logit_3.0  depressive_%logit_3.0  disorders_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  b_%logit_3.0 ron_%logit_3.0 ch_%logit_2.0 od_%logit_2.0 il_%logit_3.0 ator_%logit_2.0  in_%logit_2.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  P_%logit_3.0 IE_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  this_%logit_3.0  therapy_%logit_3.0  in_%logit_1.0  P_%logit_1.0 IE_%logit_0.0 ,_%logit_2.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  profile_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  terms_%logit_2.0  of_%logit_1.0  their_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_3.0  clinical_%logit_0.0  context_%logit_1.0  of_%logit_1.0  the_%logit_1.0  P_%logit_0.0 IE_%logit_0.0  treatment_%logit_1.0  group_%logit_2.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  B_%logit_1.0 ron_%logit_3.0 ch_%logit_1.0 oder_%logit_2.0  for_%logit_0.0  P_%logit_1.0 IE_%logit_0.0  and_%logit_1.0  its_%logit_2.0  safety_%logit_0.0  profile_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_2.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_0.0  these_%logit_2.0  drugs_%logit_3.0  to_%logit_3.0  each_%logit_3.0  other_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  bone_%logit_1.0  sc_%logit_3.0 int_%logit_3.0 igraph_%logit_3.0 y_%logit_1.0  for_%logit_2.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  L_%logit_1.0 BP_%logit_3.0 ._%logit_0.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  in_%logit_2.0  this_%logit_3.0  area_%logit_3.0 ,_%logit_0.0  particularly_%logit_2.0  in_%logit_2.0  the_%logit_1.0  areas_%logit_3.0  of_%logit_3.0  oste_%logit_0.0 op_%logit_3.0 or_%logit_3.0 osis_%logit_1.0 ,_%logit_0.0  bone_%logit_3.0  mineral_%logit_3.0 ization_%logit_3.0  and_%logit_3.0  bone_%logit_3.0  mineral_%logit_3.0 isation_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  in_%logit_2.0  areas_%logit_3.0  of_%logit_3.0  bone_%logit_1.0  mineral_%logit_3.0  density_%logit_3.0  and_%logit_3.0  thickness_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  in_%logit_3.0  areas_%logit_3.0  with_%logit_3.0  a_%logit_1.0  history_%logit_3.0  of_%logit_3.0  erosion_%logit_3.0  and_%logit_3.0  erosion_%logit_3.0 ._%logit_3.0  The_%logit_3.0  results_%logit_0.0  of_%logit_3.0  these_%logit_2.0  studies_%logit_0.0  should_%logit_2.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_0.0  caution_%logit_1.0 ,_%logit_3.0  as_%logit_2.0  they_%logit_2.0  are_%logit_3.0  based_%logit_2.0  on_%logit_0.0  only_%logit_0.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_3.0  patients_%logit_3.0  and_%logit_0.0  are_%logit_2.0  subject_%logit_2.0  to_%logit_0.0  a_%logit_0.0  high_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  bias_%logit_0.0 ._%logit_0.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_1.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  bone_%logit_1.0  scaff_%logit_1.0 olding_%logit_1.0  for_%logit_1.0  L_%logit_1.0 BP_%logit_3.0 ,_%logit_0.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  these_%logit_3.0  scaff_%logit_1.0 olding_%logit_1.0  devices_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  continuum_%logit_3.0  of_%logit_3.0  surviv_%logit_0.0 orship_%logit_3.0  after_%logit_1.0  lap_%logit_3.0 ar_%logit_3.0 otomy_%logit_0.0 ._%logit_3.0  Further_%logit_1.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  continuum_%logit_3.0  resusc_%logit_3.0 itation_%logit_3.0 ,_%logit_2.0  the_%logit_3.0  duration_%logit_3.0  of_%logit_3.0  survival_%logit_1.0 ,_%logit_1.0  and_%logit_3.0  the_%logit_3.0  extent_%logit_3.0  to_%logit_3.0  which_%logit_1.0  it_%logit_3.0  is_%logit_3.0  possible_%logit_1.0  to_%logit_1.0  achieve_%logit_1.0  this_%logit_1.0 ._%logit_1.0  Such_%logit_1.0  trials_%logit_0.0  are_%logit_1.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  continuum_%logit_3.0  survival_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  tests_%logit_0.0  are_%logit_1.0  also_%logit_2.0  required_%logit_0.0  to_%logit_0.0  assess_%logit_1.0  the_%logit_0.0  durability_%logit_3.0  of_%logit_3.0  the_%logit_3.0  continuum_%logit_3.0  of_%logit_1.0 Surv_%logit_1.0 ival_%logit_1.0 ._%logit_1.0  They_%logit_1.0  are_%logit_0.0  also_%logit_2.0  necessary_%logit_0.0  to_%logit_3.0  determine_%logit_0.0  whether_%logit_0.0  continuum_%logit_3.0  resusc_%logit_3.0 itative_%logit_0.0  techniques_%logit_2.0  are_%logit_1.0  more_%logit_1.0  or_%logit_3.0  less_%logit_1.0  effective_%logit_1.0  than_%logit_0.0  continuous_%logit_1.0  resusc_%logit_1.0 itation_%logit_1.0  techniques_%logit_1.0 ,_%logit_3.0  or_%logit_1.0  if_%logit_1.0  they_%logit_3.0  are_%logit_1.0  less_%logit_1.0  effective_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  pat_%logit_3.0 ency_%logit_3.0  and_%logit_0.0  limb_%logit_3.0  salvage_%logit_0.0  rates_%logit_3.0  between_%logit_3.0  the_%logit_3.0  two_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  bypass_%logit_1.0  graft_%logit_1.0 ing_%logit_1.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  technique_%logit_3.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_0.0  this_%logit_1.0  procedure_%logit_3.0 ,_%logit_1.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  different_%logit_3.0  techniques_%logit_3.0  of_%logit_3.0  graft_%logit_1.0 ing_%logit_1.0  and_%logit_1.0  plate_%logit_3.0 let_%logit_3.0  transf_%logit_3.0 usion_%logit_3.0 ,_%logit_2.0  and_%logit_3.0  also_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  different_%logit_2.0  types_%logit_3.0  of_%logit_3.0  graft_%logit_3.0 s_%logit_3.0  and_%logit_3.0  types_%logit_1.0  of_%logit_3.0  plate_%logit_2.0 let_%logit_3.0  inf_%logit_3.0 usion_%logit_0.0 ._%logit_2.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_0.0  assess_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  different_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  graft_%logit_1.0  clamp_%logit_3.0 ing_%logit_3.0 ,_%logit_3.0  a_%logit_3.0  meta_%logit_0.0 -_%logit_2.0 analysis_%logit_0.0  is_%logit_0.0  required_%logit_0.0  to_%logit_0.0  determine_%logit_2.0  whether_%logit_2.0  there_%logit_3.0  are_%logit_3.0  any_%logit_3.0  differences_%logit_3.0  in_%logit_3.0  mortality_%logit_3.0 ,_%logit_3.0  pat_%logit_3.0 ency_%logit_3.0  or_%logit_3.0  pat_%logit_3.0 ency_%logit_3.0  between_%logit_3.0  these_%logit_3.0  methods_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  n_%logit_3.0 if_%logit_3.0 ed_%logit_2.0 ip_%logit_1.0 ine_%logit_0.0  as_%logit_0.0  a_%logit_3.0  mon_%logit_3.0 otherapy_%logit_0.0  in_%logit_0.0  Kle_%logit_0.0 bs_%logit_3.0 ie_%logit_2.0 lla_%logit_2.0  pneumonia_%logit_2.0 ,_%logit_3.0  or_%logit_3.0  to_%logit_3.0  support_%logit_3.0  its_%logit_2.0  use_%logit_3.0  as_%logit_3.0  an_%logit_2.0  adj_%logit_3.0 u_%logit_0.0 vant_%logit_2.0  to_%logit_1.0  other_%logit_0.0  mon_%logit_3.0 otherapy_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_2.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  mon_%logit_1.0 otherapy_%logit_0.0 ,_%logit_0.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_3.0  mon_%logit_3.0 other_%logit_3.0 ap_%logit_2.0 ies_%logit_0.0 ,_%logit_0.0  such_%logit_2.0  as_%logit_3.0  oral_%logit_1.0  antibiotics_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  compare_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  mon_%logit_3.0 other_%logit_3.0 aps_%logit_2.0 ies_%logit_0.0  with_%logit_2.0  each_%logit_3.0  other_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  psych_%logit_1.0 os_%logit_3.0 ocial_%logit_0.0  interventions_%logit_0.0  for_%logit_3.0  retention_%logit_1.0  of_%logit_3.0  opioid_%logit_3.0  withdrawal_%logit_3.0  symptoms_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  interventions_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  these_%logit_1.0  approaches_%logit_3.0  in_%logit_1.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  withdrawal_%logit_1.0  symptoms_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_3.0  to_%logit_3.0  evaluate_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  psych_%logit_1.0 oses_%logit_3.0  for_%logit_1.0  retention_%logit_1.0  in_%logit_3.0  treatment_%logit_3.0 ._%logit_3.0  Recommend_%logit_3.0 ations_%logit_0.0  for_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_0.0  be_%logit_2.0  made_%logit_2.0  regarding_%logit_1.0  the_%logit_2.0  efficacy_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  psychological_%logit_3.0  therapies_%logit_1.0  for_%logit_3.0  withdrawal_%logit_1.0  symptoms_%logit_3.0  of_%logit_3.0  opioids_%logit_1.0  withdrawal_%logit_3.0  symptoms_%logit_3.0  and_%logit_3.0  for_%logit_1.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  retention_%logit_3.0  in_%logit_3.0  therapy_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  negative_%logit_3.0  feedback_%logit_3.0  loop_%logit_3.0  in_%logit_3.0  the_%logit_3.0  downward_%logit_3.0  direction_%logit_3.0  of_%logit_1.0  growth_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_1.0  whether_%logit_2.0  or_%logit_3.0  not_%logit_1.0  this_%logit_1.0  feedback_%logit_1.0  loop_%logit_3.0  has_%logit_1.0  a_%logit_3.0  negative_%logit_3.0  effect_%logit_3.0  on_%logit_1.0  growth_%logit_1.0  or_%logit_3.0  injury_%logit_3.0  rates_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  whether_%logit_3.0  it_%logit_3.0  has_%logit_3.0  a_%logit_3.0  positive_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  health_%logit_1.0  or_%logit_3.0  wellbeing_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  on_%logit_3.0  health_%logit_3.0 -_%logit_3.0 related_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  on_%logit_3.0  productivity_%logit_3.0 ,_%logit_3.0  productivity_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  quality_%logit_1.0 -_%logit_3.0 of_%logit_3.0 -_%logit_0.0 life_%logit_1.0 ._%logit_1.0  Future_%logit_0.0  research_%logit_0.0  should_%logit_0.0  focus_%logit_3.0  on_%logit_2.0  measuring_%logit_3.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  feedback_%logit_1.0  loop_%logit_3.0  feedback_%logit_3.0  on_%logit_3.0  health_%logit_3.0  and_%logit_3.0  wellbeing_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  on_%logit_2.0  productivity_%logit_3.0  and_%logit_3.0  wellbeing_%logit_3.0 ._%logit_3.0  Research_%logit_3.0  is_%logit_0.0  also_%logit_0.0  needed_%logit_0.0  to_%logit_0.0  assess_%logit_1.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  health_%logit_1.0 ,_%logit_3.0  wellbeing_%logit_3.0  and_%logit_3.0  social_%logit_3.0  functioning_%logit_3.0 ._%logit_3.0
 Functional_%logit_0.0  assessment_%logit_3.0  is_%logit_3.0  a_%logit_3.0  useful_%logit_3.0  tool_%logit_3.0  for_%logit_0.0  improving_%logit_0.0  functional_%logit_0.0  outcome_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  in_%logit_0.0  stroke_%logit_3.0  patients_%logit_0.0 ._%logit_0.0  However_%logit_1.0 ,_%logit_0.0  the_%logit_0.0  quality_%logit_1.0  of_%logit_3.0  the_%logit_3.0  evidence_%logit_0.0  is_%logit_0.0  low_%logit_3.0  and_%logit_1.0  there_%logit_2.0  is_%logit_3.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0  studies_%logit_2.0  to_%logit_2.0  evaluate_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  functional_%logit_1.0  assessment_%logit_1.0  and_%logit_1.0  social_%logit_3.0  support_%logit_0.0  services_%logit_1.0  for_%logit_1.0  stroke_%logit_1.0  patients_%logit_3.0  and_%logit_3.0  their_%logit_3.0  caregivers_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  functional_%logit_2.0  assessment_%logit_3.0  with_%logit_1.0  other_%logit_3.0  types_%logit_3.0  of_%logit_3.0  assessment_%logit_1.0  and_%logit_3.0  assessment_%logit_3.0 ._%logit_0.0  Future_%logit_3.0  research_%logit_0.0  should_%logit_0.0  focus_%logit_0.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  and_%logit_3.0  reliability_%logit_1.0  of_%logit_3.0  functional_%logit_3.0  assessments_%logit_1.0  and_%logit_1.0  assessing_%logit_1.0  functional_%logit_0.0  assessment_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  also_%logit_1.0  on_%logit_0.0  assessing_%logit_0.0  functional_%logit_3.0  outcome_%logit_3.0  measures_%logit_1.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_0.0  mobility_%logit_1.0  function_%logit_3.0 ,_%logit_3.0  balance_%logit_3.0 ,_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  LIFE_%logit_3.0 ,_%logit_0.0  and_%logit_1.0  health_%logit_3.0 -_%logit_3.0 related_%logit_0.0  quality_%logit_0.0  of_%logit_0.0  Life_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_1.0  specific_%logit_0.0  analges_%logit_3.0 ic_%logit_1.0  for_%logit_0.0  pain_%logit_3.0  relief_%logit_3.0  in_%logit_3.0  adults_%logit_3.0  with_%logit_3.0  severe_%logit_3.0  acute_%logit_3.0  pain_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_1.0  analges_%logit_3.0 ics_%logit_2.0 ,_%logit_2.0  including_%logit_1.0  oxy_%logit_3.0 toc_%logit_1.0 in_%logit_1.0 ,_%logit_0.0  ib_%logit_2.0 up_%logit_3.0 ro_%logit_1.0 fen_%logit_1.0 ,_%logit_1.0  nap_%logit_2.0 rox_%logit_1.0 en_%logit_1.0  and_%logit_1.0  ib_%logit_2.0 up_%logit_3.0 rot_%logit_2.0 roph_%logit_1.0 in_%logit_1.0 ,_%logit_1.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  other_%logit_1.0  analges_%logit_3.0 ics_%logit_3.0  on_%logit_2.0  pain_%logit_1.0  relief_%logit_3.0  and_%logit_1.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_0.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  pain_%logit_2.0  relief_%logit_3.0  for_%logit_3.0  adults_%logit_3.0  with_%logit_3.0  mild_%logit_1.0  to_%logit_1.0  moderate_%logit_3.0  acute_%logit_1.0  pain_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_1.0  compare_%logit_3.0  pain_%logit_2.0  relief_%logit_3.0  with_%logit_3.0  other_%logit_3.0  analges_%logit_3.0 ic_%logit_3.0  options_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_2.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  am_%logit_2.0 it_%logit_3.0 ript_%logit_0.0 y_%logit_0.0 line_%logit_0.0  mon_%logit_0.0 otherapy_%logit_3.0  for_%logit_2.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  pain_%logit_1.0  in_%logit_3.0  neuro_%logit_3.0 pathic_%logit_3.0  pain_%logit_3.0  or_%logit_3.0  fib_%logit_3.0 romy_%logit_3.0 algia_%logit_3.0 ,_%logit_1.0  or_%logit_3.0  to_%logit_3.0  recommend_%logit_3.0  its_%logit_2.0  use_%logit_3.0  as_%logit_3.0  an_%logit_2.0  adjunct_%logit_2.0  to_%logit_2.0  other_%logit_0.0  antidepressants_%logit_3.0  in_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_2.0  pain_%logit_3.0  relief_%logit_3.0  in_%logit_3.0  neuro_%logit_3.0 pathy_%logit_3.0 ._%logit_3.0  The_%logit_2.0  results_%logit_2.0  of_%logit_3.0  this_%logit_2.0  review_%logit_2.0  are_%logit_2.0  based_%logit_2.0  on_%logit_0.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  small_%logit_0.0  studies_%logit_0.0 ,_%logit_0.0  all_%logit_2.0  of_%logit_1.0  which_%logit_3.0  were_%logit_0.0  of_%logit_2.0  poor_%logit_0.0  quality_%logit_3.0 ,_%logit_1.0  and_%logit_2.0  are_%logit_2.0  subject_%logit_2.0  to_%logit_0.0  a_%logit_3.0  high_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  bias_%logit_0.0 ._%logit_0.0  There_%logit_2.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_1.0  studies_%logit_2.0  with_%logit_2.0  larger_%logit_2.0  sample_%logit_2.0  sizes_%logit_0.0  and_%logit_2.0  longer_%logit_2.0  follow_%logit_2.0 -_%logit_0.0 up_%logit_2.0  periods_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  am_%logit_1.0 it_%logit_3.0 osh_%logit_2.0 imon_%logit_3.0 os_%logit_2.0 ide_%logit_2.0  mon_%logit_3.0 otherapy_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  hal_%logit_3.0 oper_%logit_3.0 id_%logit_1.0 ol_%logit_0.0  as_%logit_0.0  an_%logit_3.0  adjunct_%logit_3.0  to_%logit_0.0  other_%logit_0.0  antip_%logit_3.0 sych_%logit_3.0 otic_%logit_3.0  drugs_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  epis_%logit_1.0 odic_%logit_3.0  psychotic_%logit_3.0  disorders_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  to_%logit_3.0  support_%logit_3.0  its_%logit_2.0  use_%logit_3.0  as_%logit_3.0  an_%logit_3.0  alternative_%logit_1.0  to_%logit_0.0  standard_%logit_0.0  antip_%logit_3.0 sych_%logit_3.0 otics_%logit_0.0  in_%logit_0.0  treating_%logit_3.0  epis_%logit_3.0 odic_%logit_3.0  psychosis_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  hal_%logit_1.0 per_%logit_3.0 id_%logit_1.0 ol_%logit_1.0 ,_%logit_0.0  the_%logit_1.0  optimal_%logit_3.0  dosage_%logit_0.0  and_%logit_3.0  timing_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  the_%logit_3.0  best_%logit_3.0  way_%logit_0.0  to_%logit_3.0  administer_%logit_1.0  it_%logit_2.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  trials_%logit_1.0  should_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  other_%logit_3.0  drugs_%logit_3.0  such_%logit_3.0  as_%logit_1.0  ib_%logit_1.0 up_%logit_1.0 ro_%logit_1.0 fen_%logit_1.0 ,_%logit_1.0  nap_%logit_2.0 rox_%logit_1.0 en_%logit_1.0 ,_%logit_1.0  ris_%logit_2.0 per_%logit_1.0 id_%logit_1.0 one_%logit_1.0 ,_%logit_1.0  ib_%logit_1.0 up_%logit_1.0 roph_%logit_1.0 yl_%logit_1.0 axis_%logit_1.0 ,_%logit_2.0  and_%logit_1.0  ib_%logit_1.0 up_%logit_3.0 rop_%logit_2.0 ub_%logit_1.0 ic_%logit_1.0  acid_%logit_2.0 ,_%logit_1.0  as_%logit_2.0  well_%logit_2.0  as_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  drugs_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  epis_%logit_3.0 odic_%logit_3.0  depressive_%logit_3.0  disorder_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  ip_%logit_3.0 rat_%logit_3.0 rop_%logit_1.0 ium_%logit_0.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  people_%logit_3.0  with_%logit_3.0  influenza_%logit_3.0  A_%logit_3.0 ,_%logit_3.0  nor_%logit_3.0  to_%logit_3.0  recommend_%logit_2.0  its_%logit_2.0  use_%logit_3.0  as_%logit_3.0  an_%logit_2.0  adjunct_%logit_0.0  to_%logit_0.0  other_%logit_0.0  antiv_%logit_3.0 iral_%logit_3.0  drugs_%logit_0.0 ._%logit_3.0  There_%logit_2.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0  randomized_%logit_2.0  controlled_%logit_2.0  trials_%logit_0.0  with_%logit_0.0  larger_%logit_2.0  sample_%logit_2.0  sizes_%logit_0.0  and_%logit_2.0  longer_%logit_2.0  follow_%logit_2.0 -_%logit_2.0 up_%logit_2.0  periods_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  IP_%logit_3.0 N_%logit_0.0  for_%logit_1.0  influenza_%logit_2.0  A_%logit_3.0  and_%logit_2.0  influenza_%logit_3.0  A_%logit_0.0  in_%logit_3.0  adults_%logit_3.0  and_%logit_3.0  children_%logit_2.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  IP_%logit_3.0 Ns_%logit_3.0  for_%logit_1.0  these_%logit_1.0  conditions_%logit_3.0 ._%logit_3.0  These_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  sufficient_%logit_0.0  size_%logit_2.0  to_%logit_0.0  compare_%logit_2.0  IP_%logit_2.0 Ns_%logit_3.0  with_%logit_1.0  placebo_%logit_1.0  or_%logit_3.0  no_%logit_3.0  treatment_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  retro_%logit_1.0 grade_%logit_1.0  u_%logit_1.0 reth_%logit_3.0 ral_%logit_1.0  cat_%logit_3.0 he_%logit_1.0 ters_%logit_3.0  for_%logit_3.0  post_%logit_1.0 operative_%logit_3.0  urinary_%logit_0.0  retention_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  cat_%logit_3.0 heter_%logit_1.0  type_%logit_1.0  and_%logit_1.0  timing_%logit_1.0  of_%logit_0.0  cat_%logit_1.0 heter_%logit_1.0  removal_%logit_3.0 ,_%logit_0.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  retro_%logit_1.0 grading_%logit_1.0  u_%logit_1.0 reth_%logit_3.0 rog_%logit_1.0 raph_%logit_3.0 y_%logit_2.0  with_%logit_1.0  retro_%logit_1.0 grade_%logit_3.0  U_%logit_1.0 reth_%logit_1.0 ral_%logit_1.0  Cat_%logit_0.0 he_%logit_1.0 ters_%logit_1.0  in_%logit_0.0  terms_%logit_1.0  of_%logit_3.0  bladder_%logit_0.0  empt_%logit_3.0 ying_%logit_0.0  rates_%logit_1.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_0.0  focus_%logit_3.0  on_%logit_2.0  determining_%logit_3.0  the_%logit_3.0  timing_%logit_3.0  and_%logit_3.0  duration_%logit_1.0  of_%logit_3.0  cat_%logit_0.0 he_%logit_0.0 ter_%logit_3.0  removal_%logit_3.0 ,_%logit_0.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  optimal_%logit_3.0  timing_%logit_3.0  and_%logit_0.0  frequency_%logit_1.0  of_%logit_0.0  rec_%logit_1.0 athe_%logit_0.0 ter_%logit_1.0 isation_%logit_2.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_3.0  use_%logit_3.0  of_%logit_0.0  HB_%logit_3.0 OT_%logit_0.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  people_%logit_1.0  with_%logit_3.0  acute_%logit_3.0  is_%logit_0.0 cha_%logit_0.0 emic_%logit_3.0  stroke_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  evaluate_%logit_2.0  HB_%logit_2.0 OT_%logit_3.0  for_%logit_1.0  acute_%logit_3.0  stroke_%logit_0.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_0.0  HB_%logit_2.0 OT_%logit_3.0  with_%logit_1.0  HB_%logit_3.0 OT_%logit_3.0 ,_%logit_1.0  HB_%logit_3.0 OT_%logit_3.0  alone_%logit_1.0  or_%logit_1.0  in_%logit_3.0  combination_%logit_1.0 ,_%logit_3.0  or_%logit_3.0  to_%logit_1.0  assess_%logit_3.0  its_%logit_2.0  effect_%logit_3.0  on_%logit_3.0  mortality_%logit_1.0 ,_%logit_3.0  cardiovascular_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  disability_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  an_%logit_3.0  acute_%logit_3.0  stroke_%logit_2.0 ._%logit_1.0  Such_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  assess_%logit_0.0  HB_%logit_2.0 OT_%logit_3.0  as_%logit_1.0  a_%logit_3.0  standalone_%logit_3.0  treatment_%logit_0.0  option_%logit_0.0 ,_%logit_0.0  as_%logit_0.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  HB_%logit_1.0 OTS_%logit_0.0  on_%logit_1.0  mortality_%logit_3.0  and_%logit_3.0  disability_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_1.0  of_%logit_3.0  e_%logit_3.0 os_%logit_1.0 in_%logit_0.0 oph_%logit_1.0 ils_%logit_0.0  for_%logit_0.0  IL_%logit_1.0 -_%logit_0.0 6_%logit_1.0  and_%logit_3.0  IL_%logit_1.0 -_%logit_0.0 7_%logit_1.0 ._%logit_1.0  However_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0  studies_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  these_%logit_3.0  agents_%logit_1.0  in_%logit_3.0  the_%logit_2.0  management_%logit_0.0  of_%logit_0.0  IL_%logit_3.0 -_%logit_1.0 8_%logit_1.0  and_%logit_1.0  IL_%logit_1.0 –_%logit_0.0 7_%logit_1.0 ._%logit_1.0  Such_%logit_1.0  studies_%logit_0.0  should_%logit_0.0  include_%logit_2.0  a_%logit_2.0  number_%logit_1.0  of_%logit_1.0  parameters_%logit_3.0 ,_%logit_3.0  including_%logit_0.0  the_%logit_1.0  duration_%logit_3.0  of_%logit_0.0  the_%logit_1.0  intervention_%logit_1.0 ,_%logit_1.0  the_%logit_1.0  number_%logit_1.0  of_%logit_3.0  patients_%logit_1.0  transferred_%logit_0.0  to_%logit_1.0  IC_%logit_0.0 U_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  duration_%logit_1.0  of_%logit_0.0  recovery_%logit_1.0 ._%logit_3.0  They_%logit_3.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effect_%logit_3.0  of_%logit_3.0  e_%logit_1.0 as_%logit_3.0 in_%logit_2.0 oph_%logit_1.0 ilic_%logit_0.0  agents_%logit_1.0  on_%logit_3.0  IL_%logit_1.0 -_%logit_0.0 10_%logit_1.0  and_%logit_1.0  I_%logit_1.0 PD_%logit_0.0 ,_%logit_1.0  and_%logit_1.0  on_%logit_1.0  the_%logit_0.0  incidence_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_1.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_1.0  of_%logit_3.0  serum_%logit_1.0  album_%logit_3.0 in_%logit_3.0  for_%logit_0.0  the_%logit_0.0  treatment_%logit_0.0  of_%logit_0.0  b_%logit_1.0 iliary_%logit_3.0  obstruction_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_1.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  album_%logit_3.0 in_%logit_3.0  in_%logit_1.0  this_%logit_3.0  setting_%logit_0.0 ._%logit_1.0  Such_%logit_2.0  trials_%logit_0.0  are_%logit_1.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  serum_%logit_1.0  albums_%logit_0.0 in_%logit_3.0  on_%logit_1.0  liver_%logit_3.0  function_%logit_1.0  and_%logit_1.0  liver_%logit_3.0  function_%logit_0.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_1.0  b_%logit_1.0 iliary_%logit_1.0  obstruct_%logit_1.0 ions_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  serum_%logit_3.0 album_%logit_3.0 in_%logit_3.0  with_%logit_1.0  placebo_%logit_3.0  or_%logit_3.0  no_%logit_3.0  treatment_%logit_1.0 ._%logit_0.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_1.0  efficacy_%logit_1.0  and_%logit_3.0  safety_%logit_1.0  profile_%logit_3.0  of_%logit_3.0  serum_%logit_1.0  Album_%logit_3.0 in_%logit_3.0  for_%logit_1.0  b_%logit_1.0 iliary_%logit_3.0  drainage_%logit_2.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  b_%logit_3.0 ile_%logit_3.0  acids_%logit_0.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  post_%logit_3.0 operative_%logit_3.0  b_%logit_0.0 act_%logit_3.0 ere_%logit_2.0 mia_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  b_%logit_3.0 ile_%logit_3.0  acid_%logit_1.0  solution_%logit_3.0  and_%logit_3.0  the_%logit_1.0  best_%logit_3.0  way_%logit_3.0  to_%logit_3.0  achieve_%logit_1.0  this_%logit_2.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  b_%logit_1.0 ure_%logit_3.0  acids_%logit_1.0  on_%logit_3.0  mortality_%logit_3.0 ,_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_3.0  patients_%logit_1.0  undergoing_%logit_1.0  b_%logit_1.0 ure_%logit_3.0 as_%logit_2.0 cial_%logit_3.0  surgery_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  evaluate_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_1.0  methods_%logit_3.0  of_%logit_3.0  b_%logit_1.0 iliary_%logit_3.0  drainage_%logit_1.0  in_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  these_%logit_3.0  conditions_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  mechanism_%logit_3.0  of_%logit_3.0  relaxation_%logit_3.0  of_%logit_3.0  the_%logit_3.0  hum_%logit_3.0 eral_%logit_3.0  fasc_%logit_1.0 ia_%logit_3.0 ._%logit_0.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  relaxation_%logit_3.0  techniques_%logit_3.0  in_%logit_1.0  the_%logit_1.0  management_%logit_3.0  of_%logit_3.0  hum_%logit_3.0 eral_%logit_3.0  folds_%logit_1.0  and_%logit_3.0  fasc_%logit_3.0 ia_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  relaxation_%logit_2.0  techniques_%logit_3.0  with_%logit_3.0  relaxation_%logit_1.0  techniques_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  relaxation_%logit_3.0  techniques_%logit_3.0 ,_%logit_3.0  strengthening_%logit_1.0  exercises_%logit_3.0  and_%logit_3.0  relaxation_%logit_1.0  techniques_%logit_3.0  for_%logit_3.0  relaxation_%logit_1.0  of_%logit_3.0  muscles_%logit_3.0  and_%logit_3.0  joints_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  strengthening_%logit_3.0  exercises_%logit_3.0  for_%logit_3.0  relaxation_%logit_1.0  and_%logit_3.0  flexibility_%logit_3.0  in_%logit_3.0  the_%logit_3.0  ham_%logit_3.0 ular_%logit_3.0  fasc_%logit_1.0 ia_%logit_3.0  in_%logit_2.0  the_%logit_1.0  hands_%logit_3.0  and_%logit_3.0  feet_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  EP_%logit_3.0 O_%logit_3.0  in_%logit_1.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_3.0  B_%logit_1.0 PD_%logit_3.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  EP_%logit_0.0 O_%logit_2.0  dose_%logit_1.0  and_%logit_0.0  duration_%logit_1.0 ,_%logit_0.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  EP_%logit_2.0 O_%logit_3.0  with_%logit_1.0  standard_%logit_3.0  oxygen_%logit_3.0  therapy_%logit_2.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  EP_%logit_3.0 O_%logit_0.0  does_%logit_1.0  not_%logit_1.0  appear_%logit_3.0  to_%logit_1.0  be_%logit_1.0  associated_%logit_1.0  with_%logit_0.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  the_%logit_0.0  incidence_%logit_3.0  of_%logit_3.0  P_%logit_1.0 EEP_%logit_3.0 ,_%logit_1.0  or_%logit_3.0  a_%logit_3.0  decrease_%logit_3.0  in_%logit_3.0  the_%logit_1.0  risk_%logit_3.0  of_%logit_3.0  death_%logit_1.0 ,_%logit_0.0  or_%logit_2.0  an_%logit_1.0  increase_%logit_3.0  in_%logit_0.0  the_%logit_1.0  occurrence_%logit_3.0  of_%logit_3.0  pneumonia_%logit_1.0 ,_%logit_3.0  or_%logit_3.0  both_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  intra_%logit_1.0 uter_%logit_3.0 ine_%logit_1.0  devices_%logit_0.0  for_%logit_3.0  the_%logit_1.0  prevention_%logit_3.0  of_%logit_3.0  unintended_%logit_3.0  pregnancies_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  reliability_%logit_1.0  of_%logit_3.0  intra_%logit_3.0 -_%logit_3.0 uter_%logit_1.0 ine_%logit_1.0  device_%logit_0.0  contraception_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  reliability_%logit_3.0  and_%logit_3.0  durability_%logit_3.0  of_%logit_3.0  these_%logit_3.0  interventions_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_0.0  conducted_%logit_0.0  and_%logit_2.0  reported_%logit_0.0  random_%logit_0.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  reliability_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_0.0  intra_%logit_2.0 -_%logit_3.0 per_%logit_1.0 itone_%logit_1.0 al_%logit_0.0  contraceptive_%logit_3.0  methods_%logit_3.0  and_%logit_3.0  timing_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  survival_%logit_3.0  rates_%logit_3.0  between_%logit_3.0  the_%logit_3.0  two_%logit_3.0  methods_%logit_3.0  of_%logit_1.0  survival_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  determine_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  these_%logit_3.0  methods_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  are_%logit_1.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  techniques_%logit_3.0  in_%logit_3.0  the_%logit_3.0  absence_%logit_0.0  of_%logit_3.0  a_%logit_3.0  differential_%logit_3.0  survival_%logit_3.0  rate_%logit_3.0 ._%logit_3.0  They_%logit_1.0  are_%logit_0.0  also_%logit_2.0  required_%logit_0.0  to_%logit_0.0  assess_%logit_1.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  various_%logit_1.0  types_%logit_3.0  of_%logit_3.0  radiation_%logit_3.0  therapy_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  ultraviolet_%logit_1.0  radiation_%logit_1.0  therapy_%logit_1.0  and_%logit_1.0  infrared_%logit_1.0  radiation_%logit_3.0  therapy_%logit_2.0 ._%logit_1.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  survival_%logit_1.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_0.0  life_%logit_3.0 ,_%logit_0.0  as_%logit_3.0  well_%logit_0.0  as_%logit_0.0  the_%logit_2.0  impact_%logit_0.0  on_%logit_3.0  quality_%logit_1.0  and_%logit_3.0  quantity_%logit_3.0  of_%logit_0.0  life_%logit_0.0 ._%logit_0.0  Finally_%logit_0.0 ,_%logit_0.0  they_%logit_0.0  should_%logit_1.0  evaluate_%logit_2.0  the_%logit_2.0  impact_%logit_3.0  of_%logit_3.0  the_%logit_1.0  various_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  radi_%logit_1.0 otherapy_%logit_3.0  on_%logit_0.0  survival_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  on_%logit_3.0  the_%logit_0.0  quality_%logit_0.0  of_%logit_3.0  the_%logit_3.0  life_%logit_0.0  of_%logit_0.0  survivors_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  per_%logit_3.0 iton_%logit_3.0 itis_%logit_0.0 ._%logit_1.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  the_%logit_0.0  incidence_%logit_3.0  and_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  infections_%logit_0.0 ,_%logit_0.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  antibiotic_%logit_2.0  therapy_%logit_3.0  with_%logit_3.0  other_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  antibiotic_%logit_0.0  treatment_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  high_%logit_0.0  methodological_%logit_0.0  quality_%logit_1.0 ,_%logit_3.0  with_%logit_2.0  a_%logit_2.0  focus_%logit_2.0  on_%logit_1.0  identifying_%logit_0.0  patients_%logit_3.0  who_%logit_3.0  will_%logit_3.0  benefit_%logit_2.0  from_%logit_0.0  antibiotic_%logit_3.0  therapy_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  comparing_%logit_3.0  antibiotic_%logit_0.0  therapy_%logit_3.0  to_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_3.0 ._%logit_3.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  compare_%logit_2.0  antibiotic_%logit_2.0  treatment_%logit_3.0  with_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_3.0  and_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  antibiotic_%logit_3.0  treatment_%logit_3.0  as_%logit_3.0  a_%logit_3.0  comparison_%logit_1.0  with_%logit_3.0  antibiotic_%logit_3.0  treatment_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  infection_%logit_3.0  rates_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 otherapy_%logit_3.0  for_%logit_0.0  anxiety_%logit_3.0  disorders_%logit_3.0  in_%logit_3.0  children_%logit_3.0  and_%logit_3.0  adolescents_%logit_3.0  with_%logit_0.0  anxiety_%logit_3.0  disorders_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  efficacy_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  psych_%logit_2.0 otherapy_%logit_3.0  with_%logit_0.0  other_%logit_3.0  psych_%logit_3.0 otherapy_%logit_3.0  options_%logit_0.0 ,_%logit_3.0  including_%logit_2.0  antidepressants_%logit_3.0 ,_%logit_3.0  antidepressants_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  antidepressants_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  determine_%logit_3.0  whether_%logit_2.0  psych_%logit_3.0 otherapy_%logit_3.0  is_%logit_0.0  more_%logit_1.0  effective_%logit_3.0  or_%logit_1.0  less_%logit_2.0  effective_%logit_1.0  than_%logit_1.0  placebo_%logit_2.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  evaluate_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  psychological_%logit_3.0  therapies_%logit_3.0  in_%logit_3.0  children_%logit_1.0  with_%logit_0.0  anxiety_%logit_2.0  disorder_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  also_%logit_3.0  assess_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  antidepressant_%logit_3.0  therapy_%logit_3.0 ._%logit_3.0
 The_%logit_0.0 ophy_%logit_0.0 ll_%logit_0.0 ine_%logit_0.0  has_%logit_0.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_0.0  sleep_%logit_1.0  quality_%logit_3.0  in_%logit_3.0  the_%logit_3.0  short_%logit_3.0 -_%logit_3.0 term_%logit_3.0  and_%logit_1.0  on_%logit_2.0  sleep_%logit_3.0  quantity_%logit_3.0  in_%logit_1.0  the_%logit_3.0  long_%logit_3.0 -_%logit_3.0 term_%logit_3.0 ._%logit_3.0  However_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0  studies_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  this_%logit_1.0  drug_%logit_3.0  on_%logit_3.0  sleep_%logit_2.0 iness_%logit_3.0 ,_%logit_1.0  sleep_%logit_3.0  quantity_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_3.0  chronic_%logit_1.0  asthma_%logit_3.0 ._%logit_0.0  Such_%logit_3.0  studies_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  sufficient_%logit_0.0  size_%logit_2.0  to_%logit_0.0  detect_%logit_2.0  clinically_%logit_2.0  important_%logit_3.0  differences_%logit_1.0  in_%logit_3.0  sleep_%logit_3.0  quality_%logit_3.0  and_%logit_3.0  sleep_%logit_3.0  quantity_%logit_3.0  between_%logit_3.0  the_%logit_3.0  various_%logit_3.0  classes_%logit_2.0  of_%logit_2.0  drugs_%logit_2.0 ._%logit_3.0  They_%logit_2.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effect_%logit_3.0  of_%logit_3.0  the_%logit_1.0  drug_%logit_3.0  on_%logit_2.0  symptoms_%logit_2.0  of_%logit_3.0  sleep_%logit_1.0 iness_%logit_3.0  and_%logit_3.0  sleep_%logit_3.0 iness_%logit_3.0  in_%logit_3.0  the_%logit_3.0  longer_%logit_3.0  term_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  any_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  survival_%logit_3.0  benefit_%logit_3.0  between_%logit_3.0  pro_%logit_3.0 ph_%logit_3.0 yl_%logit_2.0 actic_%logit_2.0  and_%logit_0.0  adj_%logit_3.0 u_%logit_1.0 vant_%logit_1.0  chem_%logit_1.0 op_%logit_0.0 roph_%logit_2.0 yl_%logit_1.0 actic_%logit_0.0  chemotherapy_%logit_2.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_0.0  metast_%logit_0.0 atic_%logit_3.0  T_%logit_1.0 oxicity_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  determine_%logit_1.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_2.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_0.0  chemotherapy_%logit_2.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  treatments_%logit_1.0  on_%logit_3.0  survival_%logit_1.0  and_%logit_0.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0  Such_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  chemotherapy_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  T_%logit_2.0 oxicity_%logit_0.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_0.0  the_%logit_2.0  impact_%logit_3.0  of_%logit_3.0  chemotherapy_%logit_1.0  on_%logit_3.0  quality_%logit_3.0  and_%logit_3.0  quantity_%logit_3.0  of_%logit_3.0  life_%logit_0.0  in_%logit_0.0  patients_%logit_0.0  who_%logit_1.0  are_%logit_1.0  deemed_%logit_2.0  to_%logit_2.0  be_%logit_0.0  at_%logit_2.0  high_%logit_0.0  risk_%logit_1.0  of_%logit_1.0  developing_%logit_1.0  T_%logit_3.0 oxicity_%logit_3.0  or_%logit_2.0  progression_%logit_1.0 -_%logit_1.0 free_%logit_1.0  survival_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  correlation_%logit_3.0  between_%logit_3.0  embryo_%logit_3.0  transfer_%logit_3.0  rates_%logit_3.0  and_%logit_3.0  live_%logit_3.0  birth_%logit_3.0  rate_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_3.0  the_%logit_2.0  best_%logit_3.0  way_%logit_3.0  to_%logit_3.0  integrate_%logit_1.0  embryo_%logit_2.0  transfer_%logit_3.0  into_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  live_%logit_1.0  birth_%logit_3.0  rates_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  embryo_%logit_2.0  transfer_%logit_3.0  with_%logit_3.0  other_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  embryo_%logit_1.0  retrieval_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  embryo_%logit_1.0  transfer_%logit_3.0  on_%logit_3.0  maternal_%logit_3.0  and_%logit_0.0  neon_%logit_3.0 atal_%logit_1.0  outcomes_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  impact_%logit_3.0  on_%logit_3.0  maternal_%logit_1.0  or_%logit_3.0  neon_%logit_3.0 atal_%logit_1.0  wellbeing_%logit_0.0  and_%logit_3.0  on_%logit_3.0  maternal_%logit_3.0  outcomes_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  oral_%logit_3.0  cort_%logit_3.0 ic_%logit_3.0 oster_%logit_0.0 oids_%logit_0.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  G_%logit_1.0 d_%logit_3.0 -_%logit_2.0 enh_%logit_0.0 ancing_%logit_3.0  lesions_%logit_2.0  in_%logit_3.0  adults_%logit_3.0  with_%logit_3.0  MS_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  cort_%logit_3.0 ic_%logit_3.0 ost_%logit_0.0 oster_%logit_0.0 oids_%logit_1.0  in_%logit_0.0  this_%logit_1.0  population_%logit_3.0 ,_%logit_0.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  G_%logit_3.0 D_%logit_3.0 -_%logit_1.0 enh_%logit_3.0 anced_%logit_2.0  lesions_%logit_1.0  with_%logit_3.0  placebo_%logit_1.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  these_%logit_3.0  medications_%logit_3.0  in_%logit_3.0  the_%logit_2.0  maintenance_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  MS_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  protective_%logit_3.0  mechanism_%logit_3.0  for_%logit_3.0  pancreat_%logit_3.0 ic_%logit_3.0  fist_%logit_0.0 ula_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  this_%logit_3.0  intervention_%logit_3.0 ._%logit_3.0  Such_%logit_1.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_3.0  interventions_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  intra_%logit_1.0 -_%logit_3.0 arter_%logit_1.0 ial_%logit_1.0  drainage_%logit_0.0  drainage_%logit_1.0  drainage_%logit_3.0 ,_%logit_3.0  intra_%logit_1.0 -_%logit_1.0 vag_%logit_1.0 inal_%logit_1.0  drainage_%logit_0.0  drainage_%logit_0.0  and_%logit_3.0  intraven_%logit_1.0 ous_%logit_3.0  hyd_%logit_0.0 ration_%logit_0.0  drainage_%logit_3.0  drainage_%logit_1.0 ._%logit_3.0  These_%logit_1.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  sufficient_%logit_0.0  size_%logit_0.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_3.0  and_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_3.0  interventions_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_1.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  these_%logit_2.0  interventions_%logit_3.0  to_%logit_3.0  each_%logit_1.0  other_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  them_%logit_2.0  with_%logit_3.0  each_%logit_3.0  other_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  gluc_%logit_3.0 agon_%logit_3.0  as_%logit_3.0  an_%logit_3.0  adjunct_%logit_0.0  to_%logit_0.0  insulin_%logit_0.0  therapy_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  type_%logit_1.0  2_%logit_3.0  diabetes_%logit_0.0  mell_%logit_3.0 itus_%logit_3.0 ._%logit_1.0  However_%logit_3.0 ,_%logit_2.0  gluc_%logit_3.0 agon_%logit_3.0  appears_%logit_0.0  to_%logit_2.0  have_%logit_3.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  gly_%logit_2.0 ca_%logit_3.0 emic_%logit_3.0  control_%logit_3.0  in_%logit_3.0  the_%logit_3.0  short_%logit_3.0 -_%logit_3.0 term_%logit_3.0 ._%logit_1.0  Its_%logit_2.0  use_%logit_0.0  is_%logit_3.0  associated_%logit_2.0  with_%logit_0.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  LDL_%logit_0.0 -_%logit_3.0 ch_%logit_3.0 olesterol_%logit_0.0  and_%logit_3.0  a_%logit_3.0  decrease_%logit_3.0  in_%logit_3.0  triglycer_%logit_1.0 ide_%logit_3.0  levels_%logit_0.0 ._%logit_3.0  It_%logit_3.0  is_%logit_2.0  not_%logit_2.0  clear_%logit_3.0  whether_%logit_2.0  gluc_%logit_3.0 agon_%logit_3.0  has_%logit_3.0  an_%logit_0.0  effect_%logit_3.0  on_%logit_2.0  blood_%logit_2.0  pressure_%logit_3.0  or_%logit_0.0  blood_%logit_3.0  sugar_%logit_3.0  levels_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  gluc_%logit_3.0 agon_%logit_3.0  should_%logit_3.0  be_%logit_2.0  considered_%logit_2.0  for_%logit_3.0  those_%logit_3.0  patients_%logit_3.0  who_%logit_3.0  do_%logit_2.0  not_%logit_2.0  respond_%logit_3.0  to_%logit_2.0  gluc_%logit_3.0 agon_%logit_3.0  therapy_%logit_3.0  or_%logit_3.0  insulin_%logit_2.0  therapy_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_1.0  safety_%logit_1.0  training_%logit_1.0  in_%logit_1.0  the_%logit_1.0  management_%logit_0.0  of_%logit_0.0  accidents_%logit_1.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_1.0  needed_%logit_1.0  to_%logit_1.0  identify_%logit_1.0  the_%logit_2.0  most_%logit_3.0  effective_%logit_3.0  safety_%logit_1.0  training_%logit_1.0  exercises_%logit_1.0  and_%logit_1.0  the_%logit_1.0  best_%logit_0.0  way_%logit_1.0  to_%logit_1.0  improve_%logit_1.0  safety_%logit_1.0  training_%logit_1.0 ._%logit_3.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_1.0  by_%logit_3.0  which_%logit_3.0  safety_%logit_1.0  training_%logit_1.0  works_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_1.0  safety_%logit_2.0  training_%logit_1.0  with_%logit_1.0  other_%logit_3.0  training_%logit_1.0  programmes_%logit_1.0 ._%logit_1.0  Future_%logit_1.0  research_%logit_0.0  should_%logit_0.0  focus_%logit_0.0  on_%logit_2.0  measuring_%logit_3.0  safety_%logit_1.0  training_%logit_3.0  effectiveness_%logit_3.0  and_%logit_1.0  reliability_%logit_1.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_0.0  as_%logit_1.0  assessing_%logit_2.0  the_%logit_0.0  effects_%logit_3.0  of_%logit_3.0  training_%logit_1.0  on_%logit_1.0  accidents_%logit_1.0  and_%logit_3.0  injury_%logit_1.0  rates_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  epid_%logit_1.0 ural_%logit_3.0  analges_%logit_1.0 ia_%logit_3.0  for_%logit_0.0  pain_%logit_1.0  relief_%logit_3.0  in_%logit_0.0  low_%logit_1.0 -_%logit_3.0 back_%logit_0.0  pain_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  epid_%logit_3.0 ur_%logit_1.0 als_%logit_2.0  in_%logit_0.0  low_%logit_1.0  back_%logit_3.0  pain_%logit_0.0 ._%logit_1.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_0.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  executed_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  opioid_%logit_3.0  analges_%logit_1.0 ia_%logit_3.0  in_%logit_0.0  this_%logit_1.0  condition_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0  there_%logit_0.0  is_%logit_0.0  an_%logit_2.0  urgent_%logit_1.0  need_%logit_0.0  for_%logit_0.0  an_%logit_1.0  assessment_%logit_1.0  of_%logit_0.0  the_%logit_1.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_3.0  effectiveness_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  to_%logit_3.0  other_%logit_1.0  analges_%logit_3.0 ia_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_1.0  of_%logit_3.0  e_%logit_1.0 ch_%logit_1.0 oc_%logit_0.0 ardi_%logit_3.0 ography_%logit_0.0  for_%logit_1.0  ap_%logit_3.0 nea_%logit_3.0 ._%logit_2.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  evaluate_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  e_%logit_1.0 ich_%logit_1.0 oc_%logit_1.0 ardi_%logit_1.0 ographic_%logit_0.0  techniques_%logit_2.0  in_%logit_3.0  ap_%logit_1.0 nea_%logit_3.0  and_%logit_1.0  br_%logit_1.0 ady_%logit_3.0 card_%logit_2.0 ia_%logit_2.0 ,_%logit_2.0  and_%logit_3.0  to_%logit_3.0  determine_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  techniques_%logit_3.0  in_%logit_1.0  the_%logit_2.0  management_%logit_3.0  of_%logit_0.0  ap_%logit_1.0 nea_%logit_3.0  in_%logit_1.0  the_%logit_1.0  long_%logit_3.0  term_%logit_3.0 ._%logit_3.0  Such_%logit_2.0  trials_%logit_0.0  are_%logit_1.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  assess_%logit_1.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  the_%logit_1.0  various_%logit_3.0  methods_%logit_1.0  of_%logit_1.0  electro_%logit_1.0 ch_%logit_3.0 olin_%logit_1.0 erg_%logit_1.0 ics_%logit_1.0  in_%logit_1.0  ap_%logit_1.0 ne_%logit_3.0 as_%logit_2.0 ,_%logit_1.0  as_%logit_3.0  well_%logit_3.0  as_%logit_1.0  to_%logit_2.0  assess_%logit_3.0  their_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_1.0  longer_%logit_3.0  term_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  sub_%logit_3.0 group_%logit_3.0  of_%logit_1.0  people_%logit_0.0  with_%logit_3.0  dementia_%logit_3.0  who_%logit_3.0  are_%logit_3.0  at_%logit_3.0  high_%logit_3.0  risk_%logit_1.0  of_%logit_1.0  developing_%logit_3.0  dementia_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  sub_%logit_3.0 group_%logit_3.0  therapy_%logit_2.0  in_%logit_0.0  dementia_%logit_1.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  what_%logit_2.0  types_%logit_3.0  of_%logit_3.0  people_%logit_0.0  are_%logit_0.0  most_%logit_3.0  likely_%logit_0.0  to_%logit_1.0  benefit_%logit_0.0  from_%logit_1.0  it_%logit_3.0 ._%logit_3.0  It_%logit_2.0  is_%logit_0.0  also_%logit_2.0  important_%logit_3.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  nature_%logit_3.0  of_%logit_3.0  dementia_%logit_3.0  and_%logit_3.0  the_%logit_3.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  it_%logit_0.0  relates_%logit_3.0  to_%logit_3.0  dementia_%logit_3.0  and_%logit_3.0  dementia_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  identify_%logit_3.0  the_%logit_2.0  type_%logit_3.0  of_%logit_3.0  dementia_%logit_3.0  that_%logit_3.0  may_%logit_3.0  be_%logit_3.0  most_%logit_3.0  useful_%logit_0.0  in_%logit_1.0  dementia_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  draw_%logit_2.0  conclusions_%logit_2.0  about_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 os_%logit_3.0 ocial_%logit_0.0  interventions_%logit_0.0  for_%logit_0.0  quitting_%logit_1.0  smoking_%logit_3.0 ._%logit_3.0  Recommend_%logit_3.0 ations_%logit_0.0  for_%logit_0.0  future_%logit_2.0  research_%logit_0.0  include_%logit_2.0 :_%logit_2.0  (_%logit_1.0 1_%logit_2.0 )_%logit_0.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  nicotine_%logit_1.0  gum_%logit_3.0 ,_%logit_1.0  (_%logit_2.0 2_%logit_1.0 )_%logit_2.0  the_%logit_0.0  introduction_%logit_3.0  of_%logit_3.0  nicotine_%logit_1.0  replacement_%logit_3.0  therapy_%logit_3.0 ,_%logit_3.0  and_%logit_0.0  (_%logit_1.0 3_%logit_0.0 )_%logit_2.0  the_%logit_2.0  initiation_%logit_3.0  of_%logit_3.0  a_%logit_2.0  nicotine_%logit_3.0  replacement_%logit_3.0  drug_%logit_0.0  (_%logit_1.0 N_%logit_2.0 RT_%logit_2.0 )._%logit_2.0  (_%logit_0.0 4_%logit_0.0 )_%logit_2.0  The_%logit_0.0  introduction_%logit_1.0  of_%logit_3.0  an_%logit_2.0  electronic_%logit_3.0  nicotine_%logit_0.0  replacement_%logit_0.0  product_%logit_0.0 ,_%logit_0.0  (_%logit_2.0 5_%logit_0.0 )_%logit_1.0  the_%logit_2.0  application_%logit_2.0  of_%logit_3.0  a_%logit_1.0  benz_%logit_3.0 od_%logit_3.0 iazep_%logit_2.0 ine_%logit_2.0  or_%logit_0.0  nicotine_%logit_0.0  gum_%logit_0.0  tablet_%logit_2.0 ,_%logit_2.0  and_%logit_2.0 (_%logit_2.0 6_%logit_2.0 )_%logit_2.0  the_%logit_2.0  insertion_%logit_2.0  of_%logit_3.0  an_%logit_1.0  N_%logit_3.0 RT_%logit_2.0  device_%logit_1.0 ._%logit_0.0  (_%logit_2.0 7_%logit_0.0 )_%logit_2.0  The_%logit_0.0  application_%logit_0.0  of_%logit_3.0  an_%logit_1.0  antidepressant_%logit_3.0  or_%logit_2.0  nicotine_%logit_0.0  replacement_%logit_1.0  medication_%logit_0.0  to_%logit_1.0  a_%logit_2.0  patient_%logit_0.0  or_%logit_1.0  careg_%logit_2.0 iver_%logit_1.0 ,_%logit_0.0  (_%logit_0.0 8_%logit_1.0 )_%logit_0.0  the_%logit_0.0  addition_%logit_3.0  of_%logit_3.0  an_%logit_1.0  e_%logit_3.0 -_%logit_0.0 cigarette_%logit_0.0  to_%logit_0.0  an_%logit_0.0  antidepressant_%logit_0.0 ;_%logit_0.0  (_%logit_2.0 9_%logit_3.0 )_%logit_0.0  the_%logit_0.0  provision_%logit_3.0  of_%logit_3.0  an_%logit_3.0  oral_%logit_3.0  nicotine_%logit_0.0  replacement_%logit_0.0  device_%logit_0.0 ,_%logit_1.0  (_%logit_2.0 10_%logit_3.0 )_%logit_0.0  a_%logit_0.0  nicotine_%logit_3.0  substitution_%logit_3.0  machine_%logit_2.0 ,_%logit_2.0  and_%logit_2.0  an_%logit_3.0  electronic_%logit_2.0  questionnaire_%logit_0.0  (_%logit_0.0 10_%logit_2.0 )._%logit_0.0  The_%logit_2.0  application_%logit_0.0  process_%logit_0.0  of_%logit_1.0  these_%logit_1.0  interventions_%logit_3.0  is_%logit_2.0  more_%logit_1.0  intensive_%logit_3.0  than_%logit_1.0  that_%logit_2.0  of_%logit_1.0  a_%logit_1.0  written_%logit_3.0  questionnaire_%logit_1.0 ._%logit_0.0
 Vitamin_%logit_0.0  E_%logit_0.0  supplementation_%logit_0.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_0.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  the_%logit_0.0  incidence_%logit_3.0  of_%logit_3.0  all_%logit_0.0 -_%logit_3.0 cause_%logit_3.0  mortality_%logit_0.0  and_%logit_0.0  cardiovascular_%logit_3.0  disease_%logit_3.0 ._%logit_3.0  Vitamin_%logit_3.0  E_%logit_0.0  supplements_%logit_2.0  are_%logit_3.0  associated_%logit_3.0  with_%logit_0.0  an_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  the_%logit_0.0  number_%logit_3.0  of_%logit_3.0  cases_%logit_0.0  of_%logit_0.0  adverse_%logit_0.0  events_%logit_0.0 ,_%logit_3.0  including_%logit_1.0  cardiac_%logit_3.0  arrest_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  a_%logit_3.0  decrease_%logit_3.0  in_%logit_3.0  the_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  stroke_%logit_0.0 ,_%logit_3.0  but_%logit_2.0  no_%logit_3.0  significant_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  total_%logit_3.0  deaths_%logit_3.0  or_%logit_0.0  hospital_%logit_1.0 izations_%logit_3.0 ._%logit_0.0  Vitamin_%logit_2.0  A_%logit_0.0  supplements_%logit_2.0  do_%logit_3.0  not_%logit_3.0  appear_%logit_3.0  to_%logit_2.0  have_%logit_1.0  a_%logit_2.0  significant_%logit_3.0  impact_%logit_2.0  on_%logit_2.0  mortality_%logit_2.0  or_%logit_3.0  cardiovascular_%logit_3.0  disease_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  may_%logit_3.0  have_%logit_3.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_2.0  on_%logit_0.0  the_%logit_1.0  incidence_%logit_3.0  and_%logit_3.0  severity_%logit_3.0  of_%logit_0.0  these_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ._%logit_3.0  Vit_%logit_2.0 amins_%logit_0.0  E_%logit_0.0  and_%logit_0.0  zinc_%logit_3.0  supplement_%logit_3.0 ing_%logit_0.0  supplements_%logit_3.0  may_%logit_3.0  reduce_%logit_1.0  mortality_%logit_2.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  further_%logit_3.0  research_%logit_3.0  is_%logit_2.0  needed_%logit_2.0  to_%logit_3.0  confirm_%logit_2.0  this_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 otherapy_%logit_3.0  for_%logit_0.0  t_%logit_3.0 ic_%logit_3.0 l_%logit_2.0 op_%logit_1.0 idine_%logit_1.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  ADHD_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  psych_%logit_3.0 otherapy_%logit_3.0  is_%logit_0.0  beneficial_%logit_1.0  or_%logit_3.0  harmful_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  what_%logit_3.0  dose_%logit_3.0 ,_%logit_0.0  duration_%logit_1.0  and_%logit_1.0  intensity_%logit_1.0  of_%logit_3.0  therapy_%logit_3.0  is_%logit_3.0  most_%logit_1.0  effective_%logit_1.0  in_%logit_1.0  reducing_%logit_2.0  the_%logit_3.0  severity_%logit_0.0  of_%logit_3.0  the_%logit_3.0  symptoms_%logit_0.0  of_%logit_3.0  ADHD_%logit_1.0  and_%logit_3.0  its_%logit_1.0  t_%logit_3.0 ic_%logit_3.0 -_%logit_3.0 related_%logit_2.0  symptoms_%logit_1.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  psychological_%logit_3.0  therapies_%logit_3.0  for_%logit_3.0  ADHD_%logit_1.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  psych_%logit_2.0 otherapy_%logit_3.0  with_%logit_0.0  other_%logit_3.0  treatments_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  creatine_%logit_3.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  ps_%logit_1.0 or_%logit_3.0 iasis_%logit_1.0  or_%logit_2.0  ps_%logit_3.0 ori_%logit_3.0 atic_%logit_1.0  arthritis_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  creatine_%logit_3.0  has_%logit_3.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_2.0  on_%logit_2.0  quality_%logit_2.0  of_%logit_1.0  life_%logit_3.0 ,_%logit_0.0  pain_%logit_3.0  and_%logit_3.0  function_%logit_1.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  these_%logit_1.0  conditions_%logit_1.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  creatine_%logit_2.0  with_%logit_3.0  placebo_%logit_3.0  or_%logit_3.0  no_%logit_3.0  treatment_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  whether_%logit_2.0  creatine_%logit_3.0  is_%logit_3.0  more_%logit_3.0  effective_%logit_3.0  than_%logit_3.0  placebo_%logit_2.0  or_%logit_3.0  placebo_%logit_3.0  in_%logit_3.0  reducing_%logit_3.0  pain_%logit_3.0  and_%logit_3.0  stiffness_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  who_%logit_3.0  are_%logit_2.0  unable_%logit_2.0  to_%logit_2.0  tolerate_%logit_3.0  creatine_%logit_2.0  or_%logit_3.0  its_%logit_3.0  analog_%logit_3.0 ues_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  long_%logit_2.0 -_%logit_2.0 term_%logit_2.0  data_%logit_2.0  are_%logit_2.0  needed_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  creatine_%logit_3.0  on_%logit_3.0  pain_%logit_3.0 ,_%logit_3.0  stiffness_%logit_3.0  and_%logit_3.0  function_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  iron_%logit_3.0  supplements_%logit_1.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  iron_%logit_3.0  deficiency_%logit_3.0  ana_%logit_2.0 emia_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  iron_%logit_3.0  supplements_%logit_1.0  are_%logit_0.0  beneficial_%logit_0.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_0.0  this_%logit_3.0  condition_%logit_0.0 ,_%logit_1.0  and_%logit_2.0  whether_%logit_3.0  iron_%logit_3.0  supplementation_%logit_3.0  is_%logit_2.0  beneficial_%logit_3.0  in_%logit_0.0  the_%logit_2.0  management_%logit_3.0  of_%logit_3.0  this_%logit_1.0  condition_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  iron_%logit_1.0  supplementation_%logit_3.0  on_%logit_2.0  iron_%logit_3.0  deficient_%logit_3.0  ana_%logit_2.0 emia_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  iron_%logit_2.0  supplementation_%logit_3.0  with_%logit_2.0  other_%logit_3.0  iron_%logit_3.0  supplements_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_1.0 term_%logit_2.0  data_%logit_1.0  are_%logit_2.0  needed_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  iron_%logit_3.0  supplement_%logit_1.0 ing_%logit_2.0  iron_%logit_2.0  supplements_%logit_0.0  for_%logit_2.0  iron_%logit_1.0  deficiencies_%logit_3.0  in_%logit_2.0  ana_%logit_3.0 emia_%logit_3.0  patients_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ib_%logit_3.0 up_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  for_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  acute_%logit_1.0  migraine_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  to_%logit_3.0  support_%logit_3.0  its_%logit_2.0  use_%logit_3.0  as_%logit_3.0  an_%logit_2.0  adjunct_%logit_1.0  to_%logit_0.0  other_%logit_0.0  anti_%logit_3.0 -_%logit_3.0 m_%logit_3.0 ig_%logit_1.0 raine_%logit_2.0  drugs_%logit_0.0 ,_%logit_3.0  or_%logit_2.0  as_%logit_2.0  an_%logit_2.0  adj_%logit_2.0 u_%logit_0.0 vant_%logit_2.0  to_%logit_1.0  other_%logit_0.0  treatments_%logit_3.0 ._%logit_3.0  Further_%logit_2.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_1.0  and_%logit_2.0  duration_%logit_1.0 ,_%logit_2.0  and_%logit_2.0  the_%logit_3.0  best_%logit_3.0  dose_%logit_3.0  to_%logit_2.0  use_%logit_1.0 ,_%logit_2.0  and_%logit_1.0  to_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_2.0  acute_%logit_2.0  migraine_%logit_0.0 ._%logit_0.0  Recommend_%logit_2.0 ations_%logit_0.0  for_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  be_%logit_2.0  made_%logit_2.0  in_%logit_1.0  light_%logit_2.0  of_%logit_0.0  the_%logit_0.0  increasing_%logit_3.0  prevalence_%logit_3.0  of_%logit_3.0  migraine_%logit_3.0 ,_%logit_3.0  the_%logit_3.0  increasing_%logit_3.0  frequency_%logit_3.0  of_%logit_3.0  adverse_%logit_1.0  events_%logit_3.0  and_%logit_3.0  the_%logit_1.0  increasing_%logit_3.0  number_%logit_3.0  of_%logit_3.0  patients_%logit_0.0  suffering_%logit_0.0  from_%logit_0.0  adverse_%logit_1.0  events_%logit_3.0 ._%logit_3.0
 The_%logit_0.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  support_%logit_2.0  the_%logit_2.0  use_%logit_1.0  of_%logit_3.0  aerobic_%logit_1.0  exercise_%logit_1.0  as_%logit_1.0  an_%logit_3.0  adjunct_%logit_0.0  to_%logit_0.0  conventional_%logit_0.0  physical_%logit_1.0  activity_%logit_1.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_1.0  the_%logit_3.0  results_%logit_3.0  are_%logit_3.0  based_%logit_2.0  on_%logit_0.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  small_%logit_1.0  studies_%logit_3.0 ,_%logit_0.0  all_%logit_1.0  of_%logit_1.0  which_%logit_3.0  were_%logit_3.0  conducted_%logit_1.0  in_%logit_1.0  the_%logit_3.0  1990_%logit_3.0 s_%logit_3.0  and_%logit_2.0  2000_%logit_2.0 s_%logit_3.0 ,_%logit_2.0  and_%logit_2.0  the_%logit_3.0  results_%logit_3.0  of_%logit_3.0  these_%logit_3.0  studies_%logit_3.0  are_%logit_2.0  still_%logit_2.0  the_%logit_3.0  same_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  aerobic_%logit_3.0  exercise_%logit_1.0  is_%logit_1.0  more_%logit_1.0  effective_%logit_1.0  than_%logit_1.0  manual_%logit_1.0  exercise_%logit_1.0  as_%logit_3.0  a_%logit_3.0  supplement_%logit_1.0  to_%logit_1.0  physical_%logit_0.0  activity_%logit_3.0  or_%logit_3.0  as_%logit_3.0  a_%logit_3.0  substitute_%logit_1.0  for_%logit_1.0  aerobic_%logit_0.0  exercise_%logit_1.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  bone_%logit_3.0  mineral_%logit_3.0  density_%logit_3.0  and_%logit_3.0  muscle_%logit_3.0  strength_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  aerobic_%logit_2.0  exercise_%logit_3.0  with_%logit_3.0  manual_%logit_3.0  exercise_%logit_1.0 ._%logit_3.0
 Coun_%logit_0.0 selling_%logit_0.0  attendance_%logit_1.0  appears_%logit_3.0  to_%logit_3.0  have_%logit_1.0  a_%logit_3.0  positive_%logit_3.0  effect_%logit_3.0  on_%logit_0.0  retention_%logit_3.0  of_%logit_3.0  abstinence_%logit_3.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_0.0  it_%logit_3.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0  whether_%logit_2.0  it_%logit_3.0  has_%logit_3.0  an_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  relapse_%logit_2.0  or_%logit_3.0  relapse_%logit_3.0  rates_%logit_3.0 ,_%logit_3.0  or_%logit_1.0  on_%logit_3.0  relapse_%logit_3.0  rates_%logit_3.0  or_%logit_3.0  relapse_%logit_1.0  rate_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  whether_%logit_3.0  coun_%logit_3.0 selling_%logit_3.0  attendance_%logit_1.0  has_%logit_3.0  a_%logit_3.0  negative_%logit_3.0  impact_%logit_2.0  on_%logit_2.0  relapse_%logit_2.0  rate_%logit_3.0  and_%logit_3.0  relapse_%logit_3.0  rates_%logit_3.0 ._%logit_3.0  The_%logit_3.0  results_%logit_0.0  of_%logit_3.0  this_%logit_2.0  review_%logit_0.0  suggest_%logit_2.0  that_%logit_2.0  counselling_%logit_1.0  attendance_%logit_3.0  may_%logit_3.0  have_%logit_3.0  an_%logit_3.0  important_%logit_3.0  impact_%logit_0.0  on_%logit_2.0  retention_%logit_3.0  in_%logit_3.0  abstinence_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  that_%logit_3.0  it_%logit_3.0  is_%logit_3.0  unlikely_%logit_2.0  that_%logit_3.0  it_%logit_3.0  will_%logit_1.0  have_%logit_0.0  a_%logit_2.0  significant_%logit_3.0  impact_%logit_2.0  on_%logit_2.0  quality_%logit_2.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  relapse_%logit_3.0  rate_%logit_3.0 ._%logit_3.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  counselling_%logit_1.0  attendance_%logit_3.0  on_%logit_3.0  relapse_%logit_3.0 ,_%logit_3.0  relapse_%logit_3.0  rates_%logit_3.0  and_%logit_3.0  relapse_%logit_1.0  severity_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  EB_%logit_3.0 V_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  EB_%logit_1.0 V_%logit_3.0 ,_%logit_1.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  antibiotic_%logit_2.0  therapy_%logit_3.0  with_%logit_3.0  other_%logit_3.0  treatments_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_2.0  antibiotics_%logit_1.0  for_%logit_3.0  EB_%logit_3.0 V_%logit_3.0 -_%logit_1.0 related_%logit_1.0  symptoms_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  with_%logit_3.0  other_%logit_3.0  anti_%logit_3.0 -_%logit_3.0 EB_%logit_3.0 V_%logit_3.0  treatments_%logit_0.0 ._%logit_2.0  Further_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  assess_%logit_1.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0 ,_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  the_%logit_3.0  impact_%logit_3.0  of_%logit_3.0  antibiotics_%logit_1.0  on_%logit_3.0  EB_%logit_3.0 V_%logit_3.0  symptoms_%logit_0.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  antibiotics_%logit_2.0  with_%logit_3.0  each_%logit_3.0  other_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  anti_%logit_3.0 hy_%logit_3.0 pert_%logit_3.0 ensive_%logit_0.0  drugs_%logit_0.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  album_%logit_1.0 in_%logit_3.0 uria_%logit_1.0  in_%logit_3.0  humans_%logit_3.0  with_%logit_3.0  CK_%logit_3.0 D_%logit_3.0 ._%logit_0.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_1.0  and_%logit_2.0  executed_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trials_%logit_2.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  drugs_%logit_3.0  on_%logit_3.0  renal_%logit_3.0  function_%logit_3.0 ,_%logit_3.0  kidney_%logit_3.0  function_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  in_%logit_0.0  people_%logit_3.0  with_%logit_3.0  DK_%logit_2.0 D_%logit_3.0 ._%logit_1.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  high_%logit_0.0  quality_%logit_2.0 ,_%logit_1.0  with_%logit_2.0  a_%logit_2.0  focus_%logit_2.0  on_%logit_2.0  improving_%logit_0.0  quality_%logit_3.0  and_%logit_3.0  quantity_%logit_3.0  of_%logit_0.0  data_%logit_3.0 ._%logit_0.0  They_%logit_2.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effect_%logit_3.0  of_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  on_%logit_3.0  kidney_%logit_1.0  function_%logit_3.0 ._%logit_3.0
 Family_%logit_0.0  counselling_%logit_1.0  is_%logit_0.0  effective_%logit_3.0  in_%logit_3.0  reducing_%logit_3.0  relapse_%logit_3.0  rates_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  schizophrenia_%logit_3.0  and_%logit_3.0  family_%logit_3.0  distress_%logit_3.0 ._%logit_3.0  Family_%logit_3.0  counselling_%logit_0.0  may_%logit_3.0  reduce_%logit_3.0  relapse_%logit_3.0  rates_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  it_%logit_3.0  is_%logit_3.0  not_%logit_2.0  clear_%logit_3.0  whether_%logit_2.0  it_%logit_3.0  has_%logit_3.0  an_%logit_3.0  impact_%logit_3.0  on_%logit_2.0  quality_%logit_2.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0  Family_%logit_3.0  counseling_%logit_3.0  is_%logit_1.0  effective_%logit_3.0  as_%logit_3.0  an_%logit_3.0  adjunct_%logit_3.0  to_%logit_0.0  other_%logit_0.0  psych_%logit_3.0 other_%logit_3.0 ape_%logit_0.0 utic_%logit_0.0  approaches_%logit_0.0 ,_%logit_3.0  but_%logit_1.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  higher_%logit_3.0  rate_%logit_3.0  of_%logit_3.0  psychological_%logit_1.0  distress_%logit_3.0  and_%logit_3.0  a_%logit_3.0  decreased_%logit_3.0  rate_%logit_3.0  of_%logit_3.0  depression_%logit_1.0 ._%logit_3.0  Family_%logit_3.0  therapy_%logit_2.0  may_%logit_0.0  be_%logit_1.0  effective_%logit_3.0  as_%logit_3.0  a_%logit_3.0  component_%logit_1.0  of_%logit_3.0  a_%logit_0.0  broader_%logit_3.0  range_%logit_1.0  of_%logit_0.0  psych_%logit_3.0 other_%logit_3.0 ap_%logit_3.0 ies_%logit_3.0 ,_%logit_0.0  but_%logit_1.0  its_%logit_3.0  effectiveness_%logit_3.0  is_%logit_3.0  unclear_%logit_3.0 ._%logit_3.0  Family_%logit_2.0  coun_%logit_0.0 sell_%logit_0.0 ors_%logit_1.0  may_%logit_1.0  have_%logit_1.0  a_%logit_2.0  role_%logit_3.0  to_%logit_3.0  play_%logit_3.0  in_%logit_1.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  relapse_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  the_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  the_%logit_3.0  evidence_%logit_3.0  is_%logit_3.0  low_%logit_3.0  and_%logit_3.0  the_%logit_2.0  number_%logit_3.0  of_%logit_3.0  studies_%logit_3.0  is_%logit_3.0  low_%logit_0.0 ._%logit_1.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  family_%logit_3.0  counselling_%logit_3.0  as_%logit_1.0  a_%logit_3.0  part_%logit_1.0  of_%logit_3.0  a_%logit_3.0  multif_%logit_1.0 acet_%logit_1.0 ed_%logit_2.0  approach_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  pro_%logit_3.0 ph_%logit_3.0 yl_%logit_1.0 actic_%logit_0.0  cort_%logit_0.0 ic_%logit_3.0 oster_%logit_2.0 oids_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  NIC_%logit_1.0 U_%logit_3.0  neon_%logit_1.0 ates_%logit_3.0 ._%logit_0.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_1.0  and_%logit_1.0  timing_%logit_1.0  of_%logit_3.0  treatment_%logit_2.0  and_%logit_0.0  to_%logit_1.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  NIC_%logit_1.0 U_%logit_3.0  mortality_%logit_1.0  and_%logit_1.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_3.0  neon_%logit_3.0 ates_%logit_1.0  who_%logit_1.0  are_%logit_1.0  at_%logit_2.0  risk_%logit_1.0  of_%logit_1.0  death_%logit_3.0  from_%logit_3.0  NIC_%logit_2.0 U_%logit_3.0  discharge_%logit_1.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  these_%logit_3.0  agents_%logit_3.0  in_%logit_3.0  neon_%logit_2.0 atal_%logit_3.0  resusc_%logit_3.0 itation_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  pro_%logit_3.0 ph_%logit_3.0 yl_%logit_2.0 actic_%logit_2.0  antibiotics_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  O_%logit_3.0 RT_%logit_3.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  antibiotic_%logit_3.0  for_%logit_0.0  O_%logit_2.0 RT_%logit_0.0 ,_%logit_1.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  agents_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  survival_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_1.0  O_%logit_1.0 RT_%logit_1.0  who_%logit_1.0  are_%logit_1.0  at_%logit_2.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  relapse_%logit_2.0  or_%logit_3.0  relapse_%logit_3.0 ._%logit_1.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  there_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  in_%logit_2.0  this_%logit_3.0  area_%logit_0.0 ,_%logit_0.0  as_%logit_2.0  well_%logit_2.0  as_%logit_0.0  to_%logit_2.0  evaluate_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  toxicity_%logit_3.0  profiles_%logit_3.0  of_%logit_3.0  these_%logit_1.0  drugs_%logit_3.0  in_%logit_3.0  particular_%logit_2.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  oxy_%logit_3.0 toc_%logit_3.0 in_%logit_1.0  as_%logit_0.0  an_%logit_3.0  induction_%logit_0.0  agent_%logit_0.0  for_%logit_0.0  ca_%logit_1.0 es_%logit_3.0 are_%logit_3.0 an_%logit_0.0  section_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  induction_%logit_3.0  agent_%logit_3.0  and_%logit_1.0  the_%logit_1.0  safest_%logit_3.0  induction_%logit_3.0  method_%logit_3.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  profiles_%logit_3.0  of_%logit_3.0  various_%logit_1.0  induction_%logit_3.0  methods_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  methods_%logit_3.0  to_%logit_3.0  other_%logit_3.0  induction_%logit_3.0  methods_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0  there_%logit_0.0  is_%logit_0.0  an_%logit_2.0  urgent_%logit_3.0  need_%logit_3.0  for_%logit_0.0  an_%logit_1.0  assessment_%logit_1.0  of_%logit_0.0  the_%logit_1.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  profile_%logit_3.0  of_%logit_3.0  induction_%logit_1.0  methods_%logit_3.0  and_%logit_3.0  the_%logit_1.0  risks_%logit_3.0  associated_%logit_3.0  with_%logit_1.0  them_%logit_3.0 ._%logit_3.0  This_%logit_1.0  should_%logit_0.0  be_%logit_0.0  done_%logit_2.0  in_%logit_0.0  accordance_%logit_0.0  with_%logit_0.0  the_%logit_1.0  recommendations_%logit_3.0  of_%logit_3.0  the_%logit_1.0  Coch_%logit_0.0 rane_%logit_0.0  Handbook_%logit_0.0  of_%logit_0.0  Obst_%logit_0.0 et_%logit_0.0 rics_%logit_1.0  and_%logit_1.0  Gy_%logit_0.0 nec_%logit_0.0 ology_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ib_%logit_3.0 up_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  as_%logit_1.0  an_%logit_3.0  adjunct_%logit_3.0  to_%logit_0.0  standard_%logit_0.0  analges_%logit_3.0 ia_%logit_3.0  in_%logit_2.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_1.0  acute_%logit_1.0  pain_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_2.0  of_%logit_0.0  ib_%logit_1.0 ip_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0 ,_%logit_1.0  the_%logit_3.0  optimal_%logit_3.0  duration_%logit_0.0  of_%logit_3.0  analges_%logit_1.0 ia_%logit_3.0 ,_%logit_2.0  and_%logit_1.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_0.0  and_%logit_3.0  timing_%logit_1.0  of_%logit_3.0  administration_%logit_1.0  in_%logit_1.0  acute_%logit_3.0  pain_%logit_0.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  other_%logit_3.0  analges_%logit_3.0 ia_%logit_3.0  types_%logit_2.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_2.0  should_%logit_0.0  evaluate_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_1.0  NSA_%logit_3.0 IDs_%logit_3.0  in_%logit_1.0  pain_%logit_1.0  relief_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  profiles_%logit_3.0  of_%logit_3.0  these_%logit_1.0  drugs_%logit_3.0 ._%logit_2.0
 Vigil_%logit_0.0 ant_%logit_0.0  vig_%logit_1.0 ab_%logit_1.0 at_%logit_2.0 rin_%logit_2.0  is_%logit_2.0  effective_%logit_1.0  in_%logit_0.0  reducing_%logit_2.0  the_%logit_3.0  number_%logit_3.0  of_%logit_3.0  seizures_%logit_0.0  and_%logit_0.0  the_%logit_1.0  frequency_%logit_3.0  of_%logit_3.0  adverse_%logit_0.0  events_%logit_3.0 ._%logit_3.0  Its_%logit_1.0  efficacy_%logit_0.0  appears_%logit_3.0  to_%logit_3.0  be_%logit_3.0  similar_%logit_3.0  to_%logit_3.0  that_%logit_3.0  of_%logit_1.0  g_%logit_1.0 ab_%logit_3.0 ap_%logit_1.0 entin_%logit_2.0 ,_%logit_1.0  but_%logit_2.0  with_%logit_3.0  a_%logit_3.0  higher_%logit_3.0  incidence_%logit_3.0  of_%logit_1.0  adverse_%logit_3.0  effects_%logit_3.0 ._%logit_3.0  Its_%logit_1.0  effectiveness_%logit_2.0  is_%logit_3.0  similar_%logit_3.0  to_%logit_3.0  its_%logit_2.0  effectiveness_%logit_1.0  in_%logit_3.0  the_%logit_3.0  control_%logit_3.0  of_%logit_3.0  seizures_%logit_3.0  with_%logit_3.0  G_%logit_1.0 VG_%logit_3.0 ,_%logit_2.0  but_%logit_3.0  it_%logit_3.0  is_%logit_3.0  not_%logit_2.0  clear_%logit_3.0  whether_%logit_1.0  it_%logit_2.0  is_%logit_1.0  more_%logit_1.0  effective_%logit_3.0  than_%logit_3.0  G_%logit_2.0 VG_%logit_1.0  in_%logit_2.0  reducing_%logit_3.0  seizures_%logit_3.0  with_%logit_3.0  or_%logit_3.0  without_%logit_3.0  G_%logit_2.0 VG_%logit_3.0 ._%logit_2.0  It_%logit_3.0  is_%logit_2.0  unclear_%logit_2.0  whether_%logit_3.0  it_%logit_3.0  has_%logit_3.0  an_%logit_2.0  effect_%logit_3.0  on_%logit_2.0  other_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ,_%logit_3.0  such_%logit_3.0  as_%logit_3.0  nausea_%logit_3.0  or_%logit_3.0  vomiting_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  on_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_1.0  but_%logit_3.0  its_%logit_3.0  efficacy_%logit_3.0  appears_%logit_3.0  similar_%logit_3.0  to_%logit_3.0  G_%logit_2.0 VG_%logit_1.0  with_%logit_1.0  respect_%logit_3.0  to_%logit_3.0  frequency_%logit_3.0  and_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  event_%logit_3.0  profiles_%logit_3.0 ._%logit_3.0  Vigil_%logit_2.0 ant_%logit_0.0  g_%logit_0.0 ab_%logit_1.0 av_%logit_2.0 at_%logit_2.0 rin_%logit_1.0  appears_%logit_1.0  to_%logit_3.0  have_%logit_3.0  a_%logit_3.0  similar_%logit_3.0  efficacy_%logit_3.0  to_%logit_3.0  G_%logit_3.0 GV_%logit_1.0 ,_%logit_2.0  but_%logit_2.0  has_%logit_2.0  a_%logit_3.0  higher_%logit_3.0  risk_%logit_3.0  of_%logit_1.0  having_%logit_1.0  an_%logit_3.0  adverse_%logit_3.0  event_%logit_3.0  profile_%logit_3.0 ._%logit_1.0  Its_%logit_2.0  use_%logit_2.0  is_%logit_3.0  associated_%logit_1.0  with_%logit_0.0  an_%logit_3.0  increased_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  nar_%logit_1.0 co_%logit_3.0 le_%logit_1.0 psy_%logit_1.0 ,_%logit_1.0  and_%logit_3.0  a_%logit_3.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  seizures_%logit_1.0  in_%logit_3.0  the_%logit_3.0  long_%logit_3.0  term_%logit_3.0 ._%logit_3.0  Its_%logit_2.0  adverse_%logit_2.0  effects_%logit_3.0  are_%logit_3.0  similar_%logit_3.0  to_%logit_3.0  those_%logit_1.0  of_%logit_1.0  G_%logit_1.0 VG_%logit_3.0  but_%logit_1.0  its_%logit_3.0  use_%logit_3.0  is_%logit_3.0  not_%logit_3.0  associated_%logit_3.0  with_%logit_1.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  seizures_%logit_3.0  in_%logit_3.0  G_%logit_3.0 VG_%logit_3.0  or_%logit_1.0  G_%logit_3.0 VG_%logit_3.0  alone_%logit_1.0 ._%logit_3.0  Its_%logit_2.0  duration_%logit_0.0  is_%logit_3.0  longer_%logit_2.0  than_%logit_1.0  that_%logit_3.0  of_%logit_1.0  other_%logit_1.0  G_%logit_3.0 VG_%logit_3.0  agon_%logit_1.0 ist_%logit_2.0  drugs_%logit_2.0 ._%logit_2.0  It_%logit_2.0  appears_%logit_2.0  that_%logit_2.0  Vigil_%logit_1.0 ant_%logit_3.0  G_%logit_0.0 GB_%logit_1.0  is_%logit_2.0  more_%logit_3.0  likely_%logit_0.0  to_%logit_1.0  have_%logit_1.0  an_%logit_2.0  adverse_%logit_3.0  effect_%logit_2.0  on_%logit_2.0  G_%logit_3.0 VG_%logit_3.0  and_%logit_1.0  G_%logit_3.0 VG_%logit_3.0  compared_%logit_2.0  to_%logit_3.0  G_%logit_3.0 GB_%logit_3.0 ,_%logit_2.0  but_%logit_3.0  the_%logit_3.0  exact_%logit_3.0  duration_%logit_3.0  of_%logit_2.0  the_%logit_1.0  treatment_%logit_1.0  is_%logit_3.0  unclear_%logit_1.0 ._%logit_3.0  Vigil_%logit_2.0 ante_%logit_2.0  G_%logit_0.0 GB_%logit_1.0  has_%logit_2.0  a_%logit_3.0  longer_%logit_3.0  duration_%logit_3.0  and_%logit_2.0  is_%logit_2.0  less_%logit_3.0  likely_%logit_3.0  to_%logit_1.0  cause_%logit_1.0  adverse_%logit_2.0  events_%logit_3.0  in_%logit_3.0  the_%logit_3.0  short_%logit_3.0  term_%logit_3.0 ._%logit_3.0  It_%logit_2.0  has_%logit_2.0  a_%logit_2.0  shorter_%logit_3.0  duration_%logit_3.0  and_%logit_3.0  has_%logit_2.0  a_%logit_3.0  lower_%logit_3.0  risk_%logit_1.0  of_%logit_1.0  relapse_%logit_1.0 ,_%logit_3.0  but_%logit_3.0  a_%logit_1.0  higher_%logit_3.0  rate_%logit_3.0  of_%logit_1.0  relapse_%logit_1.0  in_%logit_3.0  the_%logit_3.0  longer_%logit_3.0  term_%logit_3.0 ,_%logit_3.0  but_%logit_2.0  is_%logit_2.0  not_%logit_3.0  significantly_%logit_0.0  different_%logit_1.0  from_%logit_1.0  that_%logit_2.0  of_%logit_1.0  G_%logit_1.0 GB_%logit_2.0  with_%logit_2.0  G_%logit_2.0 GB_%logit_2.0 ._%logit_2.0  Its_%logit_2.0  long_%logit_2.0 -_%logit_3.0 term_%logit_3.0  efficacy_%logit_3.0  is_%logit_3.0  unknown_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  its_%logit_3.0  duration_%logit_3.0  is_%logit_3.0  unclear_%logit_3.0  due_%logit_3.0  to_%logit_2.0  the_%logit_3.0  rarity_%logit_3.0  of_%logit_3.0  the_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0  reported_%logit_3.0  in_%logit_1.0  this_%logit_3.0  review_%logit_0.0 ._%logit_2.0  Vigil_%logit_2.0 antes_%logit_2.0  G_%logit_2.0 GB_%logit_1.0  appear_%logit_2.0  to_%logit_2.0  have_%logit_1.0  similar_%logit_2.0  efficacy_%logit_3.0  as_%logit_3.0  G_%logit_3.0 GB_%logit_1.0  and_%logit_1.0  G_%logit_3.0 GB_%logit_3.0  in_%logit_2.0  terms_%logit_3.0  of_%logit_3.0  seizure_%logit_3.0  frequency_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  have_%logit_3.0  a_%logit_3.0  longer_%logit_3.0  course_%logit_1.0  of_%logit_3.0  action_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  sal_%logit_3.0 but_%logit_3.0 am_%logit_2.0 ol_%logit_0.0  as_%logit_2.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_0.0  sal_%logit_0.0 but_%logit_3.0 af_%logit_2.0 il_%logit_2.0  in_%logit_2.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  patients_%logit_3.0  with_%logit_3.0  asthma_%logit_3.0  who_%logit_3.0  are_%logit_3.0  unable_%logit_2.0  to_%logit_3.0  tolerate_%logit_3.0  or_%logit_2.0  tolerate_%logit_3.0  sal_%logit_2.0 but_%logit_3.0 amin_%logit_1.0 ophen_%logit_2.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  sal_%logit_3.0 ut_%logit_3.0 am_%logit_1.0 ol_%logit_0.0  in_%logit_2.0  reducing_%logit_3.0  the_%logit_3.0  number_%logit_3.0  of_%logit_3.0  exacerb_%logit_0.0 ations_%logit_0.0  and_%logit_3.0  the_%logit_1.0  severity_%logit_0.0  of_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  compare_%logit_3.0  sal_%logit_2.0 ut_%logit_3.0 amin_%logit_1.0 ophen_%logit_3.0  with_%logit_3.0  sal_%logit_3.0 ut_%logit_3.0 amide_%logit_1.0 ._%logit_2.0  Finally_%logit_3.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_2.0 term_%logit_2.0  data_%logit_2.0  are_%logit_2.0  needed_%logit_2.0  in_%logit_2.0  order_%logit_2.0  to_%logit_3.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  sal_%logit_3.0 uting_%logit_3.0  sal_%logit_1.0 ut_%logit_3.0 amy_%logit_1.0 ol_%logit_2.0  as_%logit_1.0  an_%logit_3.0  alternative_%logit_0.0  to_%logit_0.0  sal_%logit_0.0 but_%logit_3.0 amide_%logit_1.0  as_%logit_2.0  a_%logit_3.0  mon_%logit_3.0 otherapy_%logit_0.0  for_%logit_1.0  patients_%logit_0.0  who_%logit_3.0  are_%logit_3.0  able_%logit_2.0  to_%logit_3.0  tolerate_%logit_3.0  Sal_%logit_2.0 ut_%logit_3.0 amide_%logit_1.0  as_%logit_2.0  mon_%logit_3.0 otherapy_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 roc_%logit_1.0 oll_%logit_1.0 oid_%logit_3.0  gel_%logit_0.0  gel_%logit_1.0  as_%logit_3.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_3.0  saline_%logit_0.0  gel_%logit_3.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  successful_%logit_1.0  eruption_%logit_3.0  of_%logit_3.0  an_%logit_1.0  erupt_%logit_3.0 ing_%logit_1.0  volcano_%logit_2.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  formulation_%logit_3.0  and_%logit_2.0  timing_%logit_1.0  of_%logit_0.0  hyd_%logit_1.0 oc_%logit_1.0 oll_%logit_3.0 oid_%logit_1.0  fluid_%logit_2.0  gel_%logit_2.0  gel_%logit_2.0  gel_%logit_2.0  and_%logit_2.0  to_%logit_2.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_1.0  management_%logit_0.0  of_%logit_3.0  successful_%logit_3.0  eru_%logit_2.0 ptions_%logit_1.0 ._%logit_2.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  Hyd_%logit_0.0 roc_%logit_1.0 oll_%logit_3.0 oids_%logit_1.0  gel_%logit_2.0  gel_%logit_1.0  works_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effects_%logit_1.0  of_%logit_3.0  various_%logit_1.0  types_%logit_1.0  of_%logit_3.0  gel_%logit_1.0  gel_%logit_1.0  in_%logit_2.0  different_%logit_2.0  settings_%logit_1.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  dietary_%logit_3.0  fibre_%logit_1.0  supplements_%logit_3.0  for_%logit_0.0  weight_%logit_3.0  loss_%logit_3.0  in_%logit_3.0  NJ_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  whether_%logit_2.0  fibre_%logit_3.0  supplements_%logit_1.0  are_%logit_0.0  beneficial_%logit_0.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_0.0  weight_%logit_3.0  gain_%logit_0.0  in_%logit_3.0  NJ_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  fibre_%logit_1.0  supplements_%logit_1.0  on_%logit_0.0  mortality_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_1.0  also_%logit_3.0  needed_%logit_1.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effect_%logit_3.0  of_%logit_3.0  fibre_%logit_1.0  supplementation_%logit_1.0  on_%logit_3.0  mortality_%logit_3.0 ,_%logit_3.0  morbid_%logit_3.0 ity_%logit_1.0  and_%logit_3.0  mortality_%logit_3.0  in_%logit_3.0  NJ_%logit_3.0  and_%logit_3.0  to_%logit_1.0  determine_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  morbid_%logit_1.0 ity_%logit_3.0  or_%logit_3.0  mortality_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_1.0 term_%logit_1.0  data_%logit_1.0  are_%logit_0.0  required_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  fibre_%logit_3.0  supplement_%logit_1.0 ing_%logit_3.0  diets_%logit_3.0  in_%logit_3.0  NJ_%logit_1.0  as_%logit_3.0  well_%logit_1.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  fibre_%logit_2.0  supplements_%logit_3.0  with_%logit_0.0  fibre_%logit_3.0  supplements_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  nicotine_%logit_1.0  replacement_%logit_3.0  therapy_%logit_3.0  for_%logit_3.0  quitting_%logit_3.0  tobacco_%logit_3.0  use_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  therapy_%logit_3.0 ._%logit_1.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  nicotine_%logit_0.0  replacement_%logit_3.0  has_%logit_3.0  been_%logit_3.0  used_%logit_3.0  to_%logit_1.0  improve_%logit_1.0  quitting_%logit_3.0  behaviour_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  how_%logit_2.0  nicotine_%logit_3.0  replacement_%logit_3.0  is_%logit_3.0  used_%logit_3.0  in_%logit_3.0  the_%logit_3.0  context_%logit_3.0  of_%logit_3.0  a_%logit_1.0  reduction_%logit_3.0  in_%logit_3.0  smoking_%logit_0.0  frequency_%logit_3.0  and_%logit_3.0  duration_%logit_0.0  of_%logit_3.0  abstinence_%logit_0.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_2.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_1.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  other_%logit_1.0  nicotine_%logit_3.0  replacement_%logit_3.0  therapies_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  oral_%logit_1.0  meth_%logit_1.0 ad_%logit_3.0 one_%logit_2.0  and_%logit_2.0  nicotine_%logit_3.0  replacement_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  th_%logit_3.0 rom_%logit_3.0 bo_%logit_2.0 ly_%logit_0.0 tic_%logit_1.0  agents_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  recurrent_%logit_3.0  DV_%logit_3.0 T_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  th_%logit_3.0 ro_%logit_1.0 bo_%logit_2.0 ly_%logit_0.0 tics_%logit_0.0  in_%logit_2.0  reducing_%logit_1.0  the_%logit_3.0  incidence_%logit_3.0  of_%logit_3.0  DV_%logit_3.0 T_%logit_0.0  rec_%logit_1.0 urrence_%logit_3.0  and_%logit_1.0  mortality_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  these_%logit_3.0  agents_%logit_3.0  with_%logit_3.0  placebo_%logit_3.0  or_%logit_3.0  no_%logit_3.0  treatment_%logit_1.0 ,_%logit_2.0  and_%logit_2.0  also_%logit_2.0  to_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  reducing_%logit_2.0  total_%logit_3.0  mortality_%logit_0.0  and_%logit_0.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_0.0  DV_%logit_1.0 T_%logit_3.0 ,_%logit_2.0  including_%logit_1.0  in_%logit_3.0  those_%logit_3.0  with_%logit_3.0  a_%logit_3.0  history_%logit_3.0  of_%logit_3.0  major_%logit_3.0  bleeding_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_0.0  any_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  mortality_%logit_3.0  rates_%logit_3.0  between_%logit_3.0  orth_%logit_3.0 op_%logit_3.0 aed_%logit_1.0 ic_%logit_2.0  and_%logit_0.0  robotic_%logit_3.0  hip_%logit_1.0  replacements_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  way_%logit_3.0  to_%logit_1.0  minim_%logit_1.0 ise_%logit_2.0  the_%logit_0.0  risk_%logit_3.0  of_%logit_3.0  bias_%logit_1.0  in_%logit_3.0  this_%logit_3.0  review_%logit_0.0  and_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  robotic_%logit_1.0  hip_%logit_1.0  replacement_%logit_1.0  as_%logit_3.0  a_%logit_3.0  replacement_%logit_1.0  for_%logit_1.0  traditional_%logit_0.0  hip_%logit_1.0  replacement_%logit_1.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_1.0 ed_%logit_2.0  and_%logit_2.0  executed_%logit_0.0  random_%logit_2.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  robotic_%logit_1.0  replacement_%logit_1.0  on_%logit_1.0  mortality_%logit_3.0  rates_%logit_3.0  and_%logit_3.0  to_%logit_1.0  compare_%logit_3.0  robotic_%logit_2.0  replacement_%logit_3.0  with_%logit_1.0  robotic_%logit_3.0  replacement_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 roc_%logit_3.0 ort_%logit_3.0 is_%logit_3.0 one_%logit_2.0  in_%logit_0.0  reducing_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_3.0  hypertension_%logit_3.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_0.0  the_%logit_3.0  amount_%logit_3.0  of_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0  reduction_%logit_0.0  achieved_%logit_3.0  was_%logit_3.0  not_%logit_3.0  significantly_%logit_3.0  different_%logit_1.0  from_%logit_1.0  that_%logit_2.0  achieved_%logit_3.0  in_%logit_3.0  the_%logit_3.0  control_%logit_3.0  group_%logit_3.0 ._%logit_2.0  There_%logit_2.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  random_%logit_0.0 ised_%logit_0.0  controlled_%logit_0.0  trials_%logit_2.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  hyd_%logit_1.0 oc_%logit_1.0 ort_%logit_3.0 is_%logit_0.0 ones_%logit_3.0  in_%logit_3.0  hypertension_%logit_1.0  patients_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  areas_%logit_2.0  with_%logit_3.0  high_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0 ,_%logit_3.0  such_%logit_3.0  as_%logit_3.0  in_%logit_3.0  areas_%logit_3.0  where_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0  is_%logit_3.0  low_%logit_3.0 ._%logit_3.0
 Psych_%logit_0.0 otherapy_%logit_0.0  appears_%logit_1.0  to_%logit_1.0  be_%logit_0.0  a_%logit_3.0  useful_%logit_0.0  tool_%logit_3.0  in_%logit_0.0  the_%logit_0.0  treatment_%logit_0.0  of_%logit_0.0  PTSD_%logit_1.0  and_%logit_1.0  its_%logit_3.0  aftermath_%logit_3.0 ._%logit_3.0  However_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  its_%logit_2.0  use_%logit_1.0  as_%logit_3.0  an_%logit_2.0  adjunct_%logit_1.0  to_%logit_0.0  other_%logit_0.0  psych_%logit_3.0 otherapy_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_2.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  psych_%logit_1.0 otherapy_%logit_1.0  for_%logit_1.0  PTSD_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  psych_%logit_2.0 otherapy_%logit_3.0  with_%logit_1.0  other_%logit_3.0  psychological_%logit_3.0  therapies_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_1.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  other_%logit_1.0  conditions_%logit_3.0 ,_%logit_3.0  such_%logit_2.0  as_%logit_1.0  sleep_%logit_1.0  deprivation_%logit_3.0 ,_%logit_1.0  depression_%logit_3.0 ,_%logit_3.0  insomnia_%logit_3.0 ,_%logit_3.0  fatigue_%logit_3.0 ,_%logit_3.0  sleep_%logit_3.0  deprivation_%logit_3.0  and_%logit_1.0  sleep_%logit_1.0  deprivation_%logit_3.0 ._%logit_1.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  evaluate_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  psychological_%logit_1.0  therapies_%logit_1.0  for_%logit_3.0  PTSD_%logit_1.0  and_%logit_3.0  other_%logit_1.0  psychological_%logit_3.0  disorders_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  also_%logit_0.0  examine_%logit_0.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  psychological_%logit_1.0  therapy_%logit_3.0  on_%logit_3.0  sleep_%logit_1.0  deprivation_%logit_3.0  in_%logit_1.0  particular_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  on_%logit_1.0  depression_%logit_3.0  and_%logit_3.0  anxiety_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  recommend_%logit_2.0  pro_%logit_2.0 ph_%logit_0.0 yl_%logit_0.0 actic_%logit_2.0  antibiotic_%logit_0.0  use_%logit_3.0  in_%logit_3.0  UT_%logit_3.0 I_%logit_3.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  use_%logit_3.0  for_%logit_3.0  UT_%logit_3.0 I_%logit_0.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  administration_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  UT_%logit_1.0 I_%logit_0.0  in_%logit_1.0  women_%logit_1.0  with_%logit_0.0  a_%logit_1.0  history_%logit_3.0  of_%logit_3.0  bacter_%logit_1.0 i_%logit_3.0 uria_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  in_%logit_3.0  UT_%logit_3.0 Is_%logit_0.0  in_%logit_1.0  women_%logit_1.0  who_%logit_3.0  are_%logit_3.0  undergoing_%logit_2.0  antibiotic_%logit_1.0  treatment_%logit_3.0  for_%logit_3.0  py_%logit_3.0 el_%logit_3.0 one_%logit_1.0 ph_%logit_2.0 ritis_%logit_2.0 ,_%logit_2.0  and_%logit_1.0  for_%logit_1.0  those_%logit_3.0  who_%logit_3.0  are_%logit_3.0  unable_%logit_1.0  to_%logit_1.0  tolerate_%logit_3.0  antibiotic_%logit_2.0  treatment_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  oxy_%logit_3.0 toc_%logit_3.0 in_%logit_1.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  menstrual_%logit_3.0  bleeding_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  drug_%logit_3.0  for_%logit_3.0  menstrual_%logit_3.0  bleeding_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  to_%logit_3.0  other_%logit_3.0  drugs_%logit_3.0 ,_%logit_3.0  such_%logit_3.0  as_%logit_3.0  oxy_%logit_1.0 toc_%logit_3.0 ins_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  treatment_%logit_3.0  of_%logit_1.0  other_%logit_1.0  menstrual_%logit_3.0  bleeding_%logit_3.0  conditions_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0 ,_%logit_0.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_3.0  drugs_%logit_3.0  for_%logit_3.0  menstrual_%logit_2.0  blood_%logit_3.0  loss_%logit_3.0  and_%logit_2.0  fertility_%logit_3.0 ._%logit_3.0
 Vitamin_%logit_0.0  E_%logit_0.0  supplementation_%logit_2.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  mortality_%logit_0.0  and_%logit_3.0  disability_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  hepatitis_%logit_1.0  C_%logit_3.0  virus_%logit_3.0  infection_%logit_3.0 ._%logit_3.0  Vitamin_%logit_3.0  E_%logit_0.0  supplements_%logit_2.0  are_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  an_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  mortality_%logit_0.0 ,_%logit_3.0  disability_%logit_3.0 ,_%logit_3.0  liver_%logit_3.0  function_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  disability_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  no_%logit_2.0  evidence_%logit_3.0  of_%logit_3.0  an_%logit_3.0  improvement_%logit_3.0  in_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  or_%logit_0.0  health_%logit_3.0 -_%logit_3.0 related_%logit_0.0  quality_%logit_3.0  or_%logit_3.0  quantity_%logit_3.0  of_%logit_3.0  life_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  treated_%logit_0.0  with_%logit_1.0  vitamin_%logit_3.0  E_%logit_3.0  supplements_%logit_2.0 ._%logit_3.0  Treatment_%logit_2.0  with_%logit_0.0  Vitamin_%logit_3.0  E_%logit_3.0  has_%logit_2.0  a_%logit_0.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  liver_%logit_2.0  function_%logit_3.0  and_%logit_3.0  liver_%logit_3.0  function_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  who_%logit_3.0  are_%logit_1.0  not_%logit_2.0  receiving_%logit_1.0  vitamin_%logit_1.0  E_%logit_3.0  supplementation_%logit_2.0 ,_%logit_3.0  but_%logit_2.0  this_%logit_3.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0  from_%logit_3.0  this_%logit_3.0  review_%logit_2.0 ._%logit_2.0  The_%logit_2.0  number_%logit_0.0  of_%logit_0.0  patients_%logit_3.0  in_%logit_0.0  the_%logit_1.0  study_%logit_0.0  was_%logit_0.0  too_%logit_2.0  small_%logit_0.0  to_%logit_1.0  draw_%logit_2.0  conclusions_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 roc_%logit_3.0 ort_%logit_3.0 is_%logit_3.0 one_%logit_0.0  in_%logit_0.0  the_%logit_0.0  management_%logit_0.0  of_%logit_0.0  breast_%logit_3.0  milk_%logit_3.0  loss_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  hyd_%logit_3.0 roc_%logit_0.0 ORT_%logit_3.0 is_%logit_2.0 one_%logit_1.0  solution_%logit_3.0 ,_%logit_0.0  the_%logit_2.0  safest_%logit_3.0  solution_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  the_%logit_3.0  best_%logit_0.0  way_%logit_0.0  to_%logit_0.0  administer_%logit_0.0  it_%logit_2.0 ._%logit_3.0  Finally_%logit_0.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0  and_%logit_0.0  executed_%logit_0.0  random_%logit_2.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  this_%logit_3.0  solution_%logit_0.0 ._%logit_1.0  Such_%logit_1.0  a_%logit_0.0  trial_%logit_0.0  is_%logit_0.0  also_%logit_0.0  needed_%logit_0.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  solution_%logit_3.0 ._%logit_0.0  It_%logit_2.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  the_%logit_3.0  data_%logit_0.0  in_%logit_0.0  this_%logit_2.0  review_%logit_0.0  are_%logit_2.0  based_%logit_2.0  on_%logit_0.0  only_%logit_0.0  a_%logit_0.0  small_%logit_0.0  number_%logit_3.0  of_%logit_0.0  cases_%logit_0.0 ,_%logit_0.0  and_%logit_0.0  therefore_%logit_1.0  the_%logit_0.0  conclusions_%logit_0.0  of_%logit_0.0  this_%logit_3.0  review_%logit_0.0  should_%logit_2.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_0.0  caution_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_1.0  of_%logit_3.0  digital_%logit_1.0  scales_%logit_1.0  for_%logit_3.0  measuring_%logit_1.0  health_%logit_3.0  expenditure_%logit_3.0  in_%logit_3.0  health_%logit_3.0  care_%logit_0.0  settings_%logit_0.0 ._%logit_1.0  There_%logit_1.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  well_%logit_1.0 -_%logit_1.0 designed_%logit_1.0  and_%logit_2.0  executed_%logit_2.0  random_%logit_2.0 ised_%logit_0.0  controlled_%logit_0.0  trials_%logit_1.0  to_%logit_0.0  evaluate_%logit_1.0  the_%logit_2.0  effects_%logit_1.0  on_%logit_3.0  health_%logit_1.0  expenditure_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_0.0 ._%logit_0.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_1.0  be_%logit_2.0  conducted_%logit_2.0  in_%logit_0.0  health_%logit_0.0  settings_%logit_0.0  with_%logit_0.0  low_%logit_1.0  risk_%logit_1.0  of_%logit_0.0  bias_%logit_0.0  and_%logit_0.0  with_%logit_2.0  a_%logit_1.0  focus_%logit_1.0  on_%logit_1.0  measuring_%logit_3.0  health_%logit_3.0  expenditures_%logit_3.0  in_%logit_3.0  health_%logit_1.0  services_%logit_1.0  settings_%logit_3.0 ._%logit_1.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  assess_%logit_2.0  health_%logit_2.0  expenditure_%logit_3.0 ,_%logit_3.0  quality_%logit_3.0 -_%logit_3.0 of_%logit_3.0 -_%logit_0.0 life_%logit_0.0  and_%logit_0.0  cost_%logit_0.0 -_%logit_0.0 effect_%logit_3.0 iveness_%logit_0.0 ,_%logit_3.0  and_%logit_3.0  compare_%logit_1.0  digital_%logit_0.0  scales_%logit_1.0  with_%logit_1.0  digital_%logit_1.0  scales_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  electro_%logit_3.0 stim_%logit_3.0 ulation_%logit_1.0  as_%logit_0.0  an_%logit_3.0  adjunct_%logit_0.0  to_%logit_0.0  standard_%logit_0.0  IC_%logit_3.0 U_%logit_3.0  care_%logit_3.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  acute_%logit_3.0  stroke_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  establish_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  Electro_%logit_1.0 stim_%logit_1.0 ulation_%logit_1.0  in_%logit_2.0  acute_%logit_1.0  stroke_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  its_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  other_%logit_1.0  outcomes_%logit_3.0 ,_%logit_3.0  including_%logit_1.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  cost_%logit_3.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  the_%logit_3.0  results_%logit_3.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  are_%logit_0.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_0.0  number_%logit_0.0  of_%logit_0.0  patients_%logit_3.0 ,_%logit_0.0  all_%logit_1.0  of_%logit_3.0  whom_%logit_3.0  were_%logit_0.0  discharged_%logit_2.0  from_%logit_3.0  IC_%logit_3.0 U_%logit_0.0  earlier_%logit_1.0  than_%logit_3.0  expected_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  that_%logit_1.0  there_%logit_1.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  correlation_%logit_3.0  between_%logit_3.0  involuntary_%logit_3.0  falls_%logit_3.0  and_%logit_3.0  mortality_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_1.0  needed_%logit_1.0  to_%logit_1.0  establish_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  involuntary_%logit_3.0  falls_%logit_3.0  as_%logit_1.0  a_%logit_1.0  measure_%logit_0.0  of_%logit_0.0  mortality_%logit_0.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  bodily_%logit_1.0  function_%logit_3.0 ,_%logit_3.0  balance_%logit_3.0 ,_%logit_3.0  g_%logit_3.0 ait_%logit_3.0 ,_%logit_2.0  reflex_%logit_1.0 ivity_%logit_3.0 ,_%logit_1.0  and_%logit_1.0  function_%logit_1.0  of_%logit_3.0  involuntary_%logit_3.0  falling_%logit_3.0 ._%logit_1.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_1.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  involuntary_%logit_1.0  fall_%logit_1.0  on_%logit_1.0  bodily_%logit_1.0  functions_%logit_3.0 ,_%logit_3.0  balance_%logit_1.0  and_%logit_1.0  function_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_1.0  as_%logit_1.0  on_%logit_2.0  quality_%logit_0.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  injury_%logit_1.0  rates_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  on_%logit_1.0  the_%logit_0.0  impact_%logit_3.0  on_%logit_3.0  physical_%logit_1.0  function_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  oxy_%logit_3.0 toc_%logit_3.0 in_%logit_1.0  gel_%logit_0.0  as_%logit_1.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_0.0  vaginal_%logit_0.0  gel_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  cervical_%logit_3.0  rip_%logit_3.0 ening_%logit_3.0  time_%logit_1.0 ,_%logit_3.0  cervical_%logit_1.0  thickness_%logit_3.0 ,_%logit_1.0  per_%logit_3.0 in_%logit_3.0 atal_%logit_0.0  outcome_%logit_0.0 ,_%logit_0.0  and_%logit_3.0  cervical_%logit_3.0  thickness_%logit_3.0 ._%logit_1.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_3.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  treatment_%logit_1.0 ._%logit_2.0  In_%logit_1.0  addition_%logit_0.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  an_%logit_3.0  urgent_%logit_3.0  need_%logit_3.0  for_%logit_0.0  an_%logit_1.0  assessment_%logit_1.0  of_%logit_0.0  the_%logit_1.0  effectiveness_%logit_3.0  of_%logit_3.0  uter_%logit_1.0 oton_%logit_3.0 ics_%logit_0.0  as_%logit_0.0  an_%logit_1.0  adjunct_%logit_3.0  to_%logit_0.0  vaginal_%logit_0.0  gel_%logit_3.0  administration_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  vaginal_%logit_1.0  fib_%logit_3.0 ro_%logit_3.0 ids_%logit_3.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_3.0  as_%logit_1.0  a_%logit_2.0  review_%logit_3.0  of_%logit_2.0  the_%logit_0.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  profiles_%logit_3.0  of_%logit_3.0  oxy_%logit_1.0 cod_%logit_3.0 one_%logit_3.0  gel_%logit_2.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  male_%logit_3.0  hormones_%logit_3.0  in_%logit_0.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  s_%logit_3.0 per_%logit_3.0 mat_%logit_3.0 ogenesis_%logit_0.0 ._%logit_0.0  Men_%logit_3.0  using_%logit_3.0  male_%logit_2.0  hormones_%logit_3.0  should_%logit_3.0  be_%logit_2.0  encouraged_%logit_2.0  to_%logit_1.0  take_%logit_2.0  part_%logit_2.0  in_%logit_3.0  this_%logit_2.0  review_%logit_0.0 ._%logit_0.0  Men_%logit_2.0  should_%logit_0.0  be_%logit_2.0  advised_%logit_2.0  that_%logit_2.0  male_%logit_3.0  hormones_%logit_3.0  do_%logit_3.0  not_%logit_1.0  appear_%logit_3.0  to_%logit_1.0  have_%logit_1.0  a_%logit_3.0  significant_%logit_3.0  impact_%logit_3.0  on_%logit_0.0  sperm_%logit_0.0  production_%logit_3.0 ._%logit_3.0  Men_%logit_3.0  taking_%logit_0.0  male_%logit_2.0  hormones_%logit_3.0  are_%logit_3.0  unlikely_%logit_2.0  to_%logit_1.0  have_%logit_3.0  an_%logit_2.0  adverse_%logit_3.0  effect_%logit_2.0  on_%logit_2.0  their_%logit_2.0  sperm_%logit_3.0  production_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  men_%logit_3.0  taking_%logit_3.0  female_%logit_2.0  hormones_%logit_3.0  may_%logit_3.0  have_%logit_2.0  an_%logit_2.0  increased_%logit_3.0  risk_%logit_0.0  of_%logit_3.0  developing_%logit_3.0  prostate_%logit_3.0  cancer_%logit_3.0 ._%logit_3.0  Men_%logit_3.0  who_%logit_0.0  take_%logit_2.0  male_%logit_2.0  hormones_%logit_3.0  will_%logit_3.0  have_%logit_2.0  a_%logit_2.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  prostate_%logit_0.0  cancer_%logit_3.0 ,_%logit_0.0  but_%logit_3.0  the_%logit_3.0  number_%logit_3.0  of_%logit_3.0  men_%logit_3.0  who_%logit_0.0  develop_%logit_0.0  prostate_%logit_2.0  cancer_%logit_3.0  will_%logit_0.0  be_%logit_3.0  reduced_%logit_2.0  by_%logit_3.0  male_%logit_2.0  hormones_%logit_3.0 ._%logit_3.0  Women_%logit_3.0  should_%logit_0.0  be_%logit_2.0  informed_%logit_2.0  of_%logit_2.0  the_%logit_3.0  risks_%logit_3.0  and_%logit_3.0  benefits_%logit_1.0  of_%logit_3.0  male_%logit_1.0  hormonal_%logit_3.0  supplements_%logit_3.0  and_%logit_3.0  the_%logit_1.0  possibility_%logit_3.0  that_%logit_3.0  male_%logit_1.0  hormone_%logit_3.0  supplements_%logit_3.0  may_%logit_3.0  have_%logit_1.0  a_%logit_3.0  negative_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  the_%logit_3.0  sperm_%logit_3.0  production_%logit_3.0  of_%logit_3.0  sperm_%logit_3.0  producing_%logit_3.0  men_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  this_%logit_3.0  is_%logit_3.0  unlikely_%logit_0.0  to_%logit_3.0  be_%logit_2.0  a_%logit_2.0  significant_%logit_0.0  issue_%logit_2.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  manual_%logit_1.0  labour_%logit_3.0  as_%logit_1.0  an_%logit_3.0  integral_%logit_1.0  part_%logit_0.0  of_%logit_0.0  the_%logit_0.0  management_%logit_3.0  of_%logit_0.0  human_%logit_1.0  resource_%logit_3.0  problems_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_1.0  the_%logit_2.0  best_%logit_3.0  manual_%logit_3.0  labour_%logit_1.0  technique_%logit_1.0  and_%logit_1.0  the_%logit_1.0  best_%logit_3.0  way_%logit_3.0  to_%logit_3.0  integrate_%logit_1.0  manual_%logit_1.0  labour_%logit_1.0  into_%logit_3.0  management_%logit_1.0  of_%logit_1.0  resource_%logit_1.0  problems_%logit_3.0  in_%logit_3.0  human_%logit_1.0  resource_%logit_1.0  management_%logit_3.0  problems_%logit_3.0 ._%logit_1.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_1.0  by_%logit_3.0  which_%logit_3.0  manual_%logit_0.0  labour_%logit_1.0  works_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  how_%logit_1.0  it_%logit_3.0  relates_%logit_1.0  to_%logit_3.0  human_%logit_3.0  resource_%logit_3.0  util_%logit_3.0 isation_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  manual_%logit_1.0  labour_%logit_3.0  with_%logit_1.0  other_%logit_1.0  forms_%logit_1.0  of_%logit_3.0  labour_%logit_1.0  management_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_1.0  specific_%logit_3.0  analges_%logit_3.0 ic_%logit_3.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  post_%logit_1.0 -_%logit_3.0 ext_%logit_0.0 raction_%logit_1.0  pain_%logit_1.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  orth_%logit_1.0 od_%logit_3.0 ont_%logit_1.0 ic_%logit_1.0  pain_%logit_0.0 ._%logit_3.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  conducted_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  random_%logit_0.0 ised_%logit_2.0  controlled_%logit_0.0  trials_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_1.0  analges_%logit_3.0 ics_%logit_2.0  for_%logit_2.0  post_%logit_1.0 -_%logit_3.0 operative_%logit_2.0  pain_%logit_1.0  relief_%logit_3.0  in_%logit_3.0  adults_%logit_3.0  and_%logit_3.0  children_%logit_2.0 ._%logit_1.0  Such_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  analges_%logit_3.0 ic_%logit_2.0  regime_%logit_2.0  and_%logit_2.0  the_%logit_1.0  optimal_%logit_0.0  dosage_%logit_0.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  analges_%logit_1.0 ia_%logit_3.0 ,_%logit_2.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  different_%logit_2.0  analges_%logit_3.0 ic_%logit_3.0  reg_%logit_2.0 imens_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  erg_%logit_1.0 onomic_%logit_3.0  tools_%logit_1.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_0.0  K_%logit_1.0 nee_%logit_0.0  pain_%logit_2.0  and_%logit_0.0  disability_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  erg_%logit_3.0 onomic_%logit_3.0  tool_%logit_1.0  to_%logit_3.0  implement_%logit_2.0  erg_%logit_2.0 onomic_%logit_1.0  techniques_%logit_1.0  in_%logit_3.0  K_%logit_1.0 nee_%logit_1.0  Pain_%logit_1.0  Pain_%logit_0.0  and_%logit_2.0  Disability_%logit_2.0 ,_%logit_0.0  and_%logit_0.0  to_%logit_0.0  compare_%logit_3.0  erg_%logit_2.0 onomic_%logit_3.0  technologies_%logit_1.0  to_%logit_3.0  erg_%logit_1.0 onomic_%logit_1.0  methods_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  erg_%logit_1.0 onomic_%logit_1.0  devices_%logit_1.0  for_%logit_3.0  K_%logit_1.0 nee_%logit_1.0 Pain_%logit_2.0  and_%logit_0.0  Disability_%logit_1.0 ._%logit_0.0  These_%logit_0.0  findings_%logit_0.0  should_%logit_0.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_0.0  caution_%logit_1.0 ,_%logit_3.0  as_%logit_0.0  they_%logit_1.0  are_%logit_1.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_0.0  number_%logit_3.0  of_%logit_0.0  studies_%logit_1.0  with_%logit_0.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  bias_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  are_%logit_1.0  subject_%logit_3.0  to_%logit_0.0  considerable_%logit_0.0  variation_%logit_3.0  in_%logit_3.0  outcome_%logit_1.0  measures_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  AM_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_1.0  the_%logit_2.0  most_%logit_3.0  effective_%logit_3.0  antidepressant_%logit_3.0  for_%logit_3.0  AM_%logit_3.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_3.0  to_%logit_3.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  antidepressants_%logit_0.0  are_%logit_3.0  used_%logit_1.0  to_%logit_1.0  treat_%logit_3.0  AM_%logit_0.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  the_%logit_2.0  mechanism_%logit_3.0  by_%logit_3.0  which_%logit_3.0  they_%logit_1.0  are_%logit_3.0  used_%logit_0.0  in_%logit_0.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  AM_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  with_%logit_3.0  placebo_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  antidepressants_%logit_1.0  for_%logit_3.0  AM_%logit_1.0 ,_%logit_3.0  which_%logit_3.0  is_%logit_3.0  currently_%logit_3.0  in_%logit_0.0  its_%logit_0.0  infancy_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  intraven_%logit_1.0 ous_%logit_1.0  antibiotics_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  forced_%logit_3.0  exp_%logit_3.0 ir_%logit_1.0 atory_%logit_1.0  flow_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  intraven_%logit_3.0 ous_%logit_1.0  antibiotic_%logit_0.0  therapy_%logit_3.0  is_%logit_3.0  more_%logit_1.0  effective_%logit_0.0  than_%logit_1.0  oral_%logit_2.0  antibiotic_%logit_1.0  therapy_%logit_3.0  in_%logit_3.0  improving_%logit_3.0  lung_%logit_3.0  function_%logit_3.0  and_%logit_3.0  improving_%logit_3.0  pulmonary_%logit_3.0  function_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  admitted_%logit_0.0  to_%logit_1.0  intensive_%logit_3.0  care_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  intraven_%logit_2.0 ous_%logit_3.0  and_%logit_0.0  oral_%logit_3.0  antibiotics_%logit_1.0  with_%logit_3.0  oral_%logit_3.0  antibiotics_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  pulmonary_%logit_3.0  function_%logit_3.0  and_%logit_3.0  lung_%logit_3.0  function_%logit_3.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_1.0 ed_%logit_2.0  and_%logit_2.0  executed_%logit_0.0  random_%logit_0.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  intraven_%logit_1.0 ously_%logit_3.0  antibiotic_%logit_0.0  therapy_%logit_1.0  on_%logit_3.0  pulmonary_%logit_1.0  function_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  also_%logit_3.0  to_%logit_3.0  compare_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_1.0  therapy_%logit_3.0  to_%logit_3.0  oral_%logit_3.0  antibiotics_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_0.0  any_%logit_3.0  particular_%logit_3.0  surgical_%logit_3.0  technique_%logit_1.0  for_%logit_1.0  removing_%logit_1.0  surgical_%logit_0.0  s_%logit_3.0 ut_%logit_3.0 ures_%logit_3.0  in_%logit_2.0  patients_%logit_3.0  with_%logit_3.0  sin_%logit_0.0 us_%logit_3.0  infections_%logit_2.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  surgical_%logit_3.0  technique_%logit_3.0  and_%logit_3.0  the_%logit_1.0  best_%logit_0.0  way_%logit_3.0  to_%logit_3.0  minim_%logit_1.0 ise_%logit_2.0  rec_%logit_0.0 urrence_%logit_3.0  and_%logit_0.0  minim_%logit_3.0 ise_%logit_0.0  the_%logit_0.0  risk_%logit_3.0  of_%logit_3.0  rec_%logit_1.0 urrence_%logit_3.0  in_%logit_0.0  these_%logit_3.0  patients_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_1.0  surgical_%logit_3.0  techniques_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  wound_%logit_1.0  dressing_%logit_1.0 ,_%logit_3.0  s_%logit_1.0 ut_%logit_1.0 uring_%logit_1.0  devices_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  wound_%logit_1.0  dressing_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_2.0  is_%logit_0.0  required_%logit_3.0  to_%logit_3.0  investigate_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_3.0  of_%logit_3.0  various_%logit_3.0  surgical_%logit_3.0  techniques_%logit_3.0  for_%logit_3.0  treating_%logit_1.0  sin_%logit_3.0 us_%logit_3.0  infection_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  also_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  surgical_%logit_2.0  techniques_%logit_3.0  to_%logit_3.0  other_%logit_1.0  surgical_%logit_3.0  methods_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  any_%logit_3.0  of_%logit_3.0  the_%logit_3.0  interventions_%logit_0.0  reviewed_%logit_3.0  in_%logit_1.0  this_%logit_3.0  review_%logit_0.0 ._%logit_2.0  There_%logit_3.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  large_%logit_1.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  systematic_%logit_2.0  review_%logit_2.0  of_%logit_0.0  the_%logit_0.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  the_%logit_3.0  various_%logit_3.0  approaches_%logit_3.0  to_%logit_3.0  managing_%logit_1.0  compliance_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  a_%logit_0.0  review_%logit_1.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_3.0  a_%logit_1.0  large_%logit_3.0  scale_%logit_3.0 ,_%logit_3.0  multi_%logit_2.0 -_%logit_2.0 cent_%logit_2.0 re_%logit_2.0 ,_%logit_2.0  mult_%logit_0.0 icent_%logit_2.0 re_%logit_2.0 ,_%logit_2.0  placebo_%logit_0.0 -_%logit_2.0 controlled_%logit_1.0 ,_%logit_2.0  double_%logit_2.0 -_%logit_2.0 blind_%logit_0.0  controlled_%logit_0.0  trial_%logit_2.0  with_%logit_0.0  a_%logit_2.0  focus_%logit_2.0  on_%logit_2.0  compliance_%logit_3.0  with_%logit_3.0  standard_%logit_3.0  medication_%logit_3.0  and_%logit_3.0  adherence_%logit_3.0  to_%logit_3.0  standard_%logit_3.0  medication_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_3.0  specific_%logit_3.0  type_%logit_3.0  of_%logit_1.0  ant_%logit_3.0 ich_%logit_3.0 olin_%logit_2.0 erg_%logit_0.0 ics_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  sensory_%logit_1.0  nerve_%logit_3.0  block_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  ant_%logit_1.0 ico_%logit_0.0 ag_%logit_2.0 ulation_%logit_2.0 ,_%logit_0.0  the_%logit_3.0  optimal_%logit_3.0  timing_%logit_0.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_3.0  analges_%logit_1.0 ia_%logit_0.0 ,_%logit_2.0  and_%logit_1.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_0.0  timing_%logit_1.0  for_%logit_3.0  analges_%logit_1.0 ia_%logit_3.0 ._%logit_2.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  trials_%logit_2.0  should_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  various_%logit_3.0  types_%logit_3.0  of_%logit_3.0  nerve_%logit_1.0  stimulation_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_1.0  assess_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  different_%logit_1.0  types_%logit_3.0  of_%logit_3.0  anti_%logit_2.0 em_%logit_3.0 etic_%logit_3.0  agents_%logit_2.0 ,_%logit_3.0  and_%logit_1.0  their_%logit_1.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_1.0  management_%logit_3.0  of_%logit_3.0  pain_%logit_1.0 ,_%logit_3.0  function_%logit_3.0  and_%logit_3.0  function_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  positive_%logit_3.0  effect_%logit_3.0  of_%logit_3.0  relaxation_%logit_1.0  exercises_%logit_3.0  on_%logit_1.0  hand_%logit_1.0  function_%logit_3.0  and_%logit_0.0  independence_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  impaired_%logit_3.0  limb_%logit_3.0  function_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  relaxation_%logit_3.0  exercises_%logit_1.0  are_%logit_3.0  beneficial_%logit_1.0  or_%logit_3.0  harmful_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  whether_%logit_3.0  relaxing_%logit_3.0  exercises_%logit_3.0  may_%logit_3.0  be_%logit_1.0  beneficial_%logit_3.0  or_%logit_3.0  detrimental_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  studies_%logit_0.0  are_%logit_1.0  also_%logit_1.0  needed_%logit_1.0  to_%logit_1.0  evaluate_%logit_1.0  relaxation_%logit_2.0  exercises_%logit_3.0  for_%logit_3.0  impaired_%logit_1.0  limb_%logit_3.0  functions_%logit_3.0  and_%logit_3.0  independence_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  relaxation_%logit_2.0  exercises_%logit_3.0  with_%logit_3.0  relaxation_%logit_1.0  exercises_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  studies_%logit_0.0  are_%logit_1.0  needed_%logit_2.0  to_%logit_1.0  assess_%logit_1.0  relaxation_%logit_2.0  exercises_%logit_3.0  and_%logit_3.0  relaxation_%logit_1.0  exercises_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_1.0  as_%logit_1.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  relaxation_%logit_1.0  exercise_%logit_3.0  on_%logit_1.0  muscle_%logit_1.0  strength_%logit_3.0  and_%logit_3.0  flexibility_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_1.0  digital_%logit_1.0  media_%logit_0.0  editing_%logit_0.0  as_%logit_1.0  a_%logit_1.0  tool_%logit_0.0  to_%logit_0.0  improve_%logit_0.0  journalistic_%logit_0.0  integrity_%logit_3.0  and_%logit_3.0  journalistic_%logit_3.0  integrity_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_1.0  to_%logit_1.0  identify_%logit_1.0  the_%logit_2.0  most_%logit_3.0  effective_%logit_3.0  media_%logit_1.0  editing_%logit_1.0  techniques_%logit_1.0  and_%logit_1.0  to_%logit_1.0  assess_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  reliability_%logit_1.0  of_%logit_3.0  such_%logit_1.0  techniques_%logit_1.0 ._%logit_1.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_1.0  by_%logit_3.0  which_%logit_3.0  media_%logit_0.0  editing_%logit_1.0  works_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  how_%logit_1.0  they_%logit_1.0  are_%logit_1.0  used_%logit_1.0  in_%logit_1.0  the_%logit_1.0  context_%logit_0.0  of_%logit_1.0  a_%logit_1.0  multif_%logit_1.0 acet_%logit_1.0 ed_%logit_2.0  media_%logit_2.0  editing_%logit_0.0  programme_%logit_1.0 ._%logit_1.0  Future_%logit_1.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  measuring_%logit_3.0  journalistic_%logit_1.0  integrity_%logit_3.0 ,_%logit_3.0  transparency_%logit_3.0  and_%logit_0.0  accuracy_%logit_1.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_0.0  as_%logit_0.0  on_%logit_2.0  assessing_%logit_0.0  the_%logit_3.0  impact_%logit_3.0  of_%logit_3.0  media_%logit_1.0  editing_%logit_1.0  on_%logit_1.0  journalistic_%logit_1.0  integrity_%logit_3.0  in_%logit_3.0  journalism_%logit_1.0  and_%logit_1.0  journalism_%logit_1.0 ,_%logit_0.0  and_%logit_1.0  also_%logit_0.0  on_%logit_0.0  journalistic_%logit_0.0  ethics_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  cort_%logit_3.0 ic_%logit_3.0 oster_%logit_0.0 oids_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  As_%logit_1.0 per_%logit_3.0 g_%logit_1.0 illus_%logit_0.0  f_%logit_3.0 um_%logit_3.0 ig_%logit_2.0 atus_%logit_2.0 ._%logit_2.0  Further_%logit_1.0  randomized_%logit_2.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  cort_%logit_3.0 ico_%logit_1.0 ag_%logit_2.0 ulation_%logit_1.0  in_%logit_0.0  the_%logit_3.0  management_%logit_0.0  of_%logit_0.0  AS_%logit_3.0 F_%logit_3.0 ._%logit_1.0  Such_%logit_1.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_3.0  a_%logit_1.0  large_%logit_3.0  scale_%logit_3.0  randomized_%logit_3.0  controlled_%logit_0.0  trial_%logit_0.0 ,_%logit_0.0  preferably_%logit_2.0  with_%logit_2.0  a_%logit_2.0  long_%logit_2.0 -_%logit_2.0 term_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  follow_%logit_2.0 -_%logit_3.0 up_%logit_2.0 ._%logit_0.0  They_%logit_1.0  should_%logit_0.0  include_%logit_2.0  patients_%logit_2.0  with_%logit_2.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  hyp_%logit_1.0 ogly_%logit_3.0 ca_%logit_1.0 emia_%logit_0.0  and_%logit_1.0  a_%logit_1.0  low_%logit_3.0  risk_%logit_1.0  of_%logit_1.0  pneum_%logit_1.0 oth_%logit_3.0 or_%logit_0.0 ax_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  prog_%logit_3.0 est_%logit_3.0 ogens_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  PC_%logit_3.0 OS_%logit_3.0 ._%logit_1.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0 ,_%logit_2.0  conducted_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  randomized_%logit_2.0  controlled_%logit_2.0  trials_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_1.0  in_%logit_3.0  PC_%logit_2.0 OS_%logit_0.0  patients_%logit_1.0 ._%logit_1.0  Such_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  high_%logit_0.0  methodological_%logit_2.0  quality_%logit_1.0 ,_%logit_1.0  with_%logit_2.0  appropriate_%logit_2.0  attention_%logit_2.0  paid_%logit_1.0  to_%logit_2.0  outcome_%logit_0.0  measures_%logit_3.0  and_%logit_3.0  duration_%logit_1.0  of_%logit_0.0  follow_%logit_0.0 -_%logit_0.0 up_%logit_2.0 ._%logit_0.0  They_%logit_0.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0 ,_%logit_0.0  and_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  the_%logit_1.0  prog_%logit_3.0 est_%logit_0.0 ogen_%logit_0.0  as_%logit_2.0  an_%logit_2.0  adj_%logit_0.0 u_%logit_0.0 vant_%logit_1.0  treatment_%logit_0.0  for_%logit_0.0  PC_%logit_0.0 OS_%logit_0.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_0.0  as_%logit_0.0  the_%logit_2.0  quality_%logit_0.0  of_%logit_3.0  life_%logit_3.0  of_%logit_0.0  the_%logit_3.0  patients_%logit_0.0  treated_%logit_0.0 ._%logit_1.0
 Cond_%logit_0.0 oms_%logit_0.0  are_%logit_2.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_0.0  sexual_%logit_3.0  risk_%logit_0.0  behaviors_%logit_0.0  and_%logit_3.0  enhancing_%logit_3.0  condom_%logit_3.0  usage_%logit_3.0 ._%logit_3.0  Cond_%logit_3.0 oms_%logit_0.0  appear_%logit_2.0  to_%logit_3.0  reduce_%logit_3.0  sexual_%logit_3.0  risk_%logit_3.0  behaviours_%logit_3.0  and_%logit_3.0  enhance_%logit_3.0  condom_%logit_3.0  usage_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  they_%logit_3.0  do_%logit_3.0  not_%logit_2.0  appear_%logit_3.0  to_%logit_2.0  have_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  impact_%logit_2.0  on_%logit_2.0  sexual_%logit_2.0  risk_%logit_3.0  behaviour_%logit_3.0 ._%logit_3.0  The_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  Cond_%logit_1.0 oms_%logit_3.0  is_%logit_1.0  unclear_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  there_%logit_3.0  is_%logit_3.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  condoms_%logit_1.0  and_%logit_3.0  condoms_%logit_3.0  for_%logit_3.0  sexual_%logit_3.0  risk_%logit_0.0  behavior_%logit_3.0  and_%logit_3.0  sexual_%logit_3.0  risks_%logit_0.0  behaviors_%logit_3.0  in_%logit_3.0  women_%logit_3.0  and_%logit_3.0  their_%logit_3.0  partners_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  in_%logit_2.0  developing_%logit_3.0  countries_%logit_3.0 ,_%logit_3.0  where_%logit_1.0  condoms_%logit_3.0  are_%logit_3.0  widely_%logit_3.0  available_%logit_3.0 ._%logit_0.0  Cond_%logit_3.0 om_%logit_0.0  training_%logit_2.0  may_%logit_3.0  improve_%logit_3.0  condom_%logit_3.0  usage_%logit_0.0  and_%logit_3.0  reduce_%logit_3.0  sexual_%logit_3.0  risks_%logit_3.0 ,_%logit_0.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  no_%logit_3.0  evidence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  sexual_%logit_3.0  risks_%logit_3.0  or_%logit_1.0  STD_%logit_3.0  rates_%logit_3.0  between_%logit_3.0  the_%logit_1.0  two_%logit_3.0  types_%logit_1.0  of_%logit_1.0  condoms_%logit_1.0  or_%logit_1.0  the_%logit_1.0  same_%logit_3.0  type_%logit_3.0  of_%logit_1.0  condoms_%logit_1.0 ._%logit_3.0  Cond_%logit_1.0 o_%logit_0.0  training_%logit_2.0  may_%logit_1.0  also_%logit_3.0  improve_%logit_3.0  condom_%logit_3.0  use_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  it_%logit_3.0  is_%logit_3.0  not_%logit_2.0  clear_%logit_3.0  what_%logit_2.0  type_%logit_3.0  of_%logit_0.0  training_%logit_1.0  is_%logit_0.0  most_%logit_1.0  effective_%logit_0.0 ._%logit_1.0  Cond_%logit_2.0 os_%logit_0.0  should_%logit_2.0  not_%logit_1.0  be_%logit_2.0  used_%logit_2.0  for_%logit_1.0  sexual_%logit_2.0  risks_%logit_3.0  and_%logit_3.0  sexual_%logit_3.0  behaviors_%logit_3.0  in_%logit_3.0  the_%logit_3.0  context_%logit_3.0  of_%logit_3.0  condom_%logit_1.0  use_%logit_3.0  and_%logit_3.0  condom_%logit_3.0  usage_%logit_3.0  in_%logit_3.0  developing_%logit_3.0  nations_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  beta_%logit_3.0 -_%logit_3.0 block_%logit_1.0 ers_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  HELL_%logit_3.0 P_%logit_3.0  syndrome_%logit_0.0 ._%logit_3.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_3.0  in_%logit_2.0  this_%logit_3.0  area_%logit_1.0 ,_%logit_0.0  particularly_%logit_2.0  in_%logit_3.0  the_%logit_3.0  context_%logit_3.0  of_%logit_3.0  the_%logit_3.0  introduction_%logit_3.0  of_%logit_3.0  anti_%logit_3.0 plate_%logit_3.0 let_%logit_3.0  agents_%logit_2.0 ,_%logit_0.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  in_%logit_2.0  the_%logit_3.0  development_%logit_3.0  of_%logit_3.0  a_%logit_3.0  more_%logit_3.0  efficient_%logit_3.0  treatment_%logit_0.0  strategy_%logit_0.0 ._%logit_2.0  In_%logit_2.0  addition_%logit_0.0 ,_%logit_3.0  there_%logit_0.0  is_%logit_0.0  an_%logit_3.0  urgent_%logit_3.0  need_%logit_3.0  for_%logit_0.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_0.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0 ,_%logit_2.0  transparent_%logit_0.0  and_%logit_2.0  reported_%logit_0.0  random_%logit_0.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  beta_%logit_1.0  -_%logit_3.0 block_%logit_1.0 ers_%logit_1.0  on_%logit_2.0  mortality_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_3.0  these_%logit_1.0  patients_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_3.0  of_%logit_3.0  the_%logit_3.0  treatments_%logit_0.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_0.0  oral_%logit_1.0  le_%logit_3.0 uk_%logit_0.0 opl_%logit_1.0 akia_%logit_3.0 ._%logit_1.0  There_%logit_1.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  into_%logit_2.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  treatments_%logit_3.0  in_%logit_3.0  terms_%logit_2.0  of_%logit_3.0  reducing_%logit_3.0  the_%logit_3.0  number_%logit_3.0  and_%logit_3.0  severity_%logit_0.0  of_%logit_3.0  lesions_%logit_0.0  and_%logit_3.0  improving_%logit_1.0  the_%logit_3.0  quality_%logit_0.0  of_%logit_3.0  life_%logit_3.0  of_%logit_0.0  patients_%logit_2.0  with_%logit_0.0  this_%logit_1.0  condition_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  an_%logit_3.0  urgent_%logit_3.0  need_%logit_3.0  for_%logit_0.0  a_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_1.0  and_%logit_0.0  executed_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trial_%logit_2.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  the_%logit_3.0  various_%logit_3.0  treatments_%logit_0.0  in_%logit_2.0  this_%logit_1.0  population_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  laser_%logit_1.0  phot_%logit_0.0 oco_%logit_1.0 ag_%logit_1.0 ulation_%logit_1.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  BC_%logit_3.0 VA_%logit_0.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  way_%logit_3.0  to_%logit_2.0  achieve_%logit_1.0  this_%logit_2.0  goal_%logit_1.0 ,_%logit_1.0  and_%logit_2.0  to_%logit_2.0  compare_%logit_3.0  laser_%logit_2.0  phot_%logit_3.0 o_%logit_1.0 ag_%logit_0.0 ulation_%logit_1.0  with_%logit_2.0  other_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  optical_%logit_1.0  manipulation_%logit_0.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  results_%logit_0.0  of_%logit_3.0  the_%logit_1.0  two_%logit_0.0  trials_%logit_0.0 ,_%logit_0.0  which_%logit_2.0  are_%logit_1.0  currently_%logit_2.0  in_%logit_0.0  progress_%logit_0.0 ._%logit_0.0  The_%logit_2.0  results_%logit_0.0  of_%logit_0.0  these_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_0.0  caution_%logit_1.0 ,_%logit_1.0  as_%logit_2.0  they_%logit_2.0  are_%logit_0.0  based_%logit_2.0  on_%logit_0.0  only_%logit_0.0  a_%logit_0.0  small_%logit_0.0  number_%logit_3.0  of_%logit_0.0  patients_%logit_0.0  and_%logit_0.0  are_%logit_2.0  subject_%logit_2.0  to_%logit_0.0  a_%logit_0.0  high_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  bias_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  therefore_%logit_3.0  should_%logit_3.0  be_%logit_3.0  viewed_%logit_2.0  with_%logit_1.0  caution_%logit_1.0 ._%logit_1.0
 Cognitive_%logit_0.0  behavioural_%logit_0.0  therapy_%logit_0.0  is_%logit_0.0  effective_%logit_1.0  in_%logit_0.0  reducing_%logit_3.0  the_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  depression_%logit_0.0  and_%logit_3.0  reducing_%logit_3.0  the_%logit_3.0  frequency_%logit_3.0  of_%logit_3.0  depressive_%logit_0.0  symptoms_%logit_0.0 ._%logit_3.0  Positive_%logit_1.0  effects_%logit_0.0  of_%logit_3.0  cognitive_%logit_1.0  behavioural_%logit_1.0  therapy_%logit_1.0  are_%logit_1.0  similar_%logit_1.0  to_%logit_3.0  those_%logit_3.0  seen_%logit_1.0  in_%logit_3.0  other_%logit_3.0  types_%logit_3.0  of_%logit_3.0  psychiatric_%logit_2.0  therapy_%logit_3.0 ,_%logit_3.0  but_%logit_1.0  are_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  higher_%logit_3.0  incidence_%logit_3.0  of_%logit_3.0  depression_%logit_1.0 ._%logit_3.0  Cognitive_%logit_3.0  behavioral_%logit_0.0  therapy_%logit_1.0  is_%logit_1.0  less_%logit_1.0  effective_%logit_3.0  than_%logit_1.0  behavioural_%logit_2.0  therapy_%logit_1.0 ._%logit_3.0  Cognitive_%logit_1.0  behavioural_%logit_0.0  counselling_%logit_1.0  is_%logit_1.0  more_%logit_1.0  effective_%logit_1.0  than_%logit_1.0  no_%logit_2.0  treatment_%logit_1.0 ,_%logit_2.0  but_%logit_2.0  is_%logit_2.0  associated_%logit_3.0  with_%logit_3.0  an_%logit_3.0  increased_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  relapse_%logit_1.0 ._%logit_3.0  Cognitive_%logit_3.0  behaviour_%logit_0.0  therapy_%logit_1.0  is_%logit_0.0  more_%logit_1.0  likely_%logit_3.0  to_%logit_1.0  result_%logit_0.0  in_%logit_2.0  an_%logit_1.0  improvement_%logit_3.0  in_%logit_0.0  quality_%logit_1.0  of_%logit_1.0  life_%logit_3.0 ,_%logit_0.0  but_%logit_0.0  its_%logit_3.0  effectiveness_%logit_3.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0 ._%logit_1.0  Cognitive_%logit_2.0  behavior_%logit_0.0  therapy_%logit_1.0  may_%logit_0.0  be_%logit_1.0  more_%logit_3.0  effective_%logit_3.0  in_%logit_1.0  the_%logit_2.0  treatment_%logit_3.0  of_%logit_3.0  depression_%logit_2.0  or_%logit_3.0  anxiety_%logit_3.0  symptoms_%logit_3.0  than_%logit_3.0  behavioural_%logit_1.0  counselling_%logit_1.0 ,_%logit_3.0  but_%logit_1.0  there_%logit_3.0  is_%logit_3.0  no_%logit_2.0  clear_%logit_3.0  evidence_%logit_2.0  of_%logit_3.0  an_%logit_2.0  effect_%logit_3.0  on_%logit_3.0  severity_%logit_1.0  or_%logit_3.0  duration_%logit_3.0  of_%logit_3.0  depression_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  epilepsy_%logit_1.0 ._%logit_3.0  Positive_%logit_3.0  findings_%logit_2.0  of_%logit_3.0  cognitive_%logit_2.0  behaviour_%logit_1.0  therapy_%logit_3.0  are_%logit_0.0  consistent_%logit_2.0  with_%logit_3.0  those_%logit_3.0  of_%logit_1.0  the_%logit_3.0  previous_%logit_3.0  review_%logit_3.0 ,_%logit_2.0  but_%logit_2.0  more_%logit_3.0  research_%logit_3.0  is_%logit_3.0  needed_%logit_2.0  to_%logit_2.0  confirm_%logit_2.0  these_%logit_2.0  findings_%logit_3.0 ._%logit_3.0
 Screen_%logit_0.0 ing_%logit_0.0  mamm_%logit_0.0 ography_%logit_3.0  results_%logit_0.0  in_%logit_3.0  a_%logit_1.0  significant_%logit_3.0  reduction_%logit_3.0  in_%logit_0.0  the_%logit_0.0  incidence_%logit_0.0  of_%logit_0.0  pap_%logit_0.0  sm_%logit_3.0 ears_%logit_1.0 ,_%logit_1.0  but_%logit_0.0  a_%logit_3.0  significant_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  the_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  breast_%logit_1.0  cancer_%logit_3.0 ._%logit_0.0  Screen_%logit_0.0 ing_%logit_0.0  results_%logit_2.0  in_%logit_0.0  an_%logit_1.0  increase_%logit_3.0  in_%logit_3.0  breast_%logit_1.0  cancer_%logit_3.0  screening_%logit_0.0  rates_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  no_%logit_3.0  significant_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  overall_%logit_3.0  survival_%logit_3.0 ._%logit_0.0  Screen_%logit_3.0 ings_%logit_0.0  are_%logit_2.0  also_%logit_2.0  associated_%logit_0.0  with_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  decrease_%logit_3.0  in_%logit_3.0  the_%logit_1.0  number_%logit_3.0  of_%logit_3.0  smear_%logit_0.0 -_%logit_3.0 related_%logit_2.0  deaths_%logit_2.0 ,_%logit_3.0  but_%logit_0.0  this_%logit_3.0  is_%logit_3.0  based_%logit_3.0  on_%logit_3.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  studies_%logit_3.0  with_%logit_0.0  short_%logit_2.0 -_%logit_1.0 term_%logit_3.0  follow_%logit_1.0 -_%logit_0.0 up_%logit_2.0  and_%logit_0.0  a_%logit_3.0  very_%logit_3.0  low_%logit_3.0  risk_%logit_1.0  of_%logit_0.0  bias_%logit_0.0 ._%logit_0.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  screening_%logit_1.0  mamm_%logit_0.0 ography_%logit_3.0  on_%logit_2.0  quality_%logit_1.0  of_%logit_0.0  life_%logit_3.0  and_%logit_0.0  health_%logit_3.0  behaviours_%logit_0.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  screening_%logit_2.0  mamm_%logit_3.0 ograms_%logit_3.0  with_%logit_2.0  other_%logit_3.0  screening_%logit_3.0  methods_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  relaxation_%logit_3.0  exercises_%logit_3.0  in_%logit_1.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  f_%logit_3.0 ec_%logit_3.0 al_%logit_0.0  inc_%logit_3.0 ont_%logit_0.0 inence_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_1.0  whether_%logit_2.0  relaxation_%logit_3.0  exercises_%logit_1.0  are_%logit_1.0  beneficial_%logit_1.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_0.0  patients_%logit_3.0  with_%logit_0.0  F_%logit_1.0 ec_%logit_3.0 al_%logit_1.0  Inc_%logit_1.0 ont_%logit_3.0 inence_%logit_3.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  relaxation_%logit_2.0  exercises_%logit_3.0  as_%logit_3.0  an_%logit_1.0  adjunct_%logit_3.0  to_%logit_0.0  relaxation_%logit_0.0  exercises_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  relaxation_%logit_1.0  exercises_%logit_3.0  for_%logit_3.0  patients_%logit_1.0  who_%logit_3.0  are_%logit_1.0  struggling_%logit_1.0  with_%logit_1.0  relaxation_%logit_1.0 ._%logit_3.0  This_%logit_3.0  is_%logit_0.0  particularly_%logit_0.0  important_%logit_0.0  in_%logit_0.0  areas_%logit_3.0  where_%logit_0.0  relaxation_%logit_3.0  exercises_%logit_3.0  do_%logit_3.0  not_%logit_1.0  seem_%logit_1.0  to_%logit_1.0  be_%logit_1.0  beneficial_%logit_1.0  or_%logit_1.0  detrimental_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  acoustic_%logit_3.0  stimulation_%logit_3.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  s_%logit_1.0 ut_%logit_3.0 ured_%logit_3.0  vul_%logit_2.0 var_%logit_3.0  tears_%logit_2.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  acoustic_%logit_3.0  stimulating_%logit_1.0  stimulation_%logit_3.0  in_%logit_3.0  this_%logit_1.0  population_%logit_3.0 ,_%logit_0.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  acoustic_%logit_2.0  stimulation_%logit_3.0  with_%logit_3.0  other_%logit_3.0  forms_%logit_3.0  of_%logit_3.0  stimulation_%logit_1.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_1.0  vibration_%logit_1.0  stimulation_%logit_1.0 ,_%logit_3.0  vibration_%logit_1.0  stimulation_%logit_3.0  and_%logit_1.0  vibration_%logit_1.0  stimulation_%logit_3.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  acoustic_%logit_1.0  stimulation_%logit_3.0  for_%logit_3.0  s_%logit_1.0 ut_%logit_3.0 ures_%logit_2.0  vul_%logit_2.0 va_%logit_1.0  tears_%logit_2.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_1.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  electromagnetic_%logit_3.0  stimulation_%logit_1.0  in_%logit_3.0  these_%logit_1.0  populations_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0  there_%logit_0.0  is_%logit_1.0  an_%logit_2.0  urgent_%logit_3.0  need_%logit_0.0  for_%logit_0.0  research_%logit_1.0  into_%logit_1.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  vibration_%logit_1.0  stimulation_%logit_1.0  on_%logit_1.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0 ._%logit_1.0
 The_%logit_0.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  support_%logit_2.0  the_%logit_2.0  use_%logit_1.0  of_%logit_3.0  relaxation_%logit_1.0  exercises_%logit_1.0  as_%logit_1.0  a_%logit_1.0  measure_%logit_0.0  of_%logit_0.0  quality_%logit_0.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0  Relax_%logit_3.0 ation_%logit_1.0  exercises_%logit_0.0  appear_%logit_1.0  to_%logit_1.0  have_%logit_1.0  a_%logit_1.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_0.0  relaxation_%logit_1.0  exercises_%logit_3.0 ,_%logit_1.0  although_%logit_1.0  results_%logit_3.0  were_%logit_3.0  not_%logit_2.0  statistically_%logit_1.0  significant_%logit_1.0  in_%logit_1.0  the_%logit_2.0  short_%logit_1.0 -_%logit_1.0 term_%logit_1.0 ._%logit_1.0  Exercise_%logit_2.0  exercises_%logit_0.0  may_%logit_1.0  have_%logit_1.0  a_%logit_3.0  positive_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  fatigue_%logit_1.0 ,_%logit_3.0  but_%logit_3.0  further_%logit_3.0  research_%logit_3.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  whether_%logit_2.0  relaxation_%logit_3.0  exercises_%logit_1.0  are_%logit_1.0  beneficial_%logit_1.0  in_%logit_1.0  the_%logit_1.0  long_%logit_3.0 -_%logit_3.0 term_%logit_3.0  or_%logit_1.0  in_%logit_1.0  the_%logit_3.0  longer_%logit_3.0  term_%logit_3.0 ._%logit_3.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_0.0  also_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  assess_%logit_2.0  relaxation_%logit_2.0  exercises_%logit_3.0  and_%logit_1.0  relaxation_%logit_1.0  exercises_%logit_3.0  for_%logit_1.0  relaxation_%logit_1.0  exercises_%logit_0.0  after_%logit_1.0  surgery_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  mortality_%logit_3.0  or_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_3.0  acute_%logit_3.0  b_%logit_3.0 iliary_%logit_3.0  pancreat_%logit_1.0 itis_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_3.0  whether_%logit_2.0  there_%logit_3.0  are_%logit_3.0  differences_%logit_3.0  in_%logit_3.0  mortality_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  between_%logit_3.0  the_%logit_3.0  two_%logit_3.0  approaches_%logit_3.0 ._%logit_3.0  Such_%logit_1.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  the_%logit_3.0  various_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  intra_%logit_1.0 -_%logit_3.0 oral_%logit_1.0  drainage_%logit_1.0  and_%logit_0.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  methods_%logit_3.0  on_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  and_%logit_3.0  mortality_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  these_%logit_3.0  approaches_%logit_3.0  to_%logit_3.0  other_%logit_3.0  types_%logit_3.0  of_%logit_3.0  drainage_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  _%logit_3.0 ery_%logit_3.0 throp_%logit_1.0 o_%logit_1.0 iet_%logit_1.0 in_%logit_0.0  for_%logit_2.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  RA_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  randomized_%logit_2.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  _%logit_1.0 ary_%logit_3.0 throp_%logit_1.0 o_%logit_2.0 iat_%logit_2.0 in_%logit_2.0  for_%logit_1.0  RA_%logit_3.0 ._%logit_3.0  Such_%logit_1.0  trials_%logit_0.0  should_%logit_0.0  include_%logit_2.0  patients_%logit_2.0  with_%logit_2.0  a_%logit_1.0  history_%logit_3.0  of_%logit_1.0  RA_%logit_3.0  who_%logit_3.0  are_%logit_1.0  at_%logit_2.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  relapse_%logit_1.0  and_%logit_3.0  those_%logit_1.0  with_%logit_3.0  severe_%logit_3.0  ana_%logit_3.0 emia_%logit_3.0 ._%logit_2.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  other_%logit_1.0  treatments_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  gluc_%logit_1.0 oc_%logit_3.0 ort_%logit_3.0 ic_%logit_1.0 oid_%logit_1.0  therapy_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_1.0  as_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  health_%logit_3.0 -_%logit_3.0 related_%logit_0.0  productivity_%logit_0.0 ._%logit_0.0
 Manual_%logit_0.0  removal_%logit_3.0  of_%logit_3.0  the_%logit_3.0  pl_%logit_3.0 acent_%logit_3.0 a_%logit_2.0  reduces_%logit_2.0  the_%logit_1.0  risk_%logit_3.0  of_%logit_3.0  post_%logit_3.0 part_%logit_3.0 um_%logit_0.0  ha_%logit_0.0 em_%logit_3.0 or_%logit_1.0 rh_%logit_3.0 age_%logit_0.0  and_%logit_3.0  the_%logit_3.0  need_%logit_3.0  for_%logit_3.0  blood_%logit_3.0  transf_%logit_3.0 usion_%logit_3.0 ,_%logit_2.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  this_%logit_3.0  procedure_%logit_3.0  as_%logit_1.0  a_%logit_3.0  substitute_%logit_1.0  for_%logit_0.0  manual_%logit_0.0  removal_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  method_%logit_3.0  of_%logit_0.0  manual_%logit_1.0  removal_%logit_1.0  and_%logit_1.0  the_%logit_3.0  best_%logit_3.0  way_%logit_3.0  to_%logit_3.0  administer_%logit_1.0  it_%logit_2.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  an_%logit_1.0  assessment_%logit_1.0  of_%logit_0.0  the_%logit_1.0  risks_%logit_3.0  and_%logit_3.0  benefits_%logit_1.0  of_%logit_3.0  using_%logit_1.0  manual_%logit_3.0  removal_%logit_3.0  as_%logit_3.0  an_%logit_3.0  alternative_%logit_1.0  to_%logit_0.0  manual_%logit_0.0  removal_%logit_1.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  manual_%logit_2.0  removal_%logit_3.0  with_%logit_3.0  manual_%logit_3.0  removal_%logit_1.0  of_%logit_3.0  pl_%logit_3.0 acent_%logit_3.0 as_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  correlation_%logit_3.0  between_%logit_3.0  prenatal_%logit_3.0  abstinence_%logit_3.0  and_%logit_3.0  maternal_%logit_1.0  alcohol_%logit_3.0  use_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  prenatal_%logit_3.0  abstinence_%logit_1.0  as_%logit_3.0  a_%logit_3.0  measure_%logit_3.0  of_%logit_3.0  maternal_%logit_0.0  abstinence_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  prenatal_%logit_2.0  abstinence_%logit_3.0  with_%logit_3.0  prenatal_%logit_3.0  abstinence_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  prenatal_%logit_1.0  alcohol_%logit_3.0  use_%logit_3.0  on_%logit_3.0  maternal_%logit_3.0  alcohol_%logit_3.0  intake_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_0.0  assess_%logit_1.0  its_%logit_2.0  effect_%logit_3.0  on_%logit_3.0  maternal_%logit_1.0  and_%logit_3.0  neon_%logit_3.0 atal_%logit_1.0  mortality_%logit_1.0 ,_%logit_3.0  a_%logit_3.0  meta_%logit_3.0 -_%logit_3.0 analysis_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  to_%logit_1.0  determine_%logit_2.0  its_%logit_2.0  role_%logit_3.0  in_%logit_3.0  prenatal_%logit_3.0  abstinence_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  healing_%logit_3.0  rates_%logit_3.0  between_%logit_3.0  the_%logit_3.0  two_%logit_3.0  types_%logit_3.0  of_%logit_2.0  anti_%logit_1.0 em_%logit_1.0 etic_%logit_1.0  drugs_%logit_2.0  for_%logit_3.0  cor_%logit_1.0 ne_%logit_3.0 al_%logit_1.0  abras_%logit_3.0 ions_%logit_3.0 ._%logit_1.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  the_%logit_2.0  treatment_%logit_3.0  of_%logit_0.0  these_%logit_1.0  conditions_%logit_1.0  and_%logit_3.0  to_%logit_2.0  compare_%logit_3.0  them_%logit_2.0  to_%logit_3.0  each_%logit_3.0  other_%logit_3.0  in_%logit_2.0  terms_%logit_3.0  of_%logit_3.0  healing_%logit_3.0  rates_%logit_3.0 ,_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0  and_%logit_3.0  satisfaction_%logit_1.0  with_%logit_3.0  treatment_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  an_%logit_1.0  assessment_%logit_1.0  of_%logit_0.0  the_%logit_1.0  effects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  medications_%logit_3.0  on_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  pain_%logit_0.0  relief_%logit_3.0  in_%logit_1.0  the_%logit_1.0  long_%logit_1.0  term_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  anti_%logit_3.0 plate_%logit_3.0 let_%logit_3.0  agents_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  transf_%logit_3.0 usion_%logit_3.0  reactions_%logit_2.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0  trials_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  anti_%logit_1.0  plate_%logit_3.0 let_%logit_3.0  agents_%logit_2.0  on_%logit_3.0  transf_%logit_1.0 usion_%logit_3.0  response_%logit_2.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  agents_%logit_3.0  with_%logit_3.0  placebo_%logit_3.0  or_%logit_3.0  no_%logit_3.0  treatment_%logit_3.0 ._%logit_3.0  Such_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  high_%logit_0.0  quality_%logit_1.0 ,_%logit_1.0  preferably_%logit_2.0  with_%logit_2.0  low_%logit_2.0  risk_%logit_2.0  of_%logit_3.0  bias_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  should_%logit_2.0  include_%logit_2.0  patients_%logit_2.0  with_%logit_2.0  a_%logit_1.0  history_%logit_1.0  of_%logit_1.0  allergic_%logit_3.0  reactions_%logit_3.0 ._%logit_3.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  include_%logit_2.0  patients_%logit_2.0  who_%logit_0.0  are_%logit_1.0  at_%logit_2.0  high_%logit_2.0  risk_%logit_1.0  of_%logit_1.0  infection_%logit_1.0 ,_%logit_3.0  such_%logit_3.0  as_%logit_3.0  those_%logit_1.0  who_%logit_3.0  are_%logit_3.0  allergic_%logit_2.0  to_%logit_1.0  plate_%logit_3.0 let_%logit_3.0  products_%logit_0.0 ,_%logit_3.0  and_%logit_2.0  those_%logit_3.0  who_%logit_3.0  do_%logit_3.0  not_%logit_2.0  have_%logit_1.0  an_%logit_2.0  allergy_%logit_3.0  to_%logit_3.0  these_%logit_3.0  products_%logit_3.0 ._%logit_3.0
 Parent_%logit_0.0 ing_%logit_0.0  skills_%logit_0.0  are_%logit_3.0  effective_%logit_1.0  in_%logit_0.0  reducing_%logit_3.0  sexual_%logit_3.0  risk_%logit_3.0  behaviours_%logit_0.0 ,_%logit_3.0  reducing_%logit_3.0  sexual_%logit_3.0  initiation_%logit_3.0  rates_%logit_3.0 ,_%logit_3.0  reducing_%logit_0.0  violence_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  reducing_%logit_3.0  violence_%logit_3.0 ._%logit_3.0  They_%logit_3.0  are_%logit_0.0  also_%logit_2.0  effective_%logit_3.0  in_%logit_0.0  preventing_%logit_3.0  sexual_%logit_3.0  initiation_%logit_3.0  and_%logit_3.0  sexual_%logit_3.0  initiation_%logit_0.0 ,_%logit_3.0  reducing_%logit_3.0  violent_%logit_3.0  initiation_%logit_3.0  rates_%logit_3.0  and_%logit_3.0  decreasing_%logit_3.0  violence_%logit_3.0  rates_%logit_3.0 ._%logit_3.0  Parent_%logit_3.0 ing_%logit_0.0  Skills_%logit_1.0  are_%logit_1.0  effective_%logit_1.0  as_%logit_0.0  a_%logit_3.0  tool_%logit_1.0  to_%logit_3.0  reduce_%logit_0.0  sexual_%logit_0.0  initiation_%logit_0.0  rate_%logit_1.0 ,_%logit_3.0  but_%logit_3.0  they_%logit_3.0  are_%logit_3.0  also_%logit_2.0  associated_%logit_1.0  with_%logit_0.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  violence_%logit_0.0  rates_%logit_3.0  and_%logit_3.0  violence_%logit_1.0  rates_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  a_%logit_3.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  sexual_%logit_0.0  initiation_%logit_3.0 ._%logit_1.0  Parents_%logit_3.0  and_%logit_0.0  their_%logit_1.0  children_%logit_0.0  are_%logit_1.0  more_%logit_2.0  likely_%logit_0.0  to_%logit_0.0  report_%logit_0.0  positive_%logit_2.0  results_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  the_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  the_%logit_3.0  evidence_%logit_3.0  is_%logit_0.0  low_%logit_3.0 ._%logit_1.0  Parents_%logit_2.0  should_%logit_0.0  be_%logit_1.0  encouraged_%logit_2.0  to_%logit_1.0  take_%logit_1.0  part_%logit_2.0  in_%logit_0.0  the_%logit_1.0  evaluation_%logit_0.0  of_%logit_1.0  parent_%logit_3.0 -_%logit_0.0 child_%logit_1.0  relationship_%logit_1.0  skills_%logit_3.0  as_%logit_3.0  a_%logit_1.0  core_%logit_0.0  component_%logit_0.0  of_%logit_0.0  their_%logit_0.0  parenting_%logit_0.0  skills_%logit_1.0 ._%logit_1.0  Parents_%logit_1.0  need_%logit_1.0  to_%logit_1.0  be_%logit_1.0  aware_%logit_2.0  of_%logit_2.0  the_%logit_1.0  risks_%logit_3.0  and_%logit_3.0  benefits_%logit_1.0  of_%logit_3.0  parenting_%logit_1.0  skills_%logit_1.0  as_%logit_1.0  an_%logit_1.0  integral_%logit_1.0  part_%logit_0.0  of_%logit_0.0  the_%logit_0.0  parenting_%logit_1.0  skills_%logit_1.0  programme_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  of_%logit_3.0  the_%logit_3.0  role_%logit_3.0  of_%logit_3.0  parent_%logit_1.0  training_%logit_3.0  in_%logit_1.0  reducing_%logit_1.0  violence_%logit_3.0  and_%logit_3.0  violence_%logit_3.0 ._%logit_3.0  Parents_%logit_3.0  also_%logit_1.0  need_%logit_2.0  to_%logit_2.0  take_%logit_1.0  into_%logit_2.0  account_%logit_3.0  the_%logit_1.0  fact_%logit_3.0  that_%logit_3.0  parents_%logit_1.0  and_%logit_3.0  children_%logit_1.0  are_%logit_1.0  likely_%logit_2.0  to_%logit_0.0  respond_%logit_0.0  negatively_%logit_1.0  to_%logit_3.0  parenting_%logit_3.0  skills_%logit_3.0 ,_%logit_1.0  and_%logit_1.0  that_%logit_3.0  they_%logit_3.0  may_%logit_3.0  have_%logit_2.0  a_%logit_1.0  role_%logit_0.0  to_%logit_3.0  play_%logit_1.0  in_%logit_1.0  helping_%logit_1.0  parents_%logit_0.0  to_%logit_0.0  improve_%logit_1.0  their_%logit_1.0  own_%logit_3.0  parenting_%logit_3.0  skills_%logit_1.0  and_%logit_1.0  behaviours_%logit_3.0 ._%logit_0.0  Parents_%logit_3.0 ,_%logit_0.0  children_%logit_2.0  and_%logit_1.0  parents_%logit_2.0  need_%logit_3.0  to_%logit_2.0  weigh_%logit_0.0  the_%logit_2.0  potential_%logit_3.0  benefits_%logit_3.0  and_%logit_3.0  drawbacks_%logit_1.0  of_%logit_3.0  parenting_%logit_1.0  Skills_%logit_1.0  as_%logit_1.0  a_%logit_1.0  standalone_%logit_1.0  component_%logit_0.0  of_%logit_0.0  the_%logit_0.0  programme_%logit_0.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_3.0  as_%logit_1.0  the_%logit_2.0  potential_%logit_3.0  drawbacks_%logit_3.0  and_%logit_3.0  drawbacks_%logit_1.0 ._%logit_3.0  Parents_%logit_1.0  can_%logit_1.0  expect_%logit_1.0  to_%logit_2.0  be_%logit_1.0  disappointed_%logit_0.0  with_%logit_0.0  the_%logit_3.0  results_%logit_3.0  of_%logit_3.0  this_%logit_1.0  review_%logit_0.0 ._%logit_0.0  Parents_%logit_2.0  deserve_%logit_0.0  to_%logit_1.0  be_%logit_3.0  informed_%logit_2.0  of_%logit_1.0  the_%logit_3.0  potential_%logit_3.0  pitfalls_%logit_3.0  and_%logit_3.0  pitfalls_%logit_1.0  of_%logit_3.0  coaching_%logit_1.0  skills_%logit_1.0  as_%logit_1.0  part_%logit_1.0  of_%logit_1.0  their_%logit_1.0  role_%logit_1.0  in_%logit_1.0  parenting_%logit_1.0  skills_%logit_3.0  programmes_%logit_1.0 ._%logit_1.0  Parents_%logit_1.0  may_%logit_1.0  also_%logit_2.0  expect_%logit_2.0  to_%logit_2.0  find_%logit_1.0  satisfaction_%logit_2.0  with_%logit_1.0  coaching_%logit_3.0  skills_%logit_3.0 ,_%logit_1.0  but_%logit_1.0  this_%logit_3.0  is_%logit_3.0  unlikely_%logit_1.0  to_%logit_3.0  be_%logit_2.0  sustained_%logit_2.0 ._%logit_0.0  Parents_%logit_3.0  are_%logit_1.0  also_%logit_2.0  likely_%logit_1.0  to_%logit_1.0  have_%logit_1.0  an_%logit_2.0  easier_%logit_0.0  time_%logit_2.0  with_%logit_2.0  parenting_%logit_1.0  skills_%logit_1.0  than_%logit_1.0  their_%logit_1.0  children_%logit_1.0 ,_%logit_1.0  and_%logit_2.0  will_%logit_3.0  have_%logit_3.0  a_%logit_2.0  better_%logit_3.0  understanding_%logit_2.0  of_%logit_0.0  the_%logit_3.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  parenting_%logit_0.0  skills_%logit_1.0  work_%logit_1.0 ._%logit_1.0  Parents_%logit_1.0  have_%logit_1.0  a_%logit_1.0  greater_%logit_1.0  chance_%logit_1.0  of_%logit_1.0  being_%logit_1.0  disappointed_%logit_3.0  with_%logit_0.0  their_%logit_3.0  child_%logit_3.0 's_%logit_1.0  behaviour_%logit_0.0 ,_%logit_3.0  and_%logit_3.0  may_%logit_3.0  have_%logit_3.0  more_%logit_2.0  opportunities_%logit_1.0  to_%logit_3.0  seek_%logit_1.0  support_%logit_2.0  from_%logit_3.0  parents_%logit_1.0  and_%logit_0.0  their_%logit_1.0  care_%logit_1.0 rs_%logit_1.0 ._%logit_3.0  Parent_%logit_2.0  training_%logit_0.0  may_%logit_1.0  also_%logit_1.0  have_%logit_3.0  an_%logit_2.0  impact_%logit_3.0  on_%logit_2.0  behaviour_%logit_1.0  change_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  it_%logit_3.0  is_%logit_3.0  unclear_%logit_2.0  whether_%logit_3.0  this_%logit_3.0  will_%logit_1.0  translate_%logit_1.0  into_%logit_2.0  a_%logit_3.0  greater_%logit_3.0  proportion_%logit_3.0  of_%logit_0.0  successful_%logit_0.0  parenting_%logit_3.0  skills_%logit_1.0  being_%logit_1.0  employed_%logit_1.0  as_%logit_1.0  a_%logit_1.0  part_%logit_1.0  of_%logit_0.0  a_%logit_0.0  parenting_%logit_1.0  programme_%logit_1.0 ._%logit_1.0  Parents_%logit_1.0 '_%logit_0.0  satisfaction_%logit_1.0  with_%logit_3.0  parenting_%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_1.0  of_%logit_3.0  SC_%logit_3.0 S_%logit_1.0  as_%logit_3.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_0.0  SC_%logit_0.0 S_%logit_1.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_0.0  limb_%logit_3.0  survival_%logit_3.0 ,_%logit_0.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_0.0  pain_%logit_1.0  relief_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  function_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_2.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  SC_%logit_3.0 S_%logit_2.0  dose_%logit_1.0  and_%logit_2.0  duration_%logit_1.0 ,_%logit_0.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_0.0  SC_%logit_2.0 S_%logit_3.0  with_%logit_3.0  SC_%logit_3.0 S_%logit_2.0 ,_%logit_2.0  SC_%logit_1.0 S_%logit_2.0  and_%logit_2.0  SC_%logit_1.0 S_%logit_0.0  at_%logit_0.0  different_%logit_1.0  doses_%logit_1.0  and_%logit_2.0  times_%logit_2.0 ,_%logit_1.0  and_%logit_2.0  also_%logit_2.0  to_%logit_2.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_2.0  timing_%logit_1.0  of_%logit_0.0  sc_%logit_1.0 S_%logit_2.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_2.0  whether_%logit_2.0  SC_%logit_3.0 S_%logit_1.0  is_%logit_3.0  better_%logit_1.0  than_%logit_1.0  SC_%logit_1.0 S_%logit_2.0  or_%logit_1.0  SC_%logit_1.0 S_%logit_2.0  alone_%logit_1.0  or_%logit_1.0  in_%logit_1.0  combination_%logit_3.0 ,_%logit_3.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  both_%logit_3.0  methods_%logit_2.0 ._%logit_1.0  Finally_%logit_1.0  to_%logit_0.0  compare_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  methods_%logit_2.0 ,_%logit_2.0  to_%logit_1.0  compare_%logit_2.0  them_%logit_2.0  to_%logit_3.0  SC_%logit_1.0 S_%logit_3.0  using_%logit_1.0  SC_%logit_1.0 S_%logit_2.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 roc_%logit_3.0 oll_%logit_1.0 oid_%logit_3.0  tablets_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  Cro_%logit_3.0 hn_%logit_3.0 's_%logit_3.0  disease_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 oc_%logit_1.0 oll_%logit_3.0 oid_%logit_1.0  cream_%logit_2.0  in_%logit_3.0  Cro_%logit_2.0 hn_%logit_0.0 �_%logit_1.0 �_%logit_3.0 s_%logit_2.0  disease_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_0.0  a_%logit_1.0  large_%logit_3.0  scale_%logit_3.0  randomized_%logit_3.0  controlled_%logit_2.0  trial_%logit_2.0 ,_%logit_0.0  preferably_%logit_2.0  with_%logit_2.0  a_%logit_2.0  long_%logit_2.0 -_%logit_2.0 term_%logit_2.0  duration_%logit_0.0  of_%logit_0.0  follow_%logit_2.0 -_%logit_3.0 up_%logit_2.0 ,_%logit_0.0  and_%logit_1.0  with_%logit_2.0  a_%logit_2.0  focus_%logit_2.0  on_%logit_1.0  efficacy_%logit_3.0  and_%logit_3.0  toler_%logit_3.0 ability_%logit_3.0 ._%logit_0.0  They_%logit_3.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  hyd_%logit_1.0 rop_%logit_3.0 oll_%logit_3.0 oid_%logit_1.0  therapy_%logit_2.0  on_%logit_3.0  relapse_%logit_1.0  and_%logit_3.0  relapse_%logit_1.0  severity_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  on_%logit_2.0  quality_%logit_0.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_3.0  any_%logit_1.0  of_%logit_1.0  the_%logit_3.0  interventions_%logit_1.0  reviewed_%logit_0.0  in_%logit_1.0  this_%logit_1.0  review_%logit_0.0 ._%logit_0.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  various_%logit_3.0  interventions_%logit_1.0  in_%logit_1.0  the_%logit_1.0  management_%logit_0.0  of_%logit_0.0  pain_%logit_3.0  and_%logit_3.0  function_%logit_3.0  of_%logit_3.0  people_%logit_3.0  with_%logit_3.0  chronic_%logit_1.0  pain_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  their_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  various_%logit_1.0  settings_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  in_%logit_1.0  this_%logit_1.0  area_%logit_0.0 ,_%logit_0.0  particularly_%logit_2.0  in_%logit_1.0  areas_%logit_1.0  with_%logit_3.0  a_%logit_3.0  high_%logit_3.0  incidence_%logit_3.0  of_%logit_3.0  chronic_%logit_3.0  pain_%logit_3.0 ,_%logit_3.0  such_%logit_3.0  as_%logit_3.0  hospitals_%logit_1.0  and_%logit_3.0  clinics_%logit_1.0 ,_%logit_0.0  as_%logit_1.0  well_%logit_1.0  as_%logit_3.0  in_%logit_2.0  regions_%logit_0.0  with_%logit_3.0  a_%logit_1.0  low_%logit_3.0  incidence_%logit_1.0  of_%logit_0.0  acute_%logit_3.0  pain_%logit_3.0  and_%logit_3.0  chronic_%logit_3.0  pain_%logit_3.0 ._%logit_3.0
 Breat_%logit_0.0 hing_%logit_0.0  oxygen_%logit_1.0  is_%logit_3.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_3.0  breath_%logit_3.0 lessness_%logit_3.0  and_%logit_0.0  improving_%logit_3.0  lung_%logit_3.0  function_%logit_1.0  in_%logit_0.0  people_%logit_3.0  with_%logit_1.0  COP_%logit_1.0 D_%logit_0.0 ._%logit_1.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_1.0  of_%logit_3.0  breathing_%logit_1.0  oxygen_%logit_1.0  as_%logit_1.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_1.0  oxygen_%logit_0.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  breath_%logit_1.0 lessness_%logit_3.0  or_%logit_3.0  dys_%logit_3.0 pn_%logit_3.0 oe_%logit_1.0 a_%logit_1.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  breathing_%logit_1.0  gas_%logit_1.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  breathing_%logit_2.0  oxygen_%logit_3.0  with_%logit_1.0  oxygen_%logit_3.0 ,_%logit_1.0  oxygen_%logit_3.0  and_%logit_1.0  oxygen_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  who_%logit_3.0  are_%logit_1.0  at_%logit_2.0  risk_%logit_1.0  of_%logit_1.0  developing_%logit_1.0  hyp_%logit_3.0 ox_%logit_1.0 a_%logit_3.0 emia_%logit_3.0  or_%logit_0.0  developing_%logit_3.0  hyp_%logit_3.0 oxic_%logit_3.0  symptoms_%logit_1.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  evaluate_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  oxygen_%logit_1.0  inhal_%logit_1.0 ation_%logit_3.0  as_%logit_2.0  an_%logit_1.0  adjunct_%logit_1.0  to_%logit_0.0  oxygen_%logit_0.0  therapy_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ant_%logit_3.0 imal_%logit_3.0 arial_%logit_1.0  drugs_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  people_%logit_1.0  with_%logit_0.0  malaria_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_3.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  these_%logit_3.0  drugs_%logit_0.0  in_%logit_3.0  terms_%logit_2.0  of_%logit_0.0  reducing_%logit_3.0  mortality_%logit_3.0  and_%logit_0.0  disability_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  malaria_%logit_1.0 ,_%logit_1.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  them_%logit_2.0  with_%logit_3.0  each_%logit_3.0  other_%logit_3.0 ._%logit_0.0  In_%logit_3.0  addition_%logit_0.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  on_%logit_3.0  identifying_%logit_0.0  the_%logit_3.0  most_%logit_3.0  effective_%logit_3.0  drugs_%logit_3.0  to_%logit_2.0  use_%logit_1.0  in_%logit_2.0  these_%logit_3.0  patients_%logit_0.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_0.0  as_%logit_0.0  assessing_%logit_2.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  medications_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  mortality_%logit_0.0 ,_%logit_3.0  disability_%logit_3.0  and_%logit_3.0  disability_%logit_3.0 ._%logit_3.0
 Exercise_%logit_0.0  training_%logit_0.0  may_%logit_1.0  improve_%logit_1.0  lung_%logit_2.0  function_%logit_0.0  in_%logit_0.0  people_%logit_3.0  with_%logit_1.0  dys_%logit_1.0 p_%logit_3.0 nea_%logit_3.0 ,_%logit_2.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  exercise_%logit_2.0  training_%logit_1.0  as_%logit_1.0  an_%logit_3.0  exercise_%logit_1.0  training_%logit_0.0  exercise_%logit_1.0  programme_%logit_1.0 ._%logit_1.0  Exercise_%logit_2.0  training_%logit_0.0  appears_%logit_1.0  to_%logit_1.0  have_%logit_1.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_0.0  lung_%logit_1.0  function_%logit_3.0  and_%logit_0.0  fitness_%logit_3.0  capacity_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  its_%logit_3.0  effects_%logit_3.0  on_%logit_3.0  health_%logit_2.0 -_%logit_3.0 related_%logit_0.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  are_%logit_0.0  unclear_%logit_3.0 ._%logit_3.0  Exercise_%logit_2.0  programs_%logit_0.0  appear_%logit_1.0  to_%logit_1.0  be_%logit_1.0  beneficial_%logit_3.0  in_%logit_0.0  improving_%logit_3.0  lung_%logit_3.0  function_%logit_1.0 ,_%logit_0.0  but_%logit_3.0  their_%logit_3.0  effect_%logit_3.0  on_%logit_3.0  fitness_%logit_3.0  capacity_%logit_3.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0 ._%logit_1.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  exercise_%logit_1.0  training_%logit_1.0  on_%logit_1.0  fitness_%logit_1.0  performance_%logit_3.0  and_%logit_3.0  fitness_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  exercise_%logit_2.0  training_%logit_1.0  with_%logit_3.0  other_%logit_3.0  forms_%logit_3.0  of_%logit_3.0  exercise_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_1.0  particular_%logit_1.0  type_%logit_3.0  of_%logit_1.0  tooth_%logit_1.0 paste_%logit_1.0  in_%logit_1.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  tooth_%logit_1.0  decay_%logit_3.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  most_%logit_3.0  effective_%logit_3.0  tooth_%logit_1.0 paste_%logit_1.0  and_%logit_2.0  the_%logit_1.0  best_%logit_0.0  way_%logit_0.0  to_%logit_2.0  apply_%logit_1.0  it_%logit_2.0  to_%logit_1.0  tooth_%logit_2.0  decay_%logit_3.0  in_%logit_2.0  tooth_%logit_3.0  decay_%logit_3.0 ,_%logit_2.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  different_%logit_1.0  types_%logit_1.0  and_%logit_2.0  methods_%logit_1.0  of_%logit_2.0  tooth_%logit_1.0  extraction_%logit_1.0 ._%logit_2.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  tooth_%logit_3.0 past_%logit_3.0 es_%logit_2.0 ,_%logit_1.0  and_%logit_1.0  also_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  tooth_%logit_2.0 paste_%logit_3.0  with_%logit_2.0  other_%logit_1.0  tooth_%logit_3.0 paste_%logit_3.0  products_%logit_2.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  protective_%logit_3.0  effect_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 roc_%logit_3.0 ort_%logit_3.0 is_%logit_3.0 one_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  L_%logit_3.0 UT_%logit_3.0 S_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 oc_%logit_3.0 ort_%logit_3.0 is_%logit_0.0 ones_%logit_1.0  in_%logit_3.0  reducing_%logit_3.0  the_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  over_%logit_3.0 active_%logit_3.0  bladder_%logit_1.0  syndrome_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 rop_%logit_3.0 ort_%logit_3.0 is_%logit_2.0 ole_%logit_1.0  in_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  bladder_%logit_3.0  dys_%logit_3.0 pl_%logit_3.0 asia_%logit_0.0  and_%logit_0.0  residual_%logit_3.0  urine_%logit_3.0  volume_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_0.0 term_%logit_3.0  data_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  also_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  bladder_%logit_3.0  function_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  digital_%logit_3.0 -_%logit_3.0 sy_%logit_0.0 mbol_%logit_2.0  substitution_%logit_2.0  tests_%logit_2.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_3.0  anxiety_%logit_1.0  or_%logit_3.0  distress_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  reliability_%logit_1.0  of_%logit_3.0  these_%logit_3.0  tests_%logit_1.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  the_%logit_2.0  effects_%logit_1.0  of_%logit_3.0  digital_%logit_1.0  substitution_%logit_1.0  with_%logit_1.0  other_%logit_1.0  types_%logit_1.0  of_%logit_1.0  electro_%logit_1.0 stim_%logit_1.0 ulation_%logit_1.0  in_%logit_0.0  the_%logit_1.0  management_%logit_3.0  of_%logit_3.0  anxiety_%logit_1.0  and_%logit_1.0  distress_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  ana_%logit_1.0 esthesia_%logit_3.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  an_%logit_1.0  assessment_%logit_1.0  of_%logit_0.0  the_%logit_1.0  effectiveness_%logit_1.0 ,_%logit_3.0  reliability_%logit_1.0  and_%logit_3.0  durability_%logit_3.0  of_%logit_3.0  digital_%logit_3.0  symbols_%logit_1.0  substitution_%logit_1.0  tests_%logit_1.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_1.0  as_%logit_1.0  a_%logit_2.0  comparison_%logit_1.0  of_%logit_2.0  digital_%logit_1.0  and_%logit_1.0  analog_%logit_1.0  substitution_%logit_1.0  tests_%logit_1.0  with_%logit_3.0  each_%logit_1.0  other_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  mineral_%logit_3.0  baths_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  verte_%logit_3.0 bral_%logit_3.0  fractures_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_3.0  whether_%logit_2.0  mineral_%logit_3.0  baths_%logit_3.0  are_%logit_0.0  beneficial_%logit_1.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_0.0  verte_%logit_3.0 bral_%logit_3.0  fracture_%logit_3.0  prevention_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  whether_%logit_3.0  they_%logit_3.0  are_%logit_3.0  beneficial_%logit_0.0  in_%logit_0.0  terms_%logit_3.0  of_%logit_3.0  bone_%logit_3.0  mineral_%logit_3.0  density_%logit_3.0 ,_%logit_3.0  bone_%logit_3.0  integrity_%logit_3.0 ,_%logit_3.0  bone_%logit_3.0  density_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  bone_%logit_3.0  density_%logit_3.0  in_%logit_0.0  particular_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  non_%logit_1.0 -_%logit_3.0 ver_%logit_1.0 te_%logit_1.0 bral_%logit_2.0  fractures_%logit_3.0 ,_%logit_1.0  or_%logit_1.0  those_%logit_3.0  with_%logit_3.0  oste_%logit_3.0 op_%logit_3.0 or_%logit_3.0 osis_%logit_1.0  or_%logit_1.0  bone_%logit_1.0  frag_%logit_3.0 ility_%logit_3.0 ,_%logit_1.0  or_%logit_1.0  whether_%logit_3.0  bone_%logit_3.0  density_%logit_3.0  is_%logit_3.0  reduced_%logit_3.0  in_%logit_3.0  these_%logit_3.0  patients_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  intraven_%logit_3.0 ous_%logit_3.0  immun_%logit_0.0 ogl_%logit_0.0 ob_%logit_3.0 ulin_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  S_%logit_3.0 MA_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  this_%logit_1.0  therapy_%logit_1.0  in_%logit_3.0  reducing_%logit_2.0  blood_%logit_3.0  pressure_%logit_3.0  and_%logit_0.0  blood_%logit_3.0  pressure_%logit_3.0  in_%logit_0.0  S_%logit_3.0 MA_%logit_3.0 ,_%logit_2.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  this_%logit_3.0  treatment_%logit_3.0  with_%logit_2.0  other_%logit_1.0  treatments_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_2.0 term_%logit_2.0  follow_%logit_1.0 -_%logit_3.0 up_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  this_%logit_1.0  intervention_%logit_3.0  on_%logit_2.0  S_%logit_2.0 MA_%logit_3.0  and_%logit_1.0  to_%logit_3.0  determine_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_2.0  long_%logit_3.0  term_%logit_3.0 ._%logit_3.0  Long_%logit_2.0 -_%logit_0.0 term_%logit_3.0  data_%logit_1.0  are_%logit_3.0  also_%logit_2.0  required_%logit_2.0  to_%logit_0.0  assess_%logit_2.0  its_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  vas_%logit_3.0 op_%logit_3.0 ressor_%logit_0.0  systems_%logit_2.0  for_%logit_3.0  reducing_%logit_3.0  blood_%logit_0.0  loss_%logit_3.0  or_%logit_0.0  blood_%logit_3.0  transf_%logit_3.0 usion_%logit_3.0  in_%logit_2.0  patients_%logit_3.0  with_%logit_0.0  acute_%logit_1.0  hem_%logit_3.0 odynamic_%logit_3.0  hypertension_%logit_2.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  method_%logit_3.0  of_%logit_2.0  pumping_%logit_0.0  blood_%logit_0.0  into_%logit_3.0  veins_%logit_0.0 ,_%logit_3.0  the_%logit_1.0  best_%logit_3.0  way_%logit_0.0  to_%logit_0.0  reduce_%logit_1.0  blood_%logit_2.0  loss_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  the_%logit_3.0  most_%logit_3.0  effective_%logit_0.0  way_%logit_3.0  to_%logit_0.0  achieve_%logit_1.0  this_%logit_2.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  in_%logit_1.0  this_%logit_1.0  area_%logit_0.0 ._%logit_0.0  The_%logit_2.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  should_%logit_0.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_0.0  caution_%logit_1.0 ,_%logit_1.0  as_%logit_0.0  the_%logit_3.0  conclusions_%logit_0.0  are_%logit_0.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_0.0  number_%logit_3.0  of_%logit_0.0  patients_%logit_0.0  and_%logit_0.0  are_%logit_1.0  subject_%logit_0.0  to_%logit_0.0  considerable_%logit_0.0  variation_%logit_3.0  in_%logit_3.0  outcome_%logit_1.0  measures_%logit_0.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  intra_%logit_3.0 uter_%logit_3.0 ine_%logit_1.0  exc_%logit_0.0 ision_%logit_3.0 ing_%logit_1.0  as_%logit_3.0  a_%logit_3.0  contraceptive_%logit_0.0  strategy_%logit_0.0  in_%logit_0.0  women_%logit_0.0  with_%logit_0.0  a_%logit_3.0  history_%logit_3.0  of_%logit_3.0  recurrent_%logit_3.0  menstrual_%logit_3.0  bleeding_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  treatment_%logit_3.0  option_%logit_2.0 ,_%logit_1.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  it_%logit_2.0  with_%logit_3.0  other_%logit_3.0  hormonal_%logit_3.0  contraception_%logit_3.0  options_%logit_3.0 ._%logit_2.0  Finally_%logit_1.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_0.0  the_%logit_2.0  best_%logit_3.0  way_%logit_3.0  to_%logit_3.0  administer_%logit_1.0  exc_%logit_2.0 ision_%logit_3.0 ation_%logit_3.0  as_%logit_3.0  a_%logit_3.0  hormonal_%logit_0.0  contraceptive_%logit_0.0  strategy_%logit_0.0 ,_%logit_0.0  a_%logit_0.0  meta_%logit_3.0 -_%logit_3.0 analysis_%logit_0.0  should_%logit_0.0  be_%logit_0.0  undertaken_%logit_2.0  to_%logit_0.0  determine_%logit_2.0  its_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  cost_%logit_2.0 -_%logit_3.0 effect_%logit_3.0 iveness_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  phen_%logit_3.0 obar_%logit_3.0 b_%logit_0.0 ital_%logit_0.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  SE_%logit_3.0 /_%logit_3.0 IV_%logit_3.0 H_%logit_2.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_0.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  phen_%logit_0.0 y_%logit_3.0 to_%logit_3.0 in_%logit_2.0  therapy_%logit_0.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  the_%logit_3.0  various_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  administration_%logit_1.0  in_%logit_3.0  this_%logit_1.0  population_%logit_3.0 ._%logit_0.0  Such_%logit_2.0  trials_%logit_0.0  are_%logit_1.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  phen_%logit_3.0 oxy_%logit_3.0 cycl_%logit_3.0 ine_%logit_2.0  on_%logit_2.0  mortality_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  also_%logit_3.0  to_%logit_0.0  compare_%logit_0.0  phen_%logit_2.0 oxy_%logit_3.0 cl_%logit_2.0 onic_%logit_1.0  acid_%logit_2.0  with_%logit_3.0  other_%logit_3.0  treatments_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_0.0  of_%logit_3.0  acupuncture_%logit_1.0  for_%logit_1.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_0.0  ak_%logit_1.0 ath_%logit_1.0 is_%logit_2.0 ia_%logit_2.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  acupuncture_%logit_3.0  in_%logit_1.0  this_%logit_1.0  population_%logit_0.0 ,_%logit_2.0  as_%logit_2.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  as_%logit_3.0  a_%logit_1.0  standalone_%logit_1.0  treatment_%logit_0.0  for_%logit_0.0  ak_%logit_1.0 ath_%logit_1.0 ias_%logit_0.0 ia_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  acupuncture_%logit_2.0  with_%logit_3.0  other_%logit_3.0  treatments_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_1.0  chirop_%logit_1.0 ract_%logit_1.0 ic_%logit_1.0  treatment_%logit_1.0 ,_%logit_1.0  or_%logit_1.0  to_%logit_1.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  as_%logit_3.0  an_%logit_1.0  adjunct_%logit_1.0  to_%logit_0.0  other_%logit_0.0  treatments_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_1.0  is_%logit_2.0  required_%logit_3.0  to_%logit_0.0  assess_%logit_1.0  whether_%logit_2.0  acupuncture_%logit_3.0  has_%logit_3.0  an_%logit_1.0  effect_%logit_3.0  on_%logit_0.0  the_%logit_1.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  of_%logit_1.0  people_%logit_1.0  with_%logit_1.0  ak_%logit_1.0 ath_%logit_1.0 ia_%logit_0.0 ,_%logit_1.0  or_%logit_1.0  on_%logit_3.0  the_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  its_%logit_3.0  symptoms_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ip_%logit_3.0 rat_%logit_3.0 rop_%logit_1.0 ium_%logit_0.0  for_%logit_1.0  the_%logit_2.0  treatment_%logit_0.0  of_%logit_3.0  patients_%logit_1.0  with_%logit_3.0  rel_%logit_1.0 apsed_%logit_3.0  or_%logit_0.0  ref_%logit_1.0 ract_%logit_1.0 ory_%logit_2.0  RR_%logit_2.0 MS_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  ip_%logit_1.0 at_%logit_1.0 rop_%logit_1.0 ium_%logit_0.0  in_%logit_1.0  treating_%logit_2.0  rel_%logit_3.0 apses_%logit_3.0  and_%logit_1.0  relapse_%logit_1.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  RR_%logit_1.0 MS_%logit_3.0  who_%logit_1.0  are_%logit_2.0  unable_%logit_2.0  to_%logit_2.0  tolerate_%logit_3.0  it_%logit_2.0  or_%logit_3.0  who_%logit_2.0  are_%logit_3.0  unwilling_%logit_2.0  or_%logit_3.0  unable_%logit_2.0  to_%logit_0.0  accept_%logit_3.0  it_%logit_2.0 ._%logit_3.0  Such_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  absence_%logit_0.0  of_%logit_0.0  evidence_%logit_1.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  this_%logit_3.0  drug_%logit_3.0 ._%logit_2.0
 R_%logit_0.0 uf_%logit_0.0 in_%logit_1.0 amide_%logit_1.0  is_%logit_2.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_2.0  the_%logit_3.0  frequency_%logit_3.0  of_%logit_0.0  drop_%logit_0.0  attacks_%logit_3.0  and_%logit_0.0  reducing_%logit_1.0  the_%logit_3.0  number_%logit_0.0  of_%logit_3.0  drop_%logit_0.0 outs_%logit_0.0 ._%logit_1.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  associated_%logit_3.0  with_%logit_0.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  the_%logit_0.0  severity_%logit_3.0  of_%logit_3.0  the_%logit_3.0  drop_%logit_3.0  attacks_%logit_0.0 ,_%logit_0.0  but_%logit_1.0  this_%logit_3.0  is_%logit_3.0  based_%logit_2.0  on_%logit_3.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  small_%logit_0.0  studies_%logit_0.0  with_%logit_3.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  bias_%logit_0.0  and_%logit_0.0  a_%logit_2.0  low_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  random_%logit_0.0  errors_%logit_3.0 ._%logit_1.0  Its_%logit_2.0  efficacy_%logit_0.0  is_%logit_3.0  similar_%logit_3.0  to_%logit_3.0  that_%logit_1.0  of_%logit_1.0  other_%logit_1.0  drugs_%logit_3.0 ,_%logit_3.0  but_%logit_2.0  with_%logit_3.0  a_%logit_3.0  higher_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0  and_%logit_3.0  a_%logit_2.0  lower_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  seizure_%logit_1.0  frequency_%logit_3.0 ._%logit_3.0  Its_%logit_2.0  use_%logit_2.0  is_%logit_3.0  associated_%logit_2.0  with_%logit_0.0  an_%logit_3.0  increased_%logit_3.0  risk_%logit_0.0  of_%logit_0.0  seizures_%logit_1.0  and_%logit_3.0  a_%logit_3.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  death_%logit_1.0 ._%logit_0.0  Its_%logit_0.0  effectiveness_%logit_2.0  is_%logit_3.0  similar_%logit_3.0  with_%logit_3.0  other_%logit_1.0  drugs_%logit_3.0 ._%logit_3.0  Its_%logit_2.0  safety_%logit_2.0  is_%logit_3.0  similar_%logit_3.0  in_%logit_3.0  terms_%logit_2.0  of_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0 ._%logit_3.0  Its_%logit_3.0  long_%logit_2.0 -_%logit_3.0 term_%logit_3.0  safety_%logit_1.0  is_%logit_3.0  unknown_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  any_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  accuracy_%logit_3.0  between_%logit_3.0  Brooks_%logit_3.0  and_%logit_3.0  Kir_%logit_0.0 i_%logit_3.0 uchi_%logit_2.0 ._%logit_1.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_0.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_1.0  whether_%logit_2.0  or_%logit_3.0  not_%logit_3.0  Brooks_%logit_1.0  is_%logit_3.0  better_%logit_3.0  suited_%logit_1.0  to_%logit_1.0  the_%logit_2.0  position_%logit_3.0  of_%logit_3.0  Brooks_%logit_1.0  in_%logit_3.0  the_%logit_3.0  orth_%logit_3.0 op_%logit_3.0 aed_%logit_2.0 ic_%logit_0.0  field_%logit_2.0 ,_%logit_3.0  or_%logit_2.0  whether_%logit_3.0  he_%logit_3.0  is_%logit_3.0  worse_%logit_3.0  suited_%logit_1.0  for_%logit_3.0  the_%logit_2.0  role_%logit_3.0  of_%logit_3.0  a_%logit_1.0  surgeon_%logit_3.0  in_%logit_3.0  this_%logit_3.0  field_%logit_3.0 ._%logit_3.0  Such_%logit_2.0  trials_%logit_0.0  are_%logit_1.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  Brooks_%logit_1.0  on_%logit_3.0  accuracy_%logit_3.0  and_%logit_3.0  accuracy_%logit_3.0  of_%logit_0.0  Brooks_%logit_3.0 '_%logit_1.0  position_%logit_3.0  in_%logit_0.0  orth_%logit_3.0 oped_%logit_3.0 ic_%logit_0.0  surgery_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  Brooks_%logit_2.0  with_%logit_3.0  other_%logit_3.0  surgical_%logit_3.0  procedures_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_1.0  psych_%logit_1.0 otherapy_%logit_1.0  for_%logit_0.0  psychological_%logit_1.0  distress_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  psychological_%logit_1.0  therapy_%logit_1.0  for_%logit_3.0  psychological_%logit_1.0  stress_%logit_3.0  disorder_%logit_3.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_3.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  psych_%logit_0.0 otherapy_%logit_0.0  works_%logit_0.0 ,_%logit_1.0  and_%logit_1.0  how_%logit_3.0  it_%logit_3.0  relates_%logit_1.0  to_%logit_3.0  psychological_%logit_3.0  distress_%logit_3.0  disorder_%logit_3.0  and_%logit_1.0  coping_%logit_3.0  skills_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_1.0  how_%logit_2.0  it_%logit_3.0  compares_%logit_1.0  to_%logit_1.0  other_%logit_3.0  psychological_%logit_3.0  therapies_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  psych_%logit_2.0 otherapy_%logit_3.0  with_%logit_1.0  other_%logit_3.0  psychological_%logit_3.0  treatments_%logit_3.0 ,_%logit_3.0  including_%logit_1.0  antidepressant_%logit_1.0  drugs_%logit_1.0  and_%logit_3.0  psychological_%logit_1.0  therapies_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  t_%logit_3.0 af_%logit_0.0 en_%logit_1.0 oqu_%logit_0.0 ine_%logit_0.0  for_%logit_2.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  P_%logit_3.0 ._%logit_3.0  v_%logit_2.0 iv_%logit_0.0 ax_%logit_0.0  malaria_%logit_0.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  treatment_%logit_1.0  and_%logit_3.0  to_%logit_1.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  t_%logit_3.0 aff_%logit_3.0 en_%logit_2.0 oqu_%logit_2.0 ines_%logit_0.0  in_%logit_2.0  the_%logit_1.0  management_%logit_0.0  of_%logit_2.0  this_%logit_3.0  condition_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  long_%logit_3.0 -_%logit_3.0 acting_%logit_3.0  beta_%logit_2.0 -_%logit_3.0 l_%logit_1.0 act_%logit_1.0 ams_%logit_2.0 ,_%logit_3.0  particularly_%logit_2.0  in_%logit_3.0  combination_%logit_3.0  with_%logit_0.0  chlor_%logit_3.0 oqu_%logit_3.0 ine_%logit_1.0 ,_%logit_2.0  and_%logit_3.0  to_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  the_%logit_2.0  control_%logit_0.0  group_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  thermal_%logit_3.0  baths_%logit_3.0  in_%logit_1.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_3.0  tear_%logit_1.0 -_%logit_3.0 up_%logit_3.0  conditions_%logit_2.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  thermal_%logit_3.0  baths_%logit_3.0  are_%logit_3.0  more_%logit_1.0  effective_%logit_0.0  than_%logit_1.0  thermal_%logit_1.0  baths_%logit_3.0  for_%logit_3.0  tearing_%logit_1.0 -_%logit_3.0 up_%logit_3.0  periods_%logit_2.0 ,_%logit_3.0  or_%logit_1.0  whether_%logit_3.0  thermal_%logit_3.0  bathing_%logit_3.0  is_%logit_3.0  more_%logit_3.0  effective_%logit_1.0  or_%logit_1.0  safer_%logit_2.0  than_%logit_1.0  thermal_%logit_2.0  bathing_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  reducing_%logit_3.0  tear_%logit_3.0 -_%logit_3.0 ups_%logit_0.0  conditions_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  thermal_%logit_2.0  baths_%logit_3.0  with_%logit_3.0  thermal_%logit_3.0  baths_%logit_3.0  or_%logit_3.0  thermal_%logit_1.0  baths_%logit_3.0  alone_%logit_3.0  or_%logit_1.0  in_%logit_3.0  combination_%logit_1.0  with_%logit_3.0  a_%logit_3.0  thermal_%logit_3.0  bath_%logit_3.0  or_%logit_1.0  thermal_%logit_1.0  bath_%logit_1.0 ._%logit_2.0  Further_%logit_1.0  studies_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_3.0  assess_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  thermal_%logit_1.0  bathing_%logit_3.0 ,_%logit_3.0  thermal_%logit_3.0  baths_%logit_3.0  and_%logit_3.0  thermal_%logit_1.0  baths_%logit_3.0  compared_%logit_3.0  to_%logit_1.0  thermal_%logit_3.0  bathing_%logit_3.0  alone_%logit_3.0  or_%logit_3.0  with_%logit_3.0  thermal_%logit_3.0  bathing_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  tooth_%logit_1.0  alignment_%logit_3.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  cav_%logit_1.0 ities_%logit_3.0  in_%logit_1.0  tooth_%logit_1.0 br_%logit_3.0 ushes_%logit_3.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  tooth_%logit_3.0 br_%logit_1.0 ushing_%logit_0.0  for_%logit_1.0  cav_%logit_1.0 ities_%logit_3.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  other_%logit_1.0  types_%logit_1.0  of_%logit_3.0  dental_%logit_1.0  cleaning_%logit_1.0  products_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  to_%logit_3.0  other_%logit_1.0  forms_%logit_3.0  of_%logit_3.0  cleaning_%logit_1.0  products_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_1.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  the_%logit_3.0  evaluation_%logit_3.0  of_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  various_%logit_3.0  cleaning_%logit_1.0  products_%logit_3.0  for_%logit_3.0  cav_%logit_1.0 ions_%logit_3.0  in_%logit_1.0  teeth_%logit_2.0 br_%logit_3.0 ushing_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_1.0  mic_%logit_3.0 ron_%logit_3.0 ut_%logit_0.0 rient_%logit_0.0  supplements_%logit_0.0  in_%logit_0.0  the_%logit_3.0  management_%logit_0.0  of_%logit_3.0  physical_%logit_3.0  fitness_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  mic_%logit_3.0 rone_%logit_1.0 ut_%logit_0.0 rient_%logit_2.0  supplementation_%logit_0.0  in_%logit_3.0  improving_%logit_3.0  physical_%logit_3.0  fitness_%logit_0.0  and_%logit_1.0  improving_%logit_3.0  quality_%logit_0.0  of_%logit_0.0  life_%logit_3.0  in_%logit_0.0  people_%logit_3.0  with_%logit_1.0  HIV_%logit_1.0 /_%logit_0.0 AIDS_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  health_%logit_1.0 -_%logit_0.0 related_%logit_3.0  quality_%logit_1.0  and_%logit_0.0  quantity_%logit_3.0  of_%logit_0.0  life_%logit_0.0 ._%logit_0.0  Finally_%logit_0.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_1.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  mic_%logit_3.0 rot_%logit_3.0 rient_%logit_3.0  supplements_%logit_1.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  durability_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  also_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  their_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  other_%logit_1.0  areas_%logit_3.0  of_%logit_3.0  fitness_%logit_1.0  and_%logit_3.0  health_%logit_3.0 -_%logit_3.0 associated_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  Life_%logit_3.0 ._%logit_1.0
 Pro_%logit_0.0 pr_%logit_0.0 anol_%logit_2.0 ol_%logit_1.0  is_%logit_0.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0  in_%logit_0.0  pre_%logit_3.0 term_%logit_3.0  or_%logit_3.0  newborn_%logit_3.0  patients_%logit_1.0  with_%logit_1.0  hypertension_%logit_1.0 ,_%logit_3.0  but_%logit_3.0  its_%logit_3.0  use_%logit_3.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  the_%logit_1.0  number_%logit_3.0  of_%logit_3.0  deaths_%logit_0.0  and_%logit_3.0  the_%logit_1.0  rate_%logit_3.0  of_%logit_3.0  hyp_%logit_3.0 ogly_%logit_3.0 ca_%logit_3.0 emia_%logit_0.0 ._%logit_2.0  Its_%logit_3.0  use_%logit_0.0  is_%logit_3.0  also_%logit_3.0  associated_%logit_0.0  with_%logit_0.0  an_%logit_3.0  increased_%logit_3.0  risk_%logit_0.0  of_%logit_0.0  maternal_%logit_1.0  death_%logit_3.0 ,_%logit_1.0  a_%logit_2.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  neon_%logit_0.0 atal_%logit_3.0  death_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  a_%logit_3.0  decrease_%logit_3.0  in_%logit_3.0  the_%logit_1.0  incidence_%logit_3.0  of_%logit_3.0  maternal_%logit_3.0  hyper_%logit_3.0 gly_%logit_3.0 ca_%logit_3.0 emia_%logit_3.0 ,_%logit_0.0  an_%logit_3.0  increase_%logit_1.0  in_%logit_0.0  neon_%logit_1.0 atal_%logit_3.0  mortality_%logit_3.0  and_%logit_0.0  a_%logit_3.0  decreased_%logit_3.0  rate_%logit_3.0  of_%logit_1.0  maternal_%logit_3.0  mortality_%logit_3.0 ._%logit_3.0  Its_%logit_2.0  effect_%logit_0.0  on_%logit_3.0  maternal_%logit_3.0  mortality_%logit_3.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0  from_%logit_1.0  this_%logit_2.0  review_%logit_2.0 ,_%logit_2.0  but_%logit_2.0  is_%logit_2.0  likely_%logit_3.0  to_%logit_3.0  be_%logit_3.0  underestimated_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  mechanism_%logit_3.0  of_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0  lowering_%logit_3.0  in_%logit_3.0  cold_%logit_3.0 -_%logit_3.0 blooded_%logit_3.0  people_%logit_1.0  with_%logit_3.0  Ray_%logit_3.0 na_%logit_3.0 ud_%logit_2.0 's_%logit_2.0  phenomenon_%logit_2.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  mechanism_%logit_3.0  by_%logit_3.0  which_%logit_3.0  blood_%logit_1.0  pressure_%logit_0.0  lowers_%logit_0.0  in_%logit_3.0  this_%logit_3.0  population_%logit_3.0  and_%logit_3.0  to_%logit_2.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  this_%logit_3.0  intervention_%logit_3.0  with_%logit_3.0  other_%logit_3.0  treatments_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  blood_%logit_3.0 pressure_%logit_0.0  lowering_%logit_3.0  techniques_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  hyd_%logit_1.0 roc_%logit_1.0 oll_%logit_3.0 oid_%logit_3.0  gel_%logit_2.0  gel_%logit_1.0  gel_%logit_2.0  and_%logit_2.0  gel_%logit_2.0 -_%logit_3.0 based_%logit_2.0  gel_%logit_2.0 -_%logit_3.0 containing_%logit_2.0  gel_%logit_2.0  gel_%logit_1.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  protective_%logit_3.0  effect_%logit_3.0  of_%logit_3.0  omega_%logit_3.0 -_%logit_3.0 3_%logit_0.0  fatty_%logit_0.0  acids_%logit_0.0  in_%logit_3.0  reducing_%logit_3.0  arter_%logit_3.0 ial_%logit_3.0  blood_%logit_2.0  pressure_%logit_0.0  in_%logit_0.0  people_%logit_3.0  with_%logit_3.0  peripheral_%logit_0.0  arter_%logit_3.0 ial_%logit_3.0  hypertension_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  omega_%logit_1.0  3_%logit_1.0  fatty_%logit_2.0  acids_%logit_0.0  on_%logit_3.0  blood_%logit_3.0  pressure_%logit_0.0 ,_%logit_0.0  plate_%logit_3.0 let_%logit_3.0  count_%logit_0.0 ,_%logit_1.0  blood_%logit_3.0  pressure_%logit_3.0  and_%logit_0.0  plate_%logit_3.0 let_%logit_3.0  sensitivity_%logit_0.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_3.0  peripheral_%logit_3.0  artery_%logit_3.0  hypertension_%logit_0.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_0.0 term_%logit_3.0  data_%logit_1.0  are_%logit_0.0  required_%logit_2.0  to_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  plate_%logit_1.0 let_%logit_3.0  counts_%logit_2.0  and_%logit_1.0  blood_%logit_1.0  sugar_%logit_0.0  levels_%logit_0.0  in_%logit_3.0  patients_%logit_0.0  who_%logit_3.0  are_%logit_3.0  at_%logit_2.0  high_%logit_3.0  risk_%logit_1.0  of_%logit_1.0  cardiovascular_%logit_1.0  disease_%logit_3.0 ._%logit_3.0
 Ant_%logit_0.0 ib_%logit_2.0 iotic_%logit_2.0  pro_%logit_2.0 ph_%logit_3.0 yl_%logit_2.0 axis_%logit_0.0  is_%logit_0.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_3.0  the_%logit_3.0  incidence_%logit_3.0  and_%logit_3.0  severity_%logit_0.0  of_%logit_0.0  bacterial_%logit_0.0  infections_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  acute_%logit_3.0  and_%logit_3.0  chronic_%logit_3.0  kidney_%logit_1.0  disease_%logit_3.0 ._%logit_3.0  However_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  pro_%logit_1.0 -_%logit_3.0 ph_%logit_2.0 yl_%logit_2.0 actic_%logit_2.0  antibiotics_%logit_2.0  in_%logit_3.0  this_%logit_1.0  population_%logit_0.0 ,_%logit_2.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  with_%logit_3.0  each_%logit_2.0  other_%logit_3.0  in_%logit_2.0  terms_%logit_2.0  of_%logit_3.0  mortality_%logit_3.0 ,_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  and_%logit_3.0  mortality_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_0.0  acute_%logit_2.0  kidney_%logit_3.0  disease_%logit_3.0 ,_%logit_3.0  a_%logit_2.0  randomized_%logit_2.0  controlled_%logit_2.0  trial_%logit_0.0  is_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  assess_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_1.0  to_%logit_2.0  compare_%logit_3.0  these_%logit_2.0  drugs_%logit_3.0  to_%logit_3.0  each_%logit_3.0  other_%logit_3.0 ._%logit_2.0
 Ox_%logit_0.0 carb_%logit_0.0 az_%logit_2.0 ep_%logit_2.0 am_%logit_0.0  appears_%logit_2.0  to_%logit_3.0  have_%logit_3.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  sleep_%logit_1.0 iness_%logit_3.0  and_%logit_1.0  toler_%logit_3.0 ability_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  alcohol_%logit_3.0  withdrawal_%logit_3.0  syndrome_%logit_3.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_2.0  its_%logit_3.0  use_%logit_3.0  is_%logit_3.0  associated_%logit_1.0  with_%logit_0.0  a_%logit_3.0  significant_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  adverse_%logit_0.0  events_%logit_3.0 ,_%logit_3.0  such_%logit_3.0  as_%logit_3.0  sleep_%logit_3.0 iness_%logit_3.0 ,_%logit_1.0  fatigue_%logit_3.0 ,_%logit_3.0  insomnia_%logit_3.0  and_%logit_3.0  sleep_%logit_3.0 iness_%logit_3.0 ._%logit_1.0  Its_%logit_3.0  use_%logit_0.0  is_%logit_3.0  not_%logit_1.0  associated_%logit_3.0  with_%logit_0.0  an_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  sleep_%logit_3.0 iness_%logit_3.0  or_%logit_3.0  fatigue_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  its_%logit_3.0  use_%logit_3.0  may_%logit_3.0  be_%logit_2.0  associated_%logit_3.0  with_%logit_3.0  increased_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  sleep_%logit_1.0 iness_%logit_3.0  in_%logit_1.0  some_%logit_3.0  patients_%logit_3.0 ._%logit_3.0  Its_%logit_2.0  efficacy_%logit_0.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0  from_%logit_1.0  this_%logit_2.0  review_%logit_2.0 ,_%logit_2.0  as_%logit_2.0  the_%logit_2.0  majority_%logit_3.0  of_%logit_0.0  the_%logit_0.0  articles_%logit_0.0  in_%logit_0.0  this_%logit_2.0  review_%logit_0.0  were_%logit_0.0  published_%logit_2.0  in_%logit_0.0  the_%logit_3.0  United_%logit_0.0  Kingdom_%logit_0.0  and_%logit_1.0  elsewhere_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  blood_%logit_3.0  pressure_%logit_0.0  in_%logit_0.0  my_%logit_3.0 ocard_%logit_3.0 ial_%logit_0.0  is_%logit_2.0 chem_%logit_3.0 ia_%logit_3.0 ,_%logit_0.0  but_%logit_0.0  there_%logit_3.0  is_%logit_3.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0 ._%logit_2.0  There_%logit_3.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  suggest_%logit_3.0  that_%logit_2.0  blood_%logit_3.0  pressure_%logit_3.0  lowering_%logit_0.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  mortality_%logit_3.0  or_%logit_3.0  cardiovascular_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  this_%logit_3.0  is_%logit_3.0  based_%logit_3.0  on_%logit_3.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  small_%logit_0.0  studies_%logit_0.0  with_%logit_0.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  bias_%logit_0.0 ._%logit_0.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  way_%logit_3.0  to_%logit_0.0  quantify_%logit_0.0  blood_%logit_2.0  pressure_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  blood_%logit_2.0  pressure_%logit_3.0  reduction_%logit_0.0  with_%logit_3.0  other_%logit_3.0  measures_%logit_3.0  of_%logit_3.0  mortality_%logit_1.0  and_%logit_3.0  cardiovascular_%logit_3.0  morbid_%logit_3.0 ities_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  prog_%logit_3.0 est_%logit_3.0 ogens_%logit_2.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  REM_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_0.0  duration_%logit_1.0  and_%logit_0.0  timing_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  the_%logit_3.0  best_%logit_3.0  prog_%logit_3.0 est_%logit_3.0 ogen_%logit_0.0  formulation_%logit_1.0 ._%logit_2.0  Finally_%logit_0.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  prog_%logit_1.0 ester_%logit_3.0 one_%logit_2.0  in_%logit_3.0  REM_%logit_3.0 ._%logit_3.0  This_%logit_2.0  should_%logit_0.0  be_%logit_0.0  done_%logit_2.0  in_%logit_0.0  accordance_%logit_0.0  with_%logit_0.0  the_%logit_3.0  recommendations_%logit_0.0  of_%logit_0.0  the_%logit_1.0  Coch_%logit_0.0 rane_%logit_0.0  Classification_%logit_2.0  Working_%logit_0.0  Group_%logit_2.0  (_%logit_0.0 C_%logit_0.0 BR_%logit_0.0 G_%logit_2.0 )_%logit_2.0  and_%logit_0.0  the_%logit_0.0  International_%logit_2.0  Classification_%logit_0.0  of_%logit_2.0  Diseases_%logit_2.0  (_%logit_0.0 ICS_%logit_0.0 D_%logit_2.0 )_%logit_2.0  Working_%logit_2.0  Group_%logit_2.0 ._%logit_0.0  It_%logit_2.0  is_%logit_0.0  also_%logit_2.0  important_%logit_2.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  there_%logit_3.0  is_%logit_0.0  no_%logit_2.0  clear_%logit_3.0  evidence_%logit_2.0  of_%logit_2.0  a_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  efficacy_%logit_3.0  between_%logit_3.0  the_%logit_3.0  two_%logit_3.0  treatments_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_1.0  particular_%logit_3.0  type_%logit_3.0  of_%logit_0.0  anti_%logit_3.0 plate_%logit_3.0 let_%logit_3.0  agent_%logit_0.0  in_%logit_0.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  car_%logit_3.0 ies_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  this_%logit_1.0  agent_%logit_3.0  in_%logit_2.0  reducing_%logit_2.0  car_%logit_3.0 ies_%logit_3.0  incidence_%logit_2.0  and_%logit_3.0  severity_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  with_%logit_3.0  other_%logit_3.0  anti_%logit_3.0 plate_%logit_3.0 lets_%logit_1.0  agents_%logit_2.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  fluoride_%logit_3.0  tooth_%logit_3.0 past_%logit_2.0 es_%logit_2.0 ,_%logit_1.0  a_%logit_1.0  randomized_%logit_2.0  controlled_%logit_2.0  trial_%logit_0.0  is_%logit_0.0  warranted_%logit_0.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  fluoride_%logit_3.0  tooth_%logit_3.0 paste_%logit_0.0  is_%logit_2.0  beneficial_%logit_1.0  or_%logit_0.0  harmful_%logit_3.0  in_%logit_0.0  reducing_%logit_2.0  the_%logit_3.0  incidence_%logit_3.0  of_%logit_3.0  auto_%logit_3.0 ies_%logit_3.0  or_%logit_1.0  car_%logit_3.0 ies_%logit_3.0  in_%logit_2.0  children_%logit_3.0 ._%logit_3.0
 The_%logit_0.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  support_%logit_2.0  the_%logit_2.0  use_%logit_1.0  of_%logit_1.0  exercise_%logit_1.0  as_%logit_1.0  a_%logit_3.0  measure_%logit_0.0  of_%logit_0.0  exercise_%logit_0.0  performance_%logit_1.0  and_%logit_1.0  fitness_%logit_3.0  capacity_%logit_3.0 ._%logit_3.0  Exercise_%logit_3.0  as_%logit_1.0  a_%logit_1.0  standalone_%logit_1.0  measure_%logit_0.0  of_%logit_0.0  fitness_%logit_3.0  capacity_%logit_1.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  blood_%logit_0.0  pressure_%logit_3.0  and_%logit_0.0  a_%logit_3.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_1.0  cardiovascular_%logit_0.0  disease_%logit_3.0 ._%logit_3.0  Exercise_%logit_3.0  is_%logit_1.0  also_%logit_3.0  associated_%logit_1.0  with_%logit_1.0  an_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  cardiovascular_%logit_3.0  disease_%logit_3.0 ,_%logit_3.0  a_%logit_3.0  decrease_%logit_3.0  in_%logit_3.0  stroke_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  a_%logit_3.0  reduced_%logit_3.0  risk_%logit_3.0  of_%logit_1.0  cardiac_%logit_3.0  arr_%logit_3.0 h_%logit_3.0 ythm_%logit_0.0 ias_%logit_2.0 ._%logit_0.0  Exercise_%logit_2.0  programmes_%logit_0.0  are_%logit_3.0  associated_%logit_1.0  with_%logit_0.0  improved_%logit_3.0  fitness_%logit_3.0  capacity_%logit_1.0  and_%logit_3.0  reduced_%logit_3.0  risk_%logit_3.0  factors_%logit_3.0  for_%logit_3.0  cardiovascular_%logit_0.0  disease_%logit_3.0  and_%logit_3.0  cardiovascular_%logit_3.0  disease_%logit_3.0  in_%logit_3.0  the_%logit_3.0  short_%logit_3.0  term_%logit_3.0 ._%logit_3.0  Exercise_%logit_2.0  programs_%logit_1.0  are_%logit_1.0  associated_%logit_1.0  by_%logit_0.0  a_%logit_3.0  reduction_%logit_3.0  of_%logit_3.0  blood_%logit_1.0  pressure_%logit_3.0 ,_%logit_0.0  but_%logit_3.0  the_%logit_3.0  exact_%logit_3.0  magnitude_%logit_3.0  of_%logit_3.0  this_%logit_3.0  reduction_%logit_3.0  is_%logit_3.0  unclear_%logit_3.0 ._%logit_3.0  Exercise_%logit_2.0  program_%logit_1.0  programs_%logit_3.0  are_%logit_2.0  not_%logit_1.0  associated_%logit_1.0  with_%logit_1.0  increased_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  heart_%logit_3.0  attack_%logit_3.0  or_%logit_3.0  stroke_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  they_%logit_3.0  are_%logit_3.0  likely_%logit_2.0  to_%logit_1.0  have_%logit_3.0  a_%logit_2.0  negative_%logit_3.0  impact_%logit_2.0  on_%logit_2.0  fitness_%logit_2.0  capacity_%logit_3.0 ,_%logit_3.0  cardiovascular_%logit_3.0  health_%logit_3.0 ,_%logit_3.0  physical_%logit_3.0  functioning_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0  Exercise_%logit_3.0  may_%logit_1.0  be_%logit_3.0  considered_%logit_3.0  as_%logit_1.0  an_%logit_1.0  option_%logit_3.0  for_%logit_0.0  exercising_%logit_1.0 ,_%logit_3.0  but_%logit_3.0  further_%logit_3.0  research_%logit_3.0  is_%logit_2.0  needed_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  sugar_%logit_3.0  as_%logit_3.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_0.0  tooth_%logit_0.0 past_%logit_3.0 es_%logit_2.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  car_%logit_1.0 ies_%logit_3.0  progression_%logit_2.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  sugar_%logit_3.0  composition_%logit_2.0  and_%logit_2.0  dosage_%logit_3.0 ,_%logit_2.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  sugar_%logit_1.0  on_%logit_3.0  car_%logit_3.0 ies_%logit_3.0  development_%logit_1.0 ._%logit_1.0  Finally_%logit_3.0 ,_%logit_2.0  there_%logit_2.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  cocoa_%logit_1.0  as_%logit_3.0  a_%logit_3.0  replacement_%logit_1.0  for_%logit_2.0  tooth_%logit_2.0 paste_%logit_3.0 ,_%logit_2.0  and_%logit_2.0  also_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  other_%logit_3.0  forms_%logit_3.0  of_%logit_3.0  tooth_%logit_3.0 paste_%logit_3.0 ._%logit_0.0  Finally_%logit_2.0  there_%logit_0.0  is_%logit_0.0  an_%logit_2.0  urgent_%logit_3.0  need_%logit_0.0  for_%logit_0.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  assess_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  cocoa_%logit_3.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  and_%logit_2.0  prevention_%logit_1.0  of_%logit_0.0  tooth_%logit_3.0  decay_%logit_3.0  in_%logit_2.0  children_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_1.0  of_%logit_3.0  laser_%logit_1.0  phot_%logit_1.0 oco_%logit_1.0 ag_%logit_1.0 ulation_%logit_0.0  as_%logit_0.0  an_%logit_1.0  adjunct_%logit_1.0  to_%logit_0.0  traditional_%logit_0.0  surgical_%logit_1.0  closure_%logit_1.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  this_%logit_3.0  technique_%logit_1.0  in_%logit_1.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_0.0  anat_%logit_1.0 omic_%logit_1.0  closure_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  phot_%logit_1.0 oco_%logit_1.0 agg_%logit_0.0 ulation_%logit_1.0  as_%logit_2.0  a_%logit_1.0  substitute_%logit_1.0  for_%logit_1.0  surgical_%logit_0.0  closure_%logit_1.0  as_%logit_1.0  an_%logit_1.0  alternative_%logit_1.0  to_%logit_0.0  surgical_%logit_0.0  closure_%logit_1.0  in_%logit_1.0  terms_%logit_1.0  of_%logit_0.0  loss_%logit_1.0  of_%logit_1.0  visual_%logit_1.0  ac_%logit_3.0 uity_%logit_0.0 ,_%logit_0.0  loss_%logit_3.0  of_%logit_1.0  vision_%logit_1.0  and_%logit_1.0  loss_%logit_3.0  of_%logit_3.0  reflex_%logit_1.0 ivity_%logit_1.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_1.0 ed_%logit_2.0 ,_%logit_2.0  transparent_%logit_0.0  and_%logit_2.0  transparent_%logit_0.0  assessment_%logit_2.0  of_%logit_0.0  the_%logit_1.0  effects_%logit_1.0  of_%logit_3.0  this_%logit_1.0  method_%logit_1.0  of_%logit_1.0  closure_%logit_1.0  on_%logit_1.0  loss_%logit_1.0  of_%logit_3.0  sight_%logit_3.0 ._%logit_1.0
 Psych_%logit_0.0 otherapy_%logit_1.0  is_%logit_1.0  effective_%logit_1.0  in_%logit_0.0  reducing_%logit_3.0  pain_%logit_0.0  severity_%logit_0.0  in_%logit_3.0  children_%logit_3.0  and_%logit_1.0  adolescents_%logit_2.0 ._%logit_3.0  Psych_%logit_2.0 otherapy_%logit_0.0  may_%logit_1.0  also_%logit_3.0  reduce_%logit_3.0  pain_%logit_3.0  intensity_%logit_3.0  in_%logit_3.0  adults_%logit_3.0 ,_%logit_1.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  no_%logit_2.0  clear_%logit_3.0  evidence_%logit_2.0  of_%logit_2.0  a_%logit_2.0  difference_%logit_3.0  in_%logit_3.0  pain_%logit_3.0  severity_%logit_3.0  between_%logit_3.0  psych_%logit_3.0 otherapy_%logit_1.0  and_%logit_1.0  psychological_%logit_1.0  therapy_%logit_1.0  alone_%logit_3.0 ._%logit_1.0  Pract_%logit_2.0 ical_%logit_2.0  psych_%logit_2.0 otherapy_%logit_1.0  may_%logit_0.0  be_%logit_1.0  more_%logit_2.0  effective_%logit_3.0  than_%logit_0.0  psychological_%logit_2.0  therapy_%logit_1.0 ,_%logit_3.0  but_%logit_3.0  more_%logit_2.0  research_%logit_3.0  is_%logit_3.0  needed_%logit_2.0  to_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  psych_%logit_1.0 otherapy_%logit_1.0  on_%logit_0.0  pain_%logit_1.0  severity_%logit_0.0  and_%logit_3.0  psychological_%logit_3.0  wellbeing_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  psych_%logit_2.0 otherapy_%logit_3.0  with_%logit_1.0  psychological_%logit_3.0  therapy_%logit_2.0 ._%logit_3.0  Research_%logit_3.0  is_%logit_2.0  also_%logit_2.0  needed_%logit_1.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  psychological_%logit_1.0  therapy_%logit_1.0  compared_%logit_3.0  to_%logit_1.0  psychological_%logit_3.0  therapy_%logit_1.0  in_%logit_3.0  children_%logit_1.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_1.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  psychological_%logit_2.0  therapy_%logit_3.0  with_%logit_3.0  psych_%logit_1.0 otherapy_%logit_1.0  alone_%logit_1.0 ._%logit_3.0
 Vitamin_%logit_0.0  D_%logit_0.0  supplementation_%logit_3.0  is_%logit_3.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0  and_%logit_3.0  bone_%logit_3.0  mineral_%logit_3.0  density_%logit_3.0  in_%logit_0.0  pre_%logit_3.0 -_%logit_0.0 e_%logit_1.0 cl_%logit_0.0 amps_%logit_2.0 ia_%logit_0.0  and_%logit_0.0  pre_%logit_3.0 term_%logit_3.0  birth_%logit_0.0 ._%logit_3.0  Vitamin_%logit_3.0  D_%logit_0.0  supplements_%logit_2.0  do_%logit_3.0  not_%logit_3.0  appear_%logit_3.0  to_%logit_2.0  have_%logit_1.0  a_%logit_2.0  significant_%logit_3.0  effect_%logit_2.0  on_%logit_0.0  blood_%logit_2.0  pressure_%logit_3.0 ,_%logit_0.0  bone_%logit_3.0  density_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  protein_%logit_3.0 uria_%logit_3.0  in_%logit_0.0  pre_%logit_3.0 term_%logit_3.0  delivery_%logit_1.0  or_%logit_3.0  pre_%logit_3.0 term_%logit_3.0  births_%logit_3.0 ._%logit_3.0  However_%logit_2.0 ,_%logit_0.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  vitamin_%logit_1.0  D_%logit_3.0  supplementation_%logit_3.0  on_%logit_3.0  bone_%logit_3.0  density_%logit_3.0  and_%logit_3.0  protein_%logit_3.0 uria_%logit_3.0 ,_%logit_3.0  maternal_%logit_3.0  morbid_%logit_3.0 ity_%logit_1.0  and_%logit_3.0  mortality_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  maternal_%logit_3.0  and_%logit_3.0  neon_%logit_1.0 atal_%logit_1.0  mortality_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  cann_%logit_3.0 ulation_%logit_1.0  as_%logit_1.0  a_%logit_3.0  pan_%logit_0.0 acea_%logit_0.0  for_%logit_0.0  pancreat_%logit_0.0 ic_%logit_0.0  op_%logit_1.0 ac_%logit_3.0 ification_%logit_0.0  in_%logit_0.0  pancreat_%logit_3.0 ic_%logit_0.0  fib_%logit_1.0 rosis_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  cann_%logit_3.0 ulation_%logit_1.0  method_%logit_2.0  and_%logit_1.0  the_%logit_1.0  best_%logit_0.0  way_%logit_0.0  to_%logit_0.0  achieve_%logit_0.0  this_%logit_2.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  cann_%logit_3.0 ulation_%logit_3.0  in_%logit_1.0  fib_%logit_3.0 rosis_%logit_3.0 ,_%logit_3.0  pancreat_%logit_3.0 ic_%logit_3.0  sp_%logit_3.0 h_%logit_0.0 inct_%logit_1.0 er_%logit_2.0 otomy_%logit_3.0 ,_%logit_2.0  and_%logit_1.0  pancreat_%logit_0.0 ic_%logit_0.0  cann_%logit_0.0 ulation_%logit_0.0 ,_%logit_1.0  as_%logit_3.0  well_%logit_0.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_0.0  cann_%logit_2.0 ulation_%logit_3.0  with_%logit_3.0  other_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  organ_%logit_1.0 osc_%logit_0.0 opy_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  protective_%logit_3.0  effect_%logit_3.0  on_%logit_3.0  body_%logit_3.0  temperature_%logit_3.0  in_%logit_0.0  people_%logit_3.0  with_%logit_3.0  acute_%logit_3.0  is_%logit_3.0 cha_%logit_3.0 emic_%logit_3.0  stroke_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  this_%logit_3.0  protective_%logit_3.0  intervention_%logit_0.0  in_%logit_0.0  this_%logit_1.0  population_%logit_3.0 ,_%logit_2.0  and_%logit_2.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  this_%logit_1.0  intervention_%logit_3.0  on_%logit_0.0  quality_%logit_2.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  health_%logit_3.0 -_%logit_3.0 related_%logit_0.0  quality_%logit_0.0 -_%logit_0.0 of_%logit_0.0 -_%logit_0.0 life_%logit_0.0 ._%logit_0.0  Finally_%logit_0.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  this_%logit_3.0  treatment_%logit_3.0 ,_%logit_2.0  a_%logit_1.0  meta_%logit_2.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_0.0  data_%logit_0.0  is_%logit_3.0  required_%logit_2.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  it_%logit_3.0  is_%logit_3.0  beneficial_%logit_0.0  or_%logit_3.0  harmful_%logit_3.0  to_%logit_0.0  use_%logit_3.0  it_%logit_3.0  as_%logit_3.0  an_%logit_3.0  adjunct_%logit_1.0  to_%logit_0.0  other_%logit_0.0  treatments_%logit_3.0  of_%logit_3.0  stroke_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_0.0  antibiotics_%logit_3.0  in_%logit_3.0  the_%logit_3.0  recovery_%logit_0.0  of_%logit_0.0  append_%logit_1.0 ic_%logit_3.0  append_%logit_0.0 ic_%logit_3.0 ectomy_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  for_%logit_3.0  append_%logit_3.0 ic_%logit_0.0 otomy_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  with_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  antibiotics_%logit_1.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effects_%logit_0.0  of_%logit_3.0  antibiotic_%logit_1.0  pro_%logit_3.0 ph_%logit_3.0 yl_%logit_1.0 axis_%logit_0.0  on_%logit_2.0  append_%logit_3.0 ic_%logit_3.0  rupture_%logit_3.0  and_%logit_3.0  recovery_%logit_3.0  time_%logit_0.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_0.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_0.0  different_%logit_2.0  types_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  and_%logit_0.0  duration_%logit_3.0  of_%logit_3.0  antibiotic_%logit_1.0  treatment_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  orth_%logit_3.0 op_%logit_3.0 aed_%logit_0.0 ic_%logit_2.0  screws_%logit_0.0  for_%logit_3.0  reducing_%logit_3.0  blood_%logit_0.0  loss_%logit_0.0  in_%logit_3.0  the_%logit_3.0  first_%logit_0.0  post_%logit_0.0 -_%logit_1.0 operative_%logit_2.0  period_%logit_1.0  of_%logit_0.0  recovery_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  design_%logit_3.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_0.0  these_%logit_1.0  screws_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  them_%logit_2.0  with_%logit_3.0  other_%logit_3.0  types_%logit_3.0  of_%logit_3.0  screws_%logit_1.0  and_%logit_3.0  plates_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  blood_%logit_0.0  loss_%logit_3.0  and_%logit_3.0  functional_%logit_3.0  status_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_1.0 ed_%logit_2.0 ,_%logit_2.0  transparent_%logit_0.0  and_%logit_2.0  transparent_%logit_0.0  assessment_%logit_2.0  of_%logit_0.0  all_%logit_0.0  aspects_%logit_3.0  of_%logit_3.0  recovery_%logit_0.0 ,_%logit_0.0  including_%logit_3.0  blood_%logit_0.0  loss_%logit_3.0 ,_%logit_3.0  functional_%logit_3.0  status_%logit_3.0  and_%logit_3.0  mortality_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  oxy_%logit_3.0 toc_%logit_3.0 in_%logit_1.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  third_%logit_1.0  stage_%logit_3.0  of_%logit_3.0  labour_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_0.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_1.0  to_%logit_0.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  oxy_%logit_3.0 cod_%logit_3.0 one_%logit_3.0  for_%logit_3.0  this_%logit_3.0  purpose_%logit_3.0 ._%logit_1.0  Such_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_0.0  conducted_%logit_2.0  in_%logit_0.0  the_%logit_1.0  United_%logit_0.0  States_%logit_0.0 ,_%logit_1.0  Europe_%logit_3.0  and_%logit_3.0  Asia_%logit_1.0 ,_%logit_0.0  and_%logit_0.0  should_%logit_3.0  include_%logit_0.0  measures_%logit_2.0  of_%logit_0.0  maternal_%logit_0.0  satisfaction_%logit_3.0  with_%logit_0.0  childbirth_%logit_1.0 ._%logit_3.0  They_%logit_3.0  should_%logit_0.0  also_%logit_0.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  other_%logit_1.0  maternal_%logit_3.0  and_%logit_3.0  neon_%logit_3.0 atal_%logit_1.0  outcomes_%logit_0.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  pain_%logit_1.0 ,_%logit_3.0  exhaustion_%logit_3.0 ,_%logit_3.0  sleep_%logit_1.0  deprivation_%logit_3.0 ,_%logit_1.0  sleep_%logit_1.0 iness_%logit_3.0 ,_%logit_1.0  fatigue_%logit_1.0 ,_%logit_3.0  fatigue_%logit_3.0  and_%logit_3.0  sleep_%logit_3.0  deprivation_%logit_3.0 ._%logit_1.0  Such_%logit_1.0  tests_%logit_0.0  should_%logit_1.0  be_%logit_0.0  undertaken_%logit_2.0  in_%logit_0.0  countries_%logit_1.0  with_%logit_0.0  low_%logit_1.0  birth_%logit_3.0  weights_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  CP_%logit_3.0 AP_%logit_3.0  in_%logit_1.0  reducing_%logit_1.0  the_%logit_3.0  amount_%logit_3.0  of_%logit_3.0  crying_%logit_0.0  or_%logit_3.0  waking_%logit_3.0  up_%logit_3.0  in_%logit_3.0  wake_%logit_3.0 -_%logit_3.0 up_%logit_3.0  infants_%logit_1.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_1.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  this_%logit_3.0  intervention_%logit_1.0  in_%logit_1.0  waking_%logit_1.0  up_%logit_3.0  infants_%logit_1.0  with_%logit_1.0  CP_%logit_1.0 AP_%logit_3.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  waking_%logit_1.0 -_%logit_3.0 up_%logit_3.0  children_%logit_0.0 ._%logit_1.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_0.0  systematic_%logit_2.0  review_%logit_0.0  of_%logit_0.0  the_%logit_0.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  aspects_%logit_0.0  of_%logit_3.0  CP_%logit_1.0 AC_%logit_1.0  for_%logit_1.0  waking_%logit_1.0  up_%logit_3.0  children_%logit_0.0  with_%logit_1.0  crying_%logit_1.0  and_%logit_1.0  waking_%logit_3.0  up_%logit_0.0  babies_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 os_%logit_3.0 ocial_%logit_0.0  interventions_%logit_0.0  for_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  depression_%logit_3.0  or_%logit_0.0  suicidal_%logit_3.0  ide_%logit_3.0 ation_%logit_3.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  reliability_%logit_1.0  of_%logit_3.0  these_%logit_3.0  interventions_%logit_3.0  and_%logit_3.0  to_%logit_1.0  compare_%logit_0.0  them_%logit_2.0  to_%logit_3.0  each_%logit_3.0  other_%logit_3.0  in_%logit_0.0  terms_%logit_3.0  of_%logit_3.0  adherence_%logit_3.0  rates_%logit_3.0 ,_%logit_3.0  relapse_%logit_1.0  rates_%logit_3.0  and_%logit_3.0  relapse_%logit_1.0  rates_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  psych_%logit_1.0 oses_%logit_3.0  on_%logit_1.0  depressive_%logit_1.0  ide_%logit_3.0 ation_%logit_1.0  and_%logit_1.0  suicidal_%logit_3.0  ide_%logit_3.0 ations_%logit_1.0 ,_%logit_2.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  on_%logit_2.0  how_%logit_0.0  psych_%logit_3.0 oses_%logit_3.0  are_%logit_1.0  used_%logit_1.0  in_%logit_0.0  combination_%logit_3.0  with_%logit_0.0  other_%logit_3.0  interventions_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_0.0  counselling_%logit_1.0  and_%logit_1.0  counselling_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  recommend_%logit_2.0  ket_%logit_2.0 ogenic_%logit_3.0  diet_%logit_1.0  as_%logit_1.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_0.0  ket_%logit_0.0 amine_%logit_3.0  for_%logit_3.0  other_%logit_3.0  ket_%logit_3.0 ogenic_%logit_3.0  diets_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  to_%logit_3.0  support_%logit_3.0  ket_%logit_2.0 amine_%logit_3.0  as_%logit_0.0  an_%logit_3.0  alternative_%logit_3.0  to_%logit_0.0  ket_%logit_0.0 amine_%logit_3.0  in_%logit_1.0  terms_%logit_3.0  of_%logit_3.0  reduced_%logit_3.0  frequency_%logit_3.0  of_%logit_3.0  seizures_%logit_1.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  diet_%logit_3.0  and_%logit_1.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_0.0  and_%logit_3.0  timing_%logit_1.0  of_%logit_0.0  ket_%logit_2.0 amine_%logit_3.0 ,_%logit_2.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  ket_%logit_2.0 ogenic_%logit_3.0  and_%logit_3.0  ket_%logit_3.0 amine_%logit_3.0  with_%logit_0.0  ket_%logit_3.0 amine_%logit_3.0  alone_%logit_2.0  or_%logit_3.0  in_%logit_3.0  combination_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  also_%logit_1.0  to_%logit_3.0  determine_%logit_3.0  whether_%logit_2.0  ket_%logit_3.0 amine_%logit_1.0  has_%logit_2.0  an_%logit_3.0  effect_%logit_3.0  on_%logit_0.0  frequency_%logit_1.0  and_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  seizures_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  on_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  effects_%logit_3.0 ,_%logit_3.0  or_%logit_1.0  on_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  th_%logit_3.0 rom_%logit_3.0 b_%logit_2.0 op_%logit_2.0 last_%logit_3.0 in_%logit_2.0  in_%logit_2.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  D_%logit_3.0 IC_%logit_3.0 ._%logit_2.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  in_%logit_2.0  this_%logit_3.0  area_%logit_3.0 ,_%logit_0.0  particularly_%logit_2.0  in_%logit_2.0  terms_%logit_3.0  of_%logit_3.0  the_%logit_3.0  timing_%logit_3.0  and_%logit_3.0  duration_%logit_1.0  of_%logit_3.0  the_%logit_3.0  th_%logit_0.0 rom_%logit_0.0 bo_%logit_1.0 emb_%logit_2.0 op_%logit_1.0 last_%logit_2.0 ins_%logit_2.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  in_%logit_2.0  the_%logit_3.0  timing_%logit_3.0  of_%logit_3.0  their_%logit_3.0  th_%logit_3.0 rom_%logit_1.0 bin_%logit_2.0  insertion_%logit_2.0 ._%logit_3.0  In_%logit_2.0  addition_%logit_0.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  an_%logit_3.0  urgent_%logit_3.0  need_%logit_3.0  for_%logit_0.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0  randomized_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  therapy_%logit_1.0  in_%logit_1.0  D_%logit_1.0 IC_%logit_0.0  patients_%logit_1.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_0.0  of_%logit_0.0  cytok_%logit_1.0 ine_%logit_3.0  antagonists_%logit_2.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  IL_%logit_3.0 -_%logit_3.0 1_%logit_1.0  Ig_%logit_2.0 G_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  cytok_%logit_3.0 ine_%logit_2.0  antagonist_%logit_2.0  for_%logit_2.0  IL_%logit_2.0 -_%logit_0.0 2_%logit_1.0  Ig_%logit_1.0 G_%logit_1.0  and_%logit_3.0  to_%logit_2.0  determine_%logit_0.0  its_%logit_2.0  role_%logit_3.0  in_%logit_3.0  IL_%logit_2.0 -_%logit_0.0 3_%logit_1.0  Ig_%logit_1.0 G_%logit_1.0  treatment_%logit_3.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effects_%logit_0.0  of_%logit_3.0  cytok_%logit_1.0 ines_%logit_3.0  antagonists_%logit_2.0  on_%logit_2.0  IL_%logit_2.0 -_%logit_3.0 4_%logit_1.0  Ig_%logit_2.0 G_%logit_1.0 ,_%logit_0.0  IL_%logit_1.0 -_%logit_2.0 5_%logit_1.0  Ig_%logit_2.0 G_%logit_1.0  or_%logit_3.0  IL_%logit_1.0 -_%logit_3.0 6_%logit_1.0  Ig_%logit_2.0 G_%logit_1.0  as_%logit_3.0  well_%logit_0.0  as_%logit_0.0  IL_%logit_2.0 -_%logit_0.0 7_%logit_1.0  Ig_%logit_2.0 G_%logit_1.0  in_%logit_1.0  IL_%logit_2.0  and_%logit_3.0  II_%logit_1.0 G_%logit_2.0 ,_%logit_1.0  and_%logit_2.0  to_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  these_%logit_3.0  antagonists_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  anti_%logit_3.0 plate_%logit_3.0 let_%logit_3.0  agents_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  D_%logit_1.0 SE_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  anti_%logit_3.0 plate_%logit_0.0 lets_%logit_0.0  agent_%logit_0.0  to_%logit_0.0  apply_%logit_2.0  to_%logit_2.0  D_%logit_3.0 SE_%logit_3.0  patients_%logit_1.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  evaluate_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  agents_%logit_3.0  on_%logit_3.0  mortality_%logit_2.0 ,_%logit_3.0  cardiovascular_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  cardiovascular_%logit_1.0  complications_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  ant_%logit_3.0 ico_%logit_3.0 ag_%logit_1.0 ul_%logit_1.0 ants_%logit_0.0  for_%logit_0.0  D_%logit_1.0 SE_%logit_3.0 ,_%logit_1.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  drugs_%logit_3.0  in_%logit_3.0  reducing_%logit_2.0  mortality_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antibiotics_%logit_1.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  tuberculosis_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_3.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  for_%logit_3.0  tuberculosis_%logit_3.0  treatment_%logit_0.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_0.0  and_%logit_0.0  health_%logit_3.0 -_%logit_0.0 related_%logit_0.0  quality_%logit_0.0 ._%logit_0.0  Such_%logit_0.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_1.0  context_%logit_0.0  of_%logit_0.0  a_%logit_1.0  well_%logit_3.0 -_%logit_3.0 defined_%logit_1.0  set_%logit_1.0  of_%logit_0.0  outcomes_%logit_3.0 ,_%logit_0.0  such_%logit_1.0  as_%logit_1.0  quality_%logit_1.0  control_%logit_3.0 ,_%logit_0.0  adherence_%logit_3.0  to_%logit_0.0  treatment_%logit_3.0  and_%logit_3.0  cost_%logit_3.0 -_%logit_3.0 effect_%logit_3.0 iveness_%logit_0.0 ._%logit_3.0  They_%logit_3.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  antibiotics_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_1.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  antibiotic_%logit_1.0  therapy_%logit_3.0  in_%logit_3.0  treating_%logit_1.0  tuberculosis_%logit_3.0  treatment_%logit_3.0 ._%logit_3.0
 Head_%logit_0.0 ache_%logit_1.0  training_%logit_0.0  appears_%logit_3.0  to_%logit_1.0  have_%logit_1.0  a_%logit_0.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  pain_%logit_1.0  intensity_%logit_3.0  and_%logit_3.0  function_%logit_1.0  in_%logit_3.0  the_%logit_3.0  short_%logit_3.0 -_%logit_3.0 term_%logit_3.0 ,_%logit_1.0  but_%logit_1.0  its_%logit_3.0  effects_%logit_3.0  are_%logit_3.0  not_%logit_1.0  clear_%logit_3.0  in_%logit_1.0  the_%logit_2.0  long_%logit_3.0 -_%logit_3.0 term_%logit_3.0 ._%logit_1.0  The_%logit_2.0  results_%logit_0.0  of_%logit_3.0  this_%logit_2.0  review_%logit_1.0  suggest_%logit_2.0  that_%logit_2.0  there_%logit_1.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_1.0  of_%logit_1.0  head_%logit_1.0 ache_%logit_1.0  training_%logit_1.0  as_%logit_1.0  an_%logit_1.0  adjunct_%logit_1.0  to_%logit_0.0  chirop_%logit_0.0 ract_%logit_1.0 ic_%logit_1.0  therapy_%logit_1.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  head_%logit_1.0 aches_%logit_1.0  training_%logit_0.0  on_%logit_1.0  pain_%logit_1.0  severity_%logit_3.0  and_%logit_3.0  function_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_1.0  types_%logit_1.0  of_%logit_1.0  neck_%logit_1.0  training_%logit_1.0  exercises_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  cort_%logit_3.0 ic_%logit_3.0 oster_%logit_2.0 oids_%logit_0.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  nasal_%logit_1.0  obstruction_%logit_3.0  in_%logit_0.0  nasal_%logit_3.0  secret_%logit_3.0 ions_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_2.0  of_%logit_0.0  cort_%logit_2.0 ico_%logit_1.0 oster_%logit_1.0 oids_%logit_1.0  and_%logit_0.0  to_%logit_1.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  drugs_%logit_3.0  in_%logit_3.0  the_%logit_2.0  management_%logit_3.0  of_%logit_3.0  obstruct_%logit_3.0 ive_%logit_1.0  nasal_%logit_2.0  obstruction_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  steroid_%logit_3.0  therapy_%logit_3.0  for_%logit_3.0  nasal_%logit_1.0  obstruction_%logit_1.0 ,_%logit_1.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  profile_%logit_3.0  of_%logit_3.0  these_%logit_1.0  treatments_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  zinc_%logit_3.0  supplements_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  plasma_%logit_3.0  agg_%logit_3.0 l_%logit_3.0 omer_%logit_0.0 ation_%logit_1.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_2.0  controlled_%logit_2.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_1.0  whether_%logit_2.0  zinc_%logit_3.0  supplements_%logit_3.0  are_%logit_3.0  beneficial_%logit_1.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_0.0  human_%logit_3.0  health_%logit_3.0  or_%logit_1.0  well_%logit_3.0 -_%logit_3.0 being_%logit_1.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  zinc_%logit_2.0  supplements_%logit_3.0  with_%logit_3.0  placebo_%logit_3.0  or_%logit_3.0  no_%logit_3.0  treatment_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  toxicity_%logit_3.0  of_%logit_3.0  zinc_%logit_3.0  supplement_%logit_3.0 ing_%logit_3.0  powd_%logit_3.0 ers_%logit_3.0 ,_%logit_1.0  and_%logit_1.0  an_%logit_3.0  assessment_%logit_3.0  of_%logit_0.0  the_%logit_1.0  effects_%logit_3.0  of_%logit_3.0  zinc_%logit_1.0  supplementation_%logit_3.0  on_%logit_3.0  health_%logit_3.0 -_%logit_3.0 related_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_0.0  and_%logit_0.0  wellbeing_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  vitamin_%logit_3.0  D_%logit_3.0  supplements_%logit_3.0  for_%logit_3.0  reducing_%logit_3.0  plasma_%logit_3.0  P_%logit_3.0 TH_%logit_3.0  levels_%logit_1.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  P_%logit_1.0 TH_%logit_3.0 ._%logit_2.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  whether_%logit_2.0  vitamin_%logit_3.0  D_%logit_3.0  supplementation_%logit_3.0  is_%logit_0.0  beneficial_%logit_3.0  for_%logit_0.0  P_%logit_3.0 TH_%logit_3.0  and_%logit_2.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  supplementation_%logit_1.0  on_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ,_%logit_3.0  including_%logit_1.0  nausea_%logit_3.0 ,_%logit_3.0  vomiting_%logit_3.0 ,_%logit_1.0  diarr_%logit_3.0 hoe_%logit_3.0 a_%logit_1.0  and_%logit_1.0  diarrhea_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_0.0 term_%logit_2.0  data_%logit_1.0  are_%logit_0.0  required_%logit_2.0  to_%logit_2.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  supplementation_%logit_0.0  and_%logit_0.0  to_%logit_3.0  compare_%logit_0.0  vitamin_%logit_2.0  D_%logit_3.0  supplement_%logit_3.0 ing_%logit_3.0  supplements_%logit_3.0  with_%logit_3.0  calcium_%logit_3.0  supplementation_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  undergoing_%logit_3.0  dial_%logit_1.0 ysis_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  mic_%logit_3.0 ron_%logit_3.0 ut_%logit_1.0 rient_%logit_0.0  supplements_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  gest_%logit_3.0 ational_%logit_3.0  age_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  mic_%logit_3.0 ron_%logit_3.0 ot_%logit_0.0 rient_%logit_1.0  supplement_%logit_0.0  to_%logit_2.0  supplement_%logit_0.0  supplement_%logit_0.0 ing_%logit_0.0  supplements_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  other_%logit_1.0  maternal_%logit_3.0  and_%logit_3.0  infant_%logit_3.0  outcomes_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  all_%logit_2.0  the_%logit_3.0  outcomes_%logit_3.0  assessed_%logit_3.0  in_%logit_1.0  this_%logit_1.0  review_%logit_0.0 ,_%logit_0.0  including_%logit_2.0  maternal_%logit_1.0  and_%logit_3.0  neon_%logit_1.0 atal_%logit_1.0  mortality_%logit_3.0  and_%logit_0.0  developmental_%logit_0.0  outcomes_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_1.0  as_%logit_1.0  to_%logit_2.0  compare_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  mic_%logit_3.0 rone_%logit_3.0 ut_%logit_3.0 rient_%logit_2.0  supplementation_%logit_0.0  with_%logit_0.0  supplement_%logit_3.0 ing_%logit_3.0  supplement_%logit_2.0 ing_%logit_3.0  supplementation_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  hyp_%logit_3.0 other_%logit_3.0 mia_%logit_1.0  as_%logit_0.0  an_%logit_3.0  adjunct_%logit_0.0  to_%logit_0.0  other_%logit_0.0  resusc_%logit_3.0 itation_%logit_3.0  techniques_%logit_2.0  in_%logit_0.0  acute_%logit_1.0  IC_%logit_0.0 U_%logit_3.0  beds_%logit_1.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  best_%logit_3.0  method_%logit_3.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_0.0  hyp_%logit_1.0 otherapy_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  other_%logit_1.0  critical_%logit_3.0  care_%logit_3.0  outcomes_%logit_3.0 ,_%logit_3.0  including_%logit_1.0  mortality_%logit_3.0 ,_%logit_3.0  cardiovascular_%logit_3.0  morbid_%logit_1.0 ity_%logit_3.0  and_%logit_0.0  mortality_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_1.0  as_%logit_0.0  to_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  interventions_%logit_1.0  in_%logit_3.0  the_%logit_1.0  long_%logit_0.0  term_%logit_0.0 ._%logit_0.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  these_%logit_3.0  approaches_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  on_%logit_3.0  assessing_%logit_0.0  their_%logit_3.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_1.0  context_%logit_3.0  of_%logit_0.0  intensive_%logit_1.0  IC_%logit_3.0 U_%logit_1.0  bed_%logit_1.0  rest_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  correlation_%logit_3.0  between_%logit_3.0  frequency_%logit_3.0  of_%logit_3.0  exclusive_%logit_0.0  breastfeeding_%logit_3.0  and_%logit_3.0  breastfeeding_%logit_3.0  frequency_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_1.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_1.0  the_%logit_2.0  relationship_%logit_3.0  between_%logit_3.0  frequency_%logit_3.0  and_%logit_3.0  frequency_%logit_3.0  of_%logit_3.0  breastfeeding_%logit_3.0  frequency_%logit_3.0 ,_%logit_3.0  duration_%logit_3.0  of_%logit_3.0  breastfeeding_%logit_1.0 ,_%logit_3.0  frequency_%logit_3.0  of_%logit_3.0  lact_%logit_3.0 ation_%logit_3.0  support_%logit_3.0  and_%logit_3.0  frequency_%logit_1.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  there_%logit_1.0  is_%logit_1.0  no_%logit_2.0  clear_%logit_3.0  evidence_%logit_3.0  of_%logit_0.0  a_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  breastfeeding_%logit_3.0  frequency_%logit_3.0  or_%logit_3.0  duration_%logit_3.0  between_%logit_3.0  the_%logit_3.0  two_%logit_3.0  methods_%logit_3.0  of_%logit_1.0  breastfeeding_%logit_1.0 ._%logit_1.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_0.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_1.0  to_%logit_1.0  assess_%logit_1.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  frequency_%logit_1.0  and_%logit_3.0  length_%logit_3.0  of_%logit_3.0  breastfeeding_%logit_3.0  in_%logit_3.0  tandem_%logit_3.0  with_%logit_3.0  breastfeeding_%logit_3.0  frequency_%logit_3.0  and_%logit_3.0  duration_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  frequency_%logit_2.0  and_%logit_3.0  intensity_%logit_3.0  of_%logit_3.0  breastfeeding_%logit_1.0  among_%logit_3.0  the_%logit_3.0  different_%logit_3.0  methods_%logit_1.0  of_%logit_3.0  supplement_%logit_1.0 ing_%logit_3.0  breastfeeding_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  IF_%logit_3.0 H_%logit_3.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  OH_%logit_1.0 SS_%logit_3.0  in_%logit_3.0  vitro_%logit_3.0  fertil_%logit_3.0 isation_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_1.0  whether_%logit_2.0  IF_%logit_3.0 H_%logit_1.0  is_%logit_1.0  beneficial_%logit_3.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_0.0  OH_%logit_3.0 SS_%logit_0.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  IF_%logit_2.0 H_%logit_3.0  with_%logit_1.0  IF_%logit_3.0 H_%logit_3.0  or_%logit_1.0  IF_%logit_3.0 H_%logit_3.0  alone_%logit_1.0  or_%logit_3.0  in_%logit_3.0  combination_%logit_1.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  IF_%logit_3.0 H_%logit_3.0  and_%logit_1.0  IF_%logit_3.0 H_%logit_3.0  compared_%logit_1.0  to_%logit_3.0  IF_%logit_3.0 H_%logit_3.0 ,_%logit_1.0  IF_%logit_3.0 H_%logit_3.0  plus_%logit_1.0  IF_%logit_3.0 H_%logit_0.0  as_%logit_1.0  an_%logit_3.0  adj_%logit_0.0 u_%logit_0.0 vant_%logit_1.0  treatment_%logit_1.0  for_%logit_0.0  O_%logit_0.0 SS_%logit_3.0  in_%logit_1.0  vivo_%logit_3.0  fertil_%logit_1.0 ization_%logit_1.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  I_%logit_3.0 UD_%logit_3.0  insertion_%logit_2.0  for_%logit_1.0  reducing_%logit_3.0  blood_%logit_3.0  loss_%logit_3.0  or_%logit_3.0  blood_%logit_3.0  loss_%logit_3.0  in_%logit_3.0  menstrual_%logit_3.0  blood_%logit_3.0  loss_%logit_0.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  intervention_%logit_1.0  for_%logit_1.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  blood_%logit_1.0  loss_%logit_3.0  and_%logit_0.0  blood_%logit_3.0  loss_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_1.0  management_%logit_3.0  of_%logit_0.0  menstrual_%logit_3.0  bleeding_%logit_3.0  and_%logit_3.0  pain_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_0.0  its_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  its_%logit_1.0  effectiveness_%logit_3.0  and_%logit_3.0  cost_%logit_1.0 ,_%logit_3.0  and_%logit_2.0  its_%logit_3.0  usefulness_%logit_3.0  in_%logit_3.0  reducing_%logit_2.0  blood_%logit_3.0 loss_%logit_3.0  and_%logit_0.0  blood_%logit_3.0  transf_%logit_3.0 usion_%logit_0.0 ,_%logit_2.0  it_%logit_0.0  is_%logit_0.0  recommended_%logit_2.0  that_%logit_2.0  it_%logit_1.0  is_%logit_0.0  used_%logit_2.0  in_%logit_0.0  conjunction_%logit_1.0  with_%logit_0.0  other_%logit_3.0  preventive_%logit_3.0  measures_%logit_3.0 ,_%logit_3.0  such_%logit_0.0  as_%logit_1.0  hyd_%logit_1.0 ration_%logit_3.0 ,_%logit_1.0  hyd_%logit_3.0 ration_%logit_3.0  and_%logit_1.0  hyd_%logit_3.0 ration_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  N_%logit_1.0 RT_%logit_3.0 I_%logit_1.0  in_%logit_1.0  CD_%logit_3.0 4_%logit_3.0 +_%logit_2.0  T_%logit_2.0  cells_%logit_2.0 ,_%logit_2.0  but_%logit_2.0  there_%logit_3.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0 ._%logit_2.0  This_%logit_3.0  is_%logit_0.0  especially_%logit_0.0  true_%logit_0.0  in_%logit_3.0  the_%logit_3.0  context_%logit_3.0  of_%logit_3.0  the_%logit_3.0  introduction_%logit_3.0  of_%logit_3.0  new_%logit_3.0  cell_%logit_3.0  therapies_%logit_3.0 ,_%logit_2.0  which_%logit_1.0  are_%logit_3.0  now_%logit_3.0  standard_%logit_3.0  therapy_%logit_3.0  for_%logit_2.0  CD_%logit_2.0 4_%logit_0.0 -_%logit_2.0  T_%logit_2.0  cell_%logit_2.0  interrupt_%logit_2.0 ions_%logit_1.0 ,_%logit_1.0  and_%logit_2.0  in_%logit_3.0  CD_%logit_3.0 8_%logit_3.0 -_%logit_2.0 T_%logit_2.0  cell_%logit_0.0  interruption_%logit_2.0  therapy_%logit_2.0 ,_%logit_3.0  which_%logit_2.0  is_%logit_2.0  now_%logit_2.0  standard_%logit_3.0  treatment_%logit_0.0  protocol_%logit_2.0  for_%logit_2.0  CD_%logit_2.0 3_%logit_0.0 -_%logit_2.0 T_%logit_2.0  cells_%logit_0.0 ,_%logit_2.0  and_%logit_2.0  for_%logit_2.0  CD_%logit_3.0 7_%logit_3.0 -_%logit_2.0 RT_%logit_2.0 I_%logit_0.0 ,_%logit_1.0  which_%logit_2.0  includes_%logit_2.0  a_%logit_2.0  number_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  treat_%logit_0.0 ._%logit_0.0
 Iron_%logit_0.0  supplementation_%logit_0.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_0.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  the_%logit_0.0  incidence_%logit_3.0  of_%logit_3.0  adverse_%logit_0.0  events_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  no_%logit_3.0  significant_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  mortality_%logit_3.0 ._%logit_3.0  Iron_%logit_3.0  supplementation_%logit_2.0  does_%logit_2.0  not_%logit_3.0  appear_%logit_3.0  to_%logit_2.0  have_%logit_1.0  a_%logit_2.0  significant_%logit_3.0  impact_%logit_2.0  on_%logit_2.0  mortality_%logit_2.0  or_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_2.0  iron_%logit_3.0  supplementation_%logit_3.0  does_%logit_2.0  appear_%logit_3.0  to_%logit_3.0  be_%logit_3.0  associated_%logit_3.0  with_%logit_0.0  an_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  iron_%logit_1.0  consumption_%logit_3.0 ,_%logit_3.0  although_%logit_3.0  there_%logit_3.0  is_%logit_3.0  no_%logit_2.0  evidence_%logit_3.0  of_%logit_2.0  a_%logit_3.0  significant_%logit_3.0  difference_%logit_3.0  between_%logit_3.0  iron_%logit_3.0  supplementation_%logit_3.0  and_%logit_2.0  iron_%logit_3.0  supplementation_%logit_3.0  alone_%logit_2.0  or_%logit_3.0  in_%logit_3.0  combination_%logit_1.0  with_%logit_3.0  iron_%logit_3.0  supplementation_%logit_1.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  iron_%logit_3.0  supplementation_%logit_0.0  regimen_%logit_2.0  and_%logit_0.0  the_%logit_1.0  optimal_%logit_3.0  iron_%logit_3.0  composition_%logit_0.0  and_%logit_2.0  timing_%logit_3.0  of_%logit_0.0  iron_%logit_2.0  supplementation_%logit_1.0 ,_%logit_2.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  iron_%logit_2.0  supplementation_%logit_3.0  to_%logit_3.0  iron_%logit_3.0  supplementation_%logit_3.0  with_%logit_2.0  other_%logit_3.0  iron_%logit_3.0  supplements_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  insulin_%logit_3.0 -_%logit_3.0 based_%logit_3.0  glucose_%logit_1.0  monitors_%logit_3.0  in_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  weight_%logit_3.0  loss_%logit_3.0  in_%logit_3.0  diabetic_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  type_%logit_3.0  2_%logit_3.0  diabetes_%logit_2.0  mell_%logit_1.0 itus_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  insulin_%logit_3.0 -_%logit_2.0 containing_%logit_2.0  glucose_%logit_2.0  monitors_%logit_3.0  and_%logit_3.0  to_%logit_1.0  compare_%logit_3.0  them_%logit_2.0  with_%logit_3.0  insulin_%logit_3.0 -_%logit_3.0 controlled_%logit_2.0  glucose_%logit_2.0  monitors_%logit_3.0 ._%logit_1.0  Finally_%logit_2.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_2.0 term_%logit_3.0  data_%logit_1.0  are_%logit_3.0  needed_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  insulin_%logit_1.0  and_%logit_1.0  glucose_%logit_1.0  monitors_%logit_3.0  for_%logit_3.0  weight_%logit_2.0  loss_%logit_3.0  and_%logit_3.0  glucose_%logit_3.0  control_%logit_3.0  in_%logit_3.0  diabetic_%logit_3.0  populations_%logit_1.0  with_%logit_3.0  type_%logit_2.0  1_%logit_3.0  diabetes_%logit_2.0  mell_%logit_1.0 us_%logit_1.0  mell_%logit_1.0 itus_%logit_3.0  and_%logit_1.0  type_%logit_3.0  2_%logit_3.0  diabetic_%logit_2.0  mell_%logit_3.0 itus_%logit_3.0 ,_%logit_1.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  insulin_%logit_3.0  therapy_%logit_3.0  in_%logit_2.0  these_%logit_1.0  populations_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ip_%logit_3.0 rat_%logit_3.0 rop_%logit_1.0 ium_%logit_1.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  asthma_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_0.0  duration_%logit_1.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_3.0  ip_%logit_1.0 at_%logit_1.0 rop_%logit_1.0 ium_%logit_2.0 ,_%logit_2.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_2.0  management_%logit_3.0  of_%logit_3.0  asthma_%logit_3.0  exacerb_%logit_3.0 ations_%logit_3.0  in_%logit_1.0  patients_%logit_1.0  with_%logit_3.0  severe_%logit_1.0  acute_%logit_3.0  exacerb_%logit_3.0 ations_%logit_3.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0  and_%logit_2.0  executed_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  ip_%logit_1.0 ot_%logit_3.0 rop_%logit_1.0 ium_%logit_0.0  on_%logit_0.0  pulmonary_%logit_1.0  function_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  in_%logit_0.0  people_%logit_3.0  with_%logit_3.0  asthma_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_3.0  psychological_%logit_1.0  counselling_%logit_1.0  for_%logit_3.0  quitting_%logit_1.0  behaviour_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  reliability_%logit_1.0  of_%logit_3.0  psychological_%logit_3.0  counseling_%logit_1.0  for_%logit_3.0  quitting_%logit_1.0  behaviours_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_1.0  context_%logit_3.0  of_%logit_3.0  a_%logit_1.0  broader_%logit_1.0  range_%logit_3.0  of_%logit_0.0  interventions_%logit_3.0 ,_%logit_0.0  including_%logit_1.0  psychological_%logit_1.0  counselling_%logit_1.0 ,_%logit_3.0  behavioural_%logit_1.0  counselling_%logit_1.0  and_%logit_3.0  behavioural_%logit_1.0  counselling_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  counselling_%logit_2.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_2.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  psych_%logit_1.0 otherapy_%logit_1.0  for_%logit_0.0  quitting_%logit_1.0  behavior_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  on_%logit_0.0  assessing_%logit_0.0  its_%logit_3.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  protective_%logit_3.0  mechanism_%logit_3.0  to_%logit_3.0  protect_%logit_3.0  against_%logit_3.0  P_%logit_3.0 PD_%logit_3.0  reduction_%logit_0.0  in_%logit_3.0  the_%logit_3.0  developing_%logit_3.0  world_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  establish_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_3.0  of_%logit_3.0  protective_%logit_3.0  mechanisms_%logit_3.0  for_%logit_3.0  restoring_%logit_3.0  P_%logit_3.0 PD_%logit_3.0  in_%logit_0.0  developing_%logit_3.0  regions_%logit_3.0  of_%logit_3.0  the_%logit_1.0  world_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  mechanisms_%logit_3.0  with_%logit_3.0  other_%logit_3.0  interventions_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_0.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  executed_%logit_0.0  random_%logit_2.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  protective_%logit_3.0  barriers_%logit_3.0  in_%logit_3.0  developing_%logit_3.0  areas_%logit_3.0  of_%logit_3.0  the_%logit_3.0  World_%logit_3.0  Health_%logit_3.0  Organization_%logit_2.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  uncom_%logit_1.0 pl_%logit_3.0 icated_%logit_1.0  UT_%logit_0.0 Is_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  antibiotic_%logit_3.0  treatment_%logit_3.0  in_%logit_3.0  this_%logit_1.0  population_%logit_0.0 ,_%logit_2.0  as_%logit_2.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  compare_%logit_3.0  antibiotic_%logit_2.0  therapy_%logit_3.0  with_%logit_3.0  no_%logit_3.0  treatment_%logit_3.0  or_%logit_2.0  no_%logit_2.0  treatment_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0 ,_%logit_2.0  transparent_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  random_%logit_0.0 ised_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  comparing_%logit_0.0  antibiotic_%logit_2.0  therapy_%logit_3.0  to_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_3.0  alone_%logit_3.0  or_%logit_2.0  in_%logit_2.0  combination_%logit_1.0  with_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_3.0 ._%logit_3.0
 Physical_%logit_0.0  activity_%logit_1.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_0.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  BMI_%logit_0.0  and_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0 ,_%logit_0.0  but_%logit_3.0  no_%logit_3.0  significant_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  BMI_%logit_3.0  or_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0  was_%logit_0.0  found_%logit_3.0  in_%logit_3.0  physical_%logit_3.0  activity_%logit_3.0 ._%logit_3.0  Physical_%logit_3.0  activity_%logit_0.0  may_%logit_3.0  be_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  an_%logit_3.0  improvement_%logit_3.0  in_%logit_3.0  BMI_%logit_1.0 ,_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0  and_%logit_0.0  triglycer_%logit_3.0 ide_%logit_3.0  levels_%logit_0.0 ,_%logit_3.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  no_%logit_2.0  evidence_%logit_3.0  of_%logit_3.0  a_%logit_2.0  difference_%logit_3.0  in_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0  or_%logit_0.0  triglycer_%logit_3.0 ide_%logit_3.0  level_%logit_2.0 ._%logit_3.0  Physical_%logit_3.0  activities_%logit_0.0  are_%logit_3.0  associated_%logit_1.0  with_%logit_3.0  significant_%logit_3.0  decreases_%logit_3.0  in_%logit_3.0  BMI_%logit_1.0  but_%logit_3.0  no_%logit_3.0  statistically_%logit_3.0  significant_%logit_3.0  difference_%logit_2.0  was_%logit_3.0  observed_%logit_3.0  in_%logit_3.0  fasting_%logit_3.0  plasma_%logit_3.0  glucose_%logit_3.0  levels_%logit_3.0 ._%logit_3.0  Exercise_%logit_3.0  programmes_%logit_0.0  are_%logit_3.0  not_%logit_1.0  associated_%logit_1.0  with_%logit_1.0  any_%logit_3.0  significant_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  waist_%logit_1.0  circumference_%logit_3.0  or_%logit_0.0  blood_%logit_3.0  sugar_%logit_3.0  levels_%logit_3.0 ,_%logit_3.0  nor_%logit_3.0  with_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  triglycer_%logit_1.0 ides_%logit_3.0  or_%logit_2.0  triglycer_%logit_3.0 ides_%logit_3.0 ._%logit_2.0  Exercise_%logit_3.0  programs_%logit_0.0  should_%logit_3.0  be_%logit_1.0  undertaken_%logit_2.0  in_%logit_1.0  moderation_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  exercise_%logit_3.0  programmes_%logit_3.0  should_%logit_3.0  be_%logit_1.0  supervised_%logit_2.0 ._%logit_1.0
 The_%logit_0.0  results_%logit_0.0  of_%logit_3.0  this_%logit_2.0  review_%logit_0.0  suggest_%logit_2.0  that_%logit_2.0  there_%logit_3.0  is_%logit_3.0  no_%logit_3.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  D_%logit_3.0 DD_%logit_3.0 IR_%logit_1.0  as_%logit_1.0  a_%logit_1.0  measure_%logit_0.0  of_%logit_0.0  cardiac_%logit_0.0  output_%logit_3.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_0.0  the_%logit_3.0  results_%logit_3.0  are_%logit_3.0  based_%logit_2.0  on_%logit_3.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  small_%logit_3.0  studies_%logit_0.0  with_%logit_3.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  bias_%logit_0.0  and_%logit_0.0  are_%logit_2.0  therefore_%logit_3.0  not_%logit_0.0  necessarily_%logit_3.0  representative_%logit_1.0  of_%logit_1.0  the_%logit_3.0  whole_%logit_3.0  range_%logit_3.0  of_%logit_3.0  outcomes_%logit_3.0  measured_%logit_3.0  in_%logit_1.0  this_%logit_3.0  review_%logit_0.0 ._%logit_0.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  mode_%logit_3.0  of_%logit_2.0  action_%logit_1.0  and_%logit_3.0  the_%logit_3.0  best_%logit_3.0  way_%logit_3.0  of_%logit_3.0  delivering_%logit_1.0  D_%logit_3.0 DD_%logit_3.0  IR_%logit_2.0  to_%logit_1.0  patients_%logit_0.0  with_%logit_0.0  a_%logit_1.0  history_%logit_3.0  of_%logit_3.0  cardiac_%logit_3.0  arr_%logit_3.0 h_%logit_3.0 ythm_%logit_0.0 ias_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ant_%logit_3.0 ich_%logit_3.0 olin_%logit_3.0 erg_%logit_0.0 ics_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  PD_%logit_1.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  agents_%logit_3.0  in_%logit_3.0  the_%logit_2.0  management_%logit_3.0  of_%logit_3.0  PD_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  drugs_%logit_3.0  on_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  disability_%logit_3.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  these_%logit_0.0  drugs_%logit_3.0  are_%logit_3.0  used_%logit_0.0  to_%logit_0.0  treat_%logit_3.0  PD_%logit_0.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  the_%logit_2.0  mechanism_%logit_3.0  by_%logit_3.0  which_%logit_3.0  they_%logit_3.0  are_%logit_3.0  used_%logit_0.0  in_%logit_1.0  the_%logit_3.0  control_%logit_3.0  of_%logit_3.0  PD_%logit_1.0  and_%logit_3.0  its_%logit_1.0  complications_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  mechanical_%logit_3.0  ventilation_%logit_3.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_0.0  non_%logit_3.0 -_%logit_3.0 ob_%logit_1.0 structed_%logit_1.0  duct_%logit_2.0 us_%logit_1.0  shun_%logit_0.0 ts_%logit_3.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  whether_%logit_2.0  mechanical_%logit_3.0  ventilation_%logit_1.0  is_%logit_3.0  more_%logit_1.0  effective_%logit_0.0  than_%logit_1.0  mechanical_%logit_1.0  ventilation_%logit_1.0 ,_%logit_1.0  or_%logit_1.0  whether_%logit_3.0  it_%logit_3.0  is_%logit_3.0  more_%logit_1.0  efficient_%logit_3.0  than_%logit_1.0  surgical_%logit_2.0  ventilation_%logit_1.0  in_%logit_1.0  terms_%logit_1.0  of_%logit_3.0  reducing_%logit_3.0  the_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  death_%logit_1.0 ,_%logit_3.0  respiratory_%logit_3.0  distress_%logit_3.0  syndrome_%logit_0.0 ,_%logit_1.0  or_%logit_3.0  other_%logit_3.0  adverse_%logit_3.0  outcomes_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  in_%logit_2.0  this_%logit_3.0  area_%logit_3.0 ,_%logit_2.0  particularly_%logit_2.0  in_%logit_2.0  the_%logit_3.0  context_%logit_3.0  of_%logit_3.0  the_%logit_3.0  development_%logit_3.0  of_%logit_3.0  new_%logit_3.0  mechanical_%logit_3.0  ventilation_%logit_3.0  systems_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  acupuncture_%logit_3.0  for_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  trig_%logit_1.0 em_%logit_3.0 inal_%logit_0.0  neural_%logit_0.0 g_%logit_3.0 ia_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  acupuncture_%logit_3.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  with_%logit_3.0  other_%logit_1.0  treatments_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  acupuncture_%logit_2.0  with_%logit_3.0  other_%logit_3.0  forms_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0 ,_%logit_2.0  transparent_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  random_%logit_0.0 ised_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  in_%logit_1.0  trig_%logit_1.0 em_%logit_3.0 eral_%logit_0.0  neural_%logit_2.0 g_%logit_2.0 ias_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  existence_%logit_1.0  of_%logit_0.0  any_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  pain_%logit_3.0  relief_%logit_3.0  between_%logit_3.0  the_%logit_3.0  two_%logit_3.0  types_%logit_3.0  of_%logit_3.0  hyd_%logit_1.0 ration_%logit_1.0  systems_%logit_1.0  for_%logit_1.0  post_%logit_1.0 operative_%logit_3.0  pain_%logit_0.0  relief_%logit_3.0 ._%logit_3.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  conducted_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trials_%logit_0.0  in_%logit_0.0  this_%logit_1.0  area_%logit_0.0 ._%logit_0.0  Such_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  determine_%logit_2.0  whether_%logit_2.0  hyd_%logit_3.0 ration_%logit_1.0  is_%logit_3.0  beneficial_%logit_3.0  or_%logit_0.0  harmful_%logit_3.0  in_%logit_0.0  terms_%logit_3.0  of_%logit_0.0  pain_%logit_3.0  relief_%logit_0.0 ,_%logit_3.0  function_%logit_1.0 ,_%logit_0.0  quality_%logit_3.0  of_%logit_0.0  life_%logit_3.0 ,_%logit_0.0  satisfaction_%logit_1.0  with_%logit_1.0  pain_%logit_1.0  relief_%logit_1.0  and_%logit_3.0  satisfaction_%logit_1.0  with_%logit_0.0  the_%logit_3.0  hyd_%logit_3.0 ration_%logit_1.0  system_%logit_1.0 ._%logit_1.0  They_%logit_1.0  also_%logit_0.0  need_%logit_2.0  to_%logit_2.0  evaluate_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_1.0  hyd_%logit_3.0 ration_%logit_3.0  techniques_%logit_1.0 ,_%logit_1.0  such_%logit_1.0  as_%logit_1.0  oxy_%logit_1.0 toc_%logit_1.0 in_%logit_1.0 ,_%logit_3.0  oxy_%logit_1.0 cod_%logit_1.0 one_%logit_1.0 ,_%logit_2.0  and_%logit_3.0  hyd_%logit_1.0 ration_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ib_%logit_1.0 up_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  as_%logit_1.0  an_%logit_3.0  adjunct_%logit_0.0  to_%logit_0.0  standard_%logit_0.0  ana_%logit_3.0 esthetic_%logit_1.0  therapy_%logit_1.0  for_%logit_3.0  pain_%logit_1.0  relief_%logit_0.0  in_%logit_3.0  ul_%logit_3.0 cer_%logit_3.0  healing_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  ib_%logit_3.0 ip_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  in_%logit_1.0  ul_%logit_2.0 cers_%logit_3.0  healing_%logit_1.0  with_%logit_0.0  or_%logit_3.0  without_%logit_3.0  ant_%logit_2.0 icon_%logit_3.0 v_%logit_2.0 uls_%logit_2.0 ant_%logit_1.0  therapy_%logit_3.0 ,_%logit_2.0  as_%logit_2.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  ib_%logit_1.0 ap_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  on_%logit_2.0  pain_%logit_3.0  relief_%logit_3.0  and_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  healing_%logit_2.0  ul_%logit_3.0 cer_%logit_3.0  ul_%logit_1.0 cers_%logit_3.0  with_%logit_1.0  ant_%logit_1.0 ico_%logit_3.0 ag_%logit_2.0 ulation_%logit_2.0  therapy_%logit_0.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  CB_%logit_3.0 T_%logit_3.0  for_%logit_1.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  depression_%logit_3.0  or_%logit_3.0  alcohol_%logit_3.0  dependence_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  approach_%logit_3.0  to_%logit_3.0  CB_%logit_1.0 T_%logit_3.0 ,_%logit_1.0  the_%logit_1.0  best_%logit_3.0  way_%logit_3.0  to_%logit_3.0  integrate_%logit_1.0  CB_%logit_2.0 T_%logit_3.0  and_%logit_1.0  other_%logit_3.0  psych_%logit_3.0 os_%logit_3.0 ocial_%logit_0.0  interventions_%logit_0.0 ,_%logit_3.0  and_%logit_1.0  the_%logit_3.0  most_%logit_3.0  effective_%logit_0.0  way_%logit_3.0  to_%logit_3.0  deliver_%logit_1.0  CB_%logit_2.0 T_%logit_3.0  to_%logit_1.0  people_%logit_1.0  with_%logit_0.0  depression_%logit_1.0  and_%logit_3.0  alcohol_%logit_3.0  dependence_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  CB_%logit_2.0 T_%logit_3.0  with_%logit_1.0  other_%logit_3.0  types_%logit_3.0  of_%logit_3.0  psycho_%logit_3.0 active_%logit_3.0  interventions_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  standard_%logit_1.0 ised_%logit_2.0  assessment_%logit_0.0  of_%logit_0.0  the_%logit_0.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  the_%logit_3.0  CB_%logit_3.0 T_%logit_3.0  approach_%logit_1.0  to_%logit_1.0  mental_%logit_1.0  health_%logit_3.0  services_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_0.0  evaluate_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  the_%logit_3.0  various_%logit_3.0  types_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 otherapy_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  th_%logit_3.0 ym_%logit_3.0 os_%logit_1.0 upp_%logit_0.0 ression_%logit_0.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  T_%logit_3.0  cell_%logit_0.0  carcin_%logit_2.0 oma_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_1.0  and_%logit_1.0  timing_%logit_1.0  of_%logit_0.0  treatment_%logit_1.0  and_%logit_1.0  to_%logit_2.0  assess_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  agents_%logit_3.0  in_%logit_3.0  terms_%logit_2.0  of_%logit_3.0  survival_%logit_3.0  and_%logit_3.0  progression_%logit_3.0 -_%logit_3.0 free_%logit_0.0  survival_%logit_0.0  in_%logit_1.0  patients_%logit_3.0  with_%logit_3.0  metast_%logit_1.0 atic_%logit_2.0  tum_%logit_0.0 ours_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  trials_%logit_0.0  should_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  these_%logit_3.0  treatments_%logit_3.0  in_%logit_3.0  patients_%logit_2.0  who_%logit_3.0  are_%logit_1.0  undergoing_%logit_2.0  chemotherapy_%logit_2.0  for_%logit_3.0  this_%logit_3.0  condition_%logit_3.0 ,_%logit_2.0  and_%logit_2.0  to_%logit_2.0  compare_%logit_3.0  these_%logit_2.0  treatments_%logit_3.0  with_%logit_3.0  each_%logit_3.0  other_%logit_3.0 ._%logit_2.0  Finally_%logit_3.0  they_%logit_0.0  should_%logit_0.0  assess_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  toxicity_%logit_3.0  of_%logit_3.0  these_%logit_3.0  therapies_%logit_3.0  in_%logit_3.0  patients_%logit_2.0  undergoing_%logit_0.0  chemotherapy_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  draw_%logit_2.0  conclusions_%logit_2.0  about_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  visual_%logit_1.0  ac_%logit_1.0 uity_%logit_1.0  testing_%logit_1.0  in_%logit_3.0  reducing_%logit_3.0  the_%logit_3.0  incidence_%logit_3.0  of_%logit_3.0  falls_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_1.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  intervention_%logit_1.0  in_%logit_1.0  reducing_%logit_1.0  falls_%logit_3.0  and_%logit_3.0  improving_%logit_3.0  sight_%logit_3.0  ac_%logit_3.0 uity_%logit_3.0  in_%logit_1.0  people_%logit_3.0  with_%logit_3.0  a_%logit_3.0  history_%logit_3.0  of_%logit_3.0  falls_%logit_3.0  and_%logit_3.0  impair_%logit_3.0 ments_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  with_%logit_3.0  other_%logit_3.0  types_%logit_1.0  of_%logit_1.0  assessment_%logit_1.0  and_%logit_1.0  assessment_%logit_1.0 ._%logit_1.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_1.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  the_%logit_1.0  intervention_%logit_1.0  on_%logit_1.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  on_%logit_3.0  improving_%logit_3.0  the_%logit_3.0  quality_%logit_3.0  and_%logit_3.0  quantity_%logit_3.0  of_%logit_0.0  information_%logit_0.0  provided_%logit_0.0  to_%logit_0.0  people_%logit_0.0  with_%logit_0.0  an_%logit_3.0  impairment_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_1.0  of_%logit_3.0  computer_%logit_1.0 -_%logit_1.0 generated_%logit_1.0  weight_%logit_1.0  loss_%logit_0.0  calcul_%logit_3.0 ators_%logit_3.0  in_%logit_0.0  the_%logit_1.0  management_%logit_0.0  of_%logit_3.0  weight_%logit_3.0  loss_%logit_3.0  in_%logit_3.0  overweight_%logit_3.0  or_%logit_0.0  obese_%logit_3.0  individuals_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  way_%logit_3.0  to_%logit_1.0  implement_%logit_1.0  such_%logit_1.0  calcul_%logit_1.0 ators_%logit_1.0 ,_%logit_2.0  and_%logit_2.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  computer_%logit_1.0  gaming_%logit_1.0  consoles_%logit_1.0  on_%logit_1.0  body_%logit_1.0  weight_%logit_3.0  loss_%logit_0.0  and_%logit_3.0  waist_%logit_3.0  circumference_%logit_3.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_1.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  measuring_%logit_3.0  body_%logit_3.0  weight_%logit_3.0 ,_%logit_0.0  waist_%logit_3.0  circumference_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  metabolic_%logit_3.0  control_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  on_%logit_0.0  measuring_%logit_0.0  metabolic_%logit_3.0  control_%logit_3.0  and_%logit_3.0  metabolism_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_1.0  as_%logit_0.0  on_%logit_2.0  the_%logit_0.0  impact_%logit_3.0  on_%logit_3.0  waist_%logit_1.0  circumference_%logit_3.0  and_%logit_0.0  body_%logit_0.0  weight_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antibiotics_%logit_1.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  f_%logit_3.0 eb_%logit_3.0 ri_%logit_2.0 le_%logit_1.0  neut_%logit_2.0 rop_%logit_2.0 en_%logit_2.0 ia_%logit_2.0 ._%logit_2.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_1.0  whether_%logit_2.0  antibiotics_%logit_3.0  are_%logit_3.0  beneficial_%logit_3.0  or_%logit_3.0  harmful_%logit_3.0  in_%logit_0.0  terms_%logit_3.0  of_%logit_3.0  reducing_%logit_3.0  mortality_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_1.0  therapy_%logit_3.0  in_%logit_3.0  this_%logit_1.0  population_%logit_0.0 ._%logit_0.0  Such_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  high_%logit_0.0  methodological_%logit_1.0  quality_%logit_1.0 ,_%logit_1.0  with_%logit_2.0  a_%logit_2.0  focus_%logit_1.0  on_%logit_1.0  identifying_%logit_0.0  patients_%logit_3.0  who_%logit_3.0  are_%logit_3.0  most_%logit_1.0  likely_%logit_0.0  to_%logit_1.0  benefit_%logit_0.0  from_%logit_0.0  antibiotic_%logit_0.0  therapy_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  identifying_%logit_2.0  those_%logit_3.0  patients_%logit_3.0  who_%logit_3.0  will_%logit_3.0  benefit_%logit_1.0  most_%logit_0.0  from_%logit_3.0  antibiotic_%logit_3.0  treatment_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_0.0  az_%logit_3.0 ith_%logit_3.0 romy_%logit_0.0 cin_%logit_0.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  B_%logit_3.0 ._%logit_3.0  conj_%logit_1.0 unct_%logit_1.0 iv_%logit_0.0 itis_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_2.0  and_%logit_2.0  timing_%logit_2.0 ,_%logit_2.0  and_%logit_2.0  the_%logit_3.0  most_%logit_2.0  effective_%logit_3.0  antibiotic_%logit_3.0  for_%logit_2.0  the_%logit_2.0  management_%logit_0.0  of_%logit_2.0  this_%logit_3.0  condition_%logit_0.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_2.0  in_%logit_3.0  the_%logit_2.0  management_%logit_3.0  and_%logit_2.0  management_%logit_3.0  of_%logit_0.0  these_%logit_3.0  conditions_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_2.0  compare_%logit_0.0  these_%logit_2.0  drugs_%logit_3.0  with_%logit_3.0  each_%logit_3.0  other_%logit_2.0  in_%logit_2.0  terms_%logit_3.0  of_%logit_3.0  efficacy_%logit_0.0 ,_%logit_3.0  toler_%logit_3.0 ability_%logit_3.0  and_%logit_1.0  safety_%logit_1.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  OR_%logit_3.0 S_%logit_3.0  as_%logit_1.0  an_%logit_3.0  adjunct_%logit_0.0  to_%logit_0.0  OR_%logit_0.0 S_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  acute_%logit_3.0  diarr_%logit_3.0 hoe_%logit_3.0 a_%logit_1.0 ._%logit_1.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  determine_%logit_3.0  whether_%logit_2.0  OR_%logit_3.0 S_%logit_1.0  is_%logit_1.0  beneficial_%logit_1.0  or_%logit_0.0  harmful_%logit_3.0  in_%logit_0.0  terms_%logit_3.0  of_%logit_3.0  stool_%logit_3.0  integrity_%logit_3.0  and_%logit_3.0  stool_%logit_3.0  integrity_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  OR_%logit_2.0 S_%logit_3.0  with_%logit_1.0  OR_%logit_3.0 S_%logit_2.0 ,_%logit_1.0  OR_%logit_3.0 S_%logit_2.0  and_%logit_1.0  OR_%logit_3.0 S_%logit_2.0  alone_%logit_1.0  or_%logit_3.0  in_%logit_3.0  combination_%logit_1.0 ,_%logit_3.0  or_%logit_3.0  to_%logit_2.0  determine_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  OR_%logit_3.0 S_%logit_2.0  regimen_%logit_1.0 ._%logit_2.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_0.0  also_%logit_3.0  needed_%logit_1.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  AR_%logit_3.0 S_%logit_2.0  in_%logit_1.0  this_%logit_1.0  population_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  to_%logit_0.0  compare_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  IV_%logit_3.0 S_%logit_3.0  with_%logit_1.0  or_%logit_3.0  without_%logit_2.0  OR_%logit_2.0 S_%logit_2.0  or_%logit_1.0  OR_%logit_3.0 S_%logit_2.0  for_%logit_1.0  this_%logit_3.0  population_%logit_3.0 ,_%logit_0.0  a_%logit_2.0  meta_%logit_2.0 -_%logit_2.0 analysis_%logit_0.0  is_%logit_0.0  needed_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  supplemental_%logit_3.0  oxygen_%logit_3.0  as_%logit_3.0  a_%logit_3.0  supplemental_%logit_0.0  oxygen_%logit_0.0  for_%logit_0.0  the_%logit_0.0  treatment_%logit_3.0  of_%logit_0.0  t_%logit_3.0 ach_%logit_3.0 yp_%logit_2.0 n_%logit_0.0 oe_%logit_1.0 a_%logit_0.0  in_%logit_0.0  TT_%logit_3.0 N_%logit_3.0 ._%logit_2.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_0.0  duration_%logit_1.0  and_%logit_0.0  timing_%logit_0.0  of_%logit_3.0  oxygen_%logit_1.0  supplementation_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  supplemental_%logit_1.0  Oxy_%logit_3.0 gen_%logit_1.0  as_%logit_1.0  a_%logit_3.0  supplementary_%logit_3.0  oxygen_%logit_0.0  for_%logit_0.0  TT_%logit_0.0 N_%logit_3.0  in_%logit_1.0  terms_%logit_1.0  of_%logit_0.0  weight_%logit_3.0  loss_%logit_3.0 ,_%logit_3.0  oxygen_%logit_3.0  saturation_%logit_3.0  and_%logit_3.0  oxygen_%logit_3.0  saturation_%logit_3.0  in_%logit_3.0  the_%logit_3.0  first_%logit_0.0  24_%logit_3.0  hours_%logit_1.0  after_%logit_1.0  discharge_%logit_1.0  from_%logit_3.0  hospital_%logit_3.0 ._%logit_1.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  supplemental_%logit_3.0  oxygen_%logit_0.0  is_%logit_0.0  not_%logit_3.0  recommended_%logit_3.0  as_%logit_0.0  a_%logit_2.0  substitute_%logit_0.0  for_%logit_0.0  supplemental_%logit_0.0  oxygen_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  who_%logit_1.0  are_%logit_1.0  unable_%logit_1.0  to_%logit_1.0  tolerate_%logit_3.0  supplemental_%logit_2.0  oxygen_%logit_3.0  or_%logit_3.0  oxygen_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  prog_%logit_1.0 est_%logit_3.0 ogens_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  S_%logit_1.0 EM_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_0.0  in_%logit_3.0  S_%logit_2.0 EM_%logit_0.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  prog_%logit_2.0 est_%logit_3.0 ogen_%logit_0.0  with_%logit_3.0  placebo_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  high_%logit_0.0  quality_%logit_1.0 ,_%logit_1.0  preferably_%logit_2.0  with_%logit_2.0  a_%logit_2.0  high_%logit_2.0  risk_%logit_2.0  of_%logit_0.0  bias_%logit_0.0 ,_%logit_3.0  and_%logit_2.0  should_%logit_1.0  be_%logit_2.0  conducted_%logit_2.0  with_%logit_0.0  a_%logit_2.0  low_%logit_1.0  risk_%logit_1.0  of_%logit_0.0  random_%logit_0.0  errors_%logit_3.0  and_%logit_0.0  unreliable_%logit_1.0  outcome_%logit_0.0  measures_%logit_0.0 ._%logit_3.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  prog_%logit_1.0 ester_%logit_3.0 one_%logit_0.0  in_%logit_0.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  S_%logit_3.0 EMS_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  the_%logit_3.0  impact_%logit_3.0  on_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  on_%logit_3.0  the_%logit_0.0  quality_%logit_3.0  of_%logit_3.0  the_%logit_3.0  life_%logit_0.0  of_%logit_0.0  patients_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  creatine_%logit_3.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  rel_%logit_1.0 apses_%logit_0.0  in_%logit_0.0  adults_%logit_1.0  with_%logit_3.0  MS_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_2.0  of_%logit_0.0  creatine_%logit_2.0  therapy_%logit_3.0  and_%logit_3.0  to_%logit_2.0  compare_%logit_3.0  creatine_%logit_2.0  with_%logit_3.0  placebo_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_2.0 term_%logit_2.0  data_%logit_2.0  are_%logit_2.0  needed_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  creatine_%logit_3.0  in_%logit_3.0  preventing_%logit_3.0  rel_%logit_3.0 apses_%logit_1.0  and_%logit_1.0  to_%logit_3.0  determine_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_2.0  management_%logit_3.0  of_%logit_0.0  MS_%logit_3.0 ._%logit_3.0  Long_%logit_1.0 -_%logit_0.0 term_%logit_2.0  studies_%logit_2.0  are_%logit_2.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  creatine_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  its_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ip_%logit_3.0 rat_%logit_0.0 rop_%logit_1.0 ium_%logit_0.0  for_%logit_0.0  the_%logit_2.0  treatment_%logit_0.0  of_%logit_0.0  acute_%logit_3.0  bron_%logit_3.0 ch_%logit_1.0 ocon_%logit_1.0 st_%logit_3.0 riction_%logit_1.0  in_%logit_0.0  RS_%logit_0.0 Is_%logit_3.0 ._%logit_1.0  Further_%logit_1.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  ip_%logit_3.0 at_%logit_1.0 rop_%logit_1.0 ium_%logit_0.0  in_%logit_2.0  this_%logit_2.0  population_%logit_1.0 ._%logit_2.0  Such_%logit_2.0  trials_%logit_0.0  should_%logit_1.0  be_%logit_2.0  conducted_%logit_2.0  in_%logit_0.0  the_%logit_2.0  United_%logit_0.0  States_%logit_0.0 ,_%logit_1.0  Europe_%logit_2.0 ,_%logit_0.0  Asia_%logit_3.0  and_%logit_0.0  Australia_%logit_1.0 ,_%logit_0.0  and_%logit_2.0  should_%logit_3.0  be_%logit_0.0  of_%logit_2.0  high_%logit_0.0  methodological_%logit_2.0  quality_%logit_0.0 ,_%logit_3.0  with_%logit_2.0  a_%logit_2.0  focus_%logit_2.0  on_%logit_1.0  assessing_%logit_1.0  the_%logit_0.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_0.0  effectiveness_%logit_0.0  of_%logit_3.0  the_%logit_1.0  various_%logit_1.0  treatments_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_3.0  of_%logit_3.0  the_%logit_3.0  interventions_%logit_0.0  reviewed_%logit_3.0  in_%logit_1.0  this_%logit_1.0  review_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  any_%logit_3.0  interventions_%logit_3.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_3.0  T_%logit_3.0 MS_%logit_3.0 ._%logit_1.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_1.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_0.0  a_%logit_1.0  well_%logit_3.0 -_%logit_3.0 defined_%logit_1.0  set_%logit_2.0  of_%logit_0.0  outcome_%logit_0.0  measures_%logit_0.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_1.0  fatigue_%logit_1.0  and_%logit_1.0  fatigue_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_1.0  as_%logit_1.0  an_%logit_2.0  assessment_%logit_1.0  of_%logit_0.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0  They_%logit_3.0  should_%logit_0.0  also_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  various_%logit_1.0  interventions_%logit_3.0  on_%logit_3.0  T_%logit_1.0 MS_%logit_3.0 ,_%logit_1.0  including_%logit_3.0  walking_%logit_3.0 ,_%logit_3.0  cycling_%logit_0.0 ,_%logit_1.0  and_%logit_3.0  social_%logit_1.0  interaction_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  any_%logit_1.0  of_%logit_1.0  the_%logit_3.0  interventions_%logit_0.0  included_%logit_0.0  in_%logit_1.0  this_%logit_1.0  review_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  various_%logit_3.0  types_%logit_0.0  of_%logit_2.0  tobacco_%logit_2.0  cessation_%logit_2.0  interventions_%logit_2.0 ,_%logit_2.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  interventions_%logit_3.0  in_%logit_2.0  the_%logit_2.0  context_%logit_0.0  of_%logit_0.0  a_%logit_0.0  variety_%logit_0.0  of_%logit_3.0  contexts_%logit_3.0  and_%logit_0.0  settings_%logit_2.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  nicotine_%logit_3.0  replacement_%logit_3.0  therapy_%logit_3.0 ,_%logit_0.0  and_%logit_1.0  its_%logit_3.0  effectiveness_%logit_3.0  in_%logit_3.0  specific_%logit_1.0  contexts_%logit_0.0 ,_%logit_2.0  such_%logit_2.0  as_%logit_3.0  smoking_%logit_1.0  cessation_%logit_3.0  programmes_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  the_%logit_3.0  impact_%logit_3.0  on_%logit_3.0  health_%logit_1.0 -_%logit_3.0 related_%logit_3.0  quality_%logit_0.0  of_%logit_0.0  life_%logit_3.0  and_%logit_0.0  wellbeing_%logit_3.0 ,_%logit_0.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  its_%logit_2.0  effectiveness_%logit_0.0  and_%logit_3.0  cost_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  insulin_%logit_1.0  analog_%logit_3.0 ues_%logit_3.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  patients_%logit_1.0  with_%logit_3.0  diabetes_%logit_1.0  mell_%logit_3.0 itus_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  insulin_%logit_3.0 -_%logit_2.0  analog_%logit_2.0 ues_%logit_2.0  for_%logit_2.0  these_%logit_2.0  patients_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  mortality_%logit_1.0 ,_%logit_3.0  cardiovascular_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  and_%logit_1.0  morbid_%logit_3.0 ity_%logit_3.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_3.0 term_%logit_1.0  data_%logit_0.0  are_%logit_3.0  needed_%logit_2.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  gluc_%logit_1.0 oc_%logit_3.0 ort_%logit_1.0 ic_%logit_1.0 oid_%logit_0.0  therapy_%logit_0.0  on_%logit_2.0  gly_%logit_3.0 ca_%logit_3.0 emic_%logit_3.0  control_%logit_1.0  in_%logit_3.0  diabetic_%logit_3.0  mell_%logit_3.0 itus_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  on_%logit_3.0  metabolic_%logit_3.0  control_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_1.0  type_%logit_1.0  1_%logit_3.0  and_%logit_0.0  type_%logit_1.0  2_%logit_2.0  diabetes_%logit_2.0 ._%logit_0.0
 Functional_%logit_0.0  training_%logit_1.0  may_%logit_1.0  be_%logit_1.0  a_%logit_3.0  useful_%logit_3.0  tool_%logit_3.0  in_%logit_0.0  the_%logit_0.0  management_%logit_0.0  of_%logit_1.0  depression_%logit_1.0  and_%logit_3.0  anxiety_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  its_%logit_3.0  usefulness_%logit_3.0  is_%logit_3.0  limited_%logit_2.0  by_%logit_3.0  the_%logit_2.0  small_%logit_3.0  number_%logit_3.0  of_%logit_3.0  participants_%logit_1.0  and_%logit_0.0  the_%logit_1.0  high_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  bias_%logit_1.0  in_%logit_0.0  most_%logit_1.0  of_%logit_1.0  the_%logit_0.0  studies_%logit_1.0 ._%logit_0.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  functional_%logit_1.0  training_%logit_1.0  in_%logit_1.0  depression_%logit_1.0 ,_%logit_3.0  anxiety_%logit_3.0 ,_%logit_3.0  sleep_%logit_3.0  deprivation_%logit_3.0  and_%logit_1.0  sleep_%logit_1.0  deprivation_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  functional_%logit_2.0  training_%logit_1.0  with_%logit_1.0  functional_%logit_3.0  training_%logit_1.0  alone_%logit_1.0  or_%logit_1.0  in_%logit_3.0  combination_%logit_1.0  with_%logit_1.0  other_%logit_3.0  forms_%logit_1.0  of_%logit_3.0  mental_%logit_1.0  health_%logit_1.0  services_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_0.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  exercises_%logit_3.0  for_%logit_1.0  depression_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  the_%logit_3.0  impact_%logit_3.0  of_%logit_3.0  exercise_%logit_1.0  training_%logit_3.0  on_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0  and_%logit_1.0  wellbeing_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_1.0  as_%logit_1.0  the_%logit_1.0  impact_%logit_3.0  on_%logit_3.0  depression_%logit_1.0  severity_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  epid_%logit_1.0 ural_%logit_1.0  analges_%logit_1.0 ia_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  acute_%logit_1.0  pain_%logit_3.0  during_%logit_0.0  anesthesia_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  epid_%logit_1.0 ur_%logit_1.0 als_%logit_2.0  for_%logit_0.0  pain_%logit_1.0  relief_%logit_0.0  during_%logit_1.0  anesthesia_%logit_1.0  during_%logit_1.0  anesthesia_%logit_1.0 ,_%logit_0.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  intra_%logit_3.0 operative_%logit_1.0  analges_%logit_1.0 ia_%logit_3.0  during_%logit_0.0  ana_%logit_1.0 esthesia_%logit_0.0  for_%logit_1.0  acute_%logit_1.0  pain_%logit_0.0  relief_%logit_3.0  in_%logit_1.0  women_%logit_1.0  with_%logit_0.0  acute_%logit_3.0  pain_%logit_3.0  following_%logit_3.0  anesthesia_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_0.0 ed_%logit_2.0 ,_%logit_2.0  transparent_%logit_0.0  and_%logit_2.0  transparent_%logit_0.0  audit_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effectiveness_%logit_0.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_0.0  effectiveness_%logit_0.0  of_%logit_0.0  various_%logit_1.0  analges_%logit_1.0 ia_%logit_0.0  for_%logit_2.0  this_%logit_1.0  purpose_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 os_%logit_3.0 ocial_%logit_3.0  interventions_%logit_1.0  for_%logit_0.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  anxiety_%logit_3.0  disorders_%logit_3.0  in_%logit_3.0  adults_%logit_1.0  with_%logit_0.0  epilepsy_%logit_3.0 ._%logit_3.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_1.0  reported_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trials_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  interventions_%logit_3.0 ._%logit_3.0  Such_%logit_1.0  trials_%logit_0.0  should_%logit_1.0  be_%logit_2.0  of_%logit_2.0  high_%logit_0.0  methodological_%logit_1.0  quality_%logit_1.0 ,_%logit_1.0  with_%logit_2.0  appropriate_%logit_2.0  attention_%logit_1.0  paid_%logit_1.0  to_%logit_2.0  outcome_%logit_0.0  measures_%logit_0.0 ._%logit_3.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  psychological_%logit_3.0  interventions_%logit_3.0  for_%logit_3.0  anxiety_%logit_1.0  disorders_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_0.0  as_%logit_0.0  measures_%logit_2.0  of_%logit_3.0  quality_%logit_0.0  of_%logit_3.0  life_%logit_1.0  and_%logit_0.0  wellbeing_%logit_0.0 ._%logit_0.0  They_%logit_0.0  also_%logit_0.0  should_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  psychological_%logit_1.0  therapies_%logit_3.0  for_%logit_3.0  anxiety_%logit_1.0  disorder_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 os_%logit_3.0 ocial_%logit_1.0  interventions_%logit_0.0  for_%logit_3.0  depression_%logit_1.0  or_%logit_3.0  anxiety_%logit_3.0  disorders_%logit_3.0  in_%logit_3.0  adults_%logit_3.0  with_%logit_3.0  MS_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  psych_%logit_3.0 otherapy_%logit_3.0  for_%logit_1.0  depression_%logit_1.0  and_%logit_3.0  anxiety_%logit_3.0  disorders_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_1.0  to_%logit_2.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  children_%logit_1.0  with_%logit_3.0  MS_%logit_2.0  and_%logit_3.0  adults_%logit_2.0  with_%logit_3.0  depression_%logit_3.0  and_%logit_3.0  its_%logit_3.0  severity_%logit_3.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  there_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_0.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_0.0  random_%logit_2.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  psychological_%logit_1.0  therapies_%logit_0.0  for_%logit_3.0  depression_%logit_1.0  in_%logit_3.0  adults_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  V_%logit_1.0 AP_%logit_1.0  in_%logit_1.0  reducing_%logit_3.0  mortality_%logit_0.0  or_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  admitted_%logit_3.0  to_%logit_1.0  IC_%logit_3.0 U_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  this_%logit_3.0  intervention_%logit_1.0  in_%logit_1.0  improving_%logit_1.0  the_%logit_0.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  of_%logit_0.0  these_%logit_0.0  patients_%logit_0.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  impact_%logit_3.0  on_%logit_3.0  mortality_%logit_1.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  impact_%logit_3.0  of_%logit_3.0  the_%logit_1.0  intervention_%logit_3.0  on_%logit_3.0  mortality_%logit_1.0 ,_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  and_%logit_3.0  mortality_%logit_3.0  in_%logit_3.0  these_%logit_3.0  patients_%logit_1.0  and_%logit_3.0  on_%logit_2.0  cost_%logit_3.0 -_%logit_3.0 effect_%logit_3.0 iveness_%logit_0.0  of_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_0.0  any_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  survival_%logit_3.0  between_%logit_3.0  chem_%logit_3.0 op_%logit_3.0 roph_%logit_1.0 yl_%logit_2.0 axis_%logit_0.0  and_%logit_2.0  chemotherapy_%logit_1.0  alone_%logit_3.0  or_%logit_3.0  in_%logit_3.0  combination_%logit_1.0  with_%logit_3.0  chemotherapy_%logit_3.0  alone_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  chemotherapy_%logit_3.0  versus_%logit_1.0  chemotherapy_%logit_3.0  alone_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  chemotherapy_%logit_3.0  and_%logit_3.0  radiation_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  terms_%logit_1.0  of_%logit_3.0  survival_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  a_%logit_0.0  meta_%logit_0.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effects_%logit_0.0  of_%logit_3.0  radiation_%logit_1.0  therapy_%logit_3.0  versus_%logit_2.0  chemotherapy_%logit_1.0  is_%logit_3.0  warranted_%logit_2.0 ._%logit_1.0  The_%logit_2.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  are_%logit_0.0  based_%logit_2.0  on_%logit_3.0  a_%logit_0.0  small_%logit_0.0  number_%logit_0.0  of_%logit_0.0  small_%logit_0.0  studies_%logit_0.0  with_%logit_0.0  a_%logit_2.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  bias_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  are_%logit_2.0  subject_%logit_2.0  to_%logit_0.0  a_%logit_0.0  number_%logit_3.0  of_%logit_3.0  uncertainties_%logit_3.0 ._%logit_3.0
 The_%logit_0.0  evidence_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  psychological_%logit_3.0  interventions_%logit_3.0  for_%logit_0.0  domestic_%logit_1.0  violence_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  interventions_%logit_3.0 ,_%logit_0.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  them_%logit_2.0  to_%logit_3.0  each_%logit_3.0  other_%logit_3.0 ,_%logit_0.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  their_%logit_3.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_0.0  domestic_%logit_1.0  violence_%logit_3.0  and_%logit_3.0  its_%logit_3.0  aftermath_%logit_3.0 ._%logit_3.0  Recommend_%logit_3.0 ations_%logit_0.0  for_%logit_0.0  future_%logit_0.0  research_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0 ,_%logit_1.0  as_%logit_2.0  are_%logit_2.0  recommendations_%logit_0.0  on_%logit_0.0  how_%logit_1.0  best_%logit_0.0  to_%logit_0.0  implement_%logit_0.0  these_%logit_2.0  interventions_%logit_1.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_0.0  a_%logit_1.0  multi_%logit_3.0 -_%logit_3.0 disciplinary_%logit_0.0  approach_%logit_0.0  to_%logit_0.0  addressing_%logit_1.0  domestic_%logit_3.0  violence_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  how_%logit_3.0  to_%logit_3.0  tailor_%logit_0.0  them_%logit_2.0  to_%logit_1.0  the_%logit_0.0  needs_%logit_0.0  of_%logit_0.0  the_%logit_1.0  community_%logit_0.0 ._%logit_0.0
 Immun_%logit_0.0 ogl_%logit_2.0 ob_%logit_3.0 ulin_%logit_0.0  is_%logit_1.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_3.0  mortality_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  pre_%logit_1.0 -_%logit_3.0 existing_%logit_1.0  se_%logit_1.0 ps_%logit_3.0 is_%logit_0.0 ,_%logit_0.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  its_%logit_2.0  use_%logit_3.0  as_%logit_3.0  a_%logit_2.0  substitute_%logit_1.0  for_%logit_0.0  IV_%logit_0.0 IG_%logit_3.0  in_%logit_1.0  the_%logit_2.0  treatment_%logit_3.0  of_%logit_3.0  pre_%logit_1.0 -_%logit_3.0 term_%logit_1.0  infants_%logit_0.0  with_%logit_0.0  pre_%logit_1.0 term_%logit_3.0  infants_%logit_1.0  who_%logit_3.0  are_%logit_3.0  at_%logit_2.0  high_%logit_2.0  risk_%logit_1.0  of_%logit_1.0  se_%logit_3.0 ps_%logit_3.0 IS_%logit_0.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  IV_%logit_1.0 IG_%logit_3.0  therapy_%logit_1.0  in_%logit_1.0  these_%logit_1.0  infants_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  optimal_%logit_3.0  timing_%logit_3.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_0.0  administration_%logit_1.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  immun_%logit_1.0 ogl_%logit_1.0 ob_%logit_2.0 ul_%logit_2.0 ins_%logit_1.0  with_%logit_3.0  IV_%logit_1.0 IG_%logit_3.0 ,_%logit_1.0  IV_%logit_1.0 IG_%logit_2.0  and_%logit_1.0  IV_%logit_1.0 IG_%logit_2.0  alone_%logit_1.0 ._%logit_2.0
 Cognitive_%logit_0.0  performance_%logit_3.0  tests_%logit_3.0  are_%logit_3.0  effective_%logit_1.0  in_%logit_3.0  reducing_%logit_3.0  careg_%logit_3.0 iver_%logit_3.0  stress_%logit_0.0  and_%logit_3.0  improving_%logit_3.0  careg_%logit_3.0 iver_%logit_3.0  competence_%logit_1.0  in_%logit_3.0  the_%logit_3.0  short_%logit_3.0 -_%logit_3.0 term_%logit_3.0 ._%logit_1.0  Cognitive_%logit_3.0  performance_%logit_0.0  test_%logit_1.0  results_%logit_3.0  are_%logit_3.0  similar_%logit_1.0  to_%logit_3.0  those_%logit_3.0  of_%logit_1.0  other_%logit_1.0  cognitive_%logit_3.0  performance_%logit_3.0  tests_%logit_1.0 ._%logit_3.0  However_%logit_2.0 ,_%logit_0.0  the_%logit_3.0  results_%logit_1.0  are_%logit_3.0  based_%logit_2.0  on_%logit_3.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  small_%logit_3.0  studies_%logit_3.0  with_%logit_3.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  bias_%logit_0.0  and_%logit_0.0  a_%logit_2.0  low_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  random_%logit_0.0  errors_%logit_3.0 ._%logit_1.0  The_%logit_2.0  quality_%logit_0.0  of_%logit_3.0  the_%logit_3.0  evidence_%logit_0.0  is_%logit_0.0  low_%logit_3.0  and_%logit_1.0  the_%logit_2.0  results_%logit_3.0  do_%logit_3.0  not_%logit_3.0  indicate_%logit_0.0  a_%logit_2.0  significant_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  or_%logit_3.0  careg_%logit_3.0 iver_%logit_3.0  satisfaction_%logit_1.0  with_%logit_1.0  cognitive_%logit_3.0  performance_%logit_3.0  test_%logit_1.0 ._%logit_1.0  Cognitive_%logit_2.0  tests_%logit_0.0  are_%logit_1.0  also_%logit_1.0  not_%logit_3.0  significantly_%logit_1.0  different_%logit_1.0  from_%logit_1.0  those_%logit_2.0  of_%logit_1.0  the_%logit_1.0  control_%logit_3.0  group_%logit_3.0 ._%logit_2.0  Positive_%logit_2.0  findings_%logit_0.0  of_%logit_3.0  Cognitive_%logit_2.0  Performance_%logit_3.0  tests_%logit_1.0  are_%logit_1.0  similar_%logit_2.0  in_%logit_3.0  severity_%logit_3.0  and_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  dementia_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  cognitive_%logit_3.0  tests_%logit_3.0  are_%logit_1.0  significantly_%logit_1.0  more_%logit_1.0  likely_%logit_1.0  to_%logit_1.0  be_%logit_3.0  accurate_%logit_2.0  than_%logit_1.0  negative_%logit_2.0  findings_%logit_1.0 ._%logit_3.0  Positive_%logit_2.0  results_%logit_0.0  of_%logit_3.0  cognitive_%logit_2.0  Performance_%logit_1.0  tests_%logit_1.0  should_%logit_1.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_1.0  caution_%logit_1.0 ,_%logit_1.0  as_%logit_2.0  the_%logit_3.0  results_%logit_1.0  of_%logit_3.0  these_%logit_2.0  studies_%logit_0.0  were_%logit_2.0  based_%logit_2.0  on_%logit_0.0  only_%logit_3.0  one_%logit_3.0  study_%logit_3.0 ,_%logit_2.0  and_%logit_2.0  therefore_%logit_2.0  the_%logit_3.0  results_%logit_3.0  cannot_%logit_3.0  be_%logit_3.0  extrap_%logit_2.0 olated_%logit_1.0  to_%logit_1.0  all_%logit_2.0  other_%logit_3.0  cognitive_%logit_3.0  tests_%logit_3.0 ._%logit_1.0  Cognitive_%logit_2.0  Performance_%logit_2.0  test_%logit_1.0  results_%logit_1.0  should_%logit_2.0  be_%logit_3.0  viewed_%logit_2.0  with_%logit_1.0  caution_%logit_1.0  as_%logit_3.0  the_%logit_2.0  majority_%logit_3.0  of_%logit_0.0  the_%logit_0.0  studies_%logit_0.0  were_%logit_0.0  conducted_%logit_1.0  in_%logit_1.0  Japan_%logit_2.0 ,_%logit_3.0  where_%logit_2.0  cognitive_%logit_3.0  performance_%logit_3.0  scores_%logit_1.0  were_%logit_3.0  similar_%logit_1.0  to_%logit_1.0  that_%logit_3.0  of_%logit_1.0  most_%logit_3.0  of_%logit_3.0  the_%logit_3.0  other_%logit_3.0  tests_%logit_3.0  included_%logit_2.0  in_%logit_2.0  this_%logit_2.0  review_%logit_0.0 ._%logit_2.0  The_%logit_2.0  results_%logit_0.0  of_%logit_3.0  this_%logit_2.0  review_%logit_0.0  suggest_%logit_2.0  that_%logit_2.0  Cognitive_%logit_1.0  Performance_%logit_1.0  Tests_%logit_1.0  may_%logit_1.0  be_%logit_0.0  useful_%logit_2.0  in_%logit_3.0  determining_%logit_3.0  the_%logit_3.0  level_%logit_3.0  of_%logit_3.0  cognitive_%logit_3.0  performance_%logit_3.0  testing_%logit_1.0  in_%logit_3.0  Alzheimer_%logit_3.0 's_%logit_3.0  Disease_%logit_0.0 ,_%logit_3.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  beta_%logit_3.0  car_%logit_3.0 ot_%logit_1.0 ene_%logit_0.0  supplements_%logit_2.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  cat_%logit_3.0 ar_%logit_3.0 act_%logit_2.0 ._%logit_1.0  There_%logit_1.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  in_%logit_2.0  this_%logit_3.0  area_%logit_3.0 ,_%logit_2.0  particularly_%logit_2.0  in_%logit_2.0  regards_%logit_3.0  to_%logit_3.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  alpha_%logit_1.0  to_%logit_3.0 cop_%logit_3.0 he_%logit_0.0 rol_%logit_1.0  supplements_%logit_0.0  on_%logit_2.0  the_%logit_2.0  severity_%logit_0.0  of_%logit_3.0  the_%logit_1.0  cat_%logit_0.0 ar_%logit_0.0 acts_%logit_2.0 ,_%logit_2.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  on_%logit_2.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  beta_%logit_1.0 -_%logit_3.0 car_%logit_3.0 ot_%logit_2.0 ene_%logit_1.0  supplementation_%logit_2.0  in_%logit_2.0  reducing_%logit_3.0  the_%logit_3.0  incidence_%logit_0.0  and_%logit_3.0  progression_%logit_3.0  of_%logit_3.0  these_%logit_0.0  conditions_%logit_3.0 ._%logit_3.0  The_%logit_3.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  are_%logit_0.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_0.0  number_%logit_3.0  of_%logit_0.0  small_%logit_0.0  studies_%logit_0.0  with_%logit_3.0  a_%logit_2.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_0.0  bias_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  are_%logit_2.0  subject_%logit_2.0  to_%logit_0.0  change_%logit_0.0  in_%logit_3.0  interpretation_%logit_2.0  and_%logit_3.0  interpretation_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  existence_%logit_1.0  of_%logit_3.0  an_%logit_3.0  association_%logit_1.0  between_%logit_3.0  cost_%logit_1.0  effectiveness_%logit_1.0  and_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0  in_%logit_1.0  psych_%logit_3.0 opath_%logit_1.0 ology_%logit_3.0  or_%logit_3.0  social_%logit_3.0  functioning_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_1.0  the_%logit_2.0  most_%logit_3.0  effective_%logit_3.0  way_%logit_3.0  to_%logit_2.0  integrate_%logit_1.0  cost_%logit_2.0  effectiveness_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  cost_%logit_2.0  effectiveness_%logit_3.0  with_%logit_3.0  other_%logit_3.0  forms_%logit_3.0  of_%logit_3.0  psychological_%logit_1.0  therapies_%logit_1.0 ._%logit_3.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  important_%logit_2.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  cost_%logit_1.0  effectiveness_%logit_3.0  works_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  how_%logit_1.0  cost_%logit_3.0  effectiveness_%logit_1.0  relates_%logit_3.0  to_%logit_3.0  quality_%logit_3.0  and_%logit_3.0  quantity_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_1.0  as_%logit_1.0  to_%logit_2.0  the_%logit_3.0  cost_%logit_3.0  effectiveness_%logit_3.0  of_%logit_1.0  the_%logit_1.0  various_%logit_1.0  approaches_%logit_1.0  to_%logit_1.0  cost_%logit_1.0  effectiveness_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_1.0  electronic_%logit_1.0  detectors_%logit_1.0  in_%logit_3.0  preventing_%logit_1.0  injury_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_1.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  electronic_%logit_3.0  alarms_%logit_1.0  in_%logit_3.0  detecting_%logit_1.0  injury_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  their_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  injury_%logit_3.0  rates_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  their_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  cost_%logit_1.0 -_%logit_3.0 effect_%logit_3.0 iveness_%logit_1.0  in_%logit_1.0  the_%logit_1.0  prevention_%logit_3.0  of_%logit_3.0  injury_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  their_%logit_3.0  effectiveness_%logit_3.0  as_%logit_3.0  a_%logit_1.0  deterrent_%logit_1.0  to_%logit_1.0  injury_%logit_0.0 ._%logit_0.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_2.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  electronic_%logit_0.0  detectors_%logit_1.0  are_%logit_3.0  used_%logit_1.0  to_%logit_1.0  detect_%logit_1.0  injury_%logit_3.0 ,_%logit_3.0  the_%logit_3.0  types_%logit_3.0  of_%logit_3.0  detectors_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  how_%logit_1.0  they_%logit_3.0  are_%logit_1.0  used_%logit_1.0  in_%logit_1.0  addition_%logit_1.0  to_%logit_0.0  electronic_%logit_1.0  detectors_%logit_3.0 ._%logit_3.0
 Ant_%logit_0.0 ib_%logit_0.0 iotic_%logit_2.0  pro_%logit_2.0 ph_%logit_3.0 yl_%logit_2.0 axis_%logit_0.0  is_%logit_2.0  effective_%logit_3.0  in_%logit_0.0  improving_%logit_3.0  lung_%logit_3.0  function_%logit_0.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_0.0  a_%logit_1.0  P_%logit_3.0 ._%logit_3.0  aer_%logit_2.0 ug_%logit_0.0 in_%logit_0.0 osa_%logit_0.0  infection_%logit_0.0 ._%logit_1.0  However_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0  randomized_%logit_2.0  controlled_%logit_2.0  trials_%logit_2.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  pro_%logit_1.0 ph_%logit_3.0 yle_%logit_0.0 phrine_%logit_2.0  injection_%logit_0.0  on_%logit_3.0  lung_%logit_3.0  function_%logit_0.0  and_%logit_0.0  quality_%logit_3.0  of_%logit_0.0  life_%logit_3.0 ._%logit_0.0  Such_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_1.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  therapy_%logit_2.0 ,_%logit_2.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  the_%logit_3.0  combination_%logit_3.0  therapy_%logit_0.0  in_%logit_3.0  reducing_%logit_1.0  the_%logit_0.0  risk_%logit_0.0  of_%logit_3.0  pneum_%logit_1.0 oth_%logit_3.0 or_%logit_1.0 ax_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  gluc_%logit_3.0 oc_%logit_3.0 ort_%logit_1.0 ic_%logit_3.0 oids_%logit_1.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  agitation_%logit_3.0 ,_%logit_3.0  agitation_%logit_3.0  or_%logit_3.0  psychosis_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  Alzheimer_%logit_3.0 's_%logit_3.0  disease_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  treating_%logit_2.0  agitation_%logit_3.0  and_%logit_3.0  agitation_%logit_3.0  in_%logit_3.0  these_%logit_3.0  patients_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  other_%logit_3.0  outcomes_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  psychological_%logit_3.0  wellbeing_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_2.0 term_%logit_3.0  data_%logit_0.0  are_%logit_3.0  needed_%logit_2.0  to_%logit_2.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  gluc_%logit_3.0 os_%logit_3.0 ort_%logit_3.0 ic_%logit_3.0 oid_%logit_0.0  therapy_%logit_3.0  in_%logit_3.0  these_%logit_1.0  conditions_%logit_3.0 ._%logit_3.0
 Sexual_%logit_0.0  risk_%logit_0.0  behaviours_%logit_3.0  are_%logit_3.0  significantly_%logit_3.0  reduced_%logit_3.0  with_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  social_%logit_1.0  support_%logit_3.0  and_%logit_3.0  psychological_%logit_1.0  support_%logit_3.0 ._%logit_3.0  Sexual_%logit_1.0  support_%logit_0.0  appears_%logit_0.0  to_%logit_3.0  be_%logit_3.0  effective_%logit_3.0  in_%logit_3.0  reducing_%logit_3.0  sexual_%logit_3.0  risk_%logit_3.0  behaviours_%logit_0.0 ,_%logit_3.0  but_%logit_3.0  its_%logit_3.0  effectiveness_%logit_3.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0  from_%logit_1.0  this_%logit_2.0  review_%logit_0.0 ._%logit_2.0  Positive_%logit_2.0  effects_%logit_0.0  on_%logit_3.0  sexual_%logit_1.0  risk_%logit_3.0  behaviors_%logit_0.0  are_%logit_3.0  likely_%logit_3.0  to_%logit_3.0  be_%logit_3.0  sustained_%logit_3.0  over_%logit_3.0  time_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  this_%logit_3.0  is_%logit_3.0  unlikely_%logit_3.0  to_%logit_3.0  translate_%logit_2.0  into_%logit_2.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  sexual_%logit_0.0  risk_%logit_3.0  behaviour_%logit_0.0 ._%logit_3.0  Positive_%logit_3.0  results_%logit_0.0  from_%logit_3.0  social_%logit_2.0  support_%logit_1.0  are_%logit_0.0  unlikely_%logit_1.0  to_%logit_3.0  have_%logit_3.0  an_%logit_2.0  immediate_%logit_3.0  impact_%logit_2.0  on_%logit_2.0  sexual_%logit_2.0  risks_%logit_3.0  behaviours_%logit_3.0 ._%logit_3.0  Positive_%logit_3.0  findings_%logit_0.0  from_%logit_3.0  the_%logit_2.0  review_%logit_0.0  suggest_%logit_0.0  that_%logit_2.0  social_%logit_1.0  support_%logit_1.0  may_%logit_0.0  be_%logit_1.0  beneficial_%logit_3.0  for_%logit_3.0  reducing_%logit_3.0  sexual_%logit_3.0  risks_%logit_3.0  behaviors_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  further_%logit_3.0  research_%logit_3.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  this_%logit_1.0  intervention_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  of_%logit_0.0  hyd_%logit_3.0 roc_%logit_3.0 ort_%logit_3.0 is_%logit_1.0 one_%logit_2.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  abdominal_%logit_1.0  tender_%logit_0.0 ness_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_0.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  this_%logit_3.0  treatment_%logit_1.0  for_%logit_1.0  tender_%logit_1.0 ness_%logit_0.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  abs_%logit_1.0 cess_%logit_3.0 ed_%logit_3.0  abs_%logit_3.0 cess_%logit_3.0 ._%logit_1.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  sufficient_%logit_0.0  size_%logit_0.0  and_%logit_0.0  duration_%logit_2.0  to_%logit_0.0  provide_%logit_2.0  a_%logit_2.0  better_%logit_3.0  understanding_%logit_3.0  of_%logit_0.0  the_%logit_1.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  this_%logit_0.0  treatment_%logit_1.0  works_%logit_0.0 ._%logit_0.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  hyd_%logit_1.0 oc_%logit_3.0 ort_%logit_3.0 is_%logit_0.0 ones_%logit_1.0  in_%logit_3.0  the_%logit_3.0  management_%logit_0.0  of_%logit_0.0  tender_%logit_3.0 ness_%logit_3.0 ,_%logit_3.0  pain_%logit_3.0 ,_%logit_3.0  fatigue_%logit_3.0 ,_%logit_3.0  thirst_%logit_3.0 ,_%logit_3.0  fatigue_%logit_1.0  and_%logit_3.0  fatigue_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  acupuncture_%logit_3.0  for_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0  in_%logit_3.0  women_%logit_3.0  with_%logit_0.0  pelvic_%logit_3.0  pain_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  pelvic_%logit_1.0  pain_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  acupuncture_%logit_2.0  with_%logit_3.0  other_%logit_3.0  treatments_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  pain_%logit_2.0  relief_%logit_0.0  for_%logit_3.0  women_%logit_1.0  with_%logit_3.0  chronic_%logit_3.0  pain_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  a_%logit_2.0  comparison_%logit_0.0  of_%logit_0.0  acupuncture_%logit_1.0  to_%logit_3.0  other_%logit_3.0  treatments_%logit_3.0  for_%logit_3.0  pelvic_%logit_1.0  pain_%logit_3.0  relief_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0  there_%logit_0.0  is_%logit_0.0  an_%logit_2.0  urgent_%logit_3.0  need_%logit_0.0  for_%logit_0.0  an_%logit_1.0  assessment_%logit_1.0  of_%logit_0.0  the_%logit_1.0  effects_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  on_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_0.0  satisfaction_%logit_3.0  with_%logit_3.0  pain_%logit_3.0  relief_%logit_3.0  and_%logit_3.0  satisfaction_%logit_1.0  with_%logit_0.0  satisfaction_%logit_1.0  with_%logit_3.0  analges_%logit_1.0 ia_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antioxidant_%logit_3.0  supplements_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  ALS_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  whether_%logit_2.0  antioxidant_%logit_3.0  supplements_%logit_3.0  are_%logit_0.0  beneficial_%logit_0.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_0.0  ALS_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_3.0  a_%logit_3.0  well_%logit_3.0 -_%logit_3.0 defined_%logit_1.0  group_%logit_2.0  of_%logit_0.0  patients_%logit_2.0  who_%logit_0.0  are_%logit_2.0  at_%logit_2.0  high_%logit_0.0  risk_%logit_1.0  of_%logit_1.0  relapse_%logit_3.0  or_%logit_0.0  death_%logit_1.0 ,_%logit_3.0  and_%logit_2.0  those_%logit_3.0  who_%logit_3.0  are_%logit_3.0  unable_%logit_2.0  to_%logit_0.0  tolerate_%logit_3.0  or_%logit_2.0  tolerate_%logit_3.0  antioxidant_%logit_2.0  supplements_%logit_3.0 ._%logit_3.0  They_%logit_2.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  antioxidant_%logit_3.0  supplementation_%logit_3.0  on_%logit_3.0  survival_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  the_%logit_0.0  impact_%logit_0.0  of_%logit_3.0  antioxidant_%logit_3.0  supplement_%logit_3.0 ing_%logit_3.0  supplements_%logit_3.0  on_%logit_3.0  quality_%logit_1.0  and_%logit_3.0  quantity_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  k_%logit_1.0 ang_%logit_1.0 aroo_%logit_2.0  mother_%logit_2.0  care_%logit_0.0  for_%logit_0.0  reducing_%logit_3.0  mortality_%logit_3.0  or_%logit_0.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_3.0  infants_%logit_3.0  admitted_%logit_3.0  to_%logit_3.0  NIC_%logit_3.0 U_%logit_0.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  this_%logit_3.0  intervention_%logit_1.0  in_%logit_1.0  reducing_%logit_1.0  mortality_%logit_0.0 ,_%logit_0.0  morbid_%logit_3.0 ity_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  this_%logit_1.0  approach_%logit_1.0  in_%logit_1.0  improving_%logit_1.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  reducing_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  or_%logit_3.0  mortality_%logit_3.0  in_%logit_3.0  neon_%logit_3.0 ates_%logit_1.0  admitted_%logit_1.0  to_%logit_1.0  IC_%logit_3.0 U_%logit_3.0 ._%logit_1.0  Recommend_%logit_1.0 ations_%logit_0.0  for_%logit_0.0  future_%logit_0.0  research_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_1.0 ,_%logit_1.0  as_%logit_2.0  are_%logit_2.0  recommendations_%logit_2.0  to_%logit_0.0  improve_%logit_1.0  the_%logit_2.0  quality_%logit_1.0  and_%logit_3.0  quantity_%logit_3.0  of_%logit_0.0  research_%logit_2.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  testosterone_%logit_3.0  supplementation_%logit_3.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  hair_%logit_3.0  loss_%logit_3.0  or_%logit_0.0  hair_%logit_3.0  loss_%logit_3.0  in_%logit_0.0  men_%logit_3.0 opausal_%logit_3.0  women_%logit_3.0  with_%logit_3.0  HD_%logit_3.0 H_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  testosterone_%logit_1.0  therapy_%logit_1.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  testosterone_%logit_2.0  supplementation_%logit_3.0  with_%logit_3.0  other_%logit_3.0  hormonal_%logit_3.0  therapies_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  prog_%logit_1.0 est_%logit_3.0 ogens_%logit_2.0 ,_%logit_3.0  prog_%logit_3.0 est_%logit_3.0 ogen_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  est_%logit_3.0 rogens_%logit_3.0 ,_%logit_2.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  estrogen_%logit_1.0  supplementation_%logit_3.0  on_%logit_3.0  hair_%logit_3.0  loss_%logit_3.0  and_%logit_3.0  hair_%logit_3.0  loss_%logit_3.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_1.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_0.0  duration_%logit_1.0  and_%logit_3.0  frequency_%logit_1.0  of_%logit_3.0  testosterone_%logit_1.0  treatment_%logit_3.0 ,_%logit_1.0  a_%logit_1.0  meta_%logit_3.0 -_%logit_1.0 analysis_%logit_0.0  is_%logit_0.0  required_%logit_0.0  to_%logit_0.0  determine_%logit_1.0  whether_%logit_2.0  testosterone_%logit_3.0  supplementation_%logit_3.0  is_%logit_3.0  beneficial_%logit_3.0  or_%logit_0.0  harmful_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  lev_%logit_3.0 od_%logit_3.0 opa_%logit_0.0  for_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  Parkinson_%logit_3.0 's_%logit_3.0  disease_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_1.0  and_%logit_3.0  timing_%logit_3.0  of_%logit_3.0  treatment_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_3.0  duration_%logit_1.0  of_%logit_3.0  treatment_%logit_1.0 ._%logit_3.0  In_%logit_3.0  addition_%logit_0.0 ,_%logit_3.0  future_%logit_0.0  trials_%logit_3.0  should_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  this_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  particular_%logit_2.0  for_%logit_3.0  motor_%logit_3.0  impair_%logit_3.0 ments_%logit_3.0  and_%logit_1.0  impaired_%logit_1.0  function_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_1.0  treatments_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  prost_%logit_1.0 ag_%logit_3.0 land_%logit_1.0 ins_%logit_0.0 ,_%logit_0.0  and_%logit_1.0  for_%logit_3.0  improving_%logit_3.0  motor_%logit_3.0  function_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  early_%logit_3.0  PD_%logit_3.0 ._%logit_0.0
 Ant_%logit_0.0 ip_%logit_0.0 y_%logit_2.0 ret_%logit_0.0 ic_%logit_2.0  drugs_%logit_3.0  are_%logit_3.0  effective_%logit_1.0  in_%logit_0.0  reducing_%logit_3.0  fever_%logit_3.0  severity_%logit_3.0  and_%logit_3.0  duration_%logit_3.0  of_%logit_0.0  treatment_%logit_3.0 ,_%logit_1.0  but_%logit_1.0  there_%logit_3.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  the_%logit_2.0  treatment_%logit_0.0  of_%logit_0.0  fever_%logit_1.0 ish_%logit_0.0  children_%logit_2.0  with_%logit_0.0  malaria_%logit_2.0 ._%logit_1.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  medications_%logit_3.0  on_%logit_3.0  fever_%logit_2.0  severity_%logit_3.0 ,_%logit_3.0  duration_%logit_3.0  and_%logit_3.0  severity_%logit_1.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  treatments_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  temperature_%logit_3.0  severity_%logit_3.0  and_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  fever_%logit_3.0  severity_%logit_3.0  in_%logit_3.0  children_%logit_3.0  with_%logit_1.0  acute_%logit_2.0  malaria_%logit_3.0  and_%logit_3.0  in_%logit_2.0  children_%logit_3.0  younger_%logit_3.0  than_%logit_2.0  two_%logit_2.0  years_%logit_1.0  of_%logit_2.0  age_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  in_%logit_3.0  the_%logit_3.0  erad_%logit_3.0 ication_%logit_3.0  of_%logit_2.0  H_%logit_3.0 ._%logit_3.0  p_%logit_0.0 yl_%logit_0.0 ori_%logit_2.0  infection_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  determine_%logit_3.0  whether_%logit_2.0  antibiotics_%logit_3.0  are_%logit_3.0  beneficial_%logit_3.0  or_%logit_3.0  harmful_%logit_3.0  for_%logit_3.0  H_%logit_3.0 ._%logit_3.0 p_%logit_1.0 yl_%logit_1.0 ori_%logit_2.0 ,_%logit_1.0  and_%logit_3.0  whether_%logit_3.0  they_%logit_3.0  should_%logit_3.0  be_%logit_2.0  used_%logit_2.0  in_%logit_3.0  combination_%logit_3.0  with_%logit_0.0  other_%logit_3.0  antim_%logit_3.0 icro_%logit_3.0 b_%logit_2.0 ials_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  treatment_%logit_3.0  with_%logit_3.0  other_%logit_3.0  antibiotics_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  for_%logit_3.0  this_%logit_3.0  condition_%logit_3.0 ._%logit_2.0  These_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  sufficient_%logit_0.0  size_%logit_2.0  and_%logit_0.0  duration_%logit_2.0  to_%logit_0.0  compare_%logit_2.0  antibiotic_%logit_2.0  treatment_%logit_3.0  to_%logit_3.0  other_%logit_3.0  antibiotics_%logit_3.0  in_%logit_3.0  this_%logit_3.0  condition_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  also_%logit_2.0  to_%logit_2.0  compare_%logit_2.0  antibiotics_%logit_2.0  with_%logit_3.0  each_%logit_3.0  other_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  silicone_%logit_3.0  plugs_%logit_3.0  in_%logit_0.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  T_%logit_1.0 MC_%logit_3.0  O_%logit_1.0 A_%logit_3.0 ._%logit_1.0  There_%logit_3.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  random_%logit_0.0 ised_%logit_0.0  controlled_%logit_0.0  trials_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  silicone_%logit_1.0  plug_%logit_1.0  plugs_%logit_1.0  in_%logit_2.0  pain_%logit_2.0  relief_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  sufficient_%logit_0.0  size_%logit_1.0  to_%logit_0.0  compare_%logit_2.0  silicone_%logit_2.0  plugs_%logit_3.0  with_%logit_1.0  silicone_%logit_1.0  plugs_%logit_3.0 ._%logit_1.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  silicone_%logit_1.0  pads_%logit_3.0  on_%logit_1.0  pain_%logit_1.0  relief_%logit_0.0  and_%logit_1.0  function_%logit_1.0 ,_%logit_0.0  and_%logit_3.0  on_%logit_0.0  function_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  protective_%logit_3.0  mechanism_%logit_3.0  for_%logit_3.0  reducing_%logit_3.0  mortality_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  advanced_%logit_1.0  disease_%logit_3.0  who_%logit_3.0  have_%logit_3.0  been_%logit_2.0  treated_%logit_3.0  with_%logit_3.0  cis_%logit_3.0 pl_%logit_3.0 atin_%logit_1.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  this_%logit_3.0  strategy_%logit_3.0  in_%logit_3.0  this_%logit_2.0  population_%logit_0.0 ,_%logit_2.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  it_%logit_2.0  with_%logit_3.0  other_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  treating_%logit_1.0  advanced_%logit_3.0  disease_%logit_3.0  and_%logit_3.0  to_%logit_3.0  determine_%logit_3.0  whether_%logit_2.0  it_%logit_3.0  has_%logit_3.0  a_%logit_3.0  protective_%logit_3.0  effect_%logit_3.0  on_%logit_3.0  survival_%logit_2.0  or_%logit_3.0  morbid_%logit_3.0 ity_%logit_0.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  these_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  treatment_%logit_1.0  in_%logit_3.0  advanced_%logit_3.0  disease_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  orth_%logit_1.0 op_%logit_1.0 aed_%logit_1.0 ic_%logit_2.0  footwear_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  foot_%logit_1.0  pain_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_1.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_1.0  the_%logit_2.0  best_%logit_3.0  footwear_%logit_3.0  for_%logit_3.0  this_%logit_1.0  condition_%logit_1.0  and_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_1.0  types_%logit_1.0  of_%logit_3.0  footwear_%logit_1.0  in_%logit_1.0  terms_%logit_1.0  of_%logit_3.0  comfort_%logit_3.0 ,_%logit_3.0  comfort_%logit_1.0  and_%logit_3.0  comfort_%logit_1.0 ._%logit_3.0  Further_%logit_1.0  studies_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_1.0  to_%logit_1.0  assess_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  orth_%logit_3.0 oped_%logit_1.0 ic_%logit_2.0  footwear_%logit_3.0  for_%logit_3.0  pain_%logit_1.0  relief_%logit_0.0  in_%logit_3.0  people_%logit_1.0  with_%logit_1.0  a_%logit_1.0  chronic_%logit_1.0  condition_%logit_1.0  such_%logit_1.0  as_%logit_1.0  Achilles_%logit_1.0  tendon_%logit_1.0 itis_%logit_3.0  and_%logit_2.0  fib_%logit_1.0 romy_%logit_3.0 algia_%logit_1.0 ,_%logit_1.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  footwear_%logit_2.0  with_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  shoes_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  prog_%logit_3.0 est_%logit_3.0 ogen_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  premature_%logit_1.0  l_%logit_3.0 ute_%logit_3.0 al_%logit_2.0  eff_%logit_1.0 usion_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_1.0  whether_%logit_2.0  prog_%logit_3.0 est_%logit_1.0 ogens_%logit_0.0  are_%logit_1.0  beneficial_%logit_1.0  or_%logit_0.0  harmful_%logit_3.0 ._%logit_0.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  absence_%logit_0.0  of_%logit_3.0  a_%logit_3.0  clear_%logit_3.0  indication_%logit_3.0  of_%logit_3.0  the_%logit_1.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  prog_%logit_3.0 ester_%logit_3.0 one_%logit_1.0  in_%logit_3.0  this_%logit_3.0  population_%logit_3.0 ._%logit_2.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_0.0  also_%logit_3.0  needed_%logit_1.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  hyd_%logit_1.0 est_%logit_3.0 ogen_%logit_1.0  for_%logit_1.0  premature_%logit_3.0  L_%logit_3.0 ute_%logit_3.0 al_%logit_1.0  F_%logit_1.0 usion_%logit_0.0 ,_%logit_1.0  and_%logit_2.0  to_%logit_3.0  assess_%logit_3.0  its_%logit_2.0  safety_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  infrared_%logit_1.0  phot_%logit_3.0 oco_%logit_1.0 ag_%logit_1.0 ulation_%logit_2.0  for_%logit_0.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  chronic_%logit_1.0  pain_%logit_3.0  syndrome_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  method_%logit_1.0  of_%logit_1.0  treatment_%logit_1.0  for_%logit_1.0  pain_%logit_1.0  relief_%logit_3.0  in_%logit_2.0  people_%logit_1.0  with_%logit_3.0  C_%logit_0.0 TS_%logit_3.0 ._%logit_2.0  It_%logit_2.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  these_%logit_2.0  results_%logit_1.0  are_%logit_3.0  translated_%logit_1.0  to_%logit_1.0  other_%logit_2.0  chronic_%logit_3.0  pain_%logit_3.0  disorders_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_1.0  is_%logit_1.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  infrared_%logit_1.0  Phot_%logit_1.0 oco_%logit_1.0 ag_%logit_1.0 ulating_%logit_1.0  for_%logit_2.0  chronic_%logit_1.0  pain_%logit_3.0  relief_%logit_3.0  of_%logit_2.0  C_%logit_3.0 TS_%logit_3.0 ,_%logit_2.0  and_%logit_1.0  to_%logit_2.0  compare_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  infrared_%logit_1.0  optics_%logit_1.0  for_%logit_1.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  pain_%logit_2.0  relief_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ib_%logit_3.0 up_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  patients_%logit_3.0  with_%logit_3.0  active_%logit_0.0  Cro_%logit_0.0 hn_%logit_3.0 's_%logit_2.0  disease_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  ib_%logit_3.0 ip_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  as_%logit_1.0  an_%logit_2.0  adjunct_%logit_0.0  to_%logit_0.0  other_%logit_0.0  treatments_%logit_3.0  in_%logit_3.0  the_%logit_1.0  management_%logit_3.0  of_%logit_3.0  these_%logit_3.0  patients_%logit_0.0 ._%logit_3.0  Such_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_3.0  a_%logit_1.0  well_%logit_3.0 -_%logit_3.0 defined_%logit_1.0  set_%logit_2.0  of_%logit_0.0  patients_%logit_2.0  who_%logit_0.0  are_%logit_2.0  in_%logit_2.0  need_%logit_2.0  of_%logit_1.0  treatment_%logit_3.0 ._%logit_3.0  They_%logit_3.0  should_%logit_0.0  also_%logit_2.0  include_%logit_2.0  patients_%logit_2.0  with_%logit_1.0  severe_%logit_1.0  disease_%logit_2.0  who_%logit_3.0  are_%logit_3.0  at_%logit_2.0  high_%logit_2.0  risk_%logit_1.0  of_%logit_1.0  relapse_%logit_1.0  and_%logit_3.0  those_%logit_1.0  who_%logit_3.0  are_%logit_3.0  unable_%logit_2.0  to_%logit_1.0  tolerate_%logit_3.0  the_%logit_2.0  drug_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  electro_%logit_1.0 stim_%logit_1.0 ulation_%logit_1.0  as_%logit_0.0  a_%logit_3.0  method_%logit_0.0  of_%logit_0.0  resusc_%logit_0.0 itation_%logit_0.0  in_%logit_1.0  the_%logit_0.0  resusc_%logit_0.0 itation_%logit_3.0  of_%logit_2.0  patients_%logit_1.0  with_%logit_0.0  R_%logit_1.0 OS_%logit_1.0 C_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  electro_%logit_3.0 stim_%logit_1.0 ulating_%logit_1.0  agent_%logit_2.0  for_%logit_0.0  resusc_%logit_1.0 itation_%logit_0.0  and_%logit_2.0  to_%logit_3.0  assess_%logit_0.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  patients_%logit_2.0  with_%logit_0.0  cardiac_%logit_3.0  arrest_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  determine_%logit_3.0  its_%logit_2.0  role_%logit_3.0  in_%logit_3.0  other_%logit_3.0  resusc_%logit_0.0 itation_%logit_3.0  procedures_%logit_3.0 ._%logit_3.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  in_%logit_1.0  this_%logit_2.0  area_%logit_3.0 ,_%logit_0.0  as_%logit_2.0  well_%logit_2.0  as_%logit_0.0  to_%logit_2.0  evaluate_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  electro_%logit_1.0 im_%logit_1.0 aging_%logit_1.0  on_%logit_2.0  survival_%logit_3.0  and_%logit_3.0  neurological_%logit_3.0  function_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  who_%logit_1.0  have_%logit_3.0  been_%logit_2.0  discharged_%logit_3.0  from_%logit_1.0  hospital_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  correlation_%logit_3.0  between_%logit_3.0  ov_%logit_3.0 ulation_%logit_3.0  and_%logit_1.0  pregnancy_%logit_3.0  rates_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effect_%logit_3.0  of_%logit_3.0  ov_%logit_1.0 ulation_%logit_3.0  on_%logit_1.0  pregnancy_%logit_3.0  rates_%logit_0.0  and_%logit_3.0  fertility_%logit_1.0  rates_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  ov_%logit_2.0 ulation_%logit_3.0  with_%logit_1.0  other_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  fertility_%logit_1.0  management_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_1.0  oxy_%logit_1.0 toc_%logit_1.0 in_%logit_1.0 ,_%logit_0.0  prog_%logit_3.0 est_%logit_3.0 ogen_%logit_0.0 ,_%logit_3.0  prog_%logit_3.0 ester_%logit_1.0 one_%logit_0.0  or_%logit_3.0  prog_%logit_3.0 est_%logit_3.0 ogens_%logit_0.0 ,_%logit_3.0  and_%logit_1.0  other_%logit_1.0  fertility_%logit_0.0  management_%logit_3.0  strategies_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_1.0  whether_%logit_2.0  ov_%logit_3.0 ulation_%logit_3.0  rates_%logit_1.0  are_%logit_3.0  related_%logit_1.0  to_%logit_3.0  fertility_%logit_3.0  management_%logit_3.0  and_%logit_3.0  fertility_%logit_3.0  outcomes_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  how_%logit_1.0  to_%logit_3.0  tailor_%logit_1.0  ov_%logit_2.0 ulation_%logit_0.0  to_%logit_1.0  the_%logit_3.0  needs_%logit_0.0  of_%logit_0.0  the_%logit_1.0  population_%logit_0.0 ._%logit_0.0
 Functional_%logit_0.0  status_%logit_1.0  and_%logit_3.0  functional_%logit_3.0  status_%logit_0.0  of_%logit_3.0  the_%logit_3.0  foot_%logit_0.0  are_%logit_0.0  the_%logit_2.0  most_%logit_0.0  important_%logit_0.0  determin_%logit_1.0 ants_%logit_2.0  of_%logit_2.0  pain_%logit_3.0  relief_%logit_0.0  for_%logit_0.0  people_%logit_0.0  with_%logit_3.0  functional_%logit_0.0  impair_%logit_1.0 ments_%logit_3.0  in_%logit_1.0  footwear_%logit_1.0 ._%logit_3.0  Functional_%logit_1.0  status_%logit_1.0 ,_%logit_3.0  functional_%logit_3.0  status_%logit_1.0 ,_%logit_1.0  quality_%logit_1.0  of_%logit_1.0  life_%logit_3.0  and_%logit_0.0  satisfaction_%logit_1.0  with_%logit_0.0  pain_%logit_3.0  relief_%logit_0.0  are_%logit_2.0  also_%logit_3.0  important_%logit_3.0  indicators_%logit_3.0  of_%logit_3.0  improvement_%logit_3.0  in_%logit_3.0  functional_%logit_3.0  status_%logit_1.0 ._%logit_1.0  Pain_%logit_3.0  relief_%logit_0.0  is_%logit_3.0  also_%logit_1.0  associated_%logit_3.0  with_%logit_3.0  improvement_%logit_3.0  in_%logit_1.0  function_%logit_3.0 ,_%logit_1.0  pain_%logit_3.0  intensity_%logit_1.0  and_%logit_3.0  function_%logit_1.0  in_%logit_1.0  the_%logit_3.0  upper_%logit_1.0  limb_%logit_1.0 ._%logit_1.0  Pain_%logit_1.0  intensity_%logit_0.0  is_%logit_2.0  also_%logit_3.0  significantly_%logit_3.0  reduced_%logit_3.0  in_%logit_1.0  the_%logit_3.0  lower_%logit_1.0  limb_%logit_3.0 ,_%logit_1.0  but_%logit_2.0  there_%logit_1.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_1.0  to_%logit_2.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_1.0  of_%logit_1.0  functional_%logit_1.0  status_%logit_1.0  or_%logit_1.0  functional_%logit_1.0  status_%logit_1.0  in_%logit_3.0  footwear_%logit_1.0  or_%logit_1.0  footwear_%logit_1.0 ._%logit_3.0  Pain_%logit_2.0  severity_%logit_0.0  and_%logit_2.0  function_%logit_3.0  are_%logit_3.0  also_%logit_3.0  significantly_%logit_3.0  improved_%logit_3.0  in_%logit_1.0  footwear_%logit_2.0  and_%logit_1.0  footwear_%logit_2.0  compared_%logit_1.0  to_%logit_2.0  no_%logit_1.0  treatment_%logit_1.0 ._%logit_3.0  Pain_%logit_2.0  duration_%logit_0.0  and_%logit_3.0  severity_%logit_1.0  are_%logit_3.0  also_%logit_3.0  improved_%logit_3.0  in_%logit_3.0  shoes_%logit_2.0  and_%logit_1.0  shoes_%logit_2.0  compared_%logit_1.0  with_%logit_2.0  no_%logit_1.0  treatment_%logit_1.0  or_%logit_2.0  no_%logit_2.0  treatment_%logit_2.0  compared_%logit_2.0  to_%logit_2.0  other_%logit_1.0  types_%logit_1.0  of_%logit_3.0  footwear_%logit_1.0  or_%logit_1.0  shoes_%logit_2.0 ,_%logit_1.0  but_%logit_2.0  this_%logit_3.0  is_%logit_3.0  based_%logit_2.0  on_%logit_3.0  a_%logit_0.0  very_%logit_3.0  small_%logit_3.0  number_%logit_1.0  of_%logit_0.0  studies_%logit_0.0  with_%logit_0.0  short_%logit_2.0  term_%logit_1.0  follow_%logit_1.0 -_%logit_1.0 up_%logit_2.0  and_%logit_1.0  a_%logit_3.0  very_%logit_2.0  high_%logit_3.0  risk_%logit_1.0  of_%logit_1.0  bias_%logit_0.0  in_%logit_0.0  many_%logit_2.0  of_%logit_1.0  the_%logit_0.0  studies_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  epid_%logit_3.0 ural_%logit_3.0  analges_%logit_3.0 ia_%logit_3.0  for_%logit_0.0  ca_%logit_3.0 es_%logit_3.0 are_%logit_2.0 an_%logit_0.0  section_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  epid_%logit_3.0 ur_%logit_1.0 als_%logit_3.0  in_%logit_2.0  this_%logit_1.0  population_%logit_3.0 ,_%logit_0.0  as_%logit_2.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  maternal_%logit_2.0  satisfaction_%logit_3.0  with_%logit_3.0  labour_%logit_3.0  management_%logit_3.0 ,_%logit_3.0  maternal_%logit_3.0  satisfaction_%logit_3.0  and_%logit_0.0  satisfaction_%logit_1.0  with_%logit_3.0  childbirth_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  maternal_%logit_2.0  satisfaction_%logit_3.0 ,_%logit_3.0  satisfaction_%logit_3.0  with_%logit_0.0  labor_%logit_1.0  management_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  maternal_%logit_3.0  and_%logit_0.0  neon_%logit_3.0 atal_%logit_0.0  outcomes_%logit_3.0 ,_%logit_0.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  epid_%logit_2.0 ural_%logit_3.0  pain_%logit_3.0  management_%logit_3.0  with_%logit_3.0  other_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  labour_%logit_1.0  management_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ep_%logit_3.0 ine_%logit_3.0 phrine_%logit_1.0  injection_%logit_0.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  end_%logit_1.0 omet_%logit_3.0 ritis_%logit_3.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  way_%logit_3.0  to_%logit_3.0  administer_%logit_0.0  ep_%logit_2.0 oxy_%logit_3.0 cl_%logit_2.0 av_%logit_2.0 ul_%logit_2.0 opl_%logit_1.0 asty_%logit_0.0 ,_%logit_1.0  the_%logit_3.0  best_%logit_3.0  route_%logit_3.0  of_%logit_3.0  administration_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  the_%logit_3.0  most_%logit_3.0  effective_%logit_0.0  way_%logit_3.0  to_%logit_3.0  treat_%logit_1.0  end_%logit_2.0 omet_%logit_3.0 ri_%logit_0.0 osis_%logit_2.0 ._%logit_3.0  Further_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_1.0  to_%logit_1.0  assess_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  intra_%logit_3.0 uter_%logit_3.0 ine_%logit_1.0  injection_%logit_1.0  for_%logit_3.0  end_%logit_3.0 omet_%logit_3.0 rial_%logit_0.0  carcin_%logit_2.0 oma_%logit_0.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  ep_%logit_1.0 ip_%logit_3.0 hy_%logit_2.0 tic_%logit_2.0  injection_%logit_3.0  with_%logit_3.0  other_%logit_3.0  forms_%logit_3.0  of_%logit_3.0  ep_%logit_1.0 icy_%logit_3.0 cl_%logit_1.0 ic_%logit_3.0  therapy_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_3.0  relaxation_%logit_1.0  exercises_%logit_1.0  for_%logit_1.0  relaxation_%logit_1.0  exercises_%logit_0.0  in_%logit_1.0  pain_%logit_1.0  relief_%logit_0.0  or_%logit_1.0  relaxation_%logit_1.0  during_%logit_3.0  relaxation_%logit_1.0  exercises_%logit_1.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_1.0  is_%logit_2.0  needed_%logit_1.0  to_%logit_1.0  assess_%logit_1.0  relaxation_%logit_2.0  exercises_%logit_1.0  and_%logit_1.0  relaxation_%logit_1.0  exercises_%logit_0.0  during_%logit_1.0  relaxation_%logit_1.0  exercise_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_0.0  relaxation_%logit_2.0  exercises_%logit_1.0  with_%logit_1.0  relaxation_%logit_1.0  exercises_%logit_3.0 ,_%logit_1.0  relaxation_%logit_1.0  exercises_%logit_1.0  or_%logit_1.0  relaxation_%logit_1.0  exercises_%logit_3.0  alone_%logit_1.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_1.0  should_%logit_2.0  evaluate_%logit_2.0  relaxation_%logit_2.0  exercises_%logit_3.0  as_%logit_1.0  an_%logit_1.0  adjunct_%logit_1.0  to_%logit_0.0  relaxation_%logit_1.0  exercises_%logit_1.0  after_%logit_1.0  relaxation_%logit_1.0  exercises_%logit_1.0  have_%logit_1.0  been_%logit_1.0  completed_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  should_%logit_1.0  include_%logit_1.0  measures_%logit_2.0  of_%logit_1.0  relaxation_%logit_1.0  relaxation_%logit_3.0  and_%logit_1.0  relaxation_%logit_1.0  in_%logit_3.0  relaxation_%logit_1.0  exercises_%logit_1.0  (_%logit_1.0 including_%logit_1.0  relaxation_%logit_1.0  exercises_%logit_1.0 )._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  prog_%logit_3.0 ester_%logit_3.0 one_%logit_0.0  for_%logit_0.0  o_%logit_3.0 ocyte_%logit_0.0  retrieval_%logit_1.0  in_%logit_0.0  vitro_%logit_3.0  fertil_%logit_3.0 isation_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  prog_%logit_1.0 est_%logit_1.0 ogen_%logit_1.0  therapy_%logit_3.0 ,_%logit_3.0  the_%logit_1.0  optimal_%logit_3.0  dosage_%logit_0.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_0.0  hyd_%logit_1.0 raz_%logit_1.0 ole_%logit_1.0 ,_%logit_2.0  and_%logit_3.0  the_%logit_3.0  optimal_%logit_3.0  timing_%logit_0.0  of_%logit_3.0  administration_%logit_1.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  investigation_%logit_1.0  of_%logit_1.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  prog_%logit_1.0 oster_%logit_3.0 oids_%logit_2.0  for_%logit_0.0  o_%logit_1.0 ocytes_%logit_3.0  retrieved_%logit_1.0  from_%logit_1.0  vitro_%logit_1.0  fertil_%logit_1.0 ization_%logit_1.0 ,_%logit_2.0  and_%logit_3.0  to_%logit_3.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  the_%logit_1.0  management_%logit_1.0  of_%logit_1.0  o_%logit_1.0 ocytes_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  intra_%logit_3.0 uter_%logit_3.0 ine_%logit_1.0  exc_%logit_0.0 ision_%logit_3.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  S_%logit_1.0 PC_%logit_3.0 TB_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  exc_%logit_3.0 ision_%logit_3.0  for_%logit_1.0  S_%logit_3.0 PC_%logit_3.0 B_%logit_3.0  in_%logit_1.0  women_%logit_3.0  with_%logit_3.0  P_%logit_1.0 TL_%logit_1.0 ._%logit_1.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  exc_%logit_0.0 ision_%logit_3.0  may_%logit_3.0  be_%logit_3.0  performed_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  how_%logit_3.0  the_%logit_3.0  exc_%logit_3.0 ision_%logit_3.0  process_%logit_3.0  works_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_1.0  the_%logit_2.0  mechanism_%logit_3.0  by_%logit_3.0  which_%logit_3.0  it_%logit_1.0  may_%logit_1.0  be_%logit_1.0  done_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  the_%logit_1.0  timing_%logit_3.0  and_%logit_3.0  timing_%logit_1.0  of_%logit_3.0  rec_%logit_1.0 urrence_%logit_3.0  and_%logit_1.0  duration_%logit_1.0  of_%logit_3.0  the_%logit_1.0  rec_%logit_3.0 urrence_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  phot_%logit_3.0 oco_%logit_1.0 ag_%logit_1.0 ulation_%logit_1.0  in_%logit_0.0  my_%logit_3.0 opia_%logit_3.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  phot_%logit_3.0 oco_%logit_2.0 agg_%logit_2.0 ulation_%logit_1.0  technique_%logit_2.0 ,_%logit_1.0  the_%logit_1.0  best_%logit_1.0  way_%logit_3.0  to_%logit_1.0  achieve_%logit_1.0  this_%logit_2.0 ,_%logit_1.0  and_%logit_1.0  the_%logit_1.0  most_%logit_3.0  effective_%logit_3.0  way_%logit_3.0  to_%logit_1.0  minim_%logit_1.0 ise_%logit_2.0  the_%logit_1.0  risk_%logit_3.0  of_%logit_3.0  bias_%logit_1.0  in_%logit_3.0  this_%logit_1.0  review_%logit_0.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  phot_%logit_3.0 oc_%logit_1.0 ag_%logit_1.0 ulation_%logit_2.0  for_%logit_2.0  my_%logit_1.0 opia_%logit_0.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  approaches_%logit_1.0  to_%logit_3.0  other_%logit_1.0  methods_%logit_3.0  of_%logit_3.0  optical_%logit_1.0  manipulation_%logit_1.0 ,_%logit_3.0  such_%logit_3.0  as_%logit_1.0  bin_%logit_1.0 ocular_%logit_1.0  tom_%logit_1.0 ography_%logit_1.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  az_%logit_3.0 ath_%logit_3.0 iop_%logit_2.0 rine_%logit_0.0  as_%logit_2.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_3.0  am_%logit_0.0 pic_%logit_3.0 illin_%logit_2.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  people_%logit_3.0  with_%logit_3.0  malaria_%logit_1.0 ._%logit_3.0  Further_%logit_2.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_2.0  of_%logit_2.0  am_%logit_2.0 ic_%logit_1.0 illin_%logit_1.0 ,_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  duration_%logit_3.0  of_%logit_2.0  antibiotic_%logit_1.0  therapy_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_0.0  and_%logit_2.0  timing_%logit_1.0  of_%logit_3.0  therapy_%logit_2.0 ._%logit_3.0  In_%logit_1.0  addition_%logit_0.0 ,_%logit_0.0  future_%logit_0.0  trials_%logit_0.0  should_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_2.0  as_%logit_0.0  the_%logit_2.0  duration_%logit_3.0  of_%logit_3.0  treatment_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  these_%logit_2.0  drugs_%logit_3.0  with_%logit_3.0  each_%logit_3.0  other_%logit_3.0  in_%logit_2.0  terms_%logit_3.0  of_%logit_3.0  efficacy_%logit_3.0 ,_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  efficacy_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_3.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  mechanism_%logit_3.0  by_%logit_3.0  which_%logit_3.0  healthcare_%logit_0.0  professionals_%logit_0.0  can_%logit_3.0  improve_%logit_1.0  the_%logit_1.0  quality_%logit_3.0  of_%logit_3.0  healthcare_%logit_3.0  services_%logit_0.0  provided_%logit_0.0  to_%logit_1.0  patients_%logit_3.0  in_%logit_3.0  hospital_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  establish_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  this_%logit_3.0  mechanism_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  reducing_%logit_3.0  mortality_%logit_3.0  and_%logit_3.0  health_%logit_3.0  service_%logit_3.0  utilization_%logit_0.0 ,_%logit_0.0  improving_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  reducing_%logit_0.0  costs_%logit_3.0  of_%logit_3.0  care_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  improving_%logit_3.0  access_%logit_3.0  to_%logit_3.0  care_%logit_3.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  this_%logit_0.0  can_%logit_3.0  be_%logit_3.0  achieved_%logit_3.0 ,_%logit_1.0  as_%logit_2.0  well_%logit_3.0  as_%logit_1.0  how_%logit_2.0  it_%logit_3.0  relates_%logit_3.0  to_%logit_3.0  costs_%logit_3.0  and_%logit_3.0  availability_%logit_1.0  of_%logit_3.0  services_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_1.0  b_%logit_1.0 ic_%logit_3.0 arbon_%logit_1.0 ate_%logit_2.0  as_%logit_3.0  an_%logit_3.0  adjunct_%logit_0.0  to_%logit_0.0  local_%logit_0.0  ana_%logit_0.0 esthetic_%logit_1.0  therapy_%logit_1.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0  in_%logit_3.0  patients_%logit_1.0  undergoing_%logit_1.0  surgery_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_2.0  of_%logit_0.0  b_%logit_2.0 ac_%logit_2.0 arbon_%logit_1.0 ate_%logit_2.0  for_%logit_3.0  pain_%logit_2.0  relief_%logit_2.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  ana_%logit_2.0 esthesia_%logit_0.0  in_%logit_2.0  pain_%logit_1.0  relief_%logit_3.0 ._%logit_2.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_0.0  well_%logit_2.0 -_%logit_2.0 exec_%logit_2.0 uted_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  B_%logit_3.0 OC_%logit_3.0 s_%logit_2.0  in_%logit_1.0  this_%logit_1.0  population_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  pro_%logit_3.0 ph_%logit_0.0 yl_%logit_2.0 actic_%logit_2.0  antibiotics_%logit_2.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  CON_%logit_1.0 S_%logit_3.0  bacter_%logit_2.0 a_%logit_0.0 emia_%logit_0.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  to_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_0.0  in_%logit_3.0  the_%logit_1.0  management_%logit_0.0  of_%logit_3.0  these_%logit_3.0  infections_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  antibiotic_%logit_3.0  regimen_%logit_0.0  and_%logit_2.0  the_%logit_1.0  optimal_%logit_3.0  timing_%logit_0.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  antibiotic_%logit_1.0  administration_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  it_%logit_0.0  is_%logit_2.0  important_%logit_2.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  antibiotic_%logit_0.0  therapy_%logit_3.0  works_%logit_3.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  antibiotic_%logit_2.0  therapy_%logit_3.0  with_%logit_3.0  other_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  pur_%logit_1.0 ifying_%logit_3.0  bacteria_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  mechanical_%logit_1.0  ventilation_%logit_1.0  in_%logit_1.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  pneumonia_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  method_%logit_3.0  of_%logit_1.0  ventilation_%logit_1.0  in_%logit_3.0  patients_%logit_1.0  with_%logit_3.0  pneumonia_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  mechanical_%logit_2.0  ventilation_%logit_3.0  with_%logit_1.0  other_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  ventilation_%logit_1.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_1.0  mechanical_%logit_1.0  ventilation_%logit_1.0 ,_%logit_1.0  or_%logit_1.0  mechanical_%logit_1.0  ventilation_%logit_3.0  alone_%logit_1.0  or_%logit_1.0  in_%logit_1.0  combination_%logit_1.0  with_%logit_1.0  mechanical_%logit_1.0  ventilation_%logit_1.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_1.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  electro_%logit_3.0 stim_%logit_1.0 ulation_%logit_1.0  therapy_%logit_1.0  in_%logit_1.0  this_%logit_1.0  population_%logit_3.0  of_%logit_2.0  patients_%logit_2.0  who_%logit_3.0  are_%logit_3.0  at_%logit_2.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  pneumonia_%logit_1.0 ,_%logit_3.0  or_%logit_3.0  who_%logit_3.0  are_%logit_3.0  in_%logit_2.0  need_%logit_1.0  of_%logit_1.0  intensive_%logit_3.0  care_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  depression_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  dy_%logit_3.0 sth_%logit_0.0 ym_%logit_2.0 ia_%logit_3.0 ._%logit_2.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  antidepressant_%logit_3.0  for_%logit_3.0  this_%logit_3.0  condition_%logit_0.0 ,_%logit_2.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  with_%logit_3.0  other_%logit_3.0  antidepressants_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  in_%logit_3.0  the_%logit_1.0  management_%logit_3.0  of_%logit_3.0  depressive_%logit_3.0  disorders_%logit_3.0  in_%logit_3.0  these_%logit_1.0  patients_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  antidepressant_%logit_3.0  dose_%logit_2.0  and_%logit_1.0  duration_%logit_2.0  of_%logit_3.0  antidepressant_%logit_1.0  therapy_%logit_3.0 ,_%logit_3.0  a_%logit_1.0  meta_%logit_2.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_0.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  antidepressants_%logit_3.0  is_%logit_3.0  warranted_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  iodine_%logit_1.0  supplementation_%logit_3.0  for_%logit_3.0  iodine_%logit_3.0  deficiency_%logit_3.0  in_%logit_0.0  thyroid_%logit_3.0  gland_%logit_3.0  size_%logit_3.0 ,_%logit_3.0  thyroid_%logit_3.0  volume_%logit_3.0 ,_%logit_3.0  thyroid_%logit_3.0  size_%logit_3.0  or_%logit_1.0  thyroid_%logit_3.0  hormone_%logit_3.0  sensitivity_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  iodine_%logit_3.0  supplementation_%logit_3.0  is_%logit_0.0  beneficial_%logit_1.0  or_%logit_3.0  harmful_%logit_3.0  for_%logit_1.0  thyroid_%logit_3.0  gland_%logit_3.0  function_%logit_1.0 ,_%logit_3.0  thyroid_%logit_3.0  hormones_%logit_3.0 ,_%logit_1.0  thyroid_%logit_1.0  hormone_%logit_3.0  levels_%logit_1.0  and_%logit_1.0  thyroid_%logit_1.0  hormones_%logit_3.0  in_%logit_3.0  thyroid_%logit_1.0  glands_%logit_3.0 ,_%logit_1.0  thyroid_%logit_1.0  tone_%logit_3.0  and_%logit_3.0  thyroid_%logit_3.0  volume_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  iodine_%logit_3.0  supplements_%logit_3.0  for_%logit_3.0  thyroid_%logit_1.0  hormone_%logit_3.0  deficiency_%logit_1.0 ,_%logit_1.0  a_%logit_3.0  meta_%logit_3.0 -_%logit_1.0 analysis_%logit_0.0  of_%logit_0.0  thyroid_%logit_2.0  hormone_%logit_1.0  concentrations_%logit_1.0  is_%logit_3.0  warranted_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  EB_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  confirm_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  EB_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  treatment_%logit_3.0  in_%logit_3.0  EB_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_0.0  a_%logit_1.0  well_%logit_3.0 -_%logit_3.0 defined_%logit_1.0  group_%logit_2.0  of_%logit_0.0  patients_%logit_2.0  who_%logit_3.0  are_%logit_2.0  at_%logit_2.0  high_%logit_2.0  risk_%logit_1.0  of_%logit_1.0  EB_%logit_1.0  and_%logit_3.0  those_%logit_3.0  who_%logit_3.0  are_%logit_3.0  unable_%logit_2.0  to_%logit_0.0  tolerate_%logit_3.0  antibiotic_%logit_2.0  treatment_%logit_3.0  or_%logit_3.0  who_%logit_3.0  do_%logit_3.0  not_%logit_2.0  wish_%logit_3.0  to_%logit_1.0  use_%logit_3.0  it_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  for_%logit_3.0  EM_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  acupuncture_%logit_3.0  in_%logit_1.0  EM_%logit_1.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  acupuncture_%logit_0.0  works_%logit_0.0  for_%logit_1.0  EM_%logit_1.0 ,_%logit_0.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  the_%logit_2.0  types_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  used_%logit_0.0  and_%logit_1.0  how_%logit_1.0  they_%logit_3.0  are_%logit_1.0  used_%logit_1.0  in_%logit_1.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_0.0  EM_%logit_1.0 ._%logit_3.0  In_%logit_3.0  addition_%logit_0.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_0.0  random_%logit_2.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  on_%logit_1.0  EM_%logit_1.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  gluc_%logit_3.0 oc_%logit_3.0 ort_%logit_3.0 ic_%logit_2.0 oids_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  mild_%logit_3.0  le_%logit_3.0 uk_%logit_3.0 open_%logit_2.0 ia_%logit_3.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_0.0  duration_%logit_1.0  and_%logit_1.0  timing_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  duration_%logit_3.0  of_%logit_3.0  gluc_%logit_1.0 ocon_%logit_3.0 ort_%logit_3.0 ic_%logit_2.0 oid_%logit_0.0  therapy_%logit_0.0  in_%logit_3.0  this_%logit_1.0  condition_%logit_1.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  gluc_%logit_1.0 os_%logit_3.0 ort_%logit_3.0 ic_%logit_3.0 oster_%logit_0.0 oids_%logit_3.0  in_%logit_0.0  reducing_%logit_1.0  the_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  adverse_%logit_1.0  events_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  gluc_%logit_3.0 oco_%logit_3.0 ort_%logit_3.0 ic_%logit_2.0 oidal_%logit_0.0  anti_%logit_3.0 -_%logit_0.0 inflammatory_%logit_1.0  drugs_%logit_1.0  (_%logit_3.0 NSA_%logit_1.0 IDs_%logit_1.0 )_%logit_0.0  in_%logit_0.0  this_%logit_1.0  population_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  selective_%logit_1.0  clamp_%logit_3.0 ing_%logit_1.0  as_%logit_3.0  a_%logit_3.0  means_%logit_0.0  of_%logit_0.0  reducing_%logit_0.0  blood_%logit_3.0  loss_%logit_3.0  during_%logit_0.0  liver_%logit_3.0  tr_%logit_0.0 an_%logit_3.0 section_%logit_0.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  method_%logit_3.0  of_%logit_1.0  clamp_%logit_1.0 ing_%logit_3.0 ,_%logit_3.0  the_%logit_3.0  best_%logit_3.0  way_%logit_3.0  to_%logit_3.0  minim_%logit_1.0 ise_%logit_2.0  blood_%logit_0.0  loss_%logit_0.0 ,_%logit_0.0  and_%logit_3.0  the_%logit_3.0  best_%logit_0.0  technique_%logit_3.0  for_%logit_0.0  clamp_%logit_1.0 ing_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  an_%logit_1.0  assessment_%logit_1.0  of_%logit_0.0  the_%logit_1.0  effectiveness_%logit_3.0  of_%logit_3.0  selective_%logit_1.0  graft_%logit_1.0 ing_%logit_1.0  as_%logit_1.0  an_%logit_3.0  alternative_%logit_0.0  to_%logit_0.0  open_%logit_0.0  clamp_%logit_1.0 ing_%logit_1.0  in_%logit_1.0  terms_%logit_3.0  of_%logit_3.0  reduced_%logit_3.0  blood_%logit_3.0  loss_%logit_3.0  and_%logit_0.0  mortality_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  approach_%logit_3.0  to_%logit_1.0  open_%logit_3.0  graft_%logit_3.0 ing_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  pro_%logit_3.0 ph_%logit_3.0 yl_%logit_2.0 axis_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  antibiotic_%logit_1.0 -_%logit_3.0 resistant_%logit_3.0  py_%logit_2.0 el_%logit_3.0 one_%logit_2.0 ph_%logit_0.0 ritis_%logit_1.0 ._%logit_1.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  pro_%logit_1.0 ph_%logit_0.0 yle_%logit_0.0 phrine_%logit_1.0  in_%logit_0.0  reducing_%logit_2.0  antibiotic_%logit_3.0  usage_%logit_3.0  in_%logit_3.0  this_%logit_3.0  condition_%logit_3.0 ._%logit_2.0  Such_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_3.0  a_%logit_1.0  large_%logit_3.0  number_%logit_3.0  of_%logit_3.0  cases_%logit_3.0  of_%logit_3.0  antibiotic_%logit_2.0  resistance_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  should_%logit_3.0  be_%logit_0.0  of_%logit_2.0  high_%logit_0.0  methodological_%logit_3.0  quality_%logit_1.0 ._%logit_3.0  They_%logit_2.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  antibiotics_%logit_1.0  on_%logit_3.0  the_%logit_1.0  incidence_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  diarr_%logit_3.0 hoe_%logit_3.0 a_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  the_%logit_1.0  duration_%logit_3.0  of_%logit_3.0  antibiotic_%logit_1.0  treatment_%logit_3.0 ._%logit_3.0
 Sal_%logit_0.0 but_%logit_0.0 am_%logit_2.0 ol_%logit_2.0  is_%logit_2.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_2.0  the_%logit_0.0  incidence_%logit_0.0  of_%logit_3.0  pulmonary_%logit_0.0  emb_%logit_3.0 ol_%logit_1.0 isms_%logit_0.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_0.0  acute_%logit_3.0  asthma_%logit_0.0 ._%logit_0.0  It_%logit_3.0  is_%logit_0.0  also_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  the_%logit_0.0  risk_%logit_3.0  of_%logit_3.0  pneum_%logit_1.0 oth_%logit_3.0 or_%logit_1.0 ax_%logit_0.0 ,_%logit_0.0  a_%logit_2.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  respiratory_%logit_0.0  distress_%logit_3.0  syndrome_%logit_0.0 ,_%logit_1.0  and_%logit_3.0  an_%logit_3.0  increased_%logit_3.0  risk_%logit_0.0  of_%logit_0.0  hyp_%logit_0.0 ox_%logit_3.0 a_%logit_3.0 emia_%logit_2.0 ._%logit_0.0  However_%logit_2.0 ,_%logit_0.0  these_%logit_0.0  results_%logit_0.0  are_%logit_3.0  based_%logit_2.0  on_%logit_0.0  only_%logit_0.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  patients_%logit_0.0  and_%logit_0.0  are_%logit_2.0  not_%logit_0.0  representative_%logit_0.0  of_%logit_0.0  the_%logit_3.0  whole_%logit_3.0  range_%logit_3.0  of_%logit_3.0  treatments_%logit_3.0  available_%logit_3.0  in_%logit_1.0  this_%logit_3.0  review_%logit_0.0 ._%logit_2.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  sal_%logit_0.0 but_%logit_3.0 amn_%logit_1.0 ol_%logit_2.0  and_%logit_0.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_2.0  timing_%logit_1.0  of_%logit_0.0  sal_%logit_1.0 meter_%logit_3.0 ol_%logit_1.0  and_%logit_3.0  its_%logit_3.0  use_%logit_3.0  in_%logit_3.0  these_%logit_2.0  patients_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  human_%logit_3.0  insulin_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  hyp_%logit_1.0 ogly_%logit_3.0 ca_%logit_3.0 emia_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  insulin_%logit_3.0  dose_%logit_2.0  and_%logit_2.0  duration_%logit_1.0 ,_%logit_0.0  and_%logit_1.0  to_%logit_3.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  human_%logit_1.0  ins_%logit_3.0 ul_%logit_1.0 ins_%logit_1.0  in_%logit_1.0  this_%logit_1.0  population_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  animal_%logit_3.0  insulin_%logit_3.0  in_%logit_1.0  reducing_%logit_3.0  blood_%logit_3.0  glucose_%logit_3.0  levels_%logit_3.0  in_%logit_3.0  humans_%logit_1.0  and_%logit_1.0  in_%logit_3.0  developing_%logit_3.0  countries_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  human_%logit_2.0  insulin_%logit_3.0  with_%logit_3.0  animal_%logit_3.0  insulin_%logit_3.0 ._%logit_1.0  Finally_%logit_3.0  there_%logit_0.0  is_%logit_0.0  an_%logit_3.0  urgent_%logit_3.0  need_%logit_0.0  for_%logit_0.0  research_%logit_1.0  into_%logit_1.0  how_%logit_3.0  human_%logit_3.0  insulin_%logit_3.0  should_%logit_1.0  be_%logit_1.0  used_%logit_3.0  in_%logit_1.0  developing_%logit_3.0  nations_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  in_%logit_2.0  developing_%logit_3.0  regions_%logit_3.0  of_%logit_3.0  Europe_%logit_1.0  and_%logit_3.0  Asia_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  an_%logit_3.0  antip_%logit_3.0 sych_%logit_3.0 otic_%logit_1.0  drug_%logit_0.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  autism_%logit_3.0  spectrum_%logit_3.0  disorders_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  this_%logit_3.0  drug_%logit_0.0  for_%logit_2.0  autism_%logit_2.0  spectrum_%logit_0.0  disorder_%logit_1.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_3.0  antidepressant_%logit_3.0  drugs_%logit_3.0 ,_%logit_3.0  such_%logit_2.0  as_%logit_3.0  ib_%logit_3.0 up_%logit_3.0 ro_%logit_1.0 fen_%logit_1.0 ,_%logit_1.0  nap_%logit_2.0 rox_%logit_3.0 en_%logit_1.0 ,_%logit_1.0  and_%logit_2.0  serotonin_%logit_3.0  re_%logit_3.0 upt_%logit_1.0 ake_%logit_0.0  inhibitors_%logit_0.0 ,_%logit_0.0  as_%logit_1.0  well_%logit_2.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  these_%logit_2.0  drugs_%logit_3.0  with_%logit_3.0  each_%logit_3.0  other_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  them_%logit_2.0  to_%logit_3.0  each_%logit_3.0  other_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_2.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_1.0  particular_%logit_1.0  type_%logit_3.0  of_%logit_1.0  optical_%logit_1.0  device_%logit_1.0  for_%logit_1.0  reading_%logit_1.0  speed_%logit_3.0  or_%logit_3.0  accuracy_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  identify_%logit_2.0  the_%logit_2.0  most_%logit_3.0  effective_%logit_3.0  type_%logit_3.0  and_%logit_1.0  wavelength_%logit_1.0  of_%logit_2.0  optical_%logit_1.0  devices_%logit_3.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  them_%logit_2.0  to_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  visual_%logit_1.0  aids_%logit_3.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_1.0  types_%logit_1.0  and_%logit_3.0  wavelengths_%logit_1.0  of_%logit_1.0  optical_%logit_1.0  technology_%logit_1.0  for_%logit_1.0  reading_%logit_1.0  accuracy_%logit_1.0  and_%logit_1.0  accuracy_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_1.0  as_%logit_1.0  to_%logit_2.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  reliability_%logit_1.0  of_%logit_3.0  these_%logit_3.0  technologies_%logit_3.0  to_%logit_3.0  other_%logit_1.0  forms_%logit_3.0  of_%logit_3.0  optical_%logit_1.0  therapy_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  recommend_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  any_%logit_1.0  particular_%logit_3.0  type_%logit_3.0  of_%logit_2.0  intervention_%logit_2.0  for_%logit_2.0  the_%logit_1.0  prevention_%logit_3.0  of_%logit_3.0  E_%logit_3.0 TS_%logit_3.0  in_%logit_1.0  mothers_%logit_3.0  or_%logit_0.0  children_%logit_3.0 ._%logit_3.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  most_%logit_3.0  effective_%logit_3.0  intervention_%logit_3.0  and_%logit_2.0  the_%logit_1.0  best_%logit_0.0  way_%logit_0.0  to_%logit_2.0  tailor_%logit_1.0  it_%logit_2.0  to_%logit_3.0  the_%logit_0.0  needs_%logit_0.0  of_%logit_3.0  the_%logit_3.0  mother_%logit_1.0  or_%logit_3.0  child_%logit_2.0 ,_%logit_1.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  different_%logit_1.0  types_%logit_3.0  of_%logit_2.0  intervention_%logit_3.0  in_%logit_3.0  different_%logit_1.0  populations_%logit_3.0  and_%logit_3.0  settings_%logit_2.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_2.0  should_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  interventions_%logit_3.0  to_%logit_1.0  reduce_%logit_1.0  E_%logit_3.0 TS_%logit_3.0  exposure_%logit_1.0  in_%logit_1.0  mothers_%logit_3.0  and_%logit_3.0  children_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  identify_%logit_2.0  the_%logit_3.0  types_%logit_3.0  of_%logit_3.0  interventions_%logit_1.0  that_%logit_0.0  are_%logit_1.0  most_%logit_1.0  effective_%logit_0.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  nutritional_%logit_1.0  supplements_%logit_1.0  in_%logit_0.0  the_%logit_1.0  management_%logit_0.0  of_%logit_3.0  overweight_%logit_3.0  or_%logit_3.0  obesity_%logit_1.0 ._%logit_1.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  nutritional_%logit_1.0  supplement_%logit_1.0  supplementation_%logit_3.0  on_%logit_3.0  body_%logit_3.0  mass_%logit_3.0  index_%logit_3.0  cent_%logit_3.0 ile_%logit_3.0  strength_%logit_2.0  and_%logit_3.0  metabolic_%logit_3.0  fitness_%logit_3.0  in_%logit_3.0  overweight_%logit_3.0  or_%logit_1.0  obese_%logit_1.0  patients_%logit_1.0  with_%logit_1.0  moderate_%logit_1.0  to_%logit_3.0  severe_%logit_3.0  obesity_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  nutritional_%logit_2.0  supplements_%logit_3.0  with_%logit_3.0  placebo_%logit_1.0  or_%logit_3.0  no_%logit_1.0  supplementation_%logit_1.0  in_%logit_3.0  obese_%logit_1.0  patients_%logit_3.0 ._%logit_3.0  Such_%logit_1.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  assess_%logit_1.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  metabolic_%logit_1.0  fitness_%logit_3.0 ,_%logit_3.0  metabolic_%logit_3.0  fitness_%logit_3.0  and_%logit_3.0  physical_%logit_3.0  fitness_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  metabolic_%logit_2.0  fitness_%logit_0.0 ._%logit_3.0
 Sal_%logit_0.0 meter_%logit_0.0 ol_%logit_2.0  is_%logit_0.0  effective_%logit_0.0  in_%logit_0.0  reducing_%logit_2.0  the_%logit_3.0  number_%logit_3.0  of_%logit_0.0  patients_%logit_0.0  admitted_%logit_0.0  to_%logit_0.0  hospital_%logit_3.0  and_%logit_3.0  improving_%logit_3.0  lung_%logit_0.0  function_%logit_3.0  in_%logit_0.0  the_%logit_3.0  short_%logit_3.0 -_%logit_3.0 term_%logit_3.0 ,_%logit_1.0  but_%logit_2.0  its_%logit_3.0  use_%logit_3.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_0.0  a_%logit_3.0  higher_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  death_%logit_0.0  and_%logit_3.0  a_%logit_0.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  respiratory_%logit_0.0  distress_%logit_3.0  syndrome_%logit_0.0 ._%logit_1.0  Its_%logit_3.0  efficacy_%logit_0.0  is_%logit_3.0  similar_%logit_3.0  to_%logit_3.0  that_%logit_2.0  of_%logit_1.0  sal_%logit_1.0 meter_%logit_3.0 ol_%logit_2.0 ,_%logit_0.0  but_%logit_2.0  with_%logit_2.0  a_%logit_3.0  lower_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  pneumonia_%logit_0.0  and_%logit_3.0  an_%logit_3.0  increased_%logit_3.0  risk_%logit_0.0  of_%logit_3.0  bron_%logit_3.0 ch_%logit_3.0 od_%logit_1.0 il_%logit_3.0 ator_%logit_1.0  toxicity_%logit_1.0 ._%logit_3.0  Its_%logit_2.0  use_%logit_0.0  is_%logit_3.0  not_%logit_2.0  associated_%logit_3.0  with_%logit_1.0  an_%logit_3.0  increase_%logit_3.0  in_%logit_0.0  the_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  pulmonary_%logit_3.0  emb_%logit_3.0 ol_%logit_0.0 isms_%logit_0.0  or_%logit_2.0  death_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  a_%logit_3.0  decreased_%logit_3.0  rate_%logit_3.0  of_%logit_3.0  respiratory_%logit_3.0  failure_%logit_3.0 ._%logit_0.0  Its_%logit_3.0  safety_%logit_0.0  profile_%logit_3.0  is_%logit_3.0  comparable_%logit_3.0  to_%logit_3.0  that_%logit_1.0  that_%logit_3.0  of_%logit_1.0  other_%logit_1.0  inh_%logit_3.0 aled_%logit_2.0  cort_%logit_1.0 ic_%logit_0.0 oster_%logit_2.0 oids_%logit_3.0 ,_%logit_0.0  but_%logit_2.0  it_%logit_3.0  is_%logit_3.0  not_%logit_2.0  clear_%logit_3.0  whether_%logit_1.0  its_%logit_3.0  efficacy_%logit_3.0  is_%logit_3.0  related_%logit_3.0  to_%logit_3.0  its_%logit_3.0  long_%logit_3.0 -_%logit_3.0 term_%logit_3.0  safety_%logit_3.0  profile_%logit_3.0 ._%logit_3.0
 Ant_%logit_0.0 ib_%logit_2.0 iotic_%logit_2.0  pro_%logit_2.0 ph_%logit_0.0 yl_%logit_2.0 axis_%logit_0.0  is_%logit_0.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_2.0  the_%logit_3.0  incidence_%logit_3.0  of_%logit_3.0  bacterial_%logit_3.0  contamination_%logit_0.0  in_%logit_0.0  the_%logit_3.0  first_%logit_0.0  two_%logit_0.0  weeks_%logit_1.0  after_%logit_0.0  surgery_%logit_3.0 ._%logit_0.0  However_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_1.0  pro_%logit_3.0 th_%logit_0.0 yl_%logit_2.0 axis_%logit_2.0  in_%logit_2.0  this_%logit_3.0  population_%logit_0.0 ,_%logit_2.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  different_%logit_3.0  antibiotic_%logit_3.0  reg_%logit_2.0 imens_%logit_2.0 ._%logit_2.0  Finally_%logit_1.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_0.0  the_%logit_2.0  optimal_%logit_3.0  antibiotic_%logit_3.0  regimen_%logit_2.0 ,_%logit_2.0  the_%logit_0.0  optimal_%logit_2.0  dose_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  antibiotic_%logit_0.0  treatment_%logit_3.0 ,_%logit_2.0  and_%logit_1.0  the_%logit_2.0  optimal_%logit_3.0  dosage_%logit_0.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_0.0  antibiotic_%logit_0.0  therapy_%logit_0.0 ,_%logit_2.0  we_%logit_2.0  recommend_%logit_2.0  that_%logit_2.0  all_%logit_1.0  patients_%logit_0.0  receive_%logit_0.0  an_%logit_2.0  appropriate_%logit_2.0  amount_%logit_0.0  of_%logit_0.0  antibiotics_%logit_0.0  to_%logit_3.0  avoid_%logit_0.0  bacterial_%logit_0.0  contamination_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  pro_%logit_1.0 ph_%logit_3.0 yl_%logit_2.0 actic_%logit_0.0  antibiotics_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  CM_%logit_1.0 V_%logit_3.0  infections_%logit_3.0 ._%logit_2.0  Further_%logit_1.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotics_%logit_1.0  in_%logit_0.0  treating_%logit_1.0  CM_%logit_0.0 V_%logit_3.0  infection_%logit_1.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  with_%logit_3.0  no_%logit_1.0  treatment_%logit_3.0  or_%logit_3.0  no_%logit_1.0  treatment_%logit_3.0 ._%logit_2.0  Such_%logit_2.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0 ._%logit_3.0  Such_%logit_1.0  studies_%logit_0.0  should_%logit_0.0  also_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  the_%logit_1.0  management_%logit_0.0  of_%logit_2.0  MR_%logit_3.0 V_%logit_3.0  infections_%logit_1.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  quality_%logit_0.0  of_%logit_3.0  the_%logit_3.0  evidence_%logit_0.0 ._%logit_0.0
 The_%logit_0.0  results_%logit_0.0  of_%logit_3.0  this_%logit_2.0  review_%logit_0.0  support_%logit_2.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  male_%logit_3.0  condoms_%logit_3.0  in_%logit_3.0  reducing_%logit_3.0  ST_%logit_0.0 I_%logit_0.0  prevalence_%logit_0.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_3.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  male_%logit_2.0  condoms_%logit_3.0  as_%logit_3.0  a_%logit_2.0  substitute_%logit_0.0  for_%logit_0.0  female_%logit_0.0  condoms_%logit_3.0  in_%logit_0.0  the_%logit_3.0  prevention_%logit_0.0  of_%logit_0.0  ST_%logit_3.0 I_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  male_%logit_3.0  condom_%logit_3.0  use_%logit_3.0  in_%logit_3.0  preventing_%logit_3.0  ST_%logit_3.0 I_%logit_3.0  incidence_%logit_1.0  and_%logit_3.0  prevalence_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  male_%logit_2.0  condoms_%logit_3.0  with_%logit_3.0  female_%logit_3.0  condoms_%logit_3.0 ,_%logit_0.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  the_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  male_%logit_3.0  and_%logit_3.0  female_%logit_3.0  condoms_%logit_3.0  compared_%logit_3.0  to_%logit_1.0  female_%logit_3.0  condoms_%logit_3.0 ._%logit_3.0  Recommend_%logit_3.0 ations_%logit_0.0  for_%logit_0.0  male_%logit_0.0  condoms_%logit_0.0  should_%logit_0.0  also_%logit_2.0  be_%logit_2.0  made_%logit_2.0  for_%logit_1.0  women_%logit_3.0  and_%logit_3.0  their_%logit_0.0  partners_%logit_3.0 ,_%logit_0.0  and_%logit_2.0  for_%logit_3.0  women_%logit_0.0  with_%logit_0.0  ST_%logit_0.0 I_%logit_1.0  risk_%logit_1.0  factors_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  self_%logit_3.0 -_%logit_3.0 management_%logit_1.0  tools_%logit_0.0  in_%logit_3.0  the_%logit_0.0  management_%logit_0.0  of_%logit_0.0  O_%logit_3.0 AT_%logit_0.0 ._%logit_1.0  Further_%logit_0.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_3.0  identify_%logit_2.0  the_%logit_2.0  most_%logit_3.0  effective_%logit_3.0  tools_%logit_3.0  to_%logit_2.0  improve_%logit_2.0  self_%logit_2.0  management_%logit_3.0  tools_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_0.0  them_%logit_2.0  with_%logit_3.0  other_%logit_3.0  types_%logit_3.0  of_%logit_3.0  management_%logit_1.0  tools_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_0.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  self_%logit_1.0  management_%logit_3.0  technologies_%logit_1.0  in_%logit_3.0  reducing_%logit_1.0  O_%logit_0.0 AT_%logit_0.0  and_%logit_1.0  improving_%logit_0.0  quality_%logit_0.0  of_%logit_0.0  life_%logit_3.0  and_%logit_0.0  cost_%logit_0.0 -_%logit_0.0 effect_%logit_3.0 iveness_%logit_0.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_0.0  a_%logit_2.0  history_%logit_0.0  of_%logit_3.0  major_%logit_3.0  bleeding_%logit_3.0  and_%logit_0.0  a_%logit_3.0  focus_%logit_3.0  on_%logit_3.0  improving_%logit_3.0  the_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  the_%logit_3.0  evidence_%logit_0.0  base_%logit_0.0 ._%logit_2.0
 Physical_%logit_0.0  activity_%logit_0.0  programmes_%logit_3.0  are_%logit_3.0  effective_%logit_1.0  in_%logit_0.0  lowering_%logit_3.0  blood_%logit_3.0  pressure_%logit_3.0  and_%logit_3.0  reducing_%logit_3.0  triglycer_%logit_3.0 ides_%logit_3.0  in_%logit_0.0  physical_%logit_3.0  activity_%logit_1.0  programmes_%logit_3.0 ._%logit_1.0  Physical_%logit_1.0  activity_%logit_0.0  programs_%logit_1.0  are_%logit_1.0  associated_%logit_1.0  with_%logit_3.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  triglycer_%logit_1.0 ides_%logit_3.0  and_%logit_3.0  LDL_%logit_3.0 -_%logit_3.0 ch_%logit_3.0 olesterol_%logit_3.0  levels_%logit_0.0 ._%logit_3.0  Physical_%logit_3.0  activities_%logit_0.0  programmes_%logit_1.0  are_%logit_1.0  also_%logit_1.0  associated_%logit_0.0  with_%logit_1.0  an_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  triglycer_%logit_1.0 ide_%logit_3.0  levels_%logit_1.0  and_%logit_3.0  triglycer_%logit_3.0 ides_%logit_3.0  levels_%logit_3.0 ._%logit_3.0  Exercise_%logit_3.0  programmes_%logit_0.0  may_%logit_3.0  be_%logit_1.0  associated_%logit_2.0  with_%logit_1.0  reduced_%logit_3.0  triglycer_%logit_3.0 ides_%logit_3.0 ,_%logit_1.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  no_%logit_2.0  evidence_%logit_3.0  of_%logit_2.0  an_%logit_2.0  effect_%logit_3.0  on_%logit_3.0  triglycer_%logit_1.0 ides_%logit_3.0  or_%logit_2.0  cholesterol_%logit_3.0  levels_%logit_3.0  in_%logit_3.0  physical_%logit_3.0  activities_%logit_1.0  programmes_%logit_3.0 ._%logit_1.0  Exercise_%logit_2.0  programs_%logit_0.0  may_%logit_1.0  reduce_%logit_1.0  triglycer_%logit_2.0 ides_%logit_3.0  but_%logit_3.0  there_%logit_3.0  are_%logit_3.0  insufficient_%logit_2.0  data_%logit_3.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  exercise_%logit_1.0  programmes_%logit_1.0  on_%logit_3.0  blood_%logit_1.0  pressure_%logit_3.0 ,_%logit_3.0  cholesterol_%logit_3.0  levels_%logit_3.0  or_%logit_3.0  triglycer_%logit_3.0 ides_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  type_%logit_3.0  of_%logit_1.0  exercise_%logit_1.0  programme_%logit_1.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  exercise_%logit_1.0  programs_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  protective_%logit_3.0  effect_%logit_3.0  of_%logit_3.0  immun_%logit_1.0 os_%logit_3.0 upp_%logit_0.0 ressive_%logit_1.0  agents_%logit_1.0  on_%logit_3.0  mortality_%logit_1.0  from_%logit_3.0  CRC_%logit_3.0 ._%logit_3.0  Further_%logit_0.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  agents_%logit_3.0  in_%logit_3.0  the_%logit_2.0  treatment_%logit_0.0  of_%logit_0.0  CRC_%logit_1.0 ._%logit_3.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  important_%logit_3.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  these_%logit_0.0  agents_%logit_0.0  are_%logit_0.0  used_%logit_0.0  in_%logit_0.0  the_%logit_2.0  management_%logit_0.0  of_%logit_0.0  CRC_%logit_1.0 ,_%logit_3.0  and_%logit_0.0  how_%logit_3.0  they_%logit_3.0  are_%logit_0.0  applied_%logit_0.0  to_%logit_0.0  individuals_%logit_3.0  with_%logit_0.0  a_%logit_3.0  high_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  death_%logit_1.0  from_%logit_3.0  CRC_%logit_2.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  treatments_%logit_3.0  on_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  mortality_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  ip_%logit_3.0 rat_%logit_3.0 rop_%logit_1.0 ium_%logit_0.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  premature_%logit_3.0  discontin_%logit_3.0 uation_%logit_3.0  due_%logit_1.0  to_%logit_1.0  adverse_%logit_3.0  events_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  ip_%logit_1.0 at_%logit_3.0 rop_%logit_1.0 ium_%logit_0.0  in_%logit_1.0  treating_%logit_2.0  premature_%logit_3.0  discontin_%logit_3.0 uations_%logit_1.0  of_%logit_1.0  ep_%logit_1.0 ine_%logit_3.0 phrine_%logit_1.0  and_%logit_2.0  phen_%logit_2.0 y_%logit_0.0 to_%logit_1.0 in_%logit_1.0 ,_%logit_1.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  its_%logit_2.0  efficacy_%logit_3.0  in_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  these_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  its_%logit_2.0  efficacy_%logit_3.0  with_%logit_3.0  other_%logit_3.0  treatments_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  a_%logit_0.0  randomized_%logit_2.0  controlled_%logit_2.0  trial_%logit_2.0  is_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  evaluate_%logit_1.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  ip_%logit_1.0 ot_%logit_3.0 rop_%logit_1.0 ium_%logit_0.0  as_%logit_2.0  an_%logit_2.0  adj_%logit_1.0 u_%logit_0.0 vant_%logit_1.0  therapy_%logit_1.0  for_%logit_0.0  premature_%logit_0.0  discontin_%logit_3.0 ation_%logit_1.0  due_%logit_1.0  to_%logit_1.0  poor_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  the_%logit_3.0  evidence_%logit_0.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  bu_%logit_3.0 p_%logit_3.0 iv_%logit_1.0 ac_%logit_1.0 aine_%logit_1.0  as_%logit_2.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_1.0  oxy_%logit_0.0 toc_%logit_3.0 in_%logit_1.0  for_%logit_2.0  epid_%logit_3.0 ural_%logit_3.0  analges_%logit_3.0 ia_%logit_0.0 ,_%logit_2.0  or_%logit_3.0  to_%logit_3.0  support_%logit_3.0  its_%logit_2.0  use_%logit_3.0  as_%logit_3.0  an_%logit_3.0  alternative_%logit_3.0  to_%logit_0.0  epid_%logit_0.0 ural_%logit_3.0  ana_%logit_3.0 esthesia_%logit_1.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  bu_%logit_1.0 pp_%logit_0.0 iv_%logit_1.0 ac_%logit_2.0 ain_%logit_0.0 ,_%logit_2.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_3.0  epid_%logit_1.0 ural_%logit_1.0  administration_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  the_%logit_3.0  most_%logit_3.0  effective_%logit_0.0  analges_%logit_3.0 ia_%logit_2.0  for_%logit_2.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_0.0  pain_%logit_1.0  relief_%logit_3.0  in_%logit_3.0  women_%logit_3.0  in_%logit_3.0  labor_%logit_1.0  and_%logit_3.0  childbirth_%logit_2.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_1.0  analges_%logit_3.0 ia_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  cervical_%logit_3.0  dil_%logit_3.0 at_%logit_0.0 ation_%logit_3.0  as_%logit_3.0  a_%logit_3.0  treatment_%logit_3.0  for_%logit_3.0  cervical_%logit_0.0  rip_%logit_3.0 ening_%logit_0.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  cervical_%logit_3.0  d_%logit_3.0 ilation_%logit_3.0  as_%logit_0.0  an_%logit_3.0  alternative_%logit_1.0  to_%logit_0.0  cervical_%logit_0.0  dil_%logit_3.0 ation_%logit_1.0  as_%logit_1.0  an_%logit_3.0  adj_%logit_1.0 u_%logit_0.0 vant_%logit_1.0  treatment_%logit_1.0  to_%logit_0.0  cervical_%logit_0.0  exc_%logit_3.0 ision_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  cervical_%logit_2.0  dil_%logit_3.0 atal_%logit_1.0  exc_%logit_3.0 ision_%logit_3.0  with_%logit_3.0  cervical_%logit_3.0  dil_%logit_3.0 ating_%logit_1.0  as_%logit_3.0  a_%logit_3.0  non_%logit_3.0 -_%logit_3.0 ide_%logit_1.0 al_%logit_1.0  treatment_%logit_0.0 ._%logit_0.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_1.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_0.0  random_%logit_2.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  comparing_%logit_0.0  cervical_%logit_2.0  dil_%logit_3.0 ate_%logit_1.0  with_%logit_1.0  cervical_%logit_3.0  rip_%logit_3.0 ener_%logit_3.0  as_%logit_1.0  a_%logit_3.0  standard_%logit_1.0  treatment_%logit_1.0 ._%logit_0.0  Such_%logit_0.0  a_%logit_0.0  trial_%logit_0.0  is_%logit_0.0  warranted_%logit_2.0  in_%logit_0.0  order_%logit_2.0  to_%logit_3.0  determine_%logit_0.0  the_%logit_2.0  best_%logit_3.0  method_%logit_3.0  of_%logit_3.0  dil_%logit_1.0 ating_%logit_0.0  cervical_%logit_3.0  dil_%logit_3.0 ates_%logit_3.0 ._%logit_3.0
 The_%logit_0.0  results_%logit_1.0  of_%logit_3.0  this_%logit_2.0  review_%logit_0.0  suggest_%logit_2.0  that_%logit_2.0  there_%logit_1.0  is_%logit_1.0  no_%logit_3.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  manual_%logit_3.0  walking_%logit_1.0  aids_%logit_3.0  for_%logit_3.0  enhancing_%logit_1.0  walking_%logit_3.0  speed_%logit_3.0  or_%logit_3.0  endurance_%logit_3.0  in_%logit_3.0  disabled_%logit_3.0  persons_%logit_3.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  into_%logit_2.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  manual_%logit_1.0  walk_%logit_1.0  aids_%logit_1.0  for_%logit_2.0  disabled_%logit_1.0  persons_%logit_1.0  with_%logit_3.0  impaired_%logit_3.0  limb_%logit_1.0  function_%logit_1.0  and_%logit_3.0  functional_%logit_3.0  independence_%logit_3.0  after_%logit_3.0  discharge_%logit_3.0  from_%logit_0.0  hospital_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  manual_%logit_3.0 -_%logit_1.0 assisted_%logit_1.0  walking_%logit_1.0  aids_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  manual_%logit_2.0  walking_%logit_3.0  aid_%logit_1.0  with_%logit_3.0  manual_%logit_3.0 -_%logit_1.0 based_%logit_1.0  walking_%logit_1.0  aids_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  acupuncture_%logit_3.0  for_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0  in_%logit_3.0  adults_%logit_3.0  with_%logit_3.0  T_%logit_3.0 MD_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  acupuncture_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  acupuncture_%logit_2.0  with_%logit_3.0  other_%logit_3.0  treatments_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  efficacy_%logit_1.0  of_%logit_3.0  acupuncture_%logit_1.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  T_%logit_1.0 MD_%logit_3.0 ,_%logit_2.0  and_%logit_1.0  a_%logit_0.0  comparison_%logit_0.0  of_%logit_2.0  acupuncture_%logit_1.0  to_%logit_3.0  other_%logit_3.0  treatments_%logit_3.0  in_%logit_3.0  adults_%logit_1.0 ._%logit_3.0  Finally_%logit_2.0  there_%logit_0.0  is_%logit_0.0  an_%logit_2.0  issue_%logit_3.0  of_%logit_0.0  the_%logit_1.0  quality_%logit_3.0  of_%logit_3.0  the_%logit_3.0  evidence_%logit_0.0 ,_%logit_0.0  as_%logit_2.0  well_%logit_3.0  as_%logit_1.0  the_%logit_2.0  reliability_%logit_3.0  of_%logit_3.0  the_%logit_3.0  results_%logit_3.0 ,_%logit_0.0  and_%logit_1.0  the_%logit_3.0  usefulness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  findings_%logit_3.0 ._%logit_3.0
 Technical_%logit_0.0  skill_%logit_0.0  training_%logit_3.0  is_%logit_1.0  a_%logit_1.0  useful_%logit_0.0  tool_%logit_3.0  in_%logit_2.0  the_%logit_0.0  management_%logit_0.0  of_%logit_1.0  pain_%logit_1.0  and_%logit_0.0  discomfort_%logit_3.0  associated_%logit_0.0  with_%logit_1.0  end_%logit_3.0 oscopic_%logit_0.0  insertion_%logit_0.0  and_%logit_1.0  negotiation_%logit_3.0  of_%logit_0.0  rect_%logit_3.0 os_%logit_0.0 igm_%logit_3.0 oid_%logit_3.0  junction_%logit_2.0 ._%logit_3.0  However_%logit_0.0 ,_%logit_0.0  it_%logit_0.0  is_%logit_1.0  not_%logit_3.0  clear_%logit_3.0  whether_%logit_1.0  technical_%logit_3.0  skill_%logit_1.0  training_%logit_3.0  has_%logit_1.0  a_%logit_1.0  beneficial_%logit_3.0  effect_%logit_2.0  on_%logit_2.0  pain_%logit_1.0  or_%logit_0.0  discomfort_%logit_3.0 ._%logit_0.0  Pract_%logit_1.0 ition_%logit_0.0 ers_%logit_1.0  should_%logit_1.0  be_%logit_1.0  aware_%logit_2.0  that_%logit_2.0  there_%logit_1.0  is_%logit_1.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  technical_%logit_3.0  skills_%logit_3.0  training_%logit_1.0  in_%logit_1.0  this_%logit_3.0  area_%logit_0.0 ._%logit_0.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  most_%logit_3.0  effective_%logit_3.0  technical_%logit_1.0  training_%logit_1.0  and_%logit_1.0  the_%logit_1.0  most_%logit_0.0  appropriate_%logit_0.0  tool_%logit_1.0  to_%logit_1.0  employ_%logit_2.0  in_%logit_1.0  this_%logit_1.0  role_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  n_%logit_3.0 alt_%logit_3.0 rex_%logit_2.0 one_%logit_0.0  for_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  relapse_%logit_3.0  or_%logit_3.0  relapse_%logit_3.0  of_%logit_3.0  heroin_%logit_3.0  dependence_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  N_%logit_3.0 alt_%logit_3.0 rex_%logit_1.0 ones_%logit_0.0  for_%logit_3.0  relapse_%logit_3.0  and_%logit_3.0  relapse_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  N_%logit_3.0 ALT_%logit_3.0 rex_%logit_1.0 one_%logit_2.0  with_%logit_3.0  other_%logit_3.0  antidepressants_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  also_%logit_2.0  to_%logit_3.0  assess_%logit_3.0  its_%logit_2.0  efficacy_%logit_3.0  in_%logit_3.0  relapse_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_2.0  should_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  the_%logit_3.0  impact_%logit_3.0  on_%logit_3.0  relapse_%logit_1.0  severity_%logit_3.0  and_%logit_3.0  relapse_%logit_1.0  severity_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  relapse_%logit_3.0  severity_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  pressure_%logit_3.0  cat_%logit_3.0 he_%logit_3.0 ters_%logit_1.0  for_%logit_0.0  per_%logit_3.0 ip_%logit_3.0 art_%logit_0.0 al_%logit_0.0  infection_%logit_1.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_3.0  the_%logit_2.0  best_%logit_3.0  pressure_%logit_3.0  cat_%logit_1.0 heter_%logit_1.0  for_%logit_1.0  this_%logit_1.0  purpose_%logit_3.0 ,_%logit_0.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  different_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  pressure_%logit_1.0 -_%logit_3.0 cat_%logit_1.0 heter_%logit_1.0  administration_%logit_1.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0  randomized_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_1.0  methods_%logit_1.0  of_%logit_3.0  cat_%logit_1.0 heter_%logit_3.0  drainage_%logit_3.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  this_%logit_1.0  condition_%logit_0.0 ._%logit_1.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  the_%logit_3.0  data_%logit_0.0  are_%logit_0.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  cases_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  therefore_%logit_1.0  the_%logit_3.0  conclusions_%logit_3.0  of_%logit_3.0  this_%logit_3.0  review_%logit_0.0  are_%logit_0.0  not_%logit_2.0  necessarily_%logit_0.0  definitive_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  pro_%logit_2.0 ph_%logit_3.0 yl_%logit_2.0 actic_%logit_0.0  immun_%logit_2.0 ogl_%logit_3.0 ob_%logit_3.0 ulin_%logit_0.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  G_%logit_1.0 V_%logit_3.0 HD_%logit_2.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  immun_%logit_3.0 ogl_%logit_0.0 ub_%logit_1.0 ulin_%logit_2.0  regimen_%logit_2.0  and_%logit_0.0  to_%logit_1.0  assess_%logit_2.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  and_%logit_3.0  prevention_%logit_2.0  of_%logit_0.0  G_%logit_0.0 GV_%logit_1.0 HD_%logit_1.0 ._%logit_1.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  there_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  immun_%logit_1.0 ogl_%logit_3.0 ab_%logit_1.0 ulin_%logit_2.0  in_%logit_2.0  the_%logit_2.0  management_%logit_3.0  of_%logit_3.0  these_%logit_3.0  diseases_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  an_%logit_2.0  urgent_%logit_3.0  need_%logit_0.0  for_%logit_0.0  a_%logit_1.0  large_%logit_1.0  scale_%logit_2.0 ,_%logit_0.0  multi_%logit_0.0 -_%logit_2.0 cent_%logit_2.0 re_%logit_0.0  randomized_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  comparing_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  immun_%logit_3.0 os_%logit_1.0 upp_%logit_1.0 ressive_%logit_1.0  therapy_%logit_1.0  to_%logit_3.0  standard_%logit_1.0  therapy_%logit_3.0 ._%logit_3.0  Such_%logit_1.0  trials_%logit_0.0  should_%logit_1.0  include_%logit_2.0  a_%logit_2.0  large_%logit_2.0  number_%logit_1.0  of_%logit_0.0  patients_%logit_2.0  and_%logit_0.0  involve_%logit_2.0  a_%logit_2.0  number_%logit_1.0  of_%logit_1.0  participants_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  N_%logit_3.0 alt_%logit_3.0 rex_%logit_2.0 one_%logit_1.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  opioid_%logit_3.0  addicts_%logit_3.0 ._%logit_0.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  this_%logit_3.0  drug_%logit_3.0 ._%logit_3.0  It_%logit_2.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  this_%logit_0.0  drug_%logit_0.0  works_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  how_%logit_3.0  it_%logit_3.0  relates_%logit_3.0  to_%logit_3.0  other_%logit_3.0  psych_%logit_3.0 os_%logit_3.0 ocial_%logit_0.0  interventions_%logit_0.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_0.0  assess_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_1.0  interventions_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  nicotine_%logit_1.0  replacement_%logit_1.0  therapy_%logit_3.0 ,_%logit_3.0  antidepressants_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  other_%logit_3.0  psychological_%logit_3.0  therapies_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  determine_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  these_%logit_3.0  interventions_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  opioid_%logit_3.0  consumption_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  z_%logit_3.0 id_%logit_3.0 ov_%logit_2.0 ud_%logit_0.0 ine_%logit_0.0  as_%logit_0.0  a_%logit_3.0  mon_%logit_0.0 otherapy_%logit_0.0  for_%logit_0.0  the_%logit_0.0  treatment_%logit_3.0  of_%logit_0.0  d_%logit_1.0 ise_%logit_3.0 ase_%logit_2.0  progression_%logit_2.0  or_%logit_3.0  death_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  advanced_%logit_1.0  HIV_%logit_3.0  disease_%logit_3.0 ._%logit_3.0  However_%logit_2.0 ,_%logit_2.0  z_%logit_2.0 id_%logit_2.0 iv_%logit_1.0 ud_%logit_2.0 ine_%logit_0.0  appears_%logit_2.0  to_%logit_2.0  be_%logit_0.0  a_%logit_3.0  viable_%logit_0.0  option_%logit_0.0  for_%logit_0.0  those_%logit_2.0  patients_%logit_0.0  who_%logit_3.0  are_%logit_2.0  at_%logit_2.0  high_%logit_0.0  risk_%logit_1.0  of_%logit_1.0  death_%logit_2.0  from_%logit_3.0  this_%logit_2.0  treatment_%logit_3.0 ._%logit_0.0  Further_%logit_2.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_2.0  of_%logit_0.0  z_%logit_2.0 ir_%logit_1.0 av_%logit_1.0 ud_%logit_2.0 ine_%logit_0.0 ,_%logit_2.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_2.0  timing_%logit_1.0 ,_%logit_0.0  and_%logit_1.0  the_%logit_0.0  best_%logit_3.0  way_%logit_0.0  to_%logit_2.0  administer_%logit_0.0  it_%logit_2.0 ._%logit_3.0  It_%logit_2.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  the_%logit_3.0  data_%logit_0.0  in_%logit_0.0  this_%logit_2.0  review_%logit_2.0  are_%logit_0.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_0.0  number_%logit_3.0  of_%logit_0.0  patients_%logit_3.0 ,_%logit_0.0  and_%logit_2.0  therefore_%logit_1.0  the_%logit_2.0  conclusions_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  may_%logit_2.0  not_%logit_2.0  necessarily_%logit_3.0  apply_%logit_3.0  to_%logit_3.0  all_%logit_2.0  patients_%logit_2.0 ,_%logit_3.0  or_%logit_2.0  to_%logit_2.0  those_%logit_2.0  patients_%logit_2.0  with_%logit_3.0  severe_%logit_2.0  disease_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  isot_%logit_3.0 ret_%logit_0.0 ino_%logit_0.0 in_%logit_1.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  cervical_%logit_3.0  carcin_%logit_3.0 oma_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  isot_%logit_3.0 ret_%logit_2.0 o_%logit_2.0 in_%logit_2.0  concentration_%logit_0.0 ,_%logit_2.0  duration_%logit_2.0  of_%logit_3.0  therapy_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  the_%logit_3.0  optimal_%logit_3.0  dose_%logit_0.0 ._%logit_2.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  long_%logit_2.0 -_%logit_3.0 term_%logit_3.0  outcomes_%logit_1.0 ,_%logit_3.0  including_%logit_1.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  to_%logit_3.0  evaluate_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  other_%logit_1.0  aspects_%logit_3.0  of_%logit_3.0  life_%logit_1.0  and_%logit_3.0  health_%logit_3.0 -_%logit_3.0 related_%logit_3.0  quality_%logit_0.0 -_%logit_3.0 of_%logit_3.0 -_%logit_0.0 life_%logit_0.0 ,_%logit_0.0  including_%logit_0.0  the_%logit_0.0  occurrence_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  magnesium_%logit_3.0  supplementation_%logit_1.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  e_%logit_1.0 cl_%logit_3.0 amps_%logit_3.0 ia_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_0.0  duration_%logit_1.0  and_%logit_1.0  timing_%logit_1.0  of_%logit_3.0  supplementation_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  magnesium_%logit_2.0  supplementation_%logit_3.0  with_%logit_3.0  other_%logit_3.0  supplements_%logit_3.0 ,_%logit_3.0  especially_%logit_1.0  magnesium_%logit_3.0  supplements_%logit_3.0 ,_%logit_3.0  in_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  E_%logit_3.0 CL_%logit_3.0 amps_%logit_1.0 ia_%logit_1.0  in_%logit_1.0  women_%logit_1.0  with_%logit_3.0  pre_%logit_1.0 -_%logit_3.0 existing_%logit_1.0  hypertension_%logit_1.0  or_%logit_3.0  pre_%logit_3.0 -_%logit_3.0 men_%logit_0.0 opausal_%logit_1.0  conditions_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  long_%logit_1.0 -_%logit_1.0 term_%logit_3.0  data_%logit_1.0  are_%logit_3.0  needed_%logit_2.0  to_%logit_2.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  magnesium_%logit_0.0  supplements_%logit_3.0  and_%logit_3.0  to_%logit_1.0  determine_%logit_3.0  whether_%logit_2.0  magnesium_%logit_3.0  supplementation_%logit_3.0  is_%logit_3.0  beneficial_%logit_3.0  or_%logit_3.0  harmful_%logit_3.0  for_%logit_0.0  the_%logit_3.0  prevention_%logit_3.0  and_%logit_3.0  management_%logit_3.0  of_%logit_0.0  recurrent_%logit_3.0  E_%logit_3.0 CL_%logit_3.0 AMP_%logit_1.0 IA_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  gluc_%logit_3.0 oc_%logit_3.0 ort_%logit_3.0 ic_%logit_2.0 oids_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  acute_%logit_3.0  bron_%logit_3.0 ch_%logit_3.0 ocon_%logit_1.0 st_%logit_1.0 riction_%logit_1.0  in_%logit_1.0  patients_%logit_1.0  with_%logit_3.0  asthma_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  confirm_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  reducing_%logit_2.0  the_%logit_3.0  incidence_%logit_3.0  of_%logit_3.0  asthma_%logit_3.0 -_%logit_3.0 related_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  determine_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_2.0  gluc_%logit_1.0 oco_%logit_3.0 ort_%logit_3.0 ic_%logit_2.0 oid_%logit_2.0  therapy_%logit_0.0  in_%logit_2.0  these_%logit_2.0  patients_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_2.0 term_%logit_2.0  data_%logit_2.0  are_%logit_2.0  required_%logit_2.0  to_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  gluc_%logit_3.0 os_%logit_3.0 ort_%logit_3.0 ic_%logit_3.0 oster_%logit_2.0 oids_%logit_3.0  in_%logit_2.0  this_%logit_1.0  patient_%logit_3.0  population_%logit_2.0 ,_%logit_2.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  their_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_2.0  management_%logit_3.0  of_%logit_3.0  asthma_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  pro_%logit_3.0 ph_%logit_3.0 yl_%logit_2.0 actic_%logit_2.0  chem_%logit_0.0 op_%logit_3.0 roph_%logit_1.0 yl_%logit_1.0 actic_%logit_0.0  chemotherapy_%logit_2.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  cancer_%logit_3.0 -_%logit_3.0 specific_%logit_3.0  survival_%logit_1.0 ._%logit_0.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  in_%logit_2.0  this_%logit_2.0  area_%logit_0.0 ._%logit_0.0  The_%logit_2.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  are_%logit_2.0  based_%logit_2.0  on_%logit_0.0  a_%logit_3.0  small_%logit_0.0  number_%logit_3.0  of_%logit_0.0  patients_%logit_0.0 ,_%logit_0.0  all_%logit_2.0  of_%logit_3.0  whom_%logit_3.0  are_%logit_0.0  undergoing_%logit_2.0  chemotherapy_%logit_1.0  for_%logit_3.0  cancer_%logit_3.0 -_%logit_3.0 related_%logit_3.0  survival_%logit_2.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_2.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_0.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  chemotherapy_%logit_1.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_0.0  the_%logit_2.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_0.0  chemotherapy_%logit_1.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_0.0  evaluate_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  pro_%logit_1.0 -_%logit_1.0 ph_%logit_2.0 yl_%logit_1.0 axis_%logit_2.0  in_%logit_2.0  cancer_%logit_3.0 -_%logit_3.0 associated_%logit_2.0  survival_%logit_2.0 ,_%logit_3.0  a_%logit_3.0  meta_%logit_0.0 -_%logit_2.0 analysis_%logit_0.0  is_%logit_0.0  needed_%logit_2.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  o_%logit_3.0 lan_%logit_3.0 z_%logit_3.0 ap_%logit_0.0 ine_%logit_1.0  for_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  P_%logit_3.0 AN_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_3.0  its_%logit_2.0  role_%logit_3.0  in_%logit_3.0  the_%logit_2.0  management_%logit_3.0  of_%logit_3.0  weight_%logit_3.0  gain_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  schizophrenia_%logit_1.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_3.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  number_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  treat_%logit_0.0  patients_%logit_2.0  with_%logit_3.0  schizophrenia_%logit_1.0  to_%logit_3.0  prevent_%logit_3.0  them_%logit_0.0  from_%logit_3.0  relapse_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  evaluate_%logit_3.0  its_%logit_2.0  efficacy_%logit_3.0  in_%logit_3.0  the_%logit_3.0  long_%logit_3.0  term_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  an_%logit_2.0  urgent_%logit_3.0  need_%logit_3.0  for_%logit_0.0  further_%logit_1.0  research_%logit_1.0  into_%logit_3.0  the_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  this_%logit_3.0  drug_%logit_3.0  in_%logit_3.0  patients_%logit_2.0  with_%logit_3.0  severe_%logit_1.0  schizophrenia_%logit_3.0 ._%logit_3.0
 Tele_%logit_0.0 phone_%logit_1.0  bill_%logit_1.0 ings_%logit_3.0  are_%logit_0.0  effective_%logit_1.0  in_%logit_3.0  reducing_%logit_3.0  telephone_%logit_3.0  bill_%logit_3.0 ings_%logit_0.0  and_%logit_0.0  reducing_%logit_0.0  the_%logit_3.0  number_%logit_3.0  of_%logit_3.0  calls_%logit_0.0  made_%logit_0.0  by_%logit_1.0  telephone_%logit_0.0  call_%logit_0.0 ers_%logit_0.0 ._%logit_0.0  However_%logit_0.0 ,_%logit_0.0  there_%logit_1.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_1.0  of_%logit_1.0  bill_%logit_1.0 ings_%logit_1.0  as_%logit_0.0  a_%logit_3.0  substitute_%logit_1.0  for_%logit_0.0  phone_%logit_0.0  calls_%logit_1.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_0.0  reducing_%logit_3.0  phone_%logit_3.0  bill_%logit_3.0 ings_%logit_0.0  or_%logit_0.0  reducing_%logit_3.0  calls_%logit_3.0  missed_%logit_3.0  by_%logit_3.0  call_%logit_3.0 ers_%logit_3.0  or_%logit_2.0  others_%logit_2.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  bill_%logit_1.0 ing_%logit_1.0  and_%logit_3.0  phone_%logit_3.0  calls_%logit_1.0  as_%logit_3.0  alternatives_%logit_1.0  to_%logit_1.0  phone_%logit_0.0  calls_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  bill_%logit_3.0 ings_%logit_3.0  with_%logit_3.0  other_%logit_3.0  forms_%logit_3.0  of_%logit_3.0  telephone_%logit_1.0  bills_%logit_3.0  and_%logit_3.0  telephone_%logit_3.0  calls_%logit_3.0 ._%logit_3.0
 Pro_%logit_0.0 ph_%logit_0.0 yl_%logit_2.0 actic_%logit_2.0  antibiotic_%logit_0.0  therapy_%logit_3.0  with_%logit_3.0  c_%logit_1.0 ip_%logit_3.0 ro_%logit_0.0 fl_%logit_1.0 ox_%logit_0.0 ac_%logit_0.0 in_%logit_2.0  is_%logit_0.0  associated_%logit_3.0  with_%logit_0.0  a_%logit_3.0  significant_%logit_3.0  reduction_%logit_3.0  in_%logit_0.0  mortality_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  the_%logit_0.0  incidence_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ,_%logit_3.0  including_%logit_2.0  diarr_%logit_3.0 hoe_%logit_3.0 a_%logit_1.0 ,_%logit_1.0  in_%logit_3.0  patients_%logit_1.0  with_%logit_0.0  uncom_%logit_1.0 pl_%logit_3.0 icated_%logit_2.0  bacterial_%logit_1.0  per_%logit_0.0 iton_%logit_0.0 itis_%logit_0.0  who_%logit_0.0  are_%logit_2.0  receiving_%logit_2.0  antibiotic_%logit_3.0  therapy_%logit_3.0 ._%logit_3.0  The_%logit_3.0  risk_%logit_0.0 -_%logit_3.0 benefit_%logit_1.0  ratio_%logit_0.0  of_%logit_0.0  antibiotic_%logit_1.0  therapy_%logit_3.0  is_%logit_2.0  low_%logit_3.0 ,_%logit_1.0  but_%logit_2.0  the_%logit_3.0  number_%logit_3.0  of_%logit_3.0  cases_%logit_3.0  of_%logit_0.0  adverse_%logit_0.0  effects_%logit_3.0  is_%logit_3.0  very_%logit_3.0  low_%logit_1.0 ,_%logit_1.0  and_%logit_2.0  there_%logit_2.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0 ._%logit_2.0  It_%logit_3.0  is_%logit_0.0  unlikely_%logit_2.0  that_%logit_2.0  antibiotic_%logit_3.0  therapy_%logit_0.0  will_%logit_2.0  result_%logit_1.0  in_%logit_2.0  any_%logit_1.0  significant_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  mortality_%logit_3.0  or_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  receiving_%logit_0.0  antibiotic_%logit_3.0  treatment_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  phen_%logit_3.0 y_%logit_3.0 to_%logit_3.0 in_%logit_2.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  g_%logit_1.0 ing_%logit_3.0 ival_%logit_0.0  over_%logit_0.0 -_%logit_3.0 growth_%logit_3.0 ._%logit_3.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  random_%logit_0.0 ised_%logit_0.0  controlled_%logit_0.0  trials_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  this_%logit_3.0  treatment_%logit_1.0 ._%logit_3.0  Such_%logit_1.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  sufficient_%logit_0.0  size_%logit_2.0  to_%logit_0.0  detect_%logit_2.0  clinically_%logit_2.0  important_%logit_3.0  differences_%logit_1.0  in_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  between_%logit_0.0  the_%logit_3.0  two_%logit_1.0  treatments_%logit_1.0 ._%logit_3.0  They_%logit_2.0  should_%logit_0.0  also_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_3.0  treatments_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_1.0  calcium_%logit_1.0  channel_%logit_1.0  blockers_%logit_3.0 ,_%logit_3.0  magnesium_%logit_2.0  sulph_%logit_3.0 ate_%logit_3.0  and_%logit_2.0  calcium_%logit_3.0  channel_%logit_3.0  blocker_%logit_3.0  blockers_%logit_2.0 ,_%logit_2.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  treatments_%logit_3.0  on_%logit_3.0  bone_%logit_2.0  mineral_%logit_3.0  content_%logit_3.0  and_%logit_3.0  bone_%logit_3.0  mineral_%logit_3.0  density_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  intraven_%logit_1.0 ous_%logit_3.0  immun_%logit_0.0 ogl_%logit_3.0 ob_%logit_3.0 ul_%logit_0.0 ins_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  malaria_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  this_%logit_1.0  therapy_%logit_1.0  in_%logit_1.0  reducing_%logit_1.0  mortality_%logit_0.0  and_%logit_0.0  morbid_%logit_3.0 ity_%logit_0.0  in_%logit_3.0  patients_%logit_1.0  with_%logit_0.0  severe_%logit_1.0  malaria_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  treatment_%logit_3.0  with_%logit_2.0  other_%logit_1.0  treatments_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  administration_%logit_1.0 ,_%logit_1.0  the_%logit_1.0  optimal_%logit_2.0  dosage_%logit_3.0  and_%logit_2.0  timing_%logit_1.0  of_%logit_0.0  administration_%logit_1.0  and_%logit_3.0  the_%logit_1.0  best_%logit_0.0  way_%logit_0.0  to_%logit_0.0  administer_%logit_0.0  it_%logit_2.0 ,_%logit_3.0  and_%logit_2.0  the_%logit_2.0  most_%logit_3.0  effective_%logit_3.0  way_%logit_3.0  to_%logit_2.0  deliver_%logit_1.0  it_%logit_2.0  to_%logit_0.0  patients_%logit_2.0  in_%logit_0.0  severe_%logit_1.0  malaria_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_3.0  workplace_%logit_3.0  erg_%logit_3.0 onomic_%logit_1.0  interventions_%logit_1.0  for_%logit_1.0  improving_%logit_1.0  worker_%logit_3.0  satisfaction_%logit_3.0  and_%logit_3.0  productivity_%logit_3.0 ._%logit_3.0  Work_%logit_3.0 place_%logit_1.0  erg_%logit_1.0 onomic_%logit_1.0  training_%logit_1.0  may_%logit_3.0  improve_%logit_1.0  worker_%logit_3.0  satisfaction_%logit_1.0 ,_%logit_1.0  productivity_%logit_3.0  and_%logit_1.0  satisfaction_%logit_3.0  with_%logit_3.0  work_%logit_1.0 ,_%logit_3.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0 ._%logit_1.0  The_%logit_2.0  findings_%logit_0.0  of_%logit_3.0  this_%logit_2.0  review_%logit_0.0  should_%logit_2.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_1.0  caution_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  the_%logit_3.0  conclusions_%logit_1.0  are_%logit_0.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  studies_%logit_0.0 ,_%logit_0.0  with_%logit_1.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_0.0  bias_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  are_%logit_3.0  subject_%logit_3.0  to_%logit_0.0  interpretation_%logit_3.0  and_%logit_3.0  interpretation_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_1.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  these_%logit_1.0  interventions_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  them_%logit_2.0  to_%logit_3.0  other_%logit_1.0  types_%logit_1.0  of_%logit_3.0  erg_%logit_1.0 onomic_%logit_1.0  exercises_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  epid_%logit_3.0 ural_%logit_1.0  analges_%logit_1.0 ia_%logit_0.0  for_%logit_0.0  post_%logit_3.0 -_%logit_0.0 operative_%logit_0.0  complications_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  epid_%logit_1.0 ur_%logit_1.0 als_%logit_2.0  for_%logit_2.0  post_%logit_1.0 operative_%logit_0.0  complications_%logit_0.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  the_%logit_3.0  various_%logit_3.0  analges_%logit_3.0 ia_%logit_3.0  in_%logit_2.0  terms_%logit_1.0  of_%logit_3.0  pain_%logit_0.0  relief_%logit_3.0 ,_%logit_3.0  function_%logit_1.0 ,_%logit_3.0  fatigue_%logit_3.0 ,_%logit_3.0  sleep_%logit_3.0 iness_%logit_1.0 ,_%logit_1.0  fatigue_%logit_1.0  and_%logit_1.0  sleep_%logit_3.0 iness_%logit_3.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  to_%logit_0.0  evaluate_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  intra_%logit_3.0 operative_%logit_3.0  analges_%logit_1.0 ia_%logit_3.0  compared_%logit_2.0  to_%logit_1.0  epid_%logit_3.0 ural_%logit_3.0  ana_%logit_2.0 esthesia_%logit_3.0  alone_%logit_1.0  or_%logit_1.0  in_%logit_2.0  combination_%logit_1.0  with_%logit_3.0  other_%logit_3.0  analges_%logit_3.0 ia_%logit_3.0 ,_%logit_2.0  to_%logit_3.0  compare_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  epid_%logit_3.0 uran_%logit_1.0  analges_%logit_3.0 ia_%logit_3.0  versus_%logit_2.0  epid_%logit_1.0 ural_%logit_3.0  opioid_%logit_1.0  analges_%logit_1.0 ia_%logit_3.0  alone_%logit_2.0 ._%logit_1.0
 Red_%logit_0.0  blood_%logit_0.0  cell_%logit_2.0  transf_%logit_1.0 usion_%logit_3.0  does_%logit_2.0  not_%logit_3.0  appear_%logit_3.0  to_%logit_2.0  have_%logit_1.0  a_%logit_2.0  significant_%logit_3.0  effect_%logit_2.0  on_%logit_2.0  survival_%logit_2.0  or_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_3.0  advanced_%logit_1.0  cancer_%logit_3.0  receiving_%logit_0.0  chemotherapy_%logit_2.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_2.0  it_%logit_3.0  does_%logit_3.0  appear_%logit_2.0  to_%logit_2.0  reduce_%logit_3.0  the_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  death_%logit_3.0  and_%logit_3.0  the_%logit_3.0  need_%logit_3.0  for_%logit_3.0  transf_%logit_0.0 usion_%logit_3.0  in_%logit_2.0  these_%logit_3.0  patients_%logit_3.0 ._%logit_3.0  Red_%logit_2.0  blood_%logit_0.0  cells_%logit_2.0  transf_%logit_3.0 usion_%logit_2.0  is_%logit_2.0  associated_%logit_3.0  with_%logit_0.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  the_%logit_3.0  incidence_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ,_%logit_3.0  including_%logit_3.0  blood_%logit_3.0  transf_%logit_3.0 usion_%logit_3.0 -_%logit_1.0 related_%logit_3.0  deaths_%logit_0.0 ,_%logit_3.0  and_%logit_3.0  a_%logit_3.0  decrease_%logit_3.0  in_%logit_3.0  blood_%logit_3.0  transf_%logit_3.0 usions_%logit_0.0 -_%logit_2.0 related_%logit_1.0  mortality_%logit_0.0 ._%logit_3.0  Red_%logit_3.0 -_%logit_0.0 blood_%logit_2.0  transf_%logit_2.0 usion_%logit_0.0  therapy_%logit_2.0  appears_%logit_3.0  to_%logit_1.0  be_%logit_0.0  associated_%logit_3.0  with_%logit_0.0  an_%logit_3.0  increased_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  infection_%logit_1.0  and_%logit_3.0  a_%logit_3.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  transf_%logit_0.0 usion_%logit_3.0  failure_%logit_2.0 ,_%logit_2.0  but_%logit_2.0  the_%logit_3.0  exact_%logit_3.0  extent_%logit_0.0  of_%logit_2.0  this_%logit_3.0  risk_%logit_0.0  is_%logit_0.0  unclear_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  I_%logit_3.0 UD_%logit_3.0  removal_%logit_1.0  for_%logit_3.0  PID_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_0.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  this_%logit_3.0  treatment_%logit_3.0 ._%logit_1.0  Such_%logit_1.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_0.0  a_%logit_1.0  well_%logit_3.0 -_%logit_3.0 defined_%logit_1.0  group_%logit_2.0  of_%logit_0.0  patients_%logit_2.0  who_%logit_3.0  are_%logit_2.0  at_%logit_2.0  high_%logit_0.0  risk_%logit_1.0  of_%logit_1.0  PID_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  those_%logit_3.0  who_%logit_0.0  are_%logit_3.0  unable_%logit_2.0  to_%logit_0.0  tolerate_%logit_3.0  the_%logit_2.0  treatment_%logit_3.0 ._%logit_3.0  They_%logit_1.0  should_%logit_0.0  also_%logit_0.0  include_%logit_2.0  those_%logit_2.0  patients_%logit_1.0  who_%logit_3.0  do_%logit_1.0  not_%logit_2.0  have_%logit_1.0  a_%logit_1.0  history_%logit_3.0  of_%logit_3.0  PID_%logit_3.0  and_%logit_3.0  those_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  an_%logit_1.0  elevated_%logit_3.0  incidence_%logit_3.0  of_%logit_1.0  PID_%logit_1.0 ._%logit_3.0  Such_%logit_1.0  tests_%logit_0.0  should_%logit_1.0  be_%logit_2.0  carried_%logit_2.0  out_%logit_0.0  in_%logit_0.0  a_%logit_1.0  separate_%logit_0.0  setting_%logit_1.0 ,_%logit_0.0  with_%logit_2.0  appropriate_%logit_1.0  attention_%logit_1.0  to_%logit_1.0  detail_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  cort_%logit_3.0 ic_%logit_3.0 oster_%logit_0.0 oids_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  chronic_%logit_3.0  asthma_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_2.0  of_%logit_0.0  steroids_%logit_2.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_2.0  these_%logit_3.0  patients_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  a_%logit_0.0  randomized_%logit_2.0  controlled_%logit_2.0  trial_%logit_2.0  is_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  evaluate_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  these_%logit_3.0  medications_%logit_3.0  in_%logit_3.0  treating_%logit_2.0  patients_%logit_3.0  with_%logit_3.0  severe_%logit_1.0  asthma_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  assess_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  determine_%logit_0.0  whether_%logit_2.0  the_%logit_3.0  dose_%logit_3.0  is_%logit_0.0  appropriate_%logit_1.0  for_%logit_1.0  each_%logit_2.0  patient_%logit_3.0  and_%logit_0.0  their_%logit_2.0  circumstances_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  benz_%logit_3.0 od_%logit_3.0 iazep_%logit_2.0 ines_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  negative_%logit_3.0  symptoms_%logit_3.0  of_%logit_3.0  depression_%logit_3.0  or_%logit_3.0  dys_%logit_3.0 k_%logit_3.0 ines_%logit_1.0 ia_%logit_2.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_2.0  benz_%logit_1.0 ad_%logit_3.0 iazep_%logit_2.0 ines_%logit_1.0 ,_%logit_3.0  the_%logit_1.0  optimal_%logit_3.0  dosage_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  the_%logit_3.0  optimal_%logit_3.0  duration_%logit_3.0  of_%logit_3.0  treatment_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_3.0  should_%logit_0.0  focus_%logit_3.0  on_%logit_2.0  improving_%logit_3.0  the_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  of_%logit_0.0  people_%logit_3.0  with_%logit_0.0  depression_%logit_1.0  and_%logit_3.0  Dys_%logit_3.0 k_%logit_3.0 ines_%logit_1.0 ias_%logit_1.0 ,_%logit_2.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  assessing_%logit_2.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_3.0  drugs_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  antidepressants_%logit_1.0  and_%logit_3.0  antidepressants_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  any_%logit_1.0  of_%logit_1.0  the_%logit_3.0  interventions_%logit_0.0  included_%logit_0.0  in_%logit_1.0  this_%logit_1.0  review_%logit_0.0  in_%logit_0.0  terms_%logit_3.0  of_%logit_0.0  reducing_%logit_3.0  mortality_%logit_3.0  and_%logit_3.0  disability_%logit_3.0  in_%logit_3.0  hospital_%logit_3.0  wards_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  these_%logit_3.0  interventions_%logit_3.0  in_%logit_0.0  reducing_%logit_1.0  mortality_%logit_3.0 ,_%logit_3.0  disability_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_3.0  hospitals_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  them_%logit_2.0  to_%logit_3.0  each_%logit_1.0  other_%logit_3.0 ._%logit_0.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  these_%logit_0.0  interventions_%logit_0.0  are_%logit_0.0  implemented_%logit_1.0 ,_%logit_1.0  and_%logit_2.0  how_%logit_3.0  they_%logit_3.0  are_%logit_0.0  implemented_%logit_0.0  in_%logit_1.0  different_%logit_2.0  settings_%logit_0.0 ,_%logit_0.0  settings_%logit_2.0  and_%logit_1.0  settings_%logit_1.0 ._%logit_0.0
 Water_%logit_0.0  disinfect_%logit_0.0 ion_%logit_3.0  is_%logit_1.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_3.0  diarr_%logit_3.0 hoe_%logit_3.0 a_%logit_1.0  incidence_%logit_1.0  and_%logit_3.0  reducing_%logit_3.0  water_%logit_3.0  contamination_%logit_3.0  in_%logit_0.0  households_%logit_3.0 ._%logit_3.0  It_%logit_1.0  is_%logit_1.0  not_%logit_3.0  clear_%logit_3.0  whether_%logit_1.0  water_%logit_3.0  disinfect_%logit_3.0 ion_%logit_3.0  has_%logit_2.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  the_%logit_1.0  incidence_%logit_3.0  or_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  diarrhea_%logit_3.0  or_%logit_3.0  on_%logit_3.0  water_%logit_3.0  contamination_%logit_3.0 ._%logit_1.0  Water_%logit_3.0  disinfect_%logit_0.0 ions_%logit_3.0  are_%logit_1.0  effective_%logit_3.0  in_%logit_3.0  decreasing_%logit_3.0  diarr_%logit_3.0 hoe_%logit_3.0 al_%logit_1.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_3.0  households_%logit_3.0 ,_%logit_3.0  but_%logit_1.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  disinfect_%logit_1.0 ion_%logit_3.0  and_%logit_3.0  disinfect_%logit_3.0 ion_%logit_3.0  in_%logit_3.0  households_%logit_3.0  with_%logit_3.0  water_%logit_1.0  contamination_%logit_3.0 ,_%logit_2.0  and_%logit_3.0  in_%logit_3.0  households_%logit_3.0  without_%logit_3.0  water_%logit_1.0  pur_%logit_3.0 ification_%logit_3.0  or_%logit_0.0  disinfect_%logit_3.0 ion_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  for_%logit_3.0  pain_%logit_1.0  relief_%logit_0.0  in_%logit_3.0  adults_%logit_3.0  with_%logit_3.0  oste_%logit_0.0 op_%logit_3.0 or_%logit_0.0 osis_%logit_1.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  acupuncture_%logit_3.0  in_%logit_3.0  adults_%logit_1.0 ._%logit_3.0  It_%logit_2.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  acupuncture_%logit_0.0  works_%logit_0.0 ,_%logit_1.0  and_%logit_1.0  how_%logit_3.0  it_%logit_3.0  relates_%logit_3.0  to_%logit_3.0  pain_%logit_3.0  relief_%logit_3.0  and_%logit_3.0  function_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  acupuncture_%logit_3.0  with_%logit_3.0  other_%logit_3.0  types_%logit_3.0  of_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  on_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_0.0  and_%logit_0.0  satisfaction_%logit_3.0  with_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0 ,_%logit_3.0  pain_%logit_1.0  management_%logit_3.0  and_%logit_3.0  function_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  I_%logit_1.0 UD_%logit_3.0  insertion_%logit_2.0  as_%logit_1.0  an_%logit_3.0  adjunct_%logit_1.0  to_%logit_0.0  pelvic_%logit_0.0  floor_%logit_3.0  cleaning_%logit_0.0  in_%logit_3.0  preventing_%logit_3.0  accidental_%logit_0.0  vaginal_%logit_3.0  bleeding_%logit_1.0  or_%logit_0.0  accidental_%logit_3.0  vaginal_%logit_3.0  discharge_%logit_3.0  from_%logit_3.0  the_%logit_3.0  I_%logit_3.0 UD_%logit_3.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  this_%logit_3.0  intervention_%logit_1.0  as_%logit_1.0  an_%logit_1.0  adj_%logit_1.0 u_%logit_0.0 vant_%logit_1.0  treatment_%logit_0.0  for_%logit_0.0  unintentional_%logit_1.0  vaginal_%logit_3.0  discharge_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  as_%logit_3.0  a_%logit_2.0  complement_%logit_1.0  to_%logit_0.0  pelvic_%logit_0.0  floors_%logit_3.0  cleaning_%logit_0.0  in_%logit_1.0  the_%logit_1.0  management_%logit_3.0  of_%logit_3.0  accidental_%logit_1.0  vaginal_%logit_3.0  leakage_%logit_3.0  from_%logit_3.0  a_%logit_3.0  tub_%logit_3.0 al_%logit_1.0  tub_%logit_1.0 al_%logit_1.0  basin_%logit_1.0 ._%logit_1.0  Finally_%logit_0.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_1.0  should_%logit_0.0  focus_%logit_0.0  on_%logit_2.0  assessing_%logit_3.0  its_%logit_3.0  effectiveness_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  the_%logit_0.0  incidence_%logit_3.0  of_%logit_3.0  unintended_%logit_3.0  vaginal_%logit_3.0  discharge_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  on_%logit_3.0  determining_%logit_0.0  its_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  omega_%logit_3.0 -_%logit_3.0 3_%logit_3.0  fatty_%logit_0.0  acids_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  people_%logit_3.0  with_%logit_3.0  at_%logit_0.0 opic_%logit_3.0  dermat_%logit_3.0 itis_%logit_3.0 ._%logit_0.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  randomized_%logit_2.0  controlled_%logit_2.0  trials_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  omega_%logit_1.0  3_%logit_3.0  fatty_%logit_2.0  acids_%logit_0.0  on_%logit_3.0  skin_%logit_3.0  colour_%logit_3.0 ,_%logit_1.0  texture_%logit_2.0 ,_%logit_3.0  texture_%logit_0.0  and_%logit_3.0  texture_%logit_2.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_0.0  compare_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  skin_%logit_1.0  color_%logit_3.0  and_%logit_0.0  texture_%logit_2.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  an_%logit_3.0  urgent_%logit_3.0  need_%logit_3.0  for_%logit_0.0  a_%logit_1.0  standard_%logit_1.0 ised_%logit_2.0  assessment_%logit_2.0  of_%logit_0.0  the_%logit_0.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  omega_%logit_3.0  2_%logit_3.0  fatty_%logit_2.0  acids_%logit_0.0  for_%logit_3.0  dermat_%logit_1.0 itis_%logit_3.0  and_%logit_0.0  ps_%logit_3.0 or_%logit_3.0 iasis_%logit_1.0 ,_%logit_0.0  as_%logit_2.0  well_%logit_2.0  as_%logit_0.0  a_%logit_2.0  standard_%logit_3.0  assessment_%logit_2.0  of_%logit_0.0  quality_%logit_2.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  existence_%logit_1.0  of_%logit_1.0  a_%logit_3.0  positive_%logit_3.0  effect_%logit_3.0  of_%logit_1.0  media_%logit_1.0  ads_%logit_1.0  on_%logit_1.0  smoking_%logit_1.0  risk_%logit_3.0  factors_%logit_3.0  in_%logit_3.0  children_%logit_1.0  and_%logit_3.0  adolescents_%logit_2.0 ._%logit_3.0  There_%logit_1.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  into_%logit_2.0  the_%logit_1.0  effects_%logit_1.0  of_%logit_3.0  media_%logit_1.0  ad_%logit_1.0 verts_%logit_1.0  on_%logit_1.0  risk_%logit_1.0  factors_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  smoking_%logit_1.0  prevalence_%logit_3.0  and_%logit_3.0  relapse_%logit_3.0  rates_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  the_%logit_1.0  effectiveness_%logit_3.0  of_%logit_3.0  media_%logit_1.0  advertisements_%logit_1.0  in_%logit_1.0  the_%logit_1.0  prevention_%logit_0.0  of_%logit_3.0  relapse_%logit_3.0  and_%logit_3.0  relapse_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  studies_%logit_0.0  should_%logit_1.0  focus_%logit_2.0  on_%logit_2.0  identifying_%logit_3.0  the_%logit_3.0  most_%logit_3.0  effective_%logit_3.0  media_%logit_1.0  ads_%logit_1.0  and_%logit_1.0  the_%logit_1.0  most_%logit_0.0  appropriate_%logit_3.0  media_%logit_1.0  ads_%logit_1.0  for_%logit_1.0  each_%logit_1.0  type_%logit_1.0  of_%logit_1.0  media_%logit_1.0  advertisement_%logit_0.0 ._%logit_1.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  include_%logit_2.0  measures_%logit_2.0  of_%logit_1.0  relapse_%logit_1.0 ,_%logit_3.0  relapse_%logit_1.0 ,_%logit_1.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  relapse_%logit_1.0  rate_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 os_%logit_3.0 ocial_%logit_0.0  interventions_%logit_0.0  for_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  alcohol_%logit_3.0  dependence_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 otherapy_%logit_3.0  for_%logit_1.0  alcohol_%logit_1.0  dependence_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  also_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 other_%logit_3.0 ape_%logit_1.0 utic_%logit_1.0  interventions_%logit_0.0  for_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  alcoholic_%logit_2.0  dependence_%logit_3.0 ,_%logit_3.0  such_%logit_3.0  as_%logit_3.0  cocaine_%logit_3.0  or_%logit_3.0  cocaine_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  whether_%logit_2.0  psych_%logit_3.0 otherapy_%logit_3.0  is_%logit_3.0  more_%logit_3.0  effective_%logit_3.0  than_%logit_1.0  no_%logit_2.0  treatment_%logit_3.0  or_%logit_3.0  no_%logit_1.0  treatment_%logit_3.0  at_%logit_2.0  all_%logit_2.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_2.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  efficacy_%logit_3.0 ,_%logit_3.0  safety_%logit_3.0  and_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  psychological_%logit_3.0  therapies_%logit_3.0  for_%logit_3.0  alcoholism_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  on_%logit_3.0  assessing_%logit_3.0  their_%logit_3.0  effectiveness_%logit_3.0  in_%logit_3.0  reducing_%logit_3.0  alcohol_%logit_3.0  dependence_%logit_3.0  and_%logit_3.0  relapse_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_3.0  of_%logit_1.0  the_%logit_3.0  recommended_%logit_0.0  analges_%logit_3.0 ic_%logit_2.0  agents_%logit_0.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_0.0  post_%logit_1.0 operative_%logit_3.0  pain_%logit_0.0  relief_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  blood_%logit_0.0  loss_%logit_3.0 ,_%logit_0.0  reduction_%logit_3.0  in_%logit_3.0  prol_%logit_3.0 apse_%logit_3.0  rec_%logit_1.0 urrence_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  improvement_%logit_3.0  in_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  compared_%logit_0.0  to_%logit_3.0  standard_%logit_3.0  ana_%logit_3.0 esthesia_%logit_3.0 ._%logit_2.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  analges_%logit_3.0 ic_%logit_2.0  regime_%logit_2.0  and_%logit_0.0  the_%logit_1.0  optimal_%logit_0.0  dosage_%logit_0.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  analges_%logit_0.0 ia_%logit_0.0 ,_%logit_2.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_0.0  different_%logit_2.0  analges_%logit_3.0 ic_%logit_2.0  reg_%logit_2.0 imens_%logit_3.0 ._%logit_0.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_2.0  should_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_1.0  analges_%logit_3.0 ics_%logit_2.0  in_%logit_2.0  the_%logit_3.0  management_%logit_3.0  of_%logit_2.0  post_%logit_3.0 op_%logit_3.0  pain_%logit_0.0  relief_%logit_2.0  and_%logit_1.0  recovery_%logit_1.0  from_%logit_3.0  post_%logit_3.0 operative_%logit_3.0  complications_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  T_%logit_3.0 ENS_%logit_1.0  in_%logit_2.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  neck_%logit_1.0  pain_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  T_%logit_3.0 ENS_%logit_2.0  regime_%logit_1.0 ,_%logit_1.0  the_%logit_1.0  optimal_%logit_3.0  intensity_%logit_0.0  and_%logit_1.0  duration_%logit_1.0  of_%logit_0.0  T_%logit_1.0 ES_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  the_%logit_3.0  best_%logit_3.0  way_%logit_3.0  to_%logit_2.0  deliver_%logit_1.0  T_%logit_2.0 ENS_%logit_1.0  to_%logit_2.0  people_%logit_1.0  with_%logit_0.0  chronic_%logit_2.0  pain_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  evaluation_%logit_1.0  of_%logit_2.0  the_%logit_1.0  effectiveness_%logit_3.0  of_%logit_3.0  T_%logit_1.0 ens_%logit_1.0  in_%logit_1.0  chronic_%logit_1.0  pain_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  T_%logit_2.0 ENS_%logit_3.0  with_%logit_1.0  T_%logit_3.0 ENS_%logit_1.0 ,_%logit_1.0  T_%logit_3.0 ENS_%logit_2.0  and_%logit_1.0  T_%logit_1.0 ENS_%logit_1.0  for_%logit_2.0  pain_%logit_3.0  relief_%logit_3.0  and_%logit_3.0  function_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  pro_%logit_3.0 ph_%logit_3.0 yl_%logit_2.0 actic_%logit_2.0  antibiotics_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  candid_%logit_1.0 iasis_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  agents_%logit_3.0  in_%logit_3.0  terms_%logit_2.0  of_%logit_0.0  efficacy_%logit_3.0 ,_%logit_0.0  toler_%logit_3.0 ability_%logit_3.0  and_%logit_3.0  safety_%logit_1.0 ,_%logit_0.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  antibiotic_%logit_1.0  therapy_%logit_2.0  in_%logit_3.0  candid_%logit_1.0 iasis_%logit_0.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_0.0  compare_%logit_3.0  these_%logit_2.0  agents_%logit_3.0  to_%logit_3.0  each_%logit_3.0  other_%logit_3.0 ._%logit_2.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  trials_%logit_2.0  should_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  treatment_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_3.0  assess_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  antibiotic_%logit_3.0  reg_%logit_3.0 imens_%logit_3.0 ,_%logit_0.0  and_%logit_1.0  the_%logit_3.0  duration_%logit_3.0  of_%logit_3.0  treatment_%logit_1.0 ,_%logit_1.0  respectively_%logit_1.0 ._%logit_1.0
 Walking_%logit_0.0  distance_%logit_1.0  and_%logit_1.0  speed_%logit_1.0  tests_%logit_1.0  are_%logit_1.0  effective_%logit_1.0  in_%logit_0.0  improving_%logit_3.0  walking_%logit_0.0  distance_%logit_1.0  and_%logit_1.0  walking_%logit_3.0  speed_%logit_1.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  Parkinson_%logit_0.0 's_%logit_3.0  disease_%logit_0.0 ._%logit_0.0  Improvement_%logit_3.0  in_%logit_1.0  walking_%logit_3.0  distance_%logit_1.0 ,_%logit_0.0  speed_%logit_1.0  and_%logit_1.0  stride_%logit_1.0  length_%logit_1.0  were_%logit_3.0  not_%logit_1.0  significantly_%logit_3.0  different_%logit_3.0  from_%logit_3.0  decreases_%logit_2.0  in_%logit_3.0  walking_%logit_1.0  speed_%logit_1.0  or_%logit_1.0  speed_%logit_1.0 ._%logit_1.0  However_%logit_1.0 ,_%logit_1.0  the_%logit_1.0  results_%logit_1.0  are_%logit_3.0  based_%logit_2.0  on_%logit_0.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  short_%logit_1.0 -_%logit_3.0 term_%logit_1.0  studies_%logit_1.0  with_%logit_0.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  bias_%logit_0.0 ._%logit_0.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  walking_%logit_1.0  distance_%logit_1.0  tests_%logit_0.0  on_%logit_1.0  walking_%logit_1.0  speed_%logit_3.0  and_%logit_1.0  speed_%logit_3.0  and_%logit_3.0  to_%logit_1.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  treadmill_%logit_1.0  tests_%logit_1.0  in_%logit_1.0  reducing_%logit_1.0  falls_%logit_3.0  and_%logit_3.0  falling_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  CP_%logit_1.0 AP_%logit_3.0  in_%logit_1.0  the_%logit_1.0  management_%logit_3.0  of_%logit_3.0  lung_%logit_3.0  function_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  chronic_%logit_3.0  lung_%logit_3.0  disease_%logit_3.0 ._%logit_1.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_1.0  and_%logit_2.0  executed_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trials_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  this_%logit_3.0  therapy_%logit_3.0  in_%logit_0.0  these_%logit_1.0  patients_%logit_0.0 ._%logit_3.0  Such_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  high_%logit_0.0  methodological_%logit_2.0  quality_%logit_1.0 ,_%logit_1.0  with_%logit_2.0  a_%logit_2.0  focus_%logit_1.0  on_%logit_1.0  assessing_%logit_1.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  the_%logit_1.0  therapy_%logit_3.0  in_%logit_0.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  these_%logit_2.0  patients_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  on_%logit_2.0  the_%logit_0.0  long_%logit_3.0 -_%logit_3.0 term_%logit_3.0  effects_%logit_1.0  of_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0 ._%logit_0.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effect_%logit_3.0  of_%logit_3.0  the_%logit_1.0  intervention_%logit_3.0  on_%logit_3.0  lung_%logit_1.0  function_%logit_3.0  and_%logit_0.0  on_%logit_3.0  breathing_%logit_3.0  capacity_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_3.0  psych_%logit_1.0 otherapy_%logit_1.0  for_%logit_0.0  rel_%logit_1.0 apses_%logit_3.0  of_%logit_1.0  depression_%logit_1.0  or_%logit_3.0  bipolar_%logit_3.0  disorder_%logit_3.0 ._%logit_3.0  There_%logit_3.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  well_%logit_1.0 -_%logit_1.0 designed_%logit_1.0  and_%logit_2.0  executed_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trials_%logit_2.0  to_%logit_0.0  evaluate_%logit_1.0  psych_%logit_2.0 otherapy_%logit_3.0  as_%logit_0.0  an_%logit_3.0  adjunct_%logit_3.0  to_%logit_0.0  other_%logit_0.0  psych_%logit_3.0 otherapy_%logit_3.0  approaches_%logit_0.0  to_%logit_3.0  depression_%logit_1.0  and_%logit_3.0  bipolar_%logit_3.0  disorder_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  compare_%logit_3.0  psych_%logit_2.0 otherapy_%logit_3.0  with_%logit_1.0  other_%logit_3.0  psychological_%logit_3.0  therapies_%logit_3.0 ._%logit_3.0  Such_%logit_1.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  conducted_%logit_2.0  in_%logit_0.0  a_%logit_0.0  variety_%logit_3.0  of_%logit_1.0  settings_%logit_3.0 ,_%logit_3.0  with_%logit_2.0  appropriate_%logit_1.0  attention_%logit_1.0  paid_%logit_1.0  to_%logit_2.0  outcome_%logit_0.0  measures_%logit_3.0  and_%logit_3.0  time_%logit_1.0  to_%logit_0.0  relapse_%logit_1.0  and_%logit_0.0  duration_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  G_%logit_3.0 -_%logit_3.0 CS_%logit_0.0 F_%logit_0.0  as_%logit_1.0  a_%logit_3.0  pro_%logit_0.0 ph_%logit_0.0 yl_%logit_1.0 actic_%logit_0.0  agent_%logit_0.0  for_%logit_0.0  the_%logit_0.0  treatment_%logit_0.0  of_%logit_3.0  acute_%logit_1.0  neut_%logit_3.0 rop_%logit_1.0 en_%logit_1.0 ia_%logit_2.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_2.0 ,_%logit_0.0  and_%logit_0.0  duration_%logit_0.0  of_%logit_0.0  therapy_%logit_2.0 ,_%logit_2.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  best_%logit_3.0  dose_%logit_0.0  and_%logit_2.0  timing_%logit_2.0  of_%logit_0.0  therapy_%logit_2.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  agents_%logit_3.0  on_%logit_3.0  survival_%logit_2.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_0.0  life_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_0.0  this_%logit_1.0  condition_%logit_2.0 ._%logit_2.0  In_%logit_2.0  addition_%logit_0.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  evaluate_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  these_%logit_3.0  drugs_%logit_2.0  in_%logit_3.0  the_%logit_2.0  management_%logit_0.0  of_%logit_0.0  this_%logit_3.0  condition_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  also_%logit_3.0  evaluate_%logit_3.0  the_%logit_0.0  efficacy_%logit_3.0  and_%logit_3.0  toxicity_%logit_3.0  of_%logit_3.0  these_%logit_3.0  treatments_%logit_3.0  in_%logit_3.0  particular_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  testosterone_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  sexual_%logit_3.0  dysfunction_%logit_3.0  in_%logit_3.0  men_%logit_3.0  with_%logit_3.0  schizophrenia_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  identify_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  testosterone_%logit_3.0  concentration_%logit_3.0  and_%logit_2.0  duration_%logit_3.0  of_%logit_3.0  testosterone_%logit_1.0  therapy_%logit_3.0 ,_%logit_3.0  the_%logit_1.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  the_%logit_3.0  optimal_%logit_3.0  frequency_%logit_3.0  of_%logit_3.0  testosterone_%logit_1.0  injections_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  testosterone_%logit_1.0  supplementation_%logit_3.0  on_%logit_3.0  sexual_%logit_3.0  dysfunction_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  testosterone_%logit_1.0  replacement_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  preventing_%logit_1.0  deterioration_%logit_3.0  of_%logit_3.0  sexual_%logit_3.0  function_%logit_3.0  in_%logit_3.0  men_%logit_3.0  who_%logit_3.0  are_%logit_3.0  suffering_%logit_3.0  from_%logit_3.0  schizophrenia_%logit_3.0  or_%logit_3.0  bipolar_%logit_3.0  disorder_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_1.0  of_%logit_3.0  condoms_%logit_1.0  in_%logit_1.0  the_%logit_3.0  prevention_%logit_0.0  of_%logit_0.0  ST_%logit_0.0 I_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  condoms_%logit_3.0  for_%logit_3.0  ST_%logit_1.0 I_%logit_0.0  prevention_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  determine_%logit_3.0  whether_%logit_2.0  condoms_%logit_3.0  are_%logit_3.0  effective_%logit_1.0  in_%logit_0.0  preventing_%logit_3.0  ST_%logit_0.0 I_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  whether_%logit_3.0  they_%logit_3.0  are_%logit_3.0  safe_%logit_1.0  and_%logit_0.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_0.0  ST_%logit_0.0 I_%logit_0.0  incidence_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  studies_%logit_0.0  are_%logit_0.0  also_%logit_0.0  needed_%logit_1.0  to_%logit_3.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  condoms_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_0.0  contraceptive_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  cost_%logit_3.0 -_%logit_3.0 effect_%logit_3.0 iveness_%logit_0.0 ,_%logit_0.0  and_%logit_3.0  how_%logit_0.0  best_%logit_0.0  to_%logit_0.0  tailor_%logit_0.0  condoms_%logit_2.0  to_%logit_0.0  the_%logit_0.0  needs_%logit_0.0  of_%logit_0.0  the_%logit_1.0  population_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  immun_%logit_3.0 os_%logit_3.0 upp_%logit_0.0 ressive_%logit_0.0  agents_%logit_1.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_0.0  D_%logit_3.0 MD_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  immun_%logit_3.0 otherapy_%logit_1.0  in_%logit_3.0  D_%logit_3.0 MD_%logit_0.0  and_%logit_2.0  to_%logit_1.0  assess_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_3.0  efficacy_%logit_0.0  of_%logit_3.0  these_%logit_3.0  agents_%logit_3.0 ._%logit_0.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  efficacy_%logit_0.0  and_%logit_3.0  safety_%logit_1.0  profiles_%logit_3.0  of_%logit_3.0  these_%logit_1.0  treatments_%logit_0.0 ._%logit_3.0  Finally_%logit_2.0  there_%logit_0.0  is_%logit_0.0  an_%logit_2.0  issue_%logit_1.0  of_%logit_0.0  the_%logit_1.0  quality_%logit_3.0  of_%logit_3.0  the_%logit_3.0  evidence_%logit_0.0  and_%logit_0.0  the_%logit_2.0  reliability_%logit_3.0  of_%logit_3.0  the_%logit_3.0  results_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  nit_%logit_3.0 ric_%logit_3.0  oxide_%logit_1.0  as_%logit_3.0  an_%logit_0.0  adjunct_%logit_0.0  to_%logit_0.0  standard_%logit_0.0  oxygen_%logit_1.0  therapy_%logit_1.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  acute_%logit_1.0  respiratory_%logit_3.0  distress_%logit_3.0  syndrome_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_0.0  duration_%logit_2.0  of_%logit_0.0  Nit_%logit_2.0 ric_%logit_1.0  oxide_%logit_3.0  therapy_%logit_1.0  in_%logit_1.0  these_%logit_1.0  patients_%logit_0.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  this_%logit_3.0  therapy_%logit_3.0  with_%logit_1.0  standard_%logit_1.0  oxygen_%logit_3.0 ._%logit_1.0  Finally_%logit_2.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_2.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_2.0  management_%logit_0.0  of_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  severe_%logit_1.0  A_%logit_1.0 HR_%logit_3.0 F_%logit_1.0 ,_%logit_1.0  future_%logit_3.0  research_%logit_2.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  identifying_%logit_3.0  the_%logit_3.0  most_%logit_3.0  effective_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  timing_%logit_1.0  of_%logit_1.0  administration_%logit_1.0 ,_%logit_1.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  best_%logit_3.0  dose_%logit_3.0 ,_%logit_3.0  duration_%logit_1.0  and_%logit_1.0  duration_%logit_1.0 ._%logit_3.0
 Screen_%logit_0.0 ing_%logit_0.0  mamm_%logit_0.0 ography_%logit_0.0  for_%logit_0.0  breast_%logit_1.0  cancer_%logit_0.0  is_%logit_0.0  associated_%logit_0.0  with_%logit_0.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  the_%logit_0.0  incidence_%logit_0.0  of_%logit_3.0  death_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  the_%logit_1.0  rate_%logit_3.0  of_%logit_0.0  metast_%logit_1.0 atic_%logit_3.0  breast_%logit_0.0  cancer_%logit_3.0 ._%logit_0.0  Screen_%logit_3.0 ing_%logit_0.0  for_%logit_2.0  breast_%logit_0.0  cancers_%logit_3.0  for_%logit_3.0  breast_%logit_1.0  screening_%logit_3.0  for_%logit_0.0  breast_%logit_3.0  reconstruction_%logit_1.0  appears_%logit_0.0  to_%logit_3.0  have_%logit_1.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  survival_%logit_2.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_0.0  life_%logit_3.0 ._%logit_0.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  to_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  screening_%logit_1.0  on_%logit_0.0  survival_%logit_3.0 ,_%logit_3.0  quality_%logit_3.0  and_%logit_3.0  time_%logit_3.0  to_%logit_3.0  progression_%logit_0.0  and_%logit_0.0  to_%logit_3.0  compare_%logit_3.0  screening_%logit_2.0  with_%logit_3.0  other_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  screening_%logit_1.0 ,_%logit_0.0  including_%logit_3.0  mamm_%logit_3.0 ography_%logit_1.0  in_%logit_2.0  terms_%logit_3.0  of_%logit_3.0  time_%logit_3.0  to_%logit_3.0  death_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  screening_%logit_1.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  breast_%logit_2.0  cancer_%logit_3.0  mortality_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  cognitive_%logit_3.0  enh_%logit_3.0 ancers_%logit_3.0  in_%logit_1.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_0.0  cognitive_%logit_3.0  impairment_%logit_3.0  in_%logit_3.0  Alzheimer_%logit_3.0 �_%logit_3.0 �_%logit_0.0 s_%logit_3.0  dement_%logit_3.0 ed_%logit_0.0  patients_%logit_3.0  with_%logit_3.0  dementia_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  enh_%logit_3.0 ancers_%logit_1.0  are_%logit_1.0  beneficial_%logit_1.0  or_%logit_0.0  harmful_%logit_3.0  in_%logit_0.0  this_%logit_3.0  patient_%logit_3.0  population_%logit_3.0 ,_%logit_2.0  and_%logit_2.0  whether_%logit_3.0  they_%logit_3.0  are_%logit_3.0  useful_%logit_1.0  in_%logit_0.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  cognitive_%logit_3.0  impair_%logit_3.0 ments_%logit_3.0  in_%logit_1.0  dementia_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  whether_%logit_3.0  enh_%logit_3.0 ancer_%logit_3.0  therapy_%logit_2.0  is_%logit_3.0  beneficial_%logit_1.0  in_%logit_0.0  reducing_%logit_2.0  cognitive_%logit_3.0  impairment_%logit_3.0  or_%logit_3.0  dementia_%logit_3.0 -_%logit_3.0 like_%logit_3.0  symptoms_%logit_3.0  in_%logit_3.0  these_%logit_3.0  patients_%logit_3.0 ._%logit_3.0  The_%logit_2.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  should_%logit_2.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_0.0  caution_%logit_1.0 ,_%logit_3.0  as_%logit_2.0  the_%logit_2.0  conclusions_%logit_0.0  of_%logit_0.0  the_%logit_2.0  review_%logit_0.0  are_%logit_0.0  based_%logit_2.0  on_%logit_0.0  only_%logit_0.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_3.0  patients_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  the_%logit_3.0  results_%logit_3.0  of_%logit_0.0  the_%logit_2.0  two_%logit_0.0  included_%logit_0.0  studies_%logit_0.0  were_%logit_0.0  not_%logit_2.0  representative_%logit_0.0  of_%logit_1.0  the_%logit_3.0  whole_%logit_3.0  range_%logit_3.0  of_%logit_3.0  dementia_%logit_3.0  types_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 roc_%logit_3.0 ort_%logit_3.0 is_%logit_3.0 one_%logit_2.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  hypot_%logit_1.0 ension_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  undergoing_%logit_0.0  elect_%logit_1.0 ive_%logit_3.0  surgery_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  hyd_%logit_3.0 roc_%logit_1.0 ORT_%logit_3.0 is_%logit_1.0 one_%logit_1.0  formulation_%logit_3.0 ,_%logit_1.0  the_%logit_1.0  optimal_%logit_3.0  dose_%logit_0.0 ,_%logit_3.0  and_%logit_1.0  the_%logit_1.0  optimal_%logit_3.0  dosage_%logit_0.0  and_%logit_3.0  timing_%logit_1.0  of_%logit_0.0  electroly_%logit_1.0 te_%logit_1.0  administration_%logit_3.0 ._%logit_3.0  In_%logit_3.0  addition_%logit_0.0 ,_%logit_0.0  further_%logit_0.0  research_%logit_0.0  is_%logit_0.0  also_%logit_1.0  needed_%logit_1.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  hyd_%logit_1.0 oc_%logit_3.0 ort_%logit_3.0 is_%logit_0.0 ones_%logit_1.0  in_%logit_3.0  reducing_%logit_3.0  blood_%logit_3.0  loss_%logit_3.0  and_%logit_3.0  blood_%logit_3.0  loss_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  hypot_%logit_1.0 ension_%logit_1.0  during_%logit_3.0  elect_%logit_3.0 ive_%logit_3.0  surgeries_%logit_1.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  assess_%logit_3.0  their_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  mortality_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_3.0  self_%logit_1.0 -_%logit_1.0 eval_%logit_1.0 uation_%logit_1.0  tools_%logit_1.0  for_%logit_1.0  enhancing_%logit_1.0  partner_%logit_3.0 -_%logit_3.0 selection_%logit_3.0  behaviour_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  tools_%logit_3.0  to_%logit_3.0  improve_%logit_2.0  self_%logit_1.0 -_%logit_1.0 effic_%logit_1.0 acy_%logit_1.0  in_%logit_2.0  partner_%logit_3.0  selection_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_1.0  types_%logit_1.0  of_%logit_1.0  self_%logit_1.0  assessment_%logit_1.0  tools_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  also_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  their_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_1.0  context_%logit_3.0  of_%logit_3.0  a_%logit_1.0  variety_%logit_1.0  of_%logit_1.0  contexts_%logit_3.0 ,_%logit_3.0  settings_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  contexts_%logit_1.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  self_%logit_1.0  assessments_%logit_1.0  and_%logit_1.0  assessing_%logit_1.0  the_%logit_3.0  effectiveness_%logit_3.0 ,_%logit_3.0  reliability_%logit_1.0 ,_%logit_3.0  reliability_%logit_0.0  and_%logit_3.0  durability_%logit_3.0  of_%logit_3.0  self_%logit_3.0  appraisal_%logit_1.0  tools_%logit_1.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_1.0  as_%logit_0.0  assessing_%logit_2.0  their_%logit_0.0  effectiveness_%logit_3.0 ._%logit_3.0
 Immun_%logit_0.0 ogen_%logit_0.0 icity_%logit_0.0  and_%logit_3.0  immun_%logit_3.0 ogen_%logit_3.0 icity_%logit_3.0  are_%logit_3.0  similar_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_0.0  the_%logit_0.0  risk_%logit_1.0  of_%logit_3.0  toxicity_%logit_1.0  is_%logit_3.0  higher_%logit_3.0  in_%logit_1.0  those_%logit_2.0  receiving_%logit_3.0  an_%logit_3.0  immun_%logit_3.0 ogen_%logit_0.0 etic_%logit_0.0  antibody_%logit_2.0 ,_%logit_0.0  and_%logit_2.0  in_%logit_2.0  those_%logit_3.0  who_%logit_3.0  are_%logit_2.0  receiving_%logit_2.0  an_%logit_1.0  adj_%logit_3.0 u_%logit_0.0 vant_%logit_2.0  vaccine_%logit_0.0 ._%logit_2.0  The_%logit_2.0  risk_%logit_0.0  of_%logit_3.0  adverse_%logit_1.0  events_%logit_3.0  is_%logit_3.0  lower_%logit_3.0  with_%logit_3.0  an_%logit_2.0  EL_%logit_2.0 ISA_%logit_2.0  antibody_%logit_0.0 ,_%logit_2.0  but_%logit_2.0  the_%logit_2.0  number_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  treat_%logit_0.0  is_%logit_0.0  much_%logit_3.0  higher_%logit_1.0  with_%logit_1.0  a_%logit_2.0  EL_%logit_2.0 ISA_%logit_2.0  vaccine_%logit_0.0 ._%logit_2.0  There_%logit_2.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  randomized_%logit_2.0  controlled_%logit_2.0  trials_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  toxicity_%logit_3.0  of_%logit_3.0  EL_%logit_3.0 ISA_%logit_0.0  vaccines_%logit_1.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_2.0  compare_%logit_0.0  EL_%logit_2.0 ISA_%logit_3.0  with_%logit_2.0  EL_%logit_3.0 ISA_%logit_2.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  p_%logit_3.0 ali_%logit_3.0 per_%logit_2.0 id_%logit_2.0 one_%logit_2.0  pal_%logit_0.0 mit_%logit_3.0 ate_%logit_2.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  time_%logit_3.0 -_%logit_3.0 to_%logit_1.0 -_%logit_1.0 rel_%logit_0.0 apse_%logit_0.0  in_%logit_2.0  people_%logit_3.0  with_%logit_3.0  schizophrenia_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  p_%logit_1.0 ili_%logit_3.0 per_%logit_0.0 id_%logit_2.0 ones_%logit_2.0 ,_%logit_1.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_3.0  timing_%logit_1.0  of_%logit_3.0  administration_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  the_%logit_3.0  optimal_%logit_3.0  timing_%logit_0.0  of_%logit_3.0  discontin_%logit_1.0 uation_%logit_3.0 ._%logit_1.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  the_%logit_3.0  long_%logit_3.0 -_%logit_3.0 term_%logit_3.0  efficacy_%logit_1.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  on_%logit_2.0  the_%logit_3.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  they_%logit_3.0  are_%logit_3.0  used_%logit_0.0  in_%logit_0.0  the_%logit_3.0  management_%logit_3.0  of_%logit_0.0  relapse_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  orth_%logit_3.0 op_%logit_3.0 aed_%logit_2.0 ic_%logit_0.0  braces_%logit_0.0  for_%logit_3.0  skeletal_%logit_3.0  deform_%logit_3.0 ity_%logit_3.0  in_%logit_1.0  adults_%logit_3.0  with_%logit_3.0  mal_%logit_3.0 oc_%logit_0.0 clusion_%logit_0.0  of_%logit_2.0  the_%logit_3.0  upper_%logit_3.0  inc_%logit_1.0 is_%logit_1.0 ors_%logit_2.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  these_%logit_3.0  braces_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  devices_%logit_3.0  to_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  braces_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  these_%logit_2.0  to_%logit_3.0  each_%logit_3.0  other_%logit_3.0  in_%logit_1.0  terms_%logit_2.0  of_%logit_3.0  deform_%logit_3.0 ity_%logit_3.0  and_%logit_3.0  bone_%logit_3.0  deform_%logit_3.0 ity_%logit_3.0 ._%logit_1.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_1.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  the_%logit_3.0  evaluation_%logit_3.0  of_%logit_3.0  structural_%logit_3.0  deform_%logit_3.0 ity_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  on_%logit_3.0  determining_%logit_3.0  the_%logit_3.0  optimal_%logit_3.0  type_%logit_3.0  and_%logit_1.0  duration_%logit_1.0  of_%logit_0.0  treatment_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_1.0  on_%logit_3.0  the_%logit_3.0  optimal_%logit_3.0  length_%logit_3.0  of_%logit_3.0  treatment_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_1.0  of_%logit_3.0  soft_%logit_3.0  tissue_%logit_3.0  as_%logit_3.0  a_%logit_1.0  substitute_%logit_0.0  for_%logit_3.0  soft_%logit_0.0  tissue_%logit_1.0  for_%logit_1.0  soft_%logit_3.0  tissues_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  Im_%logit_1.0 plant_%logit_3.0  deform_%logit_3.0 ity_%logit_1.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_3.0  whether_%logit_2.0  soft_%logit_3.0  tissue_%logit_1.0  is_%logit_3.0  superior_%logit_1.0  to_%logit_3.0  soft_%logit_3.0  tissue_%logit_1.0  in_%logit_3.0  terms_%logit_1.0  of_%logit_3.0  bone_%logit_3.0  loss_%logit_3.0 ,_%logit_1.0  bone_%logit_3.0  regeneration_%logit_3.0  and_%logit_3.0  bone_%logit_3.0  regeneration_%logit_3.0 ,_%logit_3.0  bone_%logit_3.0  thickness_%logit_3.0 ,_%logit_3.0  bone_%logit_3.0  density_%logit_3.0 ,_%logit_3.0  bone_%logit_3.0  integrity_%logit_3.0  and_%logit_3.0  bone_%logit_3.0  density_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_1.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  soft_%logit_1.0  tissue_%logit_3.0  soft_%logit_1.0  tissues_%logit_1.0  as_%logit_3.0  a_%logit_1.0  replacement_%logit_1.0  for_%logit_0.0  rigid_%logit_0.0  tissue_%logit_1.0  soft_%logit_3.0  tissue_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  dietary_%logit_1.0  fibre_%logit_1.0  supplements_%logit_3.0  in_%logit_1.0  the_%logit_3.0  management_%logit_0.0  of_%logit_0.0  weight_%logit_1.0  loss_%logit_3.0  in_%logit_3.0  overweight_%logit_3.0  or_%logit_3.0  obese_%logit_3.0  individuals_%logit_3.0  with_%logit_3.0  diabetes_%logit_1.0  mell_%logit_3.0 itus_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  fibre_%logit_1.0  supplements_%logit_1.0  for_%logit_3.0  weight_%logit_1.0  loss_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  fiber_%logit_1.0  supplements_%logit_3.0  on_%logit_3.0  health_%logit_1.0 -_%logit_3.0 related_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  physical_%logit_3.0  fitness_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_1.0 term_%logit_3.0  data_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_3.0  determine_%logit_2.0  whether_%logit_2.0  fibre_%logit_3.0  supplements_%logit_1.0  are_%logit_3.0  beneficial_%logit_1.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_1.0  overweight_%logit_3.0  or_%logit_1.0  obesity_%logit_3.0  in_%logit_1.0  obese_%logit_3.0  patients_%logit_1.0  with_%logit_3.0  a_%logit_1.0  history_%logit_3.0  of_%logit_3.0  cardiovascular_%logit_3.0  disease_%logit_3.0 ._%logit_3.0
 Cognitive_%logit_0.0  training_%logit_1.0  may_%logit_1.0  improve_%logit_1.0  cognitive_%logit_3.0  performance_%logit_1.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  MS_%logit_3.0 ._%logit_0.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_3.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  its_%logit_0.0  use_%logit_1.0  as_%logit_3.0  an_%logit_2.0  adjunct_%logit_1.0  to_%logit_0.0  other_%logit_0.0  cognitive_%logit_3.0  training_%logit_3.0  programmes_%logit_3.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  cognitive_%logit_1.0  training_%logit_1.0  on_%logit_3.0  performance_%logit_1.0 ,_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  fatigue_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  cognitive_%logit_2.0  training_%logit_3.0  with_%logit_3.0  other_%logit_3.0  training_%logit_3.0  programmes_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  fatigue_%logit_3.0 ,_%logit_3.0  fatigue_%logit_3.0 ,_%logit_3.0  mood_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  cognitive_%logit_3.0  functioning_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  effects_%logit_3.0  on_%logit_3.0  fatigue_%logit_1.0  and_%logit_3.0  cognitive_%logit_3.0  function_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  on_%logit_3.0  assessing_%logit_3.0  fatigue_%logit_3.0  and_%logit_3.0  mood_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_1.0  as_%logit_0.0  on_%logit_1.0  fatigue_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_1.0  physical_%logit_1.0  fitness_%logit_1.0  training_%logit_1.0  for_%logit_1.0  developing_%logit_1.0  self_%logit_0.0 -_%logit_3.0 esteem_%logit_1.0  or_%logit_1.0  self_%logit_3.0 -_%logit_3.0 confidence_%logit_0.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  these_%logit_3.0  exercises_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  training_%logit_1.0  on_%logit_1.0  self_%logit_1.0  esteem_%logit_1.0  and_%logit_1.0  self_%logit_1.0  confidence_%logit_1.0 ._%logit_1.0  Future_%logit_1.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  measuring_%logit_3.0  self_%logit_1.0  esteem_%logit_3.0 ,_%logit_1.0  self_%logit_1.0  confidence_%logit_3.0  and_%logit_1.0  self_%logit_1.0  esteem_%logit_3.0  in_%logit_1.0  children_%logit_3.0  and_%logit_0.0  adolescents_%logit_1.0 ,_%logit_0.0  as_%logit_1.0  well_%logit_1.0  as_%logit_0.0  on_%logit_2.0  assessing_%logit_0.0  psychological_%logit_3.0  fitness_%logit_3.0  and_%logit_3.0  self_%logit_1.0 -_%logit_3.0 effic_%logit_1.0 acy_%logit_1.0  in_%logit_1.0  adults_%logit_3.0  and_%logit_1.0  children_%logit_1.0  with_%logit_1.0  developmental_%logit_1.0  disabilities_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  anti_%logit_3.0 plate_%logit_3.0 let_%logit_3.0  agents_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  end_%logit_1.0 ov_%logit_3.0 ascular_%logit_1.0  f_%logit_0.0 ibr_%logit_3.0 ino_%logit_3.0 ly_%logit_3.0 sis_%logit_1.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  these_%logit_3.0  agents_%logit_0.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  them_%logit_2.0  with_%logit_3.0  other_%logit_3.0  anti_%logit_3.0 plate_%logit_3.0 lets_%logit_3.0 ._%logit_0.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  plate_%logit_1.0 let_%logit_0.0  agents_%logit_2.0  on_%logit_0.0  the_%logit_1.0  development_%logit_3.0  of_%logit_3.0  end_%logit_1.0 oph_%logit_3.0 aryn_%logit_3.0 ge_%logit_1.0 al_%logit_1.0  fib_%logit_0.0 rosis_%logit_3.0 ._%logit_3.0  This_%logit_3.0  should_%logit_0.0  be_%logit_0.0  done_%logit_2.0  in_%logit_0.0  conjunction_%logit_2.0  with_%logit_3.0  an_%logit_1.0  assessment_%logit_3.0  of_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  anti_%logit_1.0 -_%logit_0.0 plate_%logit_3.0 let_%logit_3.0  drugs_%logit_0.0  in_%logit_3.0  the_%logit_1.0  management_%logit_3.0  of_%logit_3.0  this_%logit_3.0  condition_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  pro_%logit_3.0 ph_%logit_3.0 yl_%logit_0.0 actic_%logit_0.0  th_%logit_0.0 rom_%logit_3.0 bo_%logit_0.0 emb_%logit_2.0 olic_%logit_1.0  agents_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  pre_%logit_3.0 -_%logit_3.0 e_%logit_1.0 cl_%logit_2.0 amps_%logit_2.0 ia_%logit_1.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  pro_%logit_3.0 th_%logit_3.0 romy_%logit_0.0 cin_%logit_2.0  and_%logit_1.0  its_%logit_1.0  analog_%logit_3.0 ues_%logit_3.0  in_%logit_0.0  this_%logit_1.0  population_%logit_3.0 ,_%logit_0.0  as_%logit_2.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  determine_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_0.0  th_%logit_1.0 rom_%logit_3.0 b_%logit_2.0 op_%logit_2.0 roph_%logit_2.0 yl_%logit_1.0 actic_%logit_0.0  agents_%logit_2.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  agents_%logit_3.0  with_%logit_3.0  placebo_%logit_3.0  or_%logit_3.0  no_%logit_3.0  treatment_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  aspects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  interventions_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  che_%logit_3.0 mor_%logit_3.0 ad_%logit_0.0 ox_%logit_3.0 ine_%logit_2.0  as_%logit_2.0  an_%logit_3.0  adj_%logit_0.0 u_%logit_0.0 vant_%logit_0.0  to_%logit_1.0  radi_%logit_0.0 otherapy_%logit_3.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  metast_%logit_3.0 atic_%logit_3.0  lung_%logit_0.0  cancer_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_2.0  and_%logit_1.0  timing_%logit_1.0  for_%logit_3.0  che_%logit_2.0 mor_%logit_1.0 adi_%logit_2.0 otherapy_%logit_3.0 ,_%logit_2.0  and_%logit_3.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_2.0  timing_%logit_1.0  of_%logit_0.0  chemotherapy_%logit_2.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  timing_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  chemotherapy_%logit_3.0  in_%logit_3.0  these_%logit_3.0  patients_%logit_0.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_2.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  determining_%logit_3.0  the_%logit_3.0  optimal_%logit_3.0  doses_%logit_0.0  and_%logit_2.0  timing_%logit_1.0 ,_%logit_3.0  duration_%logit_1.0 ,_%logit_1.0  duration_%logit_0.0  of_%logit_1.0  chem_%logit_0.0 otherapy_%logit_3.0  and_%logit_2.0  the_%logit_1.0  most_%logit_3.0  effective_%logit_3.0  chemotherapy_%logit_3.0  reg_%logit_2.0 imens_%logit_1.0  for_%logit_2.0  these_%logit_1.0  patients_%logit_3.0 ,_%logit_0.0  as_%logit_2.0  well_%logit_1.0  as_%logit_0.0  the_%logit_2.0  optimal_%logit_3.0  duration_%logit_0.0  of_%logit_3.0  treatment_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  benz_%logit_3.0 od_%logit_3.0 iazep_%logit_2.0 ines_%logit_2.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  aggressive_%logit_3.0  aggression_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  drug_%logit_3.0 -_%logit_3.0 resistant_%logit_3.0  aggression_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_2.0  and_%logit_3.0  frequency_%logit_1.0 ,_%logit_3.0  and_%logit_2.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_3.0  timing_%logit_1.0  of_%logit_3.0  benz_%logit_2.0 ad_%logit_3.0 iazep_%logit_2.0 ines_%logit_2.0  in_%logit_3.0  this_%logit_1.0  population_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 os_%logit_3.0 ocial_%logit_3.0  interventions_%logit_3.0  for_%logit_3.0  aggressive_%logit_1.0  aggression_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  interventions_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  aggression_%logit_3.0  in_%logit_3.0  these_%logit_3.0  populations_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  t_%logit_3.0 inn_%logit_3.0 itus_%logit_2.0  management_%logit_2.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  id_%logit_3.0 iop_%logit_3.0 ath_%logit_1.0 ic_%logit_2.0  t_%logit_0.0 inn_%logit_3.0 us_%logit_2.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  this_%logit_3.0  treatment_%logit_1.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  profiles_%logit_3.0  of_%logit_3.0  t_%logit_1.0 amn_%logit_3.0 os_%logit_1.0 ide_%logit_2.0  therapy_%logit_0.0  in_%logit_3.0  this_%logit_1.0  setting_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0  there_%logit_0.0  is_%logit_0.0  an_%logit_2.0  urgent_%logit_3.0  need_%logit_0.0  for_%logit_0.0  an_%logit_1.0  assessment_%logit_2.0  of_%logit_0.0  the_%logit_1.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  the_%logit_3.0  t_%logit_3.0 inn_%logit_3.0 os_%logit_1.0 ide_%logit_2.0  treatment_%logit_1.0  in_%logit_2.0  this_%logit_1.0  population_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0  a_%logit_0.0  review_%logit_1.0  of_%logit_2.0  the_%logit_1.0  quality_%logit_3.0  of_%logit_3.0  the_%logit_3.0  current_%logit_0.0  evidence_%logit_3.0  is_%logit_3.0  warranted_%logit_2.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 os_%logit_3.0 ocial_%logit_0.0  interventions_%logit_3.0  for_%logit_0.0  reducing_%logit_1.0  smoking_%logit_3.0  behaviour_%logit_3.0  in_%logit_3.0  psychiatric_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  schizophrenia_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  interventions_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  them_%logit_2.0  to_%logit_3.0  each_%logit_1.0  other_%logit_3.0 ,_%logit_2.0  and_%logit_2.0  also_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  approaches_%logit_3.0  to_%logit_3.0  other_%logit_1.0  psychiatric_%logit_3.0  therapies_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  psych_%logit_3.0 oses_%logit_3.0  and_%logit_1.0  their_%logit_1.0  effects_%logit_3.0  on_%logit_3.0  relapse_%logit_1.0  rates_%logit_3.0  and_%logit_3.0  relapse_%logit_1.0  rates_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  on_%logit_2.0  the_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  relapse_%logit_3.0  and_%logit_3.0  relapse_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  waterproof_%logit_3.0  waterproof_%logit_3.0 ing_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  skin_%logit_3.0  imperfect_%logit_3.0 ions_%logit_0.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_1.0  whether_%logit_2.0  waterproof_%logit_3.0 ing_%logit_1.0  waterproof_%logit_0.0 ing_%logit_3.0  is_%logit_3.0  beneficial_%logit_3.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_1.0  the_%logit_3.0  healing_%logit_0.0  of_%logit_3.0  imperfect_%logit_3.0 ions_%logit_3.0  in_%logit_3.0  the_%logit_1.0  skin_%logit_3.0  imperfect_%logit_3.0 ion_%logit_2.0  of_%logit_3.0  the_%logit_3.0  inner_%logit_3.0 most_%logit_3.0  layers_%logit_3.0  of_%logit_3.0  the_%logit_1.0  outer_%logit_0.0 most_%logit_0.0  layer_%logit_3.0  of_%logit_3.0  the_%logit_1.0  skin_%logit_3.0 ._%logit_0.0  Further_%logit_1.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_1.0  to_%logit_1.0  assess_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  waterproof_%logit_1.0 ing_%logit_1.0 ,_%logit_1.0  waterproof_%logit_3.0 ing_%logit_3.0  and_%logit_0.0  waterproof_%logit_3.0 ing_%logit_3.0  on_%logit_0.0  the_%logit_3.0  inner_%logit_3.0  inner_%logit_3.0 most_%logit_3.0  layer_%logit_0.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_0.0  waterproof_%logit_2.0 ing_%logit_3.0  with_%logit_0.0  waterproof_%logit_3.0 ing_%logit_3.0  or_%logit_0.0  waterproof_%logit_3.0 ing_%logit_3.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  trials_%logit_1.0  are_%logit_1.0  needed_%logit_2.0  to_%logit_1.0  evaluate_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  waterproof_%logit_3.0  outer_%logit_3.0 most_%logit_3.0  layers_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  cran_%logit_3.0 berry_%logit_3.0  supplements_%logit_2.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  sympt_%logit_3.0 omatic_%logit_3.0  UT_%logit_0.0 I_%logit_3.0 ._%logit_1.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  in_%logit_2.0  this_%logit_3.0  area_%logit_3.0 ,_%logit_2.0  particularly_%logit_2.0  in_%logit_3.0  the_%logit_3.0  context_%logit_3.0  of_%logit_3.0  the_%logit_3.0  development_%logit_3.0  of_%logit_3.0  new_%logit_3.0  antibiotics_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  in_%logit_3.0  combination_%logit_3.0  with_%logit_3.0  the_%logit_3.0  introduction_%logit_3.0  of_%logit_3.0  newer_%logit_3.0  antibiotics_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  it_%logit_0.0  is_%logit_3.0  important_%logit_2.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  cran_%logit_3.0 berry_%logit_3.0  supplement_%logit_2.0 ing_%logit_0.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_0.0  an_%logit_3.0  increased_%logit_3.0  risk_%logit_0.0  of_%logit_0.0  bacterial_%logit_0.0  contamination_%logit_3.0  and_%logit_3.0  bacterial_%logit_3.0  contamination_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  a_%logit_2.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  infection_%logit_1.0 ,_%logit_3.0  as_%logit_3.0  compared_%logit_3.0  to_%logit_1.0  placebo_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  tr_%logit_3.0 an_%logit_0.0 ex_%logit_1.0 amic_%logit_2.0  acid_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  non_%logit_3.0 -_%logit_3.0 f_%logit_1.0 atal_%logit_3.0  acute_%logit_2.0  my_%logit_3.0 ocard_%logit_3.0 ial_%logit_2.0  inf_%logit_0.0 ar_%logit_1.0 ction_%logit_1.0 ,_%logit_2.0  or_%logit_3.0  to_%logit_3.0  support_%logit_3.0  its_%logit_2.0  use_%logit_3.0  as_%logit_3.0  an_%logit_3.0  alternative_%logit_0.0  to_%logit_0.0  aspirin_%logit_0.0  in_%logit_1.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  these_%logit_3.0  patients_%logit_3.0 ._%logit_3.0  There_%logit_2.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  in_%logit_2.0  this_%logit_3.0  area_%logit_3.0 ,_%logit_0.0  especially_%logit_2.0  in_%logit_3.0  the_%logit_3.0  context_%logit_3.0  of_%logit_3.0  the_%logit_3.0  introduction_%logit_3.0  of_%logit_3.0  anti_%logit_3.0 plate_%logit_3.0 let_%logit_3.0  agents_%logit_0.0 ,_%logit_0.0  as_%logit_2.0  well_%logit_3.0  as_%logit_3.0  in_%logit_2.0  the_%logit_3.0  development_%logit_3.0  of_%logit_3.0  new_%logit_3.0  anti_%logit_3.0 plate_%logit_3.0 lets_%logit_3.0 ,_%logit_2.0  such_%logit_2.0  as_%logit_3.0  ib_%logit_1.0 up_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0 ,_%logit_1.0  ib_%logit_2.0 up_%logit_2.0 rop_%logit_2.0 ub_%logit_1.0 ic_%logit_1.0  acid_%logit_2.0 ,_%logit_1.0  and_%logit_2.0  aspirin_%logit_2.0 ,_%logit_2.0  in_%logit_2.0  patients_%logit_2.0  with_%logit_0.0  a_%logit_1.0  history_%logit_3.0  of_%logit_1.0  vascular_%logit_3.0  death_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ib_%logit_3.0 up_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  for_%logit_1.0  pain_%logit_3.0  relief_%logit_3.0  in_%logit_3.0  adults_%logit_3.0  with_%logit_3.0  chronic_%logit_0.0  pain_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  ib_%logit_3.0 ip_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  in_%logit_1.0  children_%logit_2.0  with_%logit_3.0  acute_%logit_2.0  pain_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  ib_%logit_1.0 ap_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  as_%logit_1.0  a_%logit_2.0  substitute_%logit_1.0  for_%logit_0.0  other_%logit_0.0  analges_%logit_3.0 ics_%logit_3.0 ,_%logit_2.0  such_%logit_1.0  as_%logit_3.0  oxy_%logit_1.0 toc_%logit_1.0 in_%logit_1.0 ,_%logit_3.0  ib_%logit_2.0 up_%logit_1.0 rog_%logit_2.0 el_%logit_1.0 ,_%logit_2.0  and_%logit_2.0  aspirin_%logit_1.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_2.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  children_%logit_2.0  and_%logit_3.0  adolescents_%logit_2.0 ._%logit_3.0
 Dietary_%logit_0.0  fruit_%logit_1.0  and_%logit_3.0  vegetables_%logit_0.0  are_%logit_3.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_0.0  body_%logit_3.0  weight_%logit_0.0  and_%logit_0.0  improving_%logit_3.0  physical_%logit_0.0  fitness_%logit_3.0  in_%logit_1.0  children_%logit_3.0  and_%logit_0.0  adolescents_%logit_3.0 ._%logit_3.0  They_%logit_3.0  are_%logit_1.0  also_%logit_2.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  BMI_%logit_0.0 ,_%logit_3.0  BMI_%logit_3.0  and_%logit_3.0  triglycer_%logit_0.0 ides_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  a_%logit_3.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_1.0  cardiovascular_%logit_1.0  disease_%logit_3.0 ._%logit_3.0  They_%logit_3.0  also_%logit_0.0  appear_%logit_2.0  to_%logit_2.0  have_%logit_3.0  a_%logit_3.0  positive_%logit_3.0  effect_%logit_3.0  on_%logit_0.0  BMI_%logit_1.0  and_%logit_3.0  on_%logit_3.0  triglycer_%logit_3.0 ides_%logit_3.0  and_%logit_3.0  on_%logit_3.0  blood_%logit_0.0  pressure_%logit_3.0 ._%logit_0.0  They_%logit_3.0  do_%logit_0.0  not_%logit_2.0  appear_%logit_3.0  to_%logit_2.0  be_%logit_1.0  associated_%logit_2.0  with_%logit_0.0  an_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  BMI_%logit_1.0  or_%logit_3.0  triglycer_%logit_3.0 ides_%logit_3.0 ._%logit_2.0  They_%logit_3.0  may_%logit_0.0  have_%logit_2.0  a_%logit_2.0  negative_%logit_3.0  impact_%logit_3.0  on_%logit_0.0  BMI_%logit_3.0  or_%logit_3.0  on_%logit_3.0  triglycer_%logit_3.0 ide_%logit_3.0  levels_%logit_3.0 ._%logit_3.0  Their_%logit_3.0  effect_%logit_0.0  on_%logit_3.0  body_%logit_3.0  mass_%logit_3.0  is_%logit_0.0  not_%logit_3.0  clear_%logit_3.0 ._%logit_1.0  Their_%logit_2.0  effects_%logit_0.0  on_%logit_3.0  BMI_%logit_2.0  are_%logit_3.0  not_%logit_3.0  clear_%logit_3.0  from_%logit_1.0  this_%logit_2.0  review_%logit_2.0 ,_%logit_2.0  but_%logit_2.0  they_%logit_2.0  should_%logit_3.0  be_%logit_2.0  viewed_%logit_2.0  with_%logit_1.0  caution_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  depressive_%logit_3.0  symptoms_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  antidepressant_%logit_3.0  for_%logit_3.0  depressive_%logit_3.0  symptoms_%logit_3.0  and_%logit_3.0  the_%logit_3.0  best_%logit_3.0  combination_%logit_3.0  of_%logit_3.0  antidepressant_%logit_1.0  and_%logit_3.0  antidepressant_%logit_3.0  therapy_%logit_3.0  for_%logit_3.0  these_%logit_1.0  conditions_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  antidepressant_%logit_1.0  therapy_%logit_3.0  on_%logit_3.0  depressive_%logit_3.0  symptoms_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  a_%logit_3.0  comparison_%logit_3.0  of_%logit_2.0  antidepressant_%logit_3.0  medication_%logit_3.0  with_%logit_3.0  placebo_%logit_3.0  or_%logit_3.0  no_%logit_3.0  treatment_%logit_3.0  or_%logit_2.0  other_%logit_2.0  antidepressant_%logit_3.0  treatments_%logit_3.0  for_%logit_3.0  depressive_%logit_2.0  episodes_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0  there_%logit_0.0  is_%logit_0.0  an_%logit_0.0  issue_%logit_3.0  of_%logit_0.0  the_%logit_1.0  quality_%logit_3.0  of_%logit_3.0  the_%logit_3.0  evidence_%logit_0.0  and_%logit_0.0  the_%logit_2.0  reliability_%logit_0.0  of_%logit_3.0  the_%logit_3.0  results_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  psychological_%logit_3.0  interventions_%logit_3.0  for_%logit_3.0  enhancing_%logit_1.0  adherence_%logit_0.0  to_%logit_3.0  alcohol_%logit_0.0  treatment_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  psychological_%logit_3.0  therapies_%logit_3.0  for_%logit_3.0  reducing_%logit_1.0  compliance_%logit_0.0  with_%logit_3.0  alcohol_%logit_3.0  treatment_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  psychological_%logit_2.0  interventions_%logit_3.0  with_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  alcohol_%logit_2.0  treatment_%logit_3.0  (_%logit_3.0 e_%logit_1.0 ._%logit_0.0 g_%logit_0.0 ._%logit_1.0  alcohol_%logit_0.0  counselling_%logit_3.0 ,_%logit_3.0  behavioural_%logit_3.0  counselling_%logit_3.0 ,_%logit_3.0  cognitive_%logit_3.0  behavioural_%logit_3.0  therapy_%logit_0.0 ,_%logit_0.0  counselling_%logit_1.0 ,_%logit_3.0  counselling_%logit_1.0 )._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  psychological_%logit_1.0  interventions_%logit_3.0  to_%logit_3.0  improve_%logit_1.0  the_%logit_2.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  of_%logit_0.0  people_%logit_0.0  with_%logit_0.0  alcohol_%logit_1.0  problems_%logit_3.0 ._%logit_3.0
 Functional_%logit_0.0  strength_%logit_1.0  training_%logit_1.0  appears_%logit_1.0  to_%logit_3.0  have_%logit_0.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_0.0  walking_%logit_3.0  speed_%logit_3.0 ,_%logit_3.0  balance_%logit_3.0  and_%logit_3.0  function_%logit_3.0  in_%logit_3.0  the_%logit_3.0  short_%logit_3.0 -_%logit_3.0 term_%logit_3.0 ,_%logit_1.0  but_%logit_3.0  is_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  falls_%logit_1.0  and_%logit_3.0  disability_%logit_1.0 ._%logit_1.0  Strength_%logit_3.0  training_%logit_1.0  may_%logit_1.0  have_%logit_1.0  a_%logit_3.0  positive_%logit_3.0  effect_%logit_3.0  on_%logit_0.0  fitness_%logit_2.0 ,_%logit_3.0  but_%logit_3.0  its_%logit_3.0  effect_%logit_3.0  on_%logit_3.0  disability_%logit_1.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0  from_%logit_1.0  this_%logit_2.0  review_%logit_0.0 ._%logit_2.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  strength_%logit_1.0  training_%logit_1.0  on_%logit_1.0  fitness_%logit_1.0  and_%logit_3.0  disability_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  strength_%logit_2.0  training_%logit_3.0  with_%logit_1.0  other_%logit_3.0  types_%logit_1.0  of_%logit_1.0  physical_%logit_1.0  rehabilitation_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_1.0  to_%logit_3.0  evaluate_%logit_3.0  the_%logit_3.0  effects_%logit_3.0  on_%logit_3.0  fatigue_%logit_1.0  and_%logit_3.0  disability_%logit_3.0  in_%logit_3.0  the_%logit_3.0  longer_%logit_3.0  term_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  any_%logit_3.0  particular_%logit_3.0  form_%logit_3.0  of_%logit_3.0  anti_%logit_0.0 hy_%logit_3.0 pert_%logit_3.0 ensive_%logit_3.0  medication_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  G_%logit_3.0 OR_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  therapy_%logit_2.0  and_%logit_3.0  to_%logit_1.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  different_%logit_3.0  types_%logit_3.0  of_%logit_3.0  ant_%logit_3.0 ich_%logit_3.0 olin_%logit_1.0 erg_%logit_0.0 ics_%logit_2.0  in_%logit_3.0  G_%logit_1.0 OR_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  different_%logit_1.0  combinations_%logit_3.0  of_%logit_3.0  ant_%logit_2.0 ith_%logit_3.0 olin_%logit_2.0 erg_%logit_0.0 ic_%logit_2.0  drugs_%logit_3.0  on_%logit_3.0  G_%logit_2.0 OR_%logit_3.0  in_%logit_1.0  patients_%logit_3.0  with_%logit_3.0  asthma_%logit_1.0  and_%logit_3.0  in_%logit_3.0  those_%logit_3.0  with_%logit_3.0  G_%logit_3.0 OR_%logit_3.0  who_%logit_1.0  do_%logit_1.0  not_%logit_2.0  have_%logit_3.0  a_%logit_2.0  history_%logit_3.0  of_%logit_3.0  asthma_%logit_3.0  or_%logit_3.0  who_%logit_3.0  do_%logit_3.0  have_%logit_2.0  a_%logit_2.0  high_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  respiratory_%logit_0.0  distress_%logit_3.0  syndrome_%logit_3.0 ._%logit_1.0
 Phys_%logit_0.0 i_%logit_0.0 ore_%logit_0.0 spir_%logit_1.0 atory_%logit_0.0  fitness_%logit_0.0  tests_%logit_1.0  are_%logit_1.0  effective_%logit_1.0  in_%logit_0.0  improving_%logit_0.0  lung_%logit_0.0  function_%logit_3.0  in_%logit_1.0  children_%logit_3.0  and_%logit_3.0  adults_%logit_2.0  with_%logit_0.0  asthma_%logit_1.0 ,_%logit_3.0  but_%logit_3.0  they_%logit_3.0  do_%logit_3.0  not_%logit_1.0  appear_%logit_3.0  to_%logit_1.0  have_%logit_1.0  a_%logit_2.0  clinically_%logit_3.0  meaningful_%logit_2.0  effect_%logit_1.0  on_%logit_0.0  lung_%logit_2.0  function_%logit_3.0  or_%logit_1.0  respiratory_%logit_3.0  rate_%logit_3.0 ._%logit_3.0  They_%logit_3.0  do_%logit_0.0  not_%logit_2.0  seem_%logit_3.0  to_%logit_2.0  have_%logit_1.0  an_%logit_2.0  effect_%logit_3.0  on_%logit_0.0  respiratory_%logit_3.0  rate_%logit_3.0  or_%logit_3.0  lung_%logit_3.0  function_%logit_0.0 ._%logit_0.0  They_%logit_3.0  may_%logit_0.0  have_%logit_2.0  an_%logit_2.0  impact_%logit_3.0  on_%logit_0.0  pulmonary_%logit_3.0  function_%logit_0.0  and_%logit_3.0  respiratory_%logit_3.0  rate_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0  studies_%logit_2.0  to_%logit_0.0  evaluate_%logit_1.0  the_%logit_2.0  effects_%logit_1.0  of_%logit_3.0  exercise_%logit_1.0  training_%logit_1.0  on_%logit_1.0  respiratory_%logit_1.0  rates_%logit_0.0 ,_%logit_3.0  respiratory_%logit_1.0  rate_%logit_3.0  and_%logit_3.0  lung_%logit_3.0  function_%logit_3.0 ,_%logit_1.0  as_%logit_3.0  well_%logit_3.0  as_%logit_1.0  on_%logit_2.0  pulmonary_%logit_0.0  functions_%logit_3.0  and_%logit_3.0  respiratory_%logit_3.0  rates_%logit_3.0 ._%logit_3.0
 Pro_%logit_0.0 ph_%logit_0.0 yl_%logit_0.0 actic_%logit_2.0  band_%logit_2.0 aging_%logit_1.0  is_%logit_2.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_2.0  the_%logit_0.0  incidence_%logit_0.0  of_%logit_0.0  var_%logit_0.0 ice_%logit_3.0 al_%logit_2.0  hemorrh_%logit_3.0 age_%logit_0.0  and_%logit_0.0  reducing_%logit_3.0  the_%logit_0.0  risk_%logit_0.0  of_%logit_0.0  death_%logit_0.0 ,_%logit_0.0  but_%logit_3.0  the_%logit_3.0  extent_%logit_3.0  to_%logit_3.0  which_%logit_3.0  this_%logit_3.0  effect_%logit_0.0  is_%logit_0.0  achieved_%logit_0.0  is_%logit_3.0  unclear_%logit_3.0 ._%logit_3.0  The_%logit_2.0  number_%logit_0.0  needed_%logit_3.0  to_%logit_0.0  remove_%logit_0.0  band_%logit_2.0 aging_%logit_0.0  from_%logit_2.0  the_%logit_0.0  band_%logit_0.0 aging_%logit_0.0  does_%logit_2.0  not_%logit_1.0  appear_%logit_0.0  to_%logit_2.0  be_%logit_1.0  affected_%logit_2.0  by_%logit_1.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  band_%logit_2.0 aging_%logit_3.0 ,_%logit_2.0  but_%logit_3.0  it_%logit_3.0  is_%logit_2.0  possible_%logit_2.0  that_%logit_3.0  band_%logit_3.0 aging_%logit_3.0  may_%logit_2.0  have_%logit_0.0  a_%logit_2.0  role_%logit_3.0  in_%logit_2.0  reducing_%logit_2.0  blood_%logit_3.0  loss_%logit_0.0 ,_%logit_3.0  but_%logit_3.0  this_%logit_3.0  conclusion_%logit_3.0  is_%logit_2.0  based_%logit_2.0  on_%logit_0.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  trials_%logit_0.0  and_%logit_0.0  uncertainties_%logit_2.0 ._%logit_0.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  band_%logit_0.0 aging_%logit_2.0  and_%logit_2.0  the_%logit_2.0  best_%logit_0.0  band_%logit_0.0 aging_%logit_2.0  method_%logit_2.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  tro_%logit_3.0 cars_%logit_3.0  in_%logit_2.0  orth_%logit_3.0 oped_%logit_0.0 ic_%logit_3.0  surgery_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  determine_%logit_1.0  whether_%logit_2.0  tro_%logit_3.0 cars_%logit_1.0  are_%logit_2.0  beneficial_%logit_1.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_1.0  orth_%logit_0.0 op_%logit_0.0 aed_%logit_1.0 ic_%logit_2.0  surgery_%logit_0.0  in_%logit_0.0  this_%logit_3.0  population_%logit_0.0 ._%logit_0.0  Such_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_0.0  a_%logit_1.0  well_%logit_3.0 -_%logit_3.0 defined_%logit_1.0  set_%logit_2.0  of_%logit_0.0  outcomes_%logit_2.0 ,_%logit_3.0  such_%logit_2.0  as_%logit_1.0  complication_%logit_1.0  rates_%logit_3.0  and_%logit_3.0  length_%logit_1.0  of_%logit_3.0  hospital_%logit_1.0  stay_%logit_3.0 ,_%logit_0.0  as_%logit_0.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  extent_%logit_0.0  to_%logit_3.0  which_%logit_1.0  tro_%logit_1.0 cars_%logit_0.0  may_%logit_2.0  be_%logit_1.0  useful_%logit_0.0  in_%logit_0.0  this_%logit_0.0  patient_%logit_0.0  population_%logit_0.0 ._%logit_2.0  These_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  include_%logit_2.0  a_%logit_2.0  number_%logit_1.0  of_%logit_1.0  parameters_%logit_3.0 ,_%logit_0.0  including_%logit_1.0  length_%logit_1.0  of_%logit_3.0  stay_%logit_3.0 ,_%logit_3.0  severity_%logit_1.0  of_%logit_3.0  infection_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  duration_%logit_3.0  of_%logit_3.0  recovery_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  intraven_%logit_3.0 ous_%logit_3.0  transf_%logit_0.0 usion_%logit_1.0  as_%logit_1.0  a_%logit_3.0  means_%logit_0.0  of_%logit_0.0  reducing_%logit_0.0  blood_%logit_3.0  transf_%logit_0.0 usion_%logit_2.0  rates_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  method_%logit_3.0  of_%logit_0.0  transf_%logit_1.0 usion_%logit_1.0  and_%logit_2.0  the_%logit_3.0  best_%logit_0.0  way_%logit_3.0  to_%logit_0.0  administer_%logit_0.0  transf_%logit_2.0 usion_%logit_1.0  to_%logit_1.0  patients_%logit_3.0  with_%logit_3.0  pre_%logit_3.0 -_%logit_1.0 existing_%logit_1.0  congen_%logit_1.0 ital_%logit_1.0  heart_%logit_1.0  defects_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  investigation_%logit_1.0  of_%logit_1.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  transf_%logit_1.0 usions_%logit_3.0  as_%logit_2.0  an_%logit_1.0  alternative_%logit_1.0  to_%logit_0.0  intraven_%logit_0.0 ous_%logit_3.0  immun_%logit_0.0 ogl_%logit_1.0 ob_%logit_1.0 ul_%logit_0.0 ins_%logit_2.0  in_%logit_2.0  reducing_%logit_3.0  blood_%logit_3.0  loss_%logit_3.0  in_%logit_3.0  the_%logit_3.0  first_%logit_3.0  week_%logit_3.0  of_%logit_2.0  life_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ip_%logit_3.0 rat_%logit_3.0 rop_%logit_1.0 ium_%logit_0.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  stre_%logit_3.0 pt_%logit_3.0 ococ_%logit_1.0 cal_%logit_0.0  infections_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_0.0  duration_%logit_1.0  and_%logit_0.0  timing_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  the_%logit_3.0  best_%logit_3.0  way_%logit_3.0  to_%logit_0.0  administer_%logit_0.0  ip_%logit_2.0 rat_%logit_3.0 rep_%logit_1.0 ium_%logit_3.0  for_%logit_2.0  these_%logit_2.0  infections_%logit_0.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  terms_%logit_2.0  of_%logit_3.0  reducing_%logit_3.0  blood_%logit_3.0  loss_%logit_3.0  and_%logit_0.0  mortality_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_0.0  assess_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0 ,_%logit_3.0  a_%logit_3.0  meta_%logit_0.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  data_%logit_0.0  is_%logit_0.0  needed_%logit_2.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  relaxation_%logit_1.0  exercises_%logit_3.0  in_%logit_1.0  sleep_%logit_1.0  disturbance_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_1.0  to_%logit_1.0  determine_%logit_1.0  whether_%logit_2.0  relaxation_%logit_3.0  exercises_%logit_1.0  are_%logit_1.0  beneficial_%logit_1.0  for_%logit_0.0  sleep_%logit_3.0  disturbance_%logit_3.0 ,_%logit_3.0  wake_%logit_3.0 fulness_%logit_3.0 ,_%logit_3.0  sleep_%logit_3.0  disturbance_%logit_3.0  or_%logit_3.0  sleep_%logit_3.0  disturbance_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  insomnia_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  sleep_%logit_1.0  disturbance_%logit_3.0  and_%logit_3.0  sleep_%logit_3.0  disturbance_%logit_3.0  on_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_0.0  sleep_%logit_3.0  disturbances_%logit_3.0  and_%logit_1.0  sleep_%logit_1.0  disturbances_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  studies_%logit_0.0  are_%logit_0.0  also_%logit_1.0  needed_%logit_1.0  to_%logit_1.0  evaluate_%logit_1.0  relaxation_%logit_2.0  exercises_%logit_3.0  for_%logit_1.0  sleep_%logit_1.0  disturbances_%logit_3.0 ,_%logit_3.0  sleep_%logit_1.0  deprivation_%logit_3.0 ,_%logit_3.0  sleep_%logit_3.0 lessness_%logit_3.0 ,_%logit_3.0  sleep_%logit_3.0 iness_%logit_3.0  and_%logit_3.0  sleep_%logit_3.0  deprivation_%logit_3.0  in_%logit_3.0  people_%logit_1.0  who_%logit_3.0  are_%logit_1.0  awake_%logit_1.0  or_%logit_1.0  asleep_%logit_3.0  at_%logit_3.0  night_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  mechanism_%logit_3.0  of_%logit_3.0  action_%logit_3.0  to_%logit_3.0  reduce_%logit_3.0  mortality_%logit_3.0  or_%logit_0.0  improve_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_1.0  the_%logit_2.0  mechanism_%logit_3.0  by_%logit_3.0  which_%logit_3.0  this_%logit_1.0  mechanism_%logit_0.0  works_%logit_3.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  this_%logit_3.0  intervention_%logit_3.0  with_%logit_3.0  other_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  action_%logit_1.0  in_%logit_3.0  the_%logit_3.0  management_%logit_0.0  of_%logit_0.0  mortality_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_3.0  adults_%logit_3.0  with_%logit_0.0  dementia_%logit_1.0  or_%logit_3.0  in_%logit_3.0  children_%logit_3.0  with_%logit_3.0  dementia_%logit_2.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  this_%logit_3.0  method_%logit_3.0  of_%logit_3.0  action_%logit_3.0 ,_%logit_3.0  a_%logit_3.0  meta_%logit_0.0 -_%logit_2.0 analysis_%logit_0.0  will_%logit_0.0  be_%logit_0.0  undertaken_%logit_2.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  cort_%logit_3.0 ic_%logit_3.0 oster_%logit_0.0 oids_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  pr_%logit_1.0 ur_%logit_3.0 itus_%logit_2.0 ._%logit_2.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_0.0  determine_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_2.0  of_%logit_2.0  steroids_%logit_2.0  and_%logit_2.0  to_%logit_1.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  the_%logit_2.0  management_%logit_3.0  of_%logit_2.0  pr_%logit_3.0 uria_%logit_3.0 itus_%logit_1.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_2.0 term_%logit_2.0  data_%logit_0.0  are_%logit_2.0  needed_%logit_2.0  on_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  steroids_%logit_1.0  on_%logit_3.0  quality_%logit_3.0  of_%logit_0.0  life_%logit_3.0  and_%logit_0.0  productivity_%logit_3.0 ._%logit_0.0  Long_%logit_3.0 -_%logit_0.0 term_%logit_2.0  studies_%logit_0.0  are_%logit_2.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  steroids_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  steroids_%logit_3.0  in_%logit_3.0  the_%logit_3.0  control_%logit_3.0  group_%logit_3.0  of_%logit_1.0  patients_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  cis_%logit_3.0 pl_%logit_3.0 atin_%logit_0.0  as_%logit_1.0  an_%logit_3.0  adjunct_%logit_0.0  to_%logit_0.0  chemotherapy_%logit_0.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_0.0  survival_%logit_3.0 ,_%logit_3.0  toxicity_%logit_3.0 ,_%logit_3.0  toxicity_%logit_3.0  and_%logit_3.0  survival_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  toxicity_%logit_3.0  profiles_%logit_3.0  of_%logit_3.0  these_%logit_1.0  drugs_%logit_3.0  in_%logit_3.0  patients_%logit_2.0  with_%logit_0.0  advanced_%logit_1.0  stages_%logit_0.0  of_%logit_3.0  renal_%logit_1.0  toxicity_%logit_1.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  accordance_%logit_2.0  with_%logit_3.0  the_%logit_1.0  recommendations_%logit_0.0  of_%logit_0.0  the_%logit_1.0  Coch_%logit_0.0 rane_%logit_0.0  Guidelines_%logit_0.0  on_%logit_0.0  Immun_%logit_0.0 otherapy_%logit_0.0  for_%logit_0.0  renal_%logit_0.0  toxicity_%logit_0.0  in_%logit_0.0  advanced_%logit_2.0  stages_%logit_0.0  renal_%logit_1.0  toxicity_%logit_1.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  in_%logit_2.0  patients_%logit_3.0  who_%logit_0.0  are_%logit_1.0  undergoing_%logit_2.0  chemotherapy_%logit_2.0  in_%logit_3.0  advanced_%logit_3.0  stage_%logit_1.0  renal_%logit_1.0  toxicity_%logit_3.0  and_%logit_1.0  those_%logit_3.0  who_%logit_3.0  are_%logit_3.0  unable_%logit_2.0  to_%logit_0.0  tolerate_%logit_3.0  chemotherapy_%logit_2.0  in_%logit_3.0  these_%logit_3.0  patients_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  p_%logit_3.0 aren_%logit_0.0 ter_%logit_2.0 al_%logit_2.0  ana_%logit_0.0 esthesia_%logit_0.0  as_%logit_1.0  an_%logit_1.0  adjunct_%logit_0.0  to_%logit_0.0  other_%logit_0.0  surgical_%logit_1.0  procedures_%logit_1.0  in_%logit_3.0  terms_%logit_1.0  of_%logit_0.0  minim_%logit_3.0 ising_%logit_3.0  mortality_%logit_0.0  and_%logit_0.0  morbid_%logit_3.0 ity_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  p_%logit_1.0 ren_%logit_1.0 ter_%logit_1.0 al_%logit_2.0  an_%logit_0.0 hyd_%logit_0.0 rase_%logit_0.0  inhibitors_%logit_1.0 ,_%logit_0.0  the_%logit_1.0  optimal_%logit_3.0  duration_%logit_0.0  of_%logit_0.0  ext_%logit_1.0 rac_%logit_1.0 aps_%logit_2.0 ular_%logit_1.0  exc_%logit_1.0 ision_%logit_1.0 ,_%logit_1.0  and_%logit_3.0  the_%logit_0.0  optimal_%logit_3.0  timing_%logit_0.0  of_%logit_0.0  end_%logit_1.0 oscopic_%logit_1.0  exc_%logit_2.0 ision_%logit_1.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  determining_%logit_3.0  the_%logit_3.0  optimal_%logit_3.0  intensity_%logit_3.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_0.0  ana_%logit_1.0 esthesia_%logit_1.0  and_%logit_1.0  the_%logit_1.0  most_%logit_0.0  effective_%logit_0.0  way_%logit_1.0  of_%logit_0.0  delivering_%logit_1.0  ana_%logit_3.0 esthesia_%logit_0.0  to_%logit_0.0  the_%logit_0.0  patient_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  anti_%logit_3.0 plate_%logit_3.0 let_%logit_3.0  agents_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  vas_%logit_1.0 osp_%logit_3.0 asm_%logit_3.0 ._%logit_2.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  into_%logit_2.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  plate_%logit_1.0 let_%logit_3.0  agents_%logit_2.0  on_%logit_0.0  arter_%logit_1.0 ial_%logit_0.0  blood_%logit_2.0  flow_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  agents_%logit_3.0  in_%logit_3.0  reducing_%logit_2.0  blood_%logit_3.0  loss_%logit_3.0  and_%logit_1.0  bleeding_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  a_%logit_1.0  sub_%logit_3.0 -_%logit_3.0 group_%logit_1.0  of_%logit_1.0  patients_%logit_0.0  who_%logit_3.0  are_%logit_2.0  at_%logit_2.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  infection_%logit_3.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  an_%logit_3.0  urgent_%logit_3.0  need_%logit_3.0  for_%logit_0.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0  and_%logit_0.0  executed_%logit_0.0  random_%logit_2.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  plate_%logit_3.0 lets_%logit_3.0  and_%logit_0.0  other_%logit_0.0  agents_%logit_3.0  for_%logit_3.0  reducing_%logit_2.0  blood_%logit_0.0  flow_%logit_0.0  and_%logit_0.0  blood_%logit_3.0  loss_%logit_0.0  in_%logit_0.0  people_%logit_3.0  with_%logit_0.0  a_%logit_3.0  peripheral_%logit_3.0  artery_%logit_1.0  les_%logit_0.0 ion_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_1.0  of_%logit_3.0  visual_%logit_1.0  ac_%logit_1.0 uity_%logit_1.0  training_%logit_3.0  for_%logit_0.0  visual_%logit_1.0  health_%logit_0.0  improvement_%logit_0.0  in_%logit_1.0  people_%logit_1.0  with_%logit_3.0  visual_%logit_1.0  impair_%logit_1.0 ments_%logit_3.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_1.0  needed_%logit_1.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  this_%logit_1.0  training_%logit_1.0  for_%logit_1.0  people_%logit_1.0  with_%logit_1.0  impair_%logit_1.0 ments_%logit_1.0  with_%logit_1.0  visual_%logit_1.0  impairment_%logit_1.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  note_%logit_0.0  that_%logit_2.0  there_%logit_1.0  is_%logit_1.0  a_%logit_2.0  need_%logit_1.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  in_%logit_1.0  this_%logit_2.0  area_%logit_1.0 ,_%logit_1.0  as_%logit_2.0  well_%logit_1.0  as_%logit_0.0  in_%logit_2.0  other_%logit_0.0  areas_%logit_0.0  of_%logit_1.0  visual_%logit_1.0  impairment_%logit_3.0 ,_%logit_1.0  such_%logit_1.0  as_%logit_1.0  in_%logit_1.0  contrast_%logit_1.0  to_%logit_3.0  other_%logit_1.0  types_%logit_1.0  of_%logit_1.0  training_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  in_%logit_1.0  contrast_%logit_1.0  with_%logit_3.0  other_%logit_1.0  forms_%logit_1.0  of_%logit_1.0  training_%logit_1.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  an_%logit_1.0  urgent_%logit_1.0  need_%logit_0.0  for_%logit_0.0  a_%logit_1.0  well_%logit_1.0 -_%logit_1.0 designed_%logit_1.0 ,_%logit_1.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_1.0 ed_%logit_2.0  and_%logit_1.0  reported_%logit_0.0  randomized_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_0.0  the_%logit_2.0  effectiveness_%logit_1.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_3.0  efficacy_%logit_3.0  of_%logit_3.0  various_%logit_3.0  types_%logit_1.0  of_%logit_1.0  cognitive_%logit_1.0  training_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  solitary_%logit_3.0  confinement_%logit_3.0  as_%logit_3.0  a_%logit_3.0  means_%logit_1.0  of_%logit_0.0  reducing_%logit_0.0  the_%logit_3.0  number_%logit_3.0  of_%logit_3.0  days_%logit_0.0  spent_%logit_3.0  as_%logit_0.0  an_%logit_0.0  involuntary_%logit_1.0  ward_%logit_0.0  in_%logit_1.0  mental_%logit_0.0  health_%logit_1.0  facilities_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  solitary_%logit_1.0  solitary_%logit_3.0  confinement_%logit_3.0  in_%logit_3.0  isolation_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  solitary_%logit_2.0  confinement_%logit_3.0  with_%logit_3.0  other_%logit_3.0  forms_%logit_3.0  of_%logit_3.0  isolation_%logit_1.0  in_%logit_3.0  a_%logit_3.0  population_%logit_1.0  with_%logit_1.0  a_%logit_3.0  history_%logit_3.0  of_%logit_3.0  mental_%logit_3.0  health_%logit_3.0  problems_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  how_%logit_2.0  solitary_%logit_3.0  confinement_%logit_3.0  differs_%logit_3.0  from_%logit_3.0  isolation_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  length_%logit_3.0  of_%logit_3.0  stay_%logit_3.0  in_%logit_3.0  a_%logit_1.0  mental_%logit_1.0  health_%logit_1.0  facility_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  prost_%logit_3.0 ag_%logit_0.0 land_%logit_1.0 ins_%logit_0.0  for_%logit_0.0  ser_%logit_3.0 ocon_%logit_3.0 version_%logit_2.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  prost_%logit_1.0 ig_%logit_3.0 land_%logit_1.0 ins_%logit_0.0  in_%logit_2.0  ser_%logit_1.0 ocon_%logit_2.0 versions_%logit_0.0 ._%logit_1.0  It_%logit_1.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  prost_%logit_0.0 ag_%logit_0.0 LAND_%logit_1.0 ins_%logit_0.0  are_%logit_3.0  used_%logit_0.0  to_%logit_0.0  achieve_%logit_1.0  their_%logit_3.0  goal_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  how_%logit_3.0  they_%logit_3.0  are_%logit_0.0  used_%logit_0.0  in_%logit_1.0  the_%logit_3.0  context_%logit_1.0  of_%logit_0.0  a_%logit_1.0  reduction_%logit_1.0  in_%logit_1.0  extr_%logit_0.0 aneous_%logit_0.0  extr_%logit_1.0 aneous_%logit_1.0  organ_%logit_3.0  prol_%logit_3.0 apse_%logit_0.0 ._%logit_1.0  Further_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_1.0  to_%logit_0.0  assess_%logit_1.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0 ,_%logit_0.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  prost_%logit_2.0 ig_%logit_3.0 LAND_%logit_1.0 ins_%logit_0.0  with_%logit_1.0  other_%logit_3.0  treatments_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_1.0  oxy_%logit_1.0 toc_%logit_1.0 in_%logit_1.0 ,_%logit_3.0  ib_%logit_3.0 up_%logit_3.0 ro_%logit_1.0 fen_%logit_1.0  and_%logit_1.0  ib_%logit_2.0 up_%logit_3.0 rop_%logit_1.0 ub_%logit_1.0 ic_%logit_1.0  acid_%logit_2.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  ib_%logit_3.0 up_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  nasal_%logit_1.0  congestion_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  a_%logit_3.0  common_%logit_3.0  cold_%logit_0.0 ._%logit_0.0  There_%logit_2.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  in_%logit_2.0  this_%logit_3.0  area_%logit_3.0 ,_%logit_2.0  particularly_%logit_2.0  in_%logit_2.0  patients_%logit_3.0  who_%logit_3.0  are_%logit_2.0  at_%logit_2.0  high_%logit_2.0  risk_%logit_1.0  of_%logit_1.0  complications_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  in_%logit_3.0  those_%logit_3.0  who_%logit_3.0  are_%logit_3.0  unable_%logit_2.0  to_%logit_2.0  tolerate_%logit_2.0  the_%logit_2.0  drug_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  an_%logit_3.0  urgent_%logit_3.0  need_%logit_0.0  for_%logit_0.0  a_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_1.0  and_%logit_2.0  executed_%logit_2.0  randomized_%logit_2.0  controlled_%logit_2.0  trial_%logit_2.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  ib_%logit_3.0 ip_%logit_3.0 ro_%logit_2.0 fen_%logit_2.0  for_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  and_%logit_3.0  prevention_%logit_3.0  of_%logit_3.0  congestion_%logit_0.0  in_%logit_3.0  the_%logit_3.0  common_%logit_3.0  cold_%logit_0.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  evaluate_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  other_%logit_3.0  chronic_%logit_3.0  cold_%logit_3.0  conditions_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 roc_%logit_3.0 oll_%logit_1.0 oid_%logit_3.0  gel_%logit_0.0  as_%logit_3.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_3.0  other_%logit_0.0  analges_%logit_3.0 ics_%logit_3.0  in_%logit_2.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  acute_%logit_1.0  pain_%logit_3.0  fractures_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  Hyd_%logit_3.0 roc_%logit_1.0 oll_%logit_3.0 oids_%logit_1.0  gel_%logit_2.0  as_%logit_1.0  an_%logit_2.0  adjunct_%logit_3.0  to_%logit_0.0  other_%logit_0.0  analges_%logit_3.0 ic_%logit_3.0  treatments_%logit_2.0  for_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0  in_%logit_3.0  adults_%logit_3.0  with_%logit_3.0  fractures_%logit_3.0  of_%logit_3.0  the_%logit_3.0  inner_%logit_3.0 most_%logit_3.0  limb_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  determine_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  hyd_%logit_1.0 oc_%logit_1.0 oll_%logit_3.0 oid_%logit_1.0  therapy_%logit_2.0 ._%logit_2.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  trials_%logit_2.0  should_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  hyd_%logit_3.0 rop_%logit_3.0 oll_%logit_3.0 oid_%logit_1.0  treatment_%logit_1.0  for_%logit_2.0  acute_%logit_1.0  pain_%logit_3.0  relief_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_1.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  durability_%logit_1.0 ,_%logit_3.0  in_%logit_3.0  adults_%logit_3.0  and_%logit_3.0  children_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  cort_%logit_3.0 ic_%logit_3.0 oster_%logit_0.0 oids_%logit_0.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  ul_%logit_1.0 cer_%logit_3.0 ative_%logit_0.0  col_%logit_3.0 itis_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_2.0  of_%logit_2.0  steroids_%logit_2.0  and_%logit_3.0  to_%logit_1.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  the_%logit_2.0  management_%logit_3.0  of_%logit_3.0  these_%logit_3.0  patients_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  these_%logit_3.0  medications_%logit_3.0  in_%logit_3.0  treating_%logit_2.0  patients_%logit_3.0  with_%logit_3.0  mild_%logit_1.0  to_%logit_3.0  moderately_%logit_3.0  severe_%logit_1.0  disease_%logit_0.0 ,_%logit_3.0  and_%logit_3.0  also_%logit_3.0  to_%logit_3.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  these_%logit_3.0  treatments_%logit_3.0  in_%logit_3.0  terms_%logit_1.0  of_%logit_3.0  their_%logit_3.0  effectiveness_%logit_3.0  and_%logit_1.0  safety_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_3.0  specific_%logit_3.0  type_%logit_3.0  of_%logit_3.0  orth_%logit_1.0 op_%logit_1.0 aed_%logit_1.0 ic_%logit_0.0  instrument_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  post_%logit_1.0 -_%logit_3.0 operative_%logit_3.0  hem_%logit_0.0 em_%logit_3.0 or_%logit_0.0 rh_%logit_0.0 agic_%logit_0.0  complications_%logit_1.0 ._%logit_3.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0 ,_%logit_2.0  conducted_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trials_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  orth_%logit_3.0 oped_%logit_3.0 ic_%logit_0.0  instrument_%logit_0.0 ation_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  mortality_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  in_%logit_0.0  post_%logit_3.0 operative_%logit_3.0  hem_%logit_0.0 mor_%logit_3.0 rh_%logit_2.0 agic_%logit_0.0  injuries_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_3.0  a_%logit_1.0  large_%logit_3.0  number_%logit_3.0  of_%logit_3.0  patients_%logit_3.0 ,_%logit_0.0  with_%logit_1.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  bias_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  with_%logit_1.0  a_%logit_2.0  low_%logit_3.0  risk_%logit_1.0  of_%logit_0.0  random_%logit_0.0  errors_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  topical_%logit_1.0  gel_%logit_0.0  gel_%logit_3.0  gel_%logit_2.0  as_%logit_2.0  a_%logit_0.0  substitute_%logit_0.0  for_%logit_0.0  topical_%logit_0.0  gel_%logit_2.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  ven_%logit_1.0 ous_%logit_0.0  punct_%logit_2.0 ure_%logit_0.0  pain_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  gel_%logit_3.0  gel_%logit_1.0  is_%logit_2.0  more_%logit_1.0  effective_%logit_0.0  than_%logit_1.0  gel_%logit_2.0  gel_%logit_2.0  in_%logit_2.0  relie_%logit_2.0 ving_%logit_3.0  pain_%logit_2.0  or_%logit_3.0  discomfort_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  ven_%logit_1.0 ous_%logit_1.0  occ_%logit_1.0 l_%logit_1.0 usion_%logit_0.0  pain_%logit_0.0 ,_%logit_2.0  or_%logit_2.0  if_%logit_3.0  gel_%logit_2.0  gel_%logit_2.0  should_%logit_2.0  be_%logit_2.0  used_%logit_2.0  in_%logit_1.0  conjunction_%logit_2.0  with_%logit_3.0  gel_%logit_3.0  gel_%logit_2.0  or_%logit_2.0  gel_%logit_2.0  gel_%logit_2.0 ,_%logit_2.0  or_%logit_2.0  in_%logit_2.0  combination_%logit_2.0  with_%logit_3.0  other_%logit_2.0  gel_%logit_2.0  preparations_%logit_2.0 ._%logit_2.0  Further_%logit_2.0  trials_%logit_2.0  are_%logit_2.0  also_%logit_2.0  needed_%logit_1.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  gel_%logit_1.0  gel_%logit_1.0  and_%logit_2.0  gel_%logit_2.0  gel_%logit_2.0  for_%logit_2.0  pain_%logit_2.0  relief_%logit_0.0  in_%logit_2.0  patients_%logit_3.0  undergoing_%logit_0.0  ven_%logit_2.0 ous_%logit_1.0  ep_%logit_1.0 ine_%logit_1.0 phrine_%logit_2.0  injections_%logit_2.0 ._%logit_2.0
 Learning_%logit_0.0  aids_%logit_1.0  are_%logit_0.0  effective_%logit_1.0  in_%logit_0.0  reducing_%logit_3.0  the_%logit_3.0  incidence_%logit_3.0  of_%logit_3.0  repeat_%logit_3.0  birth_%logit_3.0 ._%logit_0.0  Learning_%logit_3.0  aids_%logit_1.0  may_%logit_3.0  reduce_%logit_1.0  the_%logit_3.0  frequency_%logit_3.0  of_%logit_3.0  unintended_%logit_1.0  pregnancies_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  they_%logit_3.0  do_%logit_3.0  not_%logit_2.0  appear_%logit_3.0  to_%logit_2.0  have_%logit_1.0  a_%logit_3.0  significant_%logit_3.0  impact_%logit_2.0  on_%logit_2.0  maternal_%logit_2.0  satisfaction_%logit_3.0  with_%logit_3.0  learning_%logit_1.0  aids_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_1.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  learning_%logit_1.0  aids_%logit_1.0  in_%logit_2.0  reducing_%logit_1.0  repeat_%logit_3.0  birth_%logit_3.0  rates_%logit_0.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  their_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  unintended_%logit_3.0  pregnancies_%logit_3.0 ._%logit_3.0  Research_%logit_3.0  is_%logit_0.0  also_%logit_2.0  needed_%logit_1.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  educational_%logit_3.0  aids_%logit_1.0  in_%logit_1.0  enhancing_%logit_1.0  knowledge_%logit_0.0  and_%logit_0.0  informing_%logit_3.0  parents_%logit_0.0  about_%logit_3.0  the_%logit_1.0  risks_%logit_3.0  and_%logit_3.0  benefits_%logit_1.0  of_%logit_3.0  knowledge_%logit_1.0  aids_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  erg_%logit_3.0 ost_%logit_3.0 asis_%logit_3.0  for_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  my_%logit_1.0 ot_%logit_0.0 onia_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  erg_%logit_3.0 ost_%logit_1.0 as_%logit_1.0 one_%logit_1.0  is_%logit_0.0  beneficial_%logit_3.0  or_%logit_3.0  harmful_%logit_3.0  for_%logit_0.0  people_%logit_3.0  with_%logit_0.0  this_%logit_3.0  condition_%logit_3.0 ,_%logit_3.0  or_%logit_2.0  whether_%logit_3.0  it_%logit_3.0  is_%logit_3.0  beneficial_%logit_3.0  for_%logit_3.0  them_%logit_3.0  to_%logit_3.0  use_%logit_2.0  it_%logit_2.0  as_%logit_1.0  an_%logit_3.0  adjunct_%logit_0.0  to_%logit_0.0  other_%logit_0.0  forms_%logit_3.0  of_%logit_3.0  physical_%logit_3.0  activity_%logit_3.0 ,_%logit_3.0  such_%logit_3.0  as_%logit_3.0  walking_%logit_1.0 ,_%logit_1.0  cycling_%logit_3.0 ,_%logit_1.0  or_%logit_3.0  other_%logit_1.0  activities_%logit_3.0  of_%logit_3.0  daily_%logit_1.0  life_%logit_3.0 ._%logit_3.0  It_%logit_3.0  is_%logit_0.0  also_%logit_2.0  important_%logit_2.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  erg_%logit_0.0 ost_%logit_1.0 asm_%logit_1.0  works_%logit_3.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_3.0  as_%logit_1.0  the_%logit_2.0  mechanism_%logit_3.0  by_%logit_3.0  which_%logit_3.0  it_%logit_3.0  works_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  interventions_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  cervical_%logit_3.0  ultr_%logit_0.0 ason_%logit_0.0 ography_%logit_1.0  as_%logit_0.0  a_%logit_3.0  diagnostic_%logit_0.0  tool_%logit_0.0  for_%logit_2.0  HPV_%logit_3.0  testing_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  cervical_%logit_3.0  ultr_%logit_0.0 ator_%logit_1.0 ography_%logit_0.0  technique_%logit_0.0  and_%logit_1.0  to_%logit_1.0  assess_%logit_0.0  the_%logit_2.0  best_%logit_3.0  way_%logit_3.0  to_%logit_3.0  achieve_%logit_1.0  this_%logit_2.0  objective_%logit_1.0 ._%logit_1.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  ultr_%logit_1.0 ason_%logit_1.0 ographic_%logit_1.0  techniques_%logit_2.0  in_%logit_3.0  HPV_%logit_1.0  testing_%logit_3.0 ,_%logit_2.0  especially_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_3.0  accuracy_%logit_3.0 ,_%logit_3.0  specificity_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  specificity_%logit_3.0 ._%logit_3.0  The_%logit_3.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  should_%logit_0.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_0.0  caution_%logit_1.0 ,_%logit_3.0  as_%logit_2.0  results_%logit_2.0  are_%logit_0.0  based_%logit_1.0  on_%logit_0.0  only_%logit_0.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_3.0  studies_%logit_3.0  and_%logit_3.0  the_%logit_2.0  results_%logit_3.0  are_%logit_0.0  not_%logit_2.0  representative_%logit_0.0  of_%logit_1.0  the_%logit_3.0  whole_%logit_3.0  range_%logit_3.0  of_%logit_3.0  HPV_%logit_2.0  testing_%logit_3.0  methods_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 roc_%logit_0.0 obal_%logit_1.0 amin_%logit_3.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  c_%logit_3.0 obal_%logit_3.0 amin_%logit_2.0  deficiency_%logit_3.0  in_%logit_1.0  people_%logit_3.0  with_%logit_0.0  C_%logit_1.0 obal_%logit_3.0 amin_%logit_2.0  deficient_%logit_3.0 ._%logit_3.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  hyd_%logit_3.0 roc_%logit_0.0 ouble_%logit_3.0 asin_%logit_2.0  formulation_%logit_2.0 ,_%logit_0.0  the_%logit_1.0  best_%logit_3.0  formulation_%logit_0.0  and_%logit_3.0  timing_%logit_0.0  of_%logit_0.0  hyd_%logit_1.0 oc_%logit_1.0 obal_%logit_3.0 amin_%logit_3.0  supplementation_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  the_%logit_3.0  best_%logit_3.0  way_%logit_0.0  to_%logit_3.0  administer_%logit_1.0  it_%logit_2.0 ._%logit_3.0  In_%logit_3.0  addition_%logit_0.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_0.0  need_%logit_1.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0  and_%logit_2.0  executed_%logit_0.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  hyd_%logit_3.0 rop_%logit_1.0 obal_%logit_3.0 amin_%logit_2.0  in_%logit_2.0  this_%logit_1.0  population_%logit_0.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  of_%logit_3.0  benz_%logit_3.0 od_%logit_3.0 iazep_%logit_2.0 ine_%logit_2.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  P_%logit_3.0 N_%logit_3.0 SS_%logit_2.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  confirm_%logit_2.0  the_%logit_2.0  existence_%logit_3.0  and_%logit_3.0  validity_%logit_3.0  of_%logit_3.0  these_%logit_3.0  findings_%logit_3.0  and_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_3.0  in_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  P_%logit_3.0 AN_%logit_3.0 SS_%logit_1.0 ._%logit_2.0  Recommend_%logit_3.0 ations_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  clarify_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  profile_%logit_3.0  of_%logit_3.0  benz_%logit_2.0 ad_%logit_3.0 iazep_%logit_2.0 ine_%logit_2.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  its_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  toler_%logit_3.0 ability_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  evaluate_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  other_%logit_2.0  situations_%logit_3.0 ,_%logit_3.0  such_%logit_2.0  as_%logit_3.0  insomnia_%logit_1.0  or_%logit_3.0  depression_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  depression_%logit_1.0  in_%logit_3.0  children_%logit_3.0  and_%logit_3.0  adolescents_%logit_3.0  with_%logit_0.0  major_%logit_3.0  depression_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  antidepressant_%logit_3.0  dose_%logit_2.0  and_%logit_2.0  duration_%logit_1.0 ,_%logit_0.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  antidepressants_%logit_1.0  with_%logit_3.0  other_%logit_1.0  antidepressants_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  for_%logit_3.0  depression_%logit_1.0  in_%logit_3.0  these_%logit_2.0  children_%logit_3.0  or_%logit_3.0  adolescents_%logit_2.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  to_%logit_0.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antidepressant_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  depression_%logit_3.0  severity_%logit_3.0  and_%logit_3.0  severity_%logit_3.0  in_%logit_3.0  these_%logit_3.0  patients_%logit_3.0 ,_%logit_3.0  a_%logit_2.0  meta_%logit_2.0 -_%logit_2.0 analysis_%logit_0.0  is_%logit_0.0  required_%logit_2.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_2.0  duration_%logit_1.0  of_%logit_0.0  antidepressants_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  erg_%logit_3.0 onomic_%logit_3.0  tools_%logit_1.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  TH_%logit_3.0 Ds_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  erg_%logit_3.0 onomic_%logit_1.0  techniques_%logit_1.0  are_%logit_3.0  effective_%logit_1.0  in_%logit_3.0  reducing_%logit_3.0  TH_%logit_0.0 Ds_%logit_3.0  in_%logit_1.0  patients_%logit_1.0  with_%logit_0.0  TH_%logit_1.0 Ds_%logit_2.0 ,_%logit_1.0  or_%logit_1.0  whether_%logit_3.0  they_%logit_3.0  should_%logit_1.0  be_%logit_1.0  used_%logit_2.0  as_%logit_1.0  a_%logit_3.0  substitute_%logit_1.0  for_%logit_0.0  erg_%logit_0.0 onomic_%logit_1.0  methods_%logit_1.0  in_%logit_3.0  treating_%logit_1.0  TH_%logit_0.0 Ds_%logit_3.0  with_%logit_1.0  erg_%logit_3.0 onomic_%logit_3.0  materials_%logit_1.0 ._%logit_3.0  In_%logit_1.0  addition_%logit_0.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  erg_%logit_2.0 onomic_%logit_1.0  technologies_%logit_1.0  for_%logit_3.0  TH_%logit_1.0 Ds_%logit_0.0  and_%logit_1.0  other_%logit_1.0  aspects_%logit_0.0  of_%logit_3.0  TH_%logit_0.0 D_%logit_0.0  management_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  F_%logit_3.0 SH_%logit_3.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  mature_%logit_1.0  o_%logit_3.0 ocytes_%logit_3.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  F_%logit_3.0 SH_%logit_1.0  should_%logit_1.0  be_%logit_1.0  used_%logit_2.0  for_%logit_1.0  mature_%logit_2.0  o_%logit_0.0 ocyte_%logit_3.0  retrieval_%logit_1.0 ,_%logit_3.0  the_%logit_3.0  timing_%logit_3.0  and_%logit_3.0  duration_%logit_1.0  of_%logit_0.0  foll_%logit_1.0 icle_%logit_1.0  retrieval_%logit_1.0 ,_%logit_1.0  and_%logit_3.0  the_%logit_3.0  optimal_%logit_3.0  timing_%logit_3.0  and_%logit_0.0  timing_%logit_1.0  of_%logit_0.0  administration_%logit_1.0  in_%logit_0.0  these_%logit_3.0  o_%logit_0.0 ocytes_%logit_3.0 ,_%logit_1.0  as_%logit_2.0  well_%logit_0.0  as_%logit_0.0  the_%logit_2.0  optimal_%logit_3.0  dosage_%logit_3.0  and_%logit_3.0  timing_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_1.0 term_%logit_3.0  follow_%logit_1.0 -_%logit_0.0 up_%logit_3.0  data_%logit_0.0  are_%logit_3.0  needed_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  the_%logit_3.0  F_%logit_0.0 SH_%logit_1.0  treatment_%logit_1.0  in_%logit_1.0  mature_%logit_1.0  and_%logit_0.0  developing_%logit_3.0  o_%logit_1.0 ocytes_%logit_3.0  and_%logit_1.0  to_%logit_1.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  the_%logit_1.0  various_%logit_3.0  F_%logit_0.0 SH_%logit_3.0  reg_%logit_1.0 imens_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  prog_%logit_3.0 est_%logit_3.0 ogens_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  uter_%logit_3.0 ine_%logit_3.0  le_%logit_0.0 i_%logit_0.0 omy_%logit_0.0 oma_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  prog_%logit_3.0 est_%logit_0.0 ogen_%logit_0.0  formulation_%logit_1.0  and_%logit_2.0  dosage_%logit_1.0 ,_%logit_3.0  duration_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  duration_%logit_3.0  of_%logit_3.0  treatment_%logit_0.0  in_%logit_1.0  this_%logit_1.0  population_%logit_0.0 ._%logit_0.0  Such_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  include_%logit_2.0  a_%logit_2.0  number_%logit_1.0  of_%logit_1.0  patients_%logit_3.0 ,_%logit_3.0  preferably_%logit_1.0  with_%logit_1.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_0.0  bias_%logit_0.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_1.0  as_%logit_1.0  follow_%logit_2.0 -_%logit_3.0 up_%logit_0.0  of_%logit_0.0  at_%logit_3.0  least_%logit_1.0  one_%logit_1.0  year_%logit_1.0 ._%logit_0.0  Such_%logit_1.0  studies_%logit_0.0  should_%logit_0.0  also_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_0.0  quality_%logit_3.0  and_%logit_3.0  quantity_%logit_0.0  of_%logit_0.0  life_%logit_0.0 ._%logit_0.0  They_%logit_0.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  prog_%logit_1.0 ester_%logit_0.0 one_%logit_0.0  in_%logit_3.0  the_%logit_3.0  management_%logit_0.0  of_%logit_0.0  my_%logit_3.0 ocard_%logit_1.0 ial_%logit_1.0  inf_%logit_1.0 ar_%logit_0.0 ction_%logit_1.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  cat_%logit_1.0 he_%logit_1.0 ters_%logit_3.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_0.0  per_%logit_3.0 iton_%logit_0.0 itis_%logit_0.0  or_%logit_3.0  exit_%logit_3.0  site_%logit_3.0  leaks_%logit_3.0 ._%logit_3.0  Cat_%logit_3.0 he_%logit_0.0 ters_%logit_3.0  should_%logit_2.0  not_%logit_1.0  be_%logit_2.0  used_%logit_2.0  as_%logit_1.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_0.0  closed_%logit_0.0  cat_%logit_3.0 heter_%logit_3.0  systems_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_0.0  cat_%logit_3.0 heter_%logit_0.0  survival_%logit_2.0  and_%logit_3.0  cat_%logit_3.0 heter_%logit_0.0  removal_%logit_2.0 ._%logit_0.0  Cat_%logit_3.0 heter_%logit_0.0  removal_%logit_3.0  should_%logit_3.0  be_%logit_3.0  carried_%logit_3.0  out_%logit_1.0  in_%logit_0.0  accordance_%logit_3.0  with_%logit_3.0  the_%logit_3.0  standard_%logit_0.0  procedure_%logit_0.0 ,_%logit_0.0  which_%logit_1.0  should_%logit_1.0  be_%logit_1.0  followed_%logit_3.0  by_%logit_1.0  a_%logit_3.0  cat_%logit_3.0 heter_%logit_1.0  cleaning_%logit_2.0  cycle_%logit_1.0 ._%logit_1.0  The_%logit_0.0  use_%logit_0.0  of_%logit_3.0  a_%logit_1.0  cat_%logit_1.0 he_%logit_1.0 ter_%logit_1.0  cleaning_%logit_2.0  cycle_%logit_1.0  should_%logit_1.0  be_%logit_1.0  considered_%logit_2.0  when_%logit_0.0  determining_%logit_3.0  the_%logit_0.0  optimal_%logit_3.0  cat_%logit_0.0 heter_%logit_1.0  configuration_%logit_1.0  and_%logit_1.0  timing_%logit_1.0  of_%logit_0.0  removal_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  causal_%logit_3.0  relationship_%logit_3.0  between_%logit_3.0  skin_%logit_3.0  colour_%logit_3.0 ing_%logit_0.0  and_%logit_0.0  the_%logit_3.0  frequency_%logit_3.0  and_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  Ray_%logit_3.0 na_%logit_3.0 ud_%logit_2.0 's_%logit_2.0  phenomenon_%logit_0.0 ._%logit_3.0  However_%logit_3.0 ,_%logit_2.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0  and_%logit_2.0  executed_%logit_2.0  random_%logit_2.0 ised_%logit_2.0  controlled_%logit_0.0  trials_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  skin_%logit_1.0  color_%logit_3.0 ning_%logit_2.0  in_%logit_2.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  this_%logit_3.0  common_%logit_3.0  phenomenon_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  high_%logit_0.0  methodological_%logit_2.0  quality_%logit_1.0 ,_%logit_1.0  with_%logit_2.0  a_%logit_2.0  focus_%logit_1.0  on_%logit_1.0  identifying_%logit_0.0  participants_%logit_3.0  who_%logit_3.0  are_%logit_1.0  most_%logit_2.0  likely_%logit_0.0  to_%logit_1.0  benefit_%logit_1.0  from_%logit_1.0  skin_%logit_1.0  color_%logit_1.0 ing_%logit_2.0 ._%logit_2.0  They_%logit_2.0  should_%logit_0.0  also_%logit_2.0  include_%logit_2.0  participants_%logit_2.0  who_%logit_1.0  have_%logit_1.0  been_%logit_2.0  diagnosed_%logit_1.0  with_%logit_1.0  a_%logit_3.0  similar_%logit_3.0  frequency_%logit_3.0  of_%logit_3.0  symptoms_%logit_1.0  as_%logit_1.0  those_%logit_1.0  who_%logit_3.0  are_%logit_1.0  not_%logit_2.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  aeros_%logit_3.0 ols_%logit_3.0  in_%logit_0.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_3.0  nasal_%logit_3.0  congestion_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  aeros_%logit_3.0 ols_%logit_2.0  for_%logit_1.0  nasal_%logit_1.0  congestion_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  aeros_%logit_2.0 ols_%logit_3.0  to_%logit_1.0  aeros_%logit_3.0 ols_%logit_3.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_2.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  aeros_%logit_1.0 ol_%logit_3.0  inhal_%logit_0.0 ation_%logit_3.0  therapy_%logit_1.0  in_%logit_3.0  the_%logit_1.0  management_%logit_3.0  of_%logit_3.0  respiratory_%logit_3.0  distress_%logit_3.0  syndrome_%logit_3.0 ._%logit_1.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_2.0  should_%logit_2.0  focus_%logit_3.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  aeros_%logit_3.0 oles_%logit_3.0  in_%logit_0.0  nasal_%logit_1.0  congestion_%logit_3.0  and_%logit_1.0  on_%logit_3.0  identifying_%logit_0.0  the_%logit_3.0  most_%logit_3.0  effective_%logit_3.0  aeros_%logit_3.0 ols_%logit_3.0  and_%logit_1.0  the_%logit_1.0  most_%logit_3.0  efficient_%logit_0.0  aeros_%logit_3.0 ols_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  pro_%logit_3.0 ph_%logit_3.0 yl_%logit_1.0 actic_%logit_0.0  blood_%logit_0.0  transf_%logit_3.0 usion_%logit_0.0  in_%logit_2.0  post_%logit_3.0 -_%logit_0.0 operative_%logit_0.0  liver_%logit_0.0  loss_%logit_0.0 ._%logit_1.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_1.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  this_%logit_3.0  intervention_%logit_0.0 ._%logit_1.0  Such_%logit_1.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  absence_%logit_0.0  of_%logit_0.0  a_%logit_3.0  documented_%logit_3.0  adverse_%logit_3.0  event_%logit_0.0  profile_%logit_1.0 ._%logit_1.0  They_%logit_1.0  should_%logit_0.0  also_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  transf_%logit_1.0 usion_%logit_3.0  on_%logit_2.0  liver_%logit_3.0  function_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_0.0  life_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  on_%logit_0.0  mortality_%logit_0.0 ,_%logit_3.0  liver_%logit_3.0  function_%logit_1.0 ,_%logit_0.0  liver_%logit_3.0  autonomy_%logit_3.0  and_%logit_0.0  liver_%logit_1.0  autonomy_%logit_3.0 ._%logit_0.0  They_%logit_3.0  also_%logit_0.0  should_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effect_%logit_3.0  of_%logit_3.0  transf_%logit_1.0 usions_%logit_3.0  on_%logit_2.0  liver_%logit_1.0  autonomy_%logit_3.0 ,_%logit_1.0  liver_%logit_1.0  independence_%logit_3.0  and_%logit_1.0  liver_%logit_3.0  function_%logit_3.0 ._%logit_3.0  They_%logit_3.0  are_%logit_0.0  also_%logit_2.0  required_%logit_0.0  to_%logit_0.0  assess_%logit_1.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  liver_%logit_1.0  integrity_%logit_3.0  and_%logit_3.0  liver_%logit_3.0  integrity_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_3.0  of_%logit_3.0  the_%logit_3.0  interventions_%logit_0.0  in_%logit_0.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_0.0  prostate_%logit_1.0  enlarg_%logit_3.0 ement_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  these_%logit_3.0  interventions_%logit_3.0 ,_%logit_0.0  and_%logit_2.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  them_%logit_3.0  in_%logit_3.0  particular_%logit_1.0  in_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  enlarged_%logit_3.0  prostate_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  them_%logit_1.0  on_%logit_3.0  quality_%logit_2.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  health_%logit_3.0 -_%logit_0.0 related_%logit_0.0  productivity_%logit_0.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_2.0  whether_%logit_2.0  these_%logit_3.0  interventions_%logit_3.0  are_%logit_0.0  beneficial_%logit_1.0  or_%logit_0.0  harmful_%logit_3.0 ,_%logit_0.0  the_%logit_3.0  results_%logit_2.0  should_%logit_3.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_0.0  caution_%logit_1.0 ,_%logit_1.0  as_%logit_2.0  they_%logit_2.0  are_%logit_3.0  based_%logit_2.0  on_%logit_0.0  only_%logit_0.0  a_%logit_0.0  small_%logit_0.0  number_%logit_3.0  of_%logit_3.0  patients_%logit_0.0  and_%logit_0.0  are_%logit_2.0  subject_%logit_0.0  to_%logit_0.0  a_%logit_0.0  high_%logit_3.0  risk_%logit_3.0  of_%logit_1.0  bias_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  depression_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  for_%logit_3.0  depression_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  with_%logit_3.0  other_%logit_1.0  antidepressants_%logit_3.0  in_%logit_3.0  terms_%logit_2.0  of_%logit_3.0  improvement_%logit_3.0  in_%logit_3.0  mood_%logit_3.0 ,_%logit_3.0  cognition_%logit_3.0  and_%logit_3.0  function_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  antidepressants_%logit_3.0  as_%logit_3.0  an_%logit_1.0  adjunct_%logit_3.0  to_%logit_0.0  other_%logit_0.0  antidepressants_%logit_3.0 ,_%logit_3.0  future_%logit_1.0  research_%logit_2.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  the_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  aspects_%logit_3.0  of_%logit_3.0  antidepressants_%logit_1.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_1.0  on_%logit_2.0  their_%logit_3.0  effectiveness_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  depressive_%logit_3.0  symptoms_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  on_%logit_3.0  improving_%logit_3.0  mood_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  prog_%logit_3.0 est_%logit_3.0 ogen_%logit_0.0  as_%logit_3.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_0.0  oxy_%logit_0.0 toc_%logit_3.0 in_%logit_1.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  IGF_%logit_1.0 -_%logit_3.0 I_%logit_1.0  or_%logit_0.0  IGF_%logit_1.0 -_%logit_0.0 II_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  whether_%logit_2.0  prog_%logit_3.0 est_%logit_1.0 ogens_%logit_2.0  are_%logit_3.0  beneficial_%logit_1.0  or_%logit_3.0  harmful_%logit_3.0  in_%logit_0.0  improving_%logit_3.0  fetal_%logit_3.0  wellbeing_%logit_3.0  and_%logit_3.0  maternal_%logit_3.0  wellbeing_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  undertaken_%logit_2.0  in_%logit_0.0  the_%logit_2.0  context_%logit_0.0  of_%logit_3.0  a_%logit_1.0  well_%logit_3.0 -_%logit_3.0 defined_%logit_1.0  group_%logit_1.0  of_%logit_0.0  women_%logit_0.0  who_%logit_3.0  are_%logit_1.0  at_%logit_2.0  risk_%logit_1.0  of_%logit_1.0  developing_%logit_1.0  IGF_%logit_1.0 -_%logit_1.0 1_%logit_1.0  deficiency_%logit_1.0  or_%logit_1.0  developing_%logit_3.0  IGF_%logit_1.0 2_%logit_3.0  deficiency_%logit_1.0 ._%logit_0.0  They_%logit_3.0  should_%logit_0.0  also_%logit_2.0  include_%logit_2.0  women_%logit_2.0  who_%logit_1.0  have_%logit_1.0  been_%logit_1.0  diagnosed_%logit_1.0  with_%logit_1.0  IGF_%logit_1.0 -_%logit_3.0 2_%logit_1.0  deficiency_%logit_0.0  and_%logit_3.0  those_%logit_1.0  who_%logit_0.0  do_%logit_3.0  not_%logit_1.0  have_%logit_3.0  an_%logit_1.0  IGF_%logit_3.0 -_%logit_0.0 3_%logit_2.0  deficiency_%logit_2.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  alcohol_%logit_3.0  as_%logit_3.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_0.0  tea_%logit_0.0  or_%logit_3.0  tea_%logit_3.0  as_%logit_3.0  an_%logit_3.0  adjunct_%logit_3.0  to_%logit_0.0  tea_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  gast_%logit_1.0 ric_%logit_3.0  volume_%logit_0.0  and_%logit_3.0  pH_%logit_3.0  imbalance_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  ana_%logit_1.0 esthesia_%logit_3.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  ratio_%logit_3.0  of_%logit_2.0  alcohol_%logit_2.0  and_%logit_3.0  tea_%logit_3.0  to_%logit_3.0  tea_%logit_3.0  and_%logit_3.0  tea_%logit_3.0  as_%logit_3.0  a_%logit_3.0  supplement_%logit_0.0  to_%logit_0.0  tea_%logit_0.0  or_%logit_3.0  water_%logit_3.0  as_%logit_3.0  a_%logit_0.0  complement_%logit_0.0  to_%logit_0.0  tea_%logit_0.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_2.0  should_%logit_2.0  evaluate_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  alcohol_%logit_3.0  on_%logit_3.0  gast_%logit_3.0 ric_%logit_3.0  volumes_%logit_3.0  and_%logit_0.0  pH_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  undergoing_%logit_1.0  ana_%logit_1.0 esthesia_%logit_3.0 ,_%logit_2.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  the_%logit_2.0  effect_%logit_3.0  of_%logit_3.0  tea_%logit_1.0  and_%logit_3.0  water_%logit_3.0  as_%logit_3.0  an_%logit_2.0  adj_%logit_0.0 u_%logit_0.0 vant_%logit_1.0  to_%logit_1.0  tea_%logit_0.0 ,_%logit_3.0  and_%logit_3.0  on_%logit_2.0  the_%logit_3.0  incidence_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  effects_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_1.0  nausea_%logit_1.0  and_%logit_3.0  vomiting_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_0.0  hyd_%logit_3.0 rog_%logit_3.0 el_%logit_1.0  in_%logit_0.0  the_%logit_2.0  treatment_%logit_0.0  of_%logit_0.0  local_%logit_1.0  tum_%logit_0.0 our_%logit_0.0  rec_%logit_0.0 urrence_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  hyd_%logit_3.0 rog_%logit_1.0 els_%logit_1.0  and_%logit_2.0  the_%logit_1.0  optimal_%logit_3.0  dose_%logit_0.0 ,_%logit_1.0  duration_%logit_1.0  and_%logit_1.0  timing_%logit_1.0  of_%logit_2.0  hyd_%logit_1.0 og_%logit_1.0 el_%logit_1.0  in_%logit_2.0  treating_%logit_2.0  local_%logit_0.0  tum_%logit_3.0 ours_%logit_0.0  and_%logit_0.0  to_%logit_3.0  determine_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  formulation_%logit_0.0  and_%logit_3.0  timing_%logit_1.0 ._%logit_0.0  The_%logit_1.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  should_%logit_2.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_0.0  caution_%logit_1.0 ,_%logit_1.0  as_%logit_2.0  the_%logit_2.0  conclusions_%logit_0.0  are_%logit_0.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_0.0  number_%logit_3.0  of_%logit_0.0  small_%logit_0.0  studies_%logit_0.0  with_%logit_0.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_0.0  bias_%logit_0.0  and_%logit_3.0  are_%logit_2.0  subject_%logit_3.0  to_%logit_0.0  change_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  difference_%logit_3.0  in_%logit_3.0  body_%logit_3.0  mass_%logit_3.0 ,_%logit_0.0  caloric_%logit_3.0  intake_%logit_3.0 ,_%logit_0.0  protein_%logit_3.0  intake_%logit_3.0  or_%logit_3.0  protein_%logit_3.0  intake_%logit_3.0  between_%logit_3.0  the_%logit_3.0  two_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  measuring_%logit_1.0  body_%logit_3.0  mass_%logit_3.0  and_%logit_0.0  protein_%logit_3.0  intake_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_3.0  the_%logit_2.0  best_%logit_3.0  way_%logit_3.0  to_%logit_3.0  measure_%logit_3.0  body_%logit_2.0  mass_%logit_3.0  in_%logit_0.0  relation_%logit_3.0  to_%logit_3.0  protein_%logit_3.0  intake_%logit_3.0 ,_%logit_0.0  carbohydrate_%logit_3.0  intake_%logit_3.0  and_%logit_3.0  protein_%logit_3.0  intakes_%logit_0.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  protein_%logit_3.0  intake_%logit_3.0  on_%logit_3.0  energy_%logit_3.0  intake_%logit_3.0  and_%logit_0.0  caloric_%logit_3.0  intake_%logit_3.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  measuring_%logit_3.0  protein_%logit_3.0  intake_%logit_3.0  and_%logit_0.0  carbohydrate_%logit_3.0  intake_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  on_%logit_3.0  measuring_%logit_3.0  energy_%logit_3.0  intake_%logit_3.0 ,_%logit_3.0  nutrient_%logit_3.0  intake_%logit_3.0  and_%logit_3.0  nutrient_%logit_3.0  intake_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_1.0  of_%logit_3.0  phot_%logit_1.0 oco_%logit_1.0 ag_%logit_1.0 ulation_%logit_2.0  for_%logit_0.0  spherical_%logit_3.0  equivalent_%logit_3.0  ref_%logit_3.0 ract_%logit_3.0 ory_%logit_2.0  vision_%logit_1.0  correction_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  phot_%logit_3.0 oco_%logit_1.0 agg_%logit_2.0 ulation_%logit_1.0  technique_%logit_2.0 ,_%logit_1.0  the_%logit_1.0  best_%logit_1.0  way_%logit_1.0  to_%logit_1.0  achieve_%logit_1.0  this_%logit_2.0 ,_%logit_1.0  and_%logit_1.0  the_%logit_1.0  most_%logit_3.0  effective_%logit_0.0  phot_%logit_1.0 o_%logit_1.0 ag_%logit_2.0 ulation_%logit_1.0  technique_%logit_2.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  evaluation_%logit_1.0  of_%logit_1.0  the_%logit_1.0  effectiveness_%logit_1.0  and_%logit_3.0  safety_%logit_1.0  aspects_%logit_3.0  of_%logit_3.0  phot_%logit_1.0 oc_%logit_1.0 ag_%logit_2.0 ulation_%logit_2.0  in_%logit_2.0  spherical_%logit_1.0  equivalent_%logit_1.0  vision_%logit_3.0  correction_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_1.0  as_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  phot_%logit_1.0 otherapy_%logit_1.0  in_%logit_1.0  spherical_%logit_1.0  or_%logit_1.0  spherical_%logit_1.0  equivalent_%logit_1.0  correction_%logit_3.0 ._%logit_3.0
 In_%logit_0.0 flix_%logit_0.0 im_%logit_0.0 ab_%logit_1.0  is_%logit_0.0  effective_%logit_0.0  in_%logit_0.0  maintaining_%logit_2.0  remission_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  Cro_%logit_3.0 hn_%logit_3.0 's_%logit_3.0  disease_%logit_0.0 ._%logit_0.0  Its_%logit_3.0  efficacy_%logit_0.0  is_%logit_3.0  similar_%logit_3.0  to_%logit_3.0  that_%logit_1.0  of_%logit_3.0  infl_%logit_1.0 ix_%logit_3.0 im_%logit_1.0 ab_%logit_2.0 ,_%logit_0.0  but_%logit_3.0  with_%logit_3.0  a_%logit_3.0  lower_%logit_3.0  incidence_%logit_3.0  of_%logit_0.0  adverse_%logit_0.0  events_%logit_3.0 ._%logit_3.0  It_%logit_3.0  is_%logit_2.0  not_%logit_2.0  clear_%logit_3.0  whether_%logit_2.0  it_%logit_3.0  has_%logit_3.0  an_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  the_%logit_2.0  number_%logit_3.0  of_%logit_3.0  days_%logit_3.0  lost_%logit_0.0  to_%logit_1.0  treatment_%logit_1.0  or_%logit_3.0  on_%logit_3.0  the_%logit_0.0  severity_%logit_3.0  of_%logit_3.0  the_%logit_3.0  disease_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  it_%logit_3.0  is_%logit_3.0  unlikely_%logit_2.0  that_%logit_3.0  it_%logit_3.0  will_%logit_3.0  have_%logit_2.0  an_%logit_2.0  impact_%logit_3.0  on_%logit_2.0  the_%logit_2.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  of_%logit_0.0  patients_%logit_2.0  who_%logit_0.0  are_%logit_2.0  unable_%logit_2.0  to_%logit_2.0  tolerate_%logit_3.0  it_%logit_2.0 ._%logit_3.0  It_%logit_2.0  may_%logit_2.0  have_%logit_2.0  a_%logit_2.0  beneficial_%logit_3.0  effect_%logit_2.0  on_%logit_2.0  blood_%logit_2.0  pressure_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  its_%logit_3.0  effects_%logit_3.0  are_%logit_3.0  not_%logit_2.0  clear_%logit_3.0  from_%logit_1.0  this_%logit_2.0  review_%logit_2.0 ._%logit_2.0  It_%logit_2.0  should_%logit_0.0  be_%logit_2.0  noted_%logit_2.0  that_%logit_1.0  the_%logit_3.0  data_%logit_0.0  in_%logit_0.0  this_%logit_2.0  review_%logit_0.0  are_%logit_2.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_3.0  number_%logit_0.0  of_%logit_0.0  patients_%logit_3.0 ,_%logit_0.0  and_%logit_2.0  therefore_%logit_3.0  the_%logit_3.0  conclusions_%logit_3.0  of_%logit_3.0  this_%logit_3.0  review_%logit_0.0  should_%logit_0.0  be_%logit_2.0  interpreted_%logit_2.0  cautiously_%logit_3.0 ._%logit_1.0
 The_%logit_0.0  results_%logit_0.0  of_%logit_3.0  this_%logit_2.0  review_%logit_0.0  support_%logit_2.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  automated_%logit_3.0  PCR_%logit_3.0  kits_%logit_3.0  to_%logit_3.0  enhance_%logit_1.0  the_%logit_3.0  uptake_%logit_3.0  of_%logit_3.0  HIV_%logit_3.0  testing_%logit_0.0  in_%logit_3.0  pregnant_%logit_3.0  women_%logit_0.0  and_%logit_3.0  their_%logit_3.0  partners_%logit_3.0 ._%logit_0.0  However_%logit_3.0 ,_%logit_1.0  there_%logit_0.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  such_%logit_1.0  kits_%logit_1.0  in_%logit_1.0  improving_%logit_1.0  the_%logit_0.0  quality_%logit_3.0  of_%logit_3.0  testing_%logit_3.0  and_%logit_1.0  reducing_%logit_1.0  attrition_%logit_0.0  in_%logit_3.0  the_%logit_3.0  workforce_%logit_0.0 ._%logit_0.0  This_%logit_2.0  is_%logit_0.0  especially_%logit_0.0  true_%logit_3.0  in_%logit_3.0  the_%logit_3.0  context_%logit_0.0  of_%logit_3.0  the_%logit_1.0  increasing_%logit_3.0  prevalence_%logit_3.0  of_%logit_3.0  HIV_%logit_3.0  infection_%logit_3.0  in_%logit_3.0  the_%logit_3.0  developing_%logit_0.0  world_%logit_3.0 ,_%logit_3.0  where_%logit_3.0  the_%logit_3.0  prevalence_%logit_3.0  of_%logit_3.0  viral_%logit_3.0  loads_%logit_3.0  is_%logit_3.0  high_%logit_3.0 ._%logit_3.0  Future_%logit_3.0  research_%logit_0.0  should_%logit_3.0  focus_%logit_3.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  these_%logit_3.0  kits_%logit_1.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  assessing_%logit_2.0  the_%logit_3.0  cost_%logit_3.0 -_%logit_3.0 effect_%logit_1.0 iveness_%logit_1.0  of_%logit_3.0  the_%logit_1.0  kits_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  also_%logit_0.0  on_%logit_0.0  the_%logit_3.0  impact_%logit_3.0  on_%logit_3.0  maternal_%logit_1.0  satisfaction_%logit_3.0  with_%logit_3.0  the_%logit_1.0  kits_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  benz_%logit_3.0 od_%logit_3.0 iazep_%logit_2.0 ines_%logit_2.0  in_%logit_3.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  autonom_%logit_3.0 ic_%logit_3.0  liability_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_1.0  and_%logit_3.0  timing_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  the_%logit_3.0  best_%logit_3.0  way_%logit_3.0  to_%logit_3.0  deliver_%logit_1.0  benz_%logit_2.0 od_%logit_1.0 ine_%logit_2.0  to_%logit_2.0  people_%logit_3.0  with_%logit_3.0  schizophrenia_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0 iazep_%logit_1.0 ines_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  other_%logit_3.0  forms_%logit_3.0  of_%logit_3.0 iazep_%logit_3.0 ine_%logit_3.0  therapy_%logit_3.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_2.0  should_%logit_0.0  evaluate_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  other_%logit_3.0  kinds_%logit_3.0  of_%logit_3.0 iazep_%logit_3.0 am_%logit_3.0  therapy_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_1.0  as_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  aspects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  treatments_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  mel_%logit_3.0 io_%logit_0.0 id_%logit_0.0 osis_%logit_2.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  establish_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  treatment_%logit_3.0  in_%logit_3.0  this_%logit_3.0  population_%logit_3.0 ._%logit_2.0  It_%logit_2.0  is_%logit_0.0  also_%logit_2.0  important_%logit_0.0  to_%logit_2.0  understand_%logit_0.0  the_%logit_2.0  mechanism_%logit_3.0  by_%logit_3.0  which_%logit_3.0  antibiotic_%logit_0.0  treatment_%logit_0.0  differs_%logit_3.0  from_%logit_3.0  antibiotic_%logit_3.0  treatment_%logit_3.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  the_%logit_2.0  mechanisms_%logit_3.0  by_%logit_3.0  which_%logit_3.0  it_%logit_1.0  differs_%logit_3.0  from_%logit_1.0  treatment_%logit_2.0  in_%logit_2.0  terms_%logit_2.0  of_%logit_3.0  duration_%logit_3.0  of_%logit_3.0  treatment_%logit_1.0  and_%logit_1.0  severity_%logit_1.0  of_%logit_3.0  mortality_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  therapy_%logit_3.0  in_%logit_3.0  this_%logit_1.0  group_%logit_3.0  of_%logit_0.0  patients_%logit_2.0 ,_%logit_3.0  and_%logit_2.0  also_%logit_3.0  to_%logit_3.0  compare_%logit_2.0  antibiotic_%logit_2.0  treatment_%logit_3.0  with_%logit_3.0  treatment_%logit_3.0  with_%logit_2.0  antibiotic_%logit_3.0  treatment_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_3.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  pur_%logit_3.0 ulent_%logit_3.0  rh_%logit_1.0 in_%logit_1.0 or_%logit_3.0 rh_%logit_0.0 oe_%logit_0.0 a_%logit_1.0 ._%logit_1.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_1.0  therapy_%logit_3.0  in_%logit_3.0  this_%logit_1.0  condition_%logit_3.0 ._%logit_2.0  In_%logit_2.0  addition_%logit_0.0 ,_%logit_3.0  there_%logit_0.0  are_%logit_3.0  concerns_%logit_3.0  about_%logit_3.0  potential_%logit_1.0  side_%logit_3.0  effects_%logit_3.0 ,_%logit_0.0  such_%logit_3.0  as_%logit_3.0  nausea_%logit_3.0 ,_%logit_3.0  vomiting_%logit_3.0 ,_%logit_3.0  diarr_%logit_3.0 hoe_%logit_3.0 a_%logit_1.0 ,_%logit_1.0  sleep_%logit_3.0 iness_%logit_3.0 ,_%logit_1.0  sleep_%logit_1.0 lessness_%logit_3.0 ,_%logit_1.0  fatigue_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  sleep_%logit_3.0 lessness_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_0.0  antibiotics_%logit_3.0  for_%logit_3.0  this_%logit_3.0  condition_%logit_0.0 ,_%logit_2.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  antibiotic_%logit_2.0  therapy_%logit_3.0  with_%logit_3.0  other_%logit_3.0  treatments_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 roc_%logit_3.0 ort_%logit_3.0 is_%logit_3.0 one_%logit_2.0  as_%logit_0.0  an_%logit_3.0  electroly_%logit_0.0 te_%logit_0.0  solution_%logit_1.0  for_%logit_0.0  the_%logit_0.0  treatment_%logit_3.0  of_%logit_3.0  hard_%logit_3.0  stool_%logit_3.0  formation_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  hyd_%logit_3.0 roc_%logit_0.0 ORT_%logit_3.0 is_%logit_2.0 one_%logit_1.0  formulation_%logit_3.0 ,_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  electroly_%logit_0.0 te_%logit_3.0  formulation_%logit_3.0 ,_%logit_3.0  and_%logit_0.0  the_%logit_3.0  best_%logit_3.0  electroly_%logit_0.0 te_%logit_3.0  composition_%logit_3.0  for_%logit_2.0  the_%logit_3.0  management_%logit_3.0  of_%logit_3.0  soft_%logit_3.0  stool_%logit_3.0  formation_%logit_3.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  hard_%logit_2.0  stool_%logit_3.0  drainage_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  toxicity_%logit_3.0  profiles_%logit_3.0  of_%logit_3.0  various_%logit_1.0  electroly_%logit_3.0 te_%logit_3.0  solutions_%logit_3.0  for_%logit_3.0  soft_%logit_1.0  stool_%logit_3.0  drainage_%logit_3.0  in_%logit_3.0  people_%logit_3.0  who_%logit_3.0  are_%logit_3.0  suffering_%logit_2.0  hard_%logit_1.0  const_%logit_3.0 ipation_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 roc_%logit_3.0 oll_%logit_3.0 oid_%logit_3.0  therapy_%logit_0.0  in_%logit_3.0  reducing_%logit_3.0  the_%logit_3.0  frequency_%logit_3.0  of_%logit_3.0  wet_%logit_3.0  nights_%logit_3.0  in_%logit_3.0  humans_%logit_3.0  with_%logit_3.0  no_%logit_3.0  known_%logit_3.0  adverse_%logit_3.0  effects_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  effectiveness_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  treatments_%logit_3.0  in_%logit_3.0  human_%logit_2.0  beings_%logit_3.0  with_%logit_3.0  no_%logit_2.0  apparent_%logit_3.0  adverse_%logit_3.0  effects_%logit_3.0  on_%logit_3.0  bladder_%logit_2.0  capacity_%logit_3.0  or_%logit_3.0  bladder_%logit_3.0  capacity_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_0.0 term_%logit_2.0  data_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  hydro_%logit_3.0 xy_%logit_3.0 ethyl_%logit_1.0 pred_%logit_1.0 nis_%logit_2.0 ol_%logit_0.0 one_%logit_3.0  in_%logit_3.0  humans_%logit_2.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  its_%logit_2.0  effectiveness_%logit_3.0  in_%logit_3.0  humans_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  phot_%logit_1.0 oco_%logit_1.0 ag_%logit_1.0 ulation_%logit_0.0  in_%logit_0.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_0.0  I_%logit_1.0 OP_%logit_0.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  phot_%logit_1.0 o_%logit_1.0 ag_%logit_1.0 ulation_%logit_1.0  for_%logit_2.0  I_%logit_1.0 OP_%logit_0.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_1.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  this_%logit_3.0  technique_%logit_1.0  with_%logit_1.0  other_%logit_1.0  methods_%logit_1.0  of_%logit_1.0  optical_%logit_1.0  infiltration_%logit_1.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_1.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  efficacy_%logit_1.0  and_%logit_1.0  safety_%logit_1.0  aspects_%logit_0.0  of_%logit_3.0  phot_%logit_1.0 oc_%logit_1.0 ag_%logit_1.0 ulation_%logit_2.0 ,_%logit_2.0  as_%logit_1.0  well_%logit_1.0  as_%logit_1.0  to_%logit_2.0  compare_%logit_0.0  these_%logit_2.0  methods_%logit_1.0  with_%logit_3.0  other_%logit_1.0  techniques_%logit_1.0  of_%logit_3.0  optical_%logit_1.0  infiltr_%logit_1.0 ators_%logit_1.0 ._%logit_1.0
 Cognitive_%logit_0.0  enh_%logit_1.0 ancers_%logit_1.0  are_%logit_1.0  effective_%logit_1.0  in_%logit_0.0  reducing_%logit_3.0  pain_%logit_3.0  intensity_%logit_0.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  chronic_%logit_1.0  low_%logit_3.0 -_%logit_3.0 back_%logit_0.0  pain_%logit_1.0 ,_%logit_0.0  but_%logit_3.0  are_%logit_3.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  higher_%logit_3.0  incidence_%logit_1.0  of_%logit_0.0  adverse_%logit_1.0  effects_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  nausea_%logit_1.0 ,_%logit_3.0  vomiting_%logit_3.0 ,_%logit_3.0  sleep_%logit_3.0 iness_%logit_1.0  and_%logit_1.0  sleep_%logit_1.0 iness_%logit_3.0 ._%logit_1.0  Positive_%logit_3.0  effects_%logit_0.0  were_%logit_3.0  found_%logit_1.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  low_%logit_1.0  pain_%logit_3.0  intensity_%logit_0.0 ,_%logit_1.0  but_%logit_2.0  were_%logit_1.0  not_%logit_3.0  statistically_%logit_3.0  significant_%logit_1.0  in_%logit_1.0  those_%logit_3.0  with_%logit_3.0  sub_%logit_3.0 ac_%logit_1.0 ute_%logit_1.0  pain_%logit_0.0  intensity_%logit_1.0 ._%logit_3.0  Negative_%logit_2.0  effects_%logit_0.0  were_%logit_3.0  observed_%logit_1.0  in_%logit_3.0  those_%logit_3.0  receiving_%logit_3.0  enh_%logit_3.0 ancers_%logit_3.0 ._%logit_1.0  Positive_%logit_2.0  results_%logit_0.0  were_%logit_3.0  consistent_%logit_3.0  with_%logit_3.0  those_%logit_3.0  seen_%logit_1.0  in_%logit_3.0  the_%logit_3.0  previous_%logit_3.0  version_%logit_0.0  of_%logit_2.0  this_%logit_2.0  review_%logit_0.0 ,_%logit_0.0  which_%logit_2.0  was_%logit_2.0  published_%logit_2.0  in_%logit_3.0  the_%logit_2.0  same_%logit_0.0  volume_%logit_0.0  as_%logit_2.0  the_%logit_2.0  original_%logit_3.0  edition_%logit_0.0 ._%logit_2.0  Positive_%logit_2.0  findings_%logit_2.0  were_%logit_3.0  consistent_%logit_3.0  in_%logit_3.0  the_%logit_3.0  assessment_%logit_3.0  of_%logit_3.0  pain_%logit_3.0  intensity_%logit_3.0  and_%logit_1.0  function_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  in_%logit_3.0  those_%logit_3.0  patients_%logit_3.0  receiving_%logit_3.0  enh_%logit_1.0 ancer_%logit_1.0  therapy_%logit_1.0 ._%logit_2.0  Negative_%logit_2.0  results_%logit_0.0  were_%logit_2.0  not_%logit_3.0  reported_%logit_3.0  in_%logit_3.0  the_%logit_2.0  original_%logit_3.0  version_%logit_3.0  of_%logit_2.0  the_%logit_2.0  review_%logit_0.0 ,_%logit_0.0  but_%logit_2.0  the_%logit_2.0  new_%logit_3.0  version_%logit_0.0  has_%logit_2.0  now_%logit_2.0  been_%logit_1.0  published_%logit_3.0  in_%logit_1.0  full_%logit_2.0 ._%logit_0.0  Positive_%logit_2.0  conclusions_%logit_2.0  from_%logit_3.0  this_%logit_3.0  review_%logit_0.0  should_%logit_2.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_3.0  caution_%logit_3.0 ,_%logit_1.0  however_%logit_3.0 ,_%logit_3.0  as_%logit_0.0  the_%logit_3.0  review_%logit_0.0  was_%logit_0.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_0.0  number_%logit_0.0  of_%logit_0.0  studies_%logit_0.0  and_%logit_0.0  therefore_%logit_2.0  the_%logit_0.0  conclusions_%logit_0.0  of_%logit_0.0  the_%logit_3.0  original_%logit_0.0  article_%logit_0.0  are_%logit_2.0  not_%logit_2.0  necessarily_%logit_0.0  the_%logit_3.0  same_%logit_3.0 ._%logit_0.0
 Mel_%logit_0.0 ars_%logit_0.0 op_%logit_2.0 rol_%logit_0.0  is_%logit_1.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_3.0  relapse_%logit_3.0  rates_%logit_3.0  and_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  its_%logit_3.0  effectiveness_%logit_3.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0 ._%logit_1.0  Its_%logit_2.0  efficacy_%logit_0.0  is_%logit_3.0  similar_%logit_3.0  to_%logit_3.0  that_%logit_3.0  of_%logit_1.0  mel_%logit_1.0 ars_%logit_3.0 op_%logit_2.0 rop_%logit_0.0 rol_%logit_1.0 ,_%logit_2.0  but_%logit_2.0  with_%logit_3.0  a_%logit_3.0  higher_%logit_3.0  incidence_%logit_3.0  of_%logit_0.0  adverse_%logit_1.0  effects_%logit_3.0 ._%logit_3.0  Its_%logit_1.0  effectiveness_%logit_0.0  is_%logit_3.0  comparable_%logit_3.0  to_%logit_3.0  that_%logit_3.0  seen_%logit_1.0  in_%logit_1.0  the_%logit_3.0  earlier_%logit_3.0  version_%logit_3.0  of_%logit_2.0  this_%logit_2.0  review_%logit_0.0 ._%logit_0.0  Its_%logit_2.0  duration_%logit_0.0  is_%logit_3.0  longer_%logit_2.0 ,_%logit_1.0  and_%logit_2.0  its_%logit_3.0  duration_%logit_3.0  is_%logit_3.0  shorter_%logit_1.0 ,_%logit_1.0  but_%logit_2.0  the_%logit_2.0  severity_%logit_3.0  of_%logit_3.0  relapse_%logit_3.0  is_%logit_3.0  less_%logit_3.0  clear_%logit_1.0 ._%logit_1.0  It_%logit_2.0  is_%logit_0.0  unlikely_%logit_2.0  that_%logit_2.0  the_%logit_1.0  new_%logit_0.0  version_%logit_3.0  will_%logit_2.0  have_%logit_2.0  a_%logit_2.0  similar_%logit_3.0  efficacy_%logit_2.0  as_%logit_3.0  the_%logit_2.0  older_%logit_0.0  version_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  hyd_%logit_3.0 roc_%logit_3.0 ort_%logit_1.0 is_%logit_3.0 one_%logit_2.0  in_%logit_0.0  the_%logit_3.0  management_%logit_0.0  of_%logit_3.0  arter_%logit_3.0 ios_%logit_3.0 us_%logit_2.0  in_%logit_1.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  vas_%logit_3.0 op_%logit_3.0 ress_%logit_3.0 in_%logit_1.0 -_%logit_0.0 induced_%logit_3.0  hyp_%logit_0.0 ogly_%logit_3.0 ca_%logit_1.0 emia_%logit_1.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  hyd_%logit_3.0 roc_%logit_1.0 ORT_%logit_3.0 is_%logit_1.0 one_%logit_1.0  formulation_%logit_3.0  and_%logit_1.0  dosage_%logit_1.0 ,_%logit_0.0  and_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  hyd_%logit_1.0 oc_%logit_3.0 ort_%logit_3.0 is_%logit_0.0 ones_%logit_1.0  in_%logit_3.0  this_%logit_1.0  population_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_1.0  the_%logit_1.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  electroly_%logit_3.0 te_%logit_3.0  supplements_%logit_3.0  in_%logit_3.0  this_%logit_1.0  setting_%logit_0.0 ._%logit_2.0  Finally_%logit_2.0  there_%logit_0.0  is_%logit_0.0  an_%logit_2.0  urgent_%logit_1.0  need_%logit_0.0  for_%logit_0.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  conducted_%logit_0.0  and_%logit_2.0  reported_%logit_0.0  randomized_%logit_2.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  and_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_3.0  electroly_%logit_1.0 te_%logit_3.0  formulations_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antiv_%logit_3.0 iral_%logit_3.0  drugs_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  candid_%logit_1.0 iasis_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  confirm_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antiv_%logit_1.0 ir_%logit_3.0 als_%logit_2.0  in_%logit_0.0  preventing_%logit_1.0  candid_%logit_3.0 iasis_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  other_%logit_1.0  candid_%logit_3.0 iasis_%logit_3.0  types_%logit_1.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  oral_%logit_1.0  antiv_%logit_3.0 iral_%logit_0.0  agents_%logit_0.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  whether_%logit_2.0  antiv_%logit_3.0 iral_%logit_3.0  medications_%logit_2.0  are_%logit_3.0  more_%logit_1.0  effective_%logit_0.0  than_%logit_1.0  antiv_%logit_2.0 iral_%logit_3.0  treatments_%logit_2.0  in_%logit_3.0  reducing_%logit_2.0  candid_%logit_3.0 iasis_%logit_3.0  severity_%logit_1.0  and_%logit_3.0  duration_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  antiv_%logit_3.0 irus_%logit_3.0  drugs_%logit_2.0  in_%logit_3.0  candid_%logit_1.0 iasis_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  antiv_%logit_2.0 iral_%logit_3.0  therapies_%logit_1.0  to_%logit_3.0  antiv_%logit_1.0 iral_%logit_3.0  ones_%logit_2.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  erg_%logit_3.0 onomic_%logit_3.0  screws_%logit_1.0  for_%logit_3.0  improving_%logit_3.0  patient_%logit_3.0  satisfaction_%logit_3.0  with_%logit_3.0  pain_%logit_1.0  management_%logit_3.0  and_%logit_3.0  function_%logit_3.0  in_%logit_3.0  low_%logit_3.0 -_%logit_0.0 back_%logit_0.0  pain_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_1.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  erg_%logit_3.0 onomic_%logit_3.0  screw_%logit_1.0  screws_%logit_3.0  improve_%logit_3.0  patient_%logit_1.0  satisfaction_%logit_1.0  or_%logit_1.0  function_%logit_1.0  in_%logit_3.0  the_%logit_3.0  short_%logit_3.0 -_%logit_1.0 term_%logit_3.0  or_%logit_1.0  long_%logit_1.0 -_%logit_3.0 term_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  erg_%logit_2.0 onomic_%logit_3.0  devices_%logit_1.0  with_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  screws_%logit_1.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  erg_%logit_3.0 onom_%logit_3.0 ics_%logit_1.0  for_%logit_2.0  reducing_%logit_1.0  patient_%logit_3.0  satisfaction_%logit_0.0  and_%logit_0.0  function_%logit_3.0 ,_%logit_3.0  a_%logit_3.0  meta_%logit_1.0 -_%logit_1.0 analysis_%logit_0.0  of_%logit_0.0  the_%logit_2.0  results_%logit_1.0  of_%logit_3.0  this_%logit_1.0  review_%logit_1.0  is_%logit_2.0  warranted_%logit_2.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  no_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_3.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  che_%logit_3.0 mor_%logit_3.0 ad_%logit_2.0 ox_%logit_0.0 ine_%logit_0.0  as_%logit_2.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_0.0  cis_%logit_0.0 pl_%logit_3.0 atin_%logit_1.0  for_%logit_1.0  radi_%logit_3.0 otherapy_%logit_3.0  in_%logit_2.0  terms_%logit_3.0  of_%logit_0.0  overall_%logit_3.0  survival_%logit_3.0  and_%logit_0.0  progression_%logit_3.0 -_%logit_3.0 free_%logit_3.0  survival_%logit_0.0 ._%logit_1.0  However_%logit_3.0 ,_%logit_2.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  into_%logit_2.0  che_%logit_2.0 mor_%logit_3.0 adi_%logit_0.0 otherapy_%logit_3.0  in_%logit_1.0  this_%logit_3.0  population_%logit_3.0 ._%logit_0.0  In_%logit_2.0  particular_%logit_0.0 ,_%logit_0.0  there_%logit_0.0  are_%logit_3.0  concerns_%logit_3.0  about_%logit_3.0  the_%logit_1.0  impact_%logit_3.0  on_%logit_3.0  survival_%logit_3.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  the_%logit_3.0  possibility_%logit_3.0  of_%logit_3.0  a_%logit_3.0  relapse_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  metast_%logit_3.0 atic_%logit_3.0  disease_%logit_0.0 ,_%logit_3.0  which_%logit_3.0  has_%logit_3.0  been_%logit_3.0  reported_%logit_3.0  in_%logit_3.0  the_%logit_3.0  past_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_3.0  specific_%logit_3.0  type_%logit_3.0  of_%logit_3.0  counselling_%logit_2.0  for_%logit_0.0  smoking_%logit_1.0  cessation_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_2.0  the_%logit_2.0  most_%logit_3.0  effective_%logit_3.0  type_%logit_3.0  and_%logit_3.0  duration_%logit_1.0  of_%logit_1.0  counselling_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  counselling_%logit_3.0  with_%logit_1.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  counselling_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  psychological_%logit_1.0  counselling_%logit_3.0  for_%logit_3.0  nicotine_%logit_1.0  replacement_%logit_0.0  therapy_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  psychological_%logit_2.0  counselling_%logit_3.0  with_%logit_3.0  counselling_%logit_3.0  alone_%logit_3.0  or_%logit_3.0  in_%logit_3.0  combination_%logit_1.0  with_%logit_3.0  other_%logit_3.0  forms_%logit_3.0  of_%logit_3.0  counselling_%logit_1.0  and_%logit_3.0  counselling_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_3.0  of_%logit_3.0  the_%logit_3.0  interventions_%logit_0.0  reviewed_%logit_3.0  in_%logit_1.0  this_%logit_3.0  review_%logit_0.0 ._%logit_0.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0  trials_%logit_2.0  to_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  interventions_%logit_3.0  in_%logit_0.0  terms_%logit_2.0  of_%logit_0.0  blood_%logit_3.0  transf_%logit_3.0 usion_%logit_1.0 ,_%logit_1.0  blood_%logit_3.0  loss_%logit_3.0 ,_%logit_3.0  transf_%logit_3.0 usion_%logit_3.0  capacity_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  transf_%logit_3.0 usion_%logit_0.0  efficiency_%logit_0.0 ._%logit_3.0  Import_%logit_3.0 antly_%logit_0.0 ,_%logit_1.0  these_%logit_0.0  trials_%logit_0.0  should_%logit_0.0  be_%logit_2.0  of_%logit_2.0  high_%logit_0.0  quality_%logit_3.0 ,_%logit_1.0  with_%logit_2.0  a_%logit_2.0  focus_%logit_2.0  on_%logit_1.0  reducing_%logit_3.0  blood_%logit_3.0  loss_%logit_3.0  and_%logit_0.0  blood_%logit_3.0  loss_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  undergoing_%logit_0.0  transf_%logit_1.0 usion_%logit_3.0  and_%logit_2.0  blood_%logit_3.0  transf_%logit_3.0 usions_%logit_3.0 ,_%logit_2.0  rather_%logit_3.0  than_%logit_3.0  on_%logit_1.0  transf_%logit_3.0 usion_%logit_3.0  duration_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  alcohol_%logit_3.0  disinfect_%logit_3.0 ion_%logit_3.0  as_%logit_1.0  an_%logit_3.0  alternative_%logit_0.0  to_%logit_0.0  manual_%logit_0.0  cord_%logit_3.0  cleaning_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  umb_%logit_3.0 il_%logit_3.0 ical_%logit_1.0  cord_%logit_0.0  separation_%logit_0.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  disinfect_%logit_3.0 ion_%logit_3.0  regimen_%logit_2.0 ,_%logit_1.0  the_%logit_1.0  best_%logit_3.0  method_%logit_3.0  of_%logit_3.0  disinfect_%logit_1.0 ion_%logit_3.0 ,_%logit_2.0  and_%logit_3.0  the_%logit_3.0  most_%logit_3.0  effective_%logit_3.0  disinfect_%logit_3.0 ion_%logit_2.0  method_%logit_2.0 ._%logit_1.0  Further_%logit_1.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_1.0  to_%logit_1.0  assess_%logit_1.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  water_%logit_1.0  disinfect_%logit_3.0 ion_%logit_3.0  in_%logit_2.0  reducing_%logit_3.0  cord_%logit_3.0  separation_%logit_3.0  time_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  disinfect_%logit_2.0 ion_%logit_3.0  with_%logit_3.0  manual_%logit_3.0  cord_%logit_3.0  cleansing_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  future_%logit_0.0  trials_%logit_1.0  should_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  disinfect_%logit_3.0 ing_%logit_3.0  cord_%logit_3.0  cleaning_%logit_3.0  as_%logit_3.0  a_%logit_1.0  complementary_%logit_1.0  treatment_%logit_3.0  to_%logit_0.0  manual_%logit_1.0  disinfect_%logit_3.0 ion_%logit_3.0 ._%logit_3.0
 Walking_%logit_0.0  speed_%logit_1.0  and_%logit_0.0  g_%logit_1.0 ait_%logit_0.0  speed_%logit_0.0  are_%logit_3.0  similar_%logit_3.0  to_%logit_3.0  those_%logit_3.0  measured_%logit_1.0  in_%logit_1.0  the_%logit_3.0  Functional_%logit_1.0  Balance_%logit_0.0  Scale_%logit_1.0 ,_%logit_0.0  but_%logit_0.0  the_%logit_0.0  difference_%logit_3.0  in_%logit_3.0  fitness_%logit_3.0  is_%logit_3.0  smaller_%logit_3.0 ._%logit_3.0  Walking_%logit_2.0  speed_%logit_1.0  is_%logit_1.0  associated_%logit_1.0  with_%logit_3.0  a_%logit_3.0  decreased_%logit_1.0  risk_%logit_3.0  of_%logit_1.0  falls_%logit_1.0  and_%logit_3.0  falls_%logit_3.0 ,_%logit_1.0  but_%logit_3.0  is_%logit_1.0  not_%logit_3.0  associated_%logit_3.0  with_%logit_1.0  an_%logit_3.0  increase_%logit_3.0  in_%logit_3.0  risk_%logit_3.0  of_%logit_3.0  falling_%logit_3.0 ._%logit_3.0  Running_%logit_3.0  speed_%logit_1.0  appears_%logit_1.0  to_%logit_1.0  have_%logit_1.0  a_%logit_3.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_2.0  fitness_%logit_3.0 ,_%logit_1.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  no_%logit_2.0  evidence_%logit_3.0  of_%logit_2.0  an_%logit_2.0  improvement_%logit_3.0  in_%logit_0.0  fitness_%logit_1.0 ._%logit_1.0  Running_%logit_3.0  Speed_%logit_1.0  appears_%logit_1.0  to_%logit_1.0  be_%logit_1.0  faster_%logit_3.0  than_%logit_3.0  walking_%logit_1.0  speed_%logit_1.0  or_%logit_1.0  g_%logit_3.0 ait_%logit_1.0  velocity_%logit_1.0 ,_%logit_1.0  but_%logit_3.0  this_%logit_3.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0  from_%logit_3.0  this_%logit_3.0  review_%logit_1.0 ._%logit_2.0  Running_%logit_2.0  time_%logit_1.0  is_%logit_1.0  slower_%logit_1.0  than_%logit_1.0  treadmill_%logit_1.0  speed_%logit_1.0 ._%logit_1.0  Running_%logit_3.0  speeds_%logit_1.0  appear_%logit_1.0  to_%logit_1.0  be_%logit_1.0  slower_%logit_3.0  in_%logit_3.0  the_%logit_1.0  short_%logit_1.0 -_%logit_1.0 term_%logit_3.0 ,_%logit_1.0  but_%logit_3.0  not_%logit_3.0  in_%logit_3.0  the_%logit_3.0  long_%logit_3.0 -_%logit_3.0 term_%logit_3.0 ._%logit_1.0  Run_%logit_3.0  time_%logit_1.0  is_%logit_1.0  faster_%logit_1.0  in_%logit_1.0  the_%logit_1.0  intermediate_%logit_3.0 -_%logit_3.0 term_%logit_3.0  and_%logit_1.0  longer_%logit_2.0 -_%logit_3.0 term_%logit_3.0  than_%logit_1.0  in_%logit_3.0  the_%logit_1.0  shorter_%logit_3.0 -_%logit_3.0 term_%logit_3.0  but_%logit_1.0  the_%logit_2.0  longer_%logit_3.0  term_%logit_3.0  results_%logit_3.0  are_%logit_3.0  still_%logit_2.0  not_%logit_3.0  clear_%logit_3.0 ._%logit_2.0  Running_%logit_2.0  times_%logit_1.0  are_%logit_1.0  slower_%logit_1.0  than_%logit_1.0  walking_%logit_3.0  time_%logit_1.0 ,_%logit_1.0  but_%logit_1.0  more_%logit_3.0  accurate_%logit_3.0 ._%logit_3.0  Running_%logit_2.0  distances_%logit_0.0  are_%logit_1.0  slower_%logit_1.0 ,_%logit_1.0  but_%logit_1.0  slower_%logit_1.0 ._%logit_3.0  Running_%logit_3.0  distance_%logit_1.0  is_%logit_1.0  slower_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  slower_%logit_1.0  in_%logit_1.0  shorter_%logit_1.0  intervals_%logit_1.0 ,_%logit_3.0  but_%logit_2.0  faster_%logit_3.0  in_%logit_3.0  longer_%logit_3.0  intervals_%logit_1.0 ._%logit_3.0  Running_%logit_2.0  lengths_%logit_1.0  are_%logit_1.0  slower_%logit_1.0  and_%logit_1.0  faster_%logit_1.0  in_%logit_1.0  shorter_%logit_3.0  periods_%logit_1.0 ,_%logit_3.0  but_%logit_2.0  are_%logit_3.0  not_%logit_3.0  as_%logit_3.0  fast_%logit_1.0  as_%logit_1.0  treadmill_%logit_2.0  speed_%logit_1.0  or_%logit_1.0  treadmill_%logit_1.0  speed_%logit_1.0 ,_%logit_1.0  or_%logit_1.0  faster_%logit_3.0  in_%logit_1.0  slower_%logit_1.0  periods_%logit_1.0 ,_%logit_3.0  or_%logit_2.0  longer_%logit_3.0  periods_%logit_1.0 ._%logit_3.0  Running_%logit_2.0  intervals_%logit_1.0  are_%logit_1.0  slower_%logit_1.0  in_%logit_1.0  slower_%logit_1.0 -_%logit_1.0 term_%logit_1.0  runners_%logit_1.0  than_%logit_3.0  treadmill_%logit_1.0  speeds_%logit_1.0 ,_%logit_1.0  but_%logit_1.0  shorter_%logit_1.0  in_%logit_3.0  shorter_%logit_3.0  term_%logit_1.0  runners_%logit_3.0 ._%logit_3.0  Run_%logit_2.0 -_%logit_1.0 time_%logit_1.0  is_%logit_1.0  slower_%logit_1.0  in_%logit_3.0  older_%logit_1.0  runners_%logit_1.0  than_%logit_3.0  in_%logit_2.0  younger_%logit_1.0  runners_%logit_1.0 ._%logit_3.0  Running_%logit_2.0  tests_%logit_1.0  are_%logit_1.0  faster_%logit_1.0  in_%logit_1.0  older_%logit_1.0  people_%logit_1.0 ,_%logit_3.0  but_%logit_2.0  longer_%logit_1.0  term_%logit_3.0  data_%logit_3.0  are_%logit_1.0  still_%logit_2.0  lacking_%logit_2.0 ._%logit_2.0  Running_%logit_2.0  machines_%logit_1.0  appear_%logit_1.0  to_%logit_1.0  have_%logit_1.0  fewer_%logit_1.0  adverse_%logit_3.0  effects_%logit_1.0  in_%logit_3.0  younger_%logit_1.0  people_%logit_1.0  than_%logit_1.0  treadmill_%logit_2.0  time_%logit_1.0 ._%logit_1.0  Running_%logit_2.0  shoes_%logit_1.0  appear_%logit_1.0  to_%logit_1.0  improve_%logit_1.0  speed_%logit_3.0  and_%logit_1.0  fitness_%logit_3.0  in_%logit_3.0  slower_%logit_3.0  runners_%logit_1.0 ,_%logit_1.0  but_%logit_2.0  further_%logit_1.0  research_%logit_3.0  is_%logit_1.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  this_%logit_3.0  is_%logit_1.0  true_%logit_1.0  for_%logit_3.0  younger_%logit_3.0  people_%logit_1.0  or_%logit_3.0  older_%logit_1.0  people_%logit_3.0 ._%logit_3.0  Run_%logit_1.0  tests_%logit_1.0  are_%logit_1.0  more_%logit_1.0  likely_%logit_1.0  to_%logit_1.0  have_%logit_1.0  an_%logit_1.0  adverse_%logit_1.0  impact_%logit_0.0  on_%logit_0.0  fitness_%logit_1.0  and_%logit_3.0  fitness_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  are_%logit_3.0  less_%logit_3.0  likely_%logit_3.0  to_%logit_1.0  be_%logit_1.0  carried_%logit_1.0  out_%logit_1.0  in_%logit_0.0  older_%logit_3.0  patients_%logit_1.0 ._%logit_3.0  Running_%logit_2.0  test_%logit_1.0  results_%logit_1.0  are_%logit_2.0  less_%logit_1.0  consistent_%logit_3.0  in_%logit_1.0  younger_%logit_2.0  and_%logit_1.0  older_%logit_1.0  people_%logit_1.0  than_%logit_3.0  in_%logit_2.0  older_%logit_1.0  adults_%logit_1.0 ,_%logit_1.0  but_%logit_1.0  results_%logit_1.0  are_%logit_3.0  more_%logit_1.0  consistent_%logit_3.0  in_%logit_1.0  older_%logit_3.0  and_%logit_1.0  younger_%logit_3.0  people_%logit_1.0 ,_%logit_3.0  and_%logit_2.0  in_%logit_1.0  younger_%logit_3.0  adults_%logit_1.0 ._%logit_1.0  Run_%logit_1.0  test_%logit_1.0  results_%logit_1.0  should_%logit_2.0  be_%logit_1.0  interpreted_%logit_2.0  with_%logit_1.0  caution_%logit_1.0 ,_%logit_1.0  however_%logit_2.0 ,_%logit_3.0  as_%logit_1.0  they_%logit_1.0  are_%logit_3.0  based_%logit_2.0  on_%logit_1.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  repet_%logit_1.0 itions_%logit_1.0  of_%logit_1.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_3.0  use_%logit_3.0  of_%logit_3.0  pro_%logit_3.0 ph_%logit_1.0 yl_%logit_0.0 actic_%logit_2.0  st_%logit_0.0 enting_%logit_1.0  as_%logit_0.0  an_%logit_3.0  alternative_%logit_0.0  to_%logit_0.0  conventional_%logit_0.0  st_%logit_1.0 enting_%logit_1.0  in_%logit_1.0  patients_%logit_3.0  with_%logit_0.0  a_%logit_1.0  prox_%logit_3.0 imal_%logit_1.0  risk_%logit_1.0  of_%logit_1.0  death_%logit_1.0 ,_%logit_3.0  or_%logit_2.0  who_%logit_3.0  are_%logit_3.0  unable_%logit_2.0  to_%logit_1.0  tolerate_%logit_3.0  st_%logit_2.0 enting_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  st_%logit_3.0 enting_%logit_1.0  technique_%logit_1.0 ,_%logit_1.0  the_%logit_1.0  optimal_%logit_0.0  timing_%logit_0.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  st_%logit_1.0 enting_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  the_%logit_0.0  optimal_%logit_0.0  duration_%logit_0.0  of_%logit_0.0  the_%logit_1.0  st_%logit_1.0 ent_%logit_0.0  procedure_%logit_2.0 ._%logit_2.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  evaluate_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  cost_%logit_1.0 -_%logit_3.0 effect_%logit_3.0 iveness_%logit_0.0  of_%logit_3.0  anti_%logit_1.0 -_%logit_1.0 ang_%logit_3.0 inal_%logit_2.0  drugs_%logit_2.0  as_%logit_0.0  alternatives_%logit_1.0  to_%logit_0.0  traditional_%logit_0.0  st_%logit_1.0 enting_%logit_1.0  and_%logit_1.0  replace_%logit_1.0  st_%logit_3.0 enting_%logit_3.0  with_%logit_1.0  anti_%logit_1.0 plate_%logit_3.0 let_%logit_1.0  agents_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  to_%logit_2.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  drugs_%logit_1.0  in_%logit_3.0  terms_%logit_1.0  of_%logit_0.0  reduced_%logit_3.0  mortality_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  IL_%logit_3.0 -_%logit_3.0 2_%logit_1.0  inhibitors_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  rel_%logit_1.0 apses_%logit_3.0  in_%logit_1.0  patients_%logit_1.0  with_%logit_3.0  rel_%logit_3.0 apses_%logit_3.0  rem_%logit_1.0 itting_%logit_1.0  or_%logit_0.0  rel_%logit_0.0 apse_%logit_3.0 -_%logit_1.0 rem_%logit_3.0 itting_%logit_0.0  MS_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_2.0  duration_%logit_2.0  of_%logit_0.0  IL_%logit_1.0 2_%logit_1.0  inhibitors_%logit_1.0 ,_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dosage_%logit_0.0 ,_%logit_0.0  and_%logit_1.0  the_%logit_0.0  optimal_%logit_3.0  duration_%logit_0.0  of_%logit_0.0  therapy_%logit_2.0  in_%logit_0.0  these_%logit_1.0  patients_%logit_0.0 ._%logit_0.0  Finally_%logit_2.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_2.0 term_%logit_2.0  data_%logit_2.0  are_%logit_2.0  required_%logit_2.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  IL_%logit_1.0 3_%logit_1.0  inhibitors_%logit_1.0  in_%logit_2.0  removing_%logit_2.0  rel_%logit_3.0 apses_%logit_0.0  and_%logit_1.0  rel_%logit_1.0 aps_%logit_3.0 ing_%logit_1.0  rem_%logit_1.0 itting_%logit_3.0  and_%logit_3.0  rel_%logit_1.0 apses_%logit_3.0 ,_%logit_2.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  drugs_%logit_1.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  acupuncture_%logit_3.0  for_%logit_3.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0  in_%logit_3.0  neural_%logit_3.0 g_%logit_3.0 ia_%logit_3.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  acupuncture_%logit_3.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  acupuncture_%logit_2.0  with_%logit_3.0  other_%logit_3.0  forms_%logit_3.0  of_%logit_3.0  analges_%logit_1.0 ic_%logit_3.0  therapy_%logit_2.0  for_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_3.0  to_%logit_3.0  determine_%logit_3.0  whether_%logit_2.0  acupuncture_%logit_3.0  is_%logit_3.0  more_%logit_1.0  effective_%logit_1.0  than_%logit_1.0  no_%logit_2.0  treatment_%logit_3.0  or_%logit_2.0  no_%logit_1.0  treatment_%logit_3.0  at_%logit_2.0  all_%logit_2.0 ._%logit_1.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  trials_%logit_2.0  should_%logit_2.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  compared_%logit_3.0  to_%logit_1.0  no_%logit_3.0  treatment_%logit_3.0 ,_%logit_2.0  and_%logit_2.0  should_%logit_2.0  include_%logit_0.0  participants_%logit_2.0  with_%logit_1.0  a_%logit_1.0  history_%logit_1.0  of_%logit_1.0  pain_%logit_1.0  disorders_%logit_3.0 ._%logit_3.0
 Pro_%logit_0.0 l_%logit_0.0 act_%logit_2.0 in_%logit_2.0  is_%logit_2.0  an_%logit_3.0  effective_%logit_0.0  treatment_%logit_0.0  for_%logit_0.0  people_%logit_0.0  with_%logit_3.0  schizophrenia_%logit_3.0  who_%logit_3.0  are_%logit_3.0  struggling_%logit_3.0  with_%logit_3.0  relapse_%logit_3.0 ._%logit_3.0  Its_%logit_3.0  use_%logit_0.0  is_%logit_3.0  associated_%logit_1.0  with_%logit_3.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  relapse_%logit_0.0  severity_%logit_3.0  and_%logit_3.0  a_%logit_3.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  relapse_%logit_0.0 ,_%logit_3.0  but_%logit_3.0  its_%logit_3.0  use_%logit_3.0  is_%logit_3.0  not_%logit_1.0  associated_%logit_3.0  with_%logit_1.0  an_%logit_3.0  improvement_%logit_3.0  in_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ._%logit_0.0  It_%logit_3.0  is_%logit_0.0  not_%logit_2.0  clear_%logit_3.0  whether_%logit_1.0  it_%logit_3.0  has_%logit_3.0  an_%logit_3.0  effect_%logit_3.0  on_%logit_0.0  relapse_%logit_1.0  severity_%logit_3.0  or_%logit_3.0  severity_%logit_3.0 ._%logit_3.0  Its_%logit_3.0  efficacy_%logit_0.0  is_%logit_3.0  unclear_%logit_3.0  due_%logit_3.0  to_%logit_2.0  the_%logit_3.0  rarity_%logit_3.0  of_%logit_3.0  the_%logit_3.0  disorder_%logit_3.0  and_%logit_3.0  the_%logit_3.0  fact_%logit_3.0  that_%logit_3.0  the_%logit_1.0  majority_%logit_3.0  of_%logit_3.0  patients_%logit_3.0  relapse_%logit_0.0  within_%logit_1.0  a_%logit_3.0  few_%logit_1.0  weeks_%logit_1.0  of_%logit_3.0  treatment_%logit_1.0 ._%logit_3.0  Its_%logit_3.0  adverse_%logit_0.0  effects_%logit_3.0  are_%logit_3.0  usually_%logit_3.0  mild_%logit_3.0  and_%logit_3.0  mild_%logit_3.0  and_%logit_3.0  its_%logit_3.0  duration_%logit_3.0  is_%logit_3.0  short_%logit_3.0 -_%logit_1.0 lived_%logit_3.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  recommend_%logit_2.0  magnesium_%logit_2.0  sulph_%logit_3.0 ate_%logit_0.0  as_%logit_0.0  an_%logit_3.0  adjunct_%logit_0.0  to_%logit_0.0  oxy_%logit_0.0 toc_%logit_3.0 in_%logit_1.0  in_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  e_%logit_1.0 cl_%logit_3.0 amps_%logit_3.0 ia_%logit_0.0 ._%logit_2.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_3.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_0.0  duration_%logit_1.0  and_%logit_3.0  timing_%logit_1.0  of_%logit_3.0  treatment_%logit_3.0 ,_%logit_1.0  as_%logit_3.0  well_%logit_3.0  as_%logit_3.0  the_%logit_2.0  best_%logit_3.0  dose_%logit_3.0  and_%logit_3.0  duration_%logit_1.0  of_%logit_3.0  treatment_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  magnesium_%logit_1.0  sulph_%logit_3.0 ates_%logit_0.0  on_%logit_2.0  maternal_%logit_3.0  and_%logit_3.0  neon_%logit_3.0 atal_%logit_1.0  mortality_%logit_0.0  and_%logit_3.0  maternal_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  maternal_%logit_1.0  or_%logit_3.0  neon_%logit_1.0 atal_%logit_1.0  death_%logit_3.0  and_%logit_0.0  maternal_%logit_1.0  health_%logit_3.0 ._%logit_3.0
 Cognitive_%logit_0.0  enh_%logit_0.0 ancers_%logit_1.0  are_%logit_1.0  effective_%logit_1.0  in_%logit_0.0  enhancing_%logit_3.0  cognitive_%logit_3.0  performance_%logit_3.0  and_%logit_3.0  enhancing_%logit_3.0  careg_%logit_3.0 iver_%logit_3.0 -_%logit_1.0 related_%logit_3.0  skills_%logit_1.0 ._%logit_3.0  Positive_%logit_3.0  effects_%logit_1.0  on_%logit_3.0  careg_%logit_1.0 iver_%logit_3.0  performance_%logit_1.0  were_%logit_1.0  observed_%logit_3.0  in_%logit_3.0  the_%logit_3.0  control_%logit_3.0  group_%logit_3.0 ,_%logit_1.0  but_%logit_1.0  the_%logit_3.0  results_%logit_3.0  were_%logit_3.0  not_%logit_2.0  statistically_%logit_3.0  significant_%logit_1.0  in_%logit_1.0  the_%logit_2.0  comparison_%logit_3.0  group_%logit_3.0 ._%logit_3.0  Positive_%logit_2.0  results_%logit_1.0  were_%logit_3.0  found_%logit_3.0  in_%logit_3.0  the_%logit_3.0  cognitive_%logit_3.0  enh_%logit_3.0 ancers_%logit_1.0  group_%logit_2.0 ,_%logit_1.0  which_%logit_2.0  were_%logit_3.0  not_%logit_3.0  significantly_%logit_3.0  different_%logit_1.0  from_%logit_1.0  the_%logit_2.0  control_%logit_3.0  groups_%logit_3.0 ._%logit_3.0  Positive_%logit_1.0  findings_%logit_0.0  were_%logit_3.0  found_%logit_3.0  for_%logit_3.0  cognitive_%logit_3.0  enh_%logit_3.0 ancer_%logit_1.0  therapy_%logit_2.0 ,_%logit_3.0  which_%logit_1.0  was_%logit_1.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  significant_%logit_3.0  improvement_%logit_3.0  in_%logit_3.0  cognitive_%logit_1.0  performance_%logit_3.0 ._%logit_1.0  Cognitive_%logit_3.0  enh_%logit_1.0 arm_%logit_1.0 aceutical_%logit_0.0  therapy_%logit_2.0  is_%logit_3.0  effective_%logit_1.0  in_%logit_3.0  improving_%logit_3.0  cognitive_%logit_3.0  enh_%logit_3.0 arm_%logit_3.0 ancy_%logit_1.0  in_%logit_1.0  the_%logit_3.0  assessment_%logit_3.0  of_%logit_3.0  careg_%logit_3.0 iver_%logit_3.0  skills_%logit_1.0  and_%logit_1.0  enhancing_%logit_3.0  social_%logit_3.0  functioning_%logit_3.0 ._%logit_1.0  Positive_%logit_3.0  conclusions_%logit_0.0  were_%logit_3.0  also_%logit_3.0  found_%logit_3.0  for_%logit_3.0  psychological_%logit_3.0  enh_%logit_3.0 arm_%logit_1.0 our_%logit_2.0  therapy_%logit_2.0 ,_%logit_2.0  but_%logit_1.0  these_%logit_1.0  conclusions_%logit_3.0  are_%logit_3.0  based_%logit_2.0  on_%logit_3.0  a_%logit_3.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  studies_%logit_3.0  with_%logit_3.0  short_%logit_1.0 -_%logit_1.0 term_%logit_3.0  follow_%logit_1.0 -_%logit_3.0 up_%logit_3.0  and_%logit_1.0  are_%logit_3.0  not_%logit_3.0  necessarily_%logit_0.0  representative_%logit_3.0  of_%logit_3.0  the_%logit_3.0  whole_%logit_3.0  range_%logit_3.0  of_%logit_1.0  developmental_%logit_3.0  enh_%logit_3.0 arm_%logit_3.0 ours_%logit_2.0  evaluated_%logit_2.0  in_%logit_1.0  this_%logit_2.0  review_%logit_0.0 ._%logit_2.0  Further_%logit_2.0  research_%logit_2.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  enh_%logit_1.0 arm_%logit_3.0 OUR_%logit_2.0  therapy_%logit_2.0  on_%logit_3.0  social_%logit_1.0  functioning_%logit_3.0  and_%logit_1.0  developmental_%logit_3.0  outcomes_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_1.0  for_%logit_2.0  developmental_%logit_3.0  outcomes_%logit_3.0  such_%logit_3.0  as_%logit_1.0  language_%logit_1.0  development_%logit_3.0 ,_%logit_1.0  social_%logit_3.0  functioning_%logit_1.0 ,_%logit_1.0  cognitive_%logit_3.0  functioning_%logit_3.0 ,_%logit_3.0  language_%logit_3.0  comprehension_%logit_1.0  and_%logit_1.0  social_%logit_3.0  functioning_%logit_3.0  in_%logit_1.0  the_%logit_3.0  developmental_%logit_3.0  group_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  alcohol_%logit_3.0  diversion_%logit_3.0  programmes_%logit_3.0  in_%logit_3.0  reducing_%logit_1.0  alcohol_%logit_0.0  diversion_%logit_3.0  rates_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  these_%logit_3.0  programmes_%logit_3.0  and_%logit_3.0  to_%logit_2.0  compare_%logit_3.0  them_%logit_2.0  with_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  diversion_%logit_2.0  programmes_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  alcohol_%logit_1.0  diversion_%logit_3.0  programs_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_1.0  assess_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  these_%logit_1.0  interventions_%logit_3.0  on_%logit_3.0  alcohol_%logit_2.0  diversion_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_2.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  executed_%logit_2.0  random_%logit_2.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0 ,_%logit_3.0  safety_%logit_1.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_3.0  programs_%logit_3.0 ._%logit_3.0  Such_%logit_2.0  a_%logit_0.0  trial_%logit_0.0  is_%logit_0.0  warranted_%logit_2.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  ib_%logit_3.0 up_%logit_3.0 ro_%logit_2.0 fen_%logit_1.0  as_%logit_1.0  an_%logit_3.0  adjunct_%logit_0.0  to_%logit_0.0  standard_%logit_0.0  analges_%logit_3.0 ia_%logit_3.0  in_%logit_2.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  acute_%logit_1.0  pain_%logit_3.0 ,_%logit_3.0  or_%logit_3.0  to_%logit_3.0  support_%logit_3.0  its_%logit_2.0  use_%logit_3.0  as_%logit_3.0  a_%logit_2.0  substitute_%logit_0.0  for_%logit_2.0  standard_%logit_0.0  analges_%logit_3.0 ic_%logit_3.0  therapy_%logit_2.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_3.0  acute_%logit_2.0  pain_%logit_2.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_2.0  duration_%logit_2.0  and_%logit_3.0  duration_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  the_%logit_3.0  optimal_%logit_3.0  dosage_%logit_3.0 ,_%logit_2.0  duration_%logit_1.0 ,_%logit_1.0  duration_%logit_0.0  of_%logit_3.0  treatment_%logit_0.0 ,_%logit_3.0  and_%logit_1.0  duration_%logit_3.0  of_%logit_3.0  therapy_%logit_2.0  in_%logit_3.0  these_%logit_1.0  patients_%logit_1.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  evaluate_%logit_0.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  other_%logit_3.0  analges_%logit_3.0 ic_%logit_3.0  therapies_%logit_2.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_3.0  assess_%logit_3.0  the_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  other_%logit_1.0  types_%logit_3.0  of_%logit_3.0  analges_%logit_2.0 ia_%logit_3.0 ,_%logit_2.0  such_%logit_2.0  as_%logit_3.0  oral_%logit_1.0  opioids_%logit_1.0 ,_%logit_3.0  and_%logit_1.0  other_%logit_1.0  analges_%logit_3.0 ics_%logit_3.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  cort_%logit_3.0 ic_%logit_3.0 oster_%logit_0.0 oids_%logit_0.0  in_%logit_2.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_0.0  people_%logit_3.0  with_%logit_3.0  chronic_%logit_0.0  lung_%logit_3.0  disease_%logit_0.0 ._%logit_3.0  There_%logit_3.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_2.0 -_%logit_2.0 designed_%logit_2.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_2.0  randomized_%logit_2.0  controlled_%logit_2.0  trials_%logit_2.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  these_%logit_3.0  medications_%logit_3.0  in_%logit_3.0  the_%logit_2.0  management_%logit_3.0  of_%logit_2.0  these_%logit_3.0  patients_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  an_%logit_3.0  urgent_%logit_3.0  need_%logit_3.0  for_%logit_0.0  a_%logit_1.0  standard_%logit_2.0 ised_%logit_2.0  assessment_%logit_0.0  of_%logit_0.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  cort_%logit_3.0 ico_%logit_3.0 ag_%logit_1.0 ul_%logit_1.0 ants_%logit_0.0  in_%logit_3.0  the_%logit_1.0  control_%logit_3.0  of_%logit_2.0  chronic_%logit_2.0  lung_%logit_3.0  diseases_%logit_3.0 ,_%logit_3.0  including_%logit_3.0  those_%logit_3.0  with_%logit_3.0  asthma_%logit_3.0  who_%logit_3.0  have_%logit_3.0  a_%logit_2.0  history_%logit_3.0  of_%logit_3.0  exacerb_%logit_3.0 ations_%logit_3.0  requiring_%logit_3.0  rescue_%logit_3.0  medication_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  recommend_%logit_2.0  s_%logit_2.0 ert_%logit_3.0 ral_%logit_0.0 ine_%logit_0.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  depression_%logit_1.0  in_%logit_3.0  people_%logit_3.0  with_%logit_3.0  depression_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_3.0  identify_%logit_2.0  the_%logit_2.0  best_%logit_3.0  antidepressant_%logit_3.0  for_%logit_2.0  depression_%logit_3.0  in_%logit_3.0  a_%logit_3.0  population_%logit_3.0  with_%logit_1.0  a_%logit_2.0  history_%logit_3.0  of_%logit_1.0  depressive_%logit_3.0  symptoms_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_3.0  its_%logit_2.0  efficacy_%logit_3.0  in_%logit_3.0  a_%logit_3.0  broader_%logit_3.0  range_%logit_3.0  of_%logit_0.0  conditions_%logit_3.0 ,_%logit_3.0  including_%logit_2.0  depression_%logit_3.0  severity_%logit_3.0 ,_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0 ,_%logit_1.0  psychological_%logit_3.0  wellbeing_%logit_3.0  and_%logit_3.0  psychological_%logit_3.0  wellbeing_%logit_3.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_1.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_1.0  of_%logit_3.0  other_%logit_3.0  antidepressants_%logit_3.0  in_%logit_3.0  depression_%logit_2.0  patients_%logit_3.0  with_%logit_3.0  depression_%logit_2.0  and_%logit_3.0  anxiety_%logit_3.0  disorders_%logit_3.0 ,_%logit_3.0  as_%logit_2.0  well_%logit_3.0  as_%logit_3.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  antidepressants_%logit_3.0  in_%logit_3.0  this_%logit_1.0  population_%logit_3.0 ._%logit_2.0
 Influ_%logit_0.0 enza_%logit_0.0  vaccination_%logit_1.0  is_%logit_3.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_3.0  mortality_%logit_3.0  in_%logit_0.0  healthcare_%logit_3.0  staff_%logit_3.0  and_%logit_3.0  reducing_%logit_3.0  hospital_%logit_3.0 izations_%logit_3.0  in_%logit_0.0  patients_%logit_3.0  with_%logit_3.0  IL_%logit_1.0 I_%logit_1.0 ._%logit_1.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_1.0  of_%logit_3.0  influenza_%logit_1.0  vaccination_%logit_0.0  for_%logit_0.0  IL_%logit_3.0 I_%logit_0.0  or_%logit_1.0  IL_%logit_3.0 I_%logit_3.0  in_%logit_1.0  health_%logit_3.0  care_%logit_3.0  staff_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  flu_%logit_3.0  vaccination_%logit_0.0  and_%logit_1.0  to_%logit_1.0  assess_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  flu_%logit_1.0  vaccines_%logit_3.0  in_%logit_1.0  IL_%logit_1.0 I_%logit_3.0  and_%logit_1.0  IL_%logit_0.0 I_%logit_0.0  patients_%logit_1.0 ,_%logit_3.0  and_%logit_2.0  to_%logit_3.0  compare_%logit_0.0  influenza_%logit_2.0  vaccination_%logit_3.0  with_%logit_3.0  other_%logit_3.0  preventive_%logit_3.0  measures_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_2.0  antibiotic_%logit_1.0  use_%logit_3.0  and_%logit_3.0  duration_%logit_3.0  of_%logit_3.0  hospital_%logit_3.0 isation_%logit_3.0 ._%logit_0.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  influenza_%logit_1.0  vaccines_%logit_0.0  on_%logit_0.0  IL_%logit_1.0 I_%logit_3.0  mortality_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  on_%logit_3.0  improving_%logit_0.0  the_%logit_3.0  quality_%logit_3.0  of_%logit_3.0  the_%logit_3.0  evidence_%logit_0.0  base_%logit_0.0 ._%logit_2.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  V_%logit_3.0 AS_%logit_0.0  in_%logit_1.0  the_%logit_0.0  treatment_%logit_0.0  of_%logit_3.0  men_%logit_1.0 or_%logit_3.0 rh_%logit_3.0 oe_%logit_0.0 a_%logit_0.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_0.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  V_%logit_3.0 AS_%logit_1.0  is_%logit_0.0  beneficial_%logit_0.0  or_%logit_0.0  harmful_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  V_%logit_2.0 AS_%logit_3.0  with_%logit_0.0  other_%logit_3.0  methods_%logit_0.0  of_%logit_3.0  prog_%logit_1.0 est_%logit_3.0 ogen_%logit_0.0  suppression_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  also_%logit_3.0  to_%logit_0.0  determine_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  V_%logit_1.0 ASS_%logit_1.0  in_%logit_1.0  the_%logit_1.0  management_%logit_3.0  of_%logit_0.0  these_%logit_3.0  conditions_%logit_3.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  to_%logit_0.0  determine_%logit_0.0  if_%logit_2.0  V_%logit_3.0 AS_%logit_0.0  has_%logit_0.0  a_%logit_0.0  beneficial_%logit_3.0  effect_%logit_3.0  on_%logit_0.0  the_%logit_1.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  of_%logit_0.0  these_%logit_3.0  women_%logit_3.0 ,_%logit_3.0  a_%logit_1.0  randomized_%logit_0.0  controlled_%logit_2.0  trial_%logit_0.0  is_%logit_0.0  needed_%logit_0.0 ._%logit_1.0  Such_%logit_1.0  a_%logit_0.0  trial_%logit_0.0  is_%logit_0.0  also_%logit_2.0  needed_%logit_0.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  prog_%logit_3.0 est_%logit_3.0 ogens_%logit_0.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  rec_%logit_1.0 urrence_%logit_3.0 -_%logit_3.0 free_%logit_3.0  interval_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_2.0  trials_%logit_2.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_2.0  whether_%logit_2.0  prog_%logit_3.0 est_%logit_1.0 ogen_%logit_1.0  is_%logit_3.0  beneficial_%logit_3.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_0.0  survival_%logit_3.0  or_%logit_3.0  progression_%logit_3.0  free_%logit_3.0  interval_%logit_3.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_1.0  rec_%logit_1.0 urrence_%logit_1.0  free_%logit_1.0  interval_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_0.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  prog_%logit_1.0 ester_%logit_3.0 one_%logit_0.0  on_%logit_3.0  overall_%logit_3.0  survival_%logit_3.0  and_%logit_3.0  progression_%logit_3.0  free_%logit_0.0  survival_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  assess_%logit_0.0  the_%logit_2.0  impact_%logit_3.0  on_%logit_3.0  survival_%logit_1.0  and_%logit_3.0  quality_%logit_3.0  of_%logit_0.0  life_%logit_3.0  in_%logit_0.0  these_%logit_3.0  patients_%logit_1.0 ._%logit_1.0  These_%logit_2.0  trials_%logit_0.0  should_%logit_0.0  also_%logit_2.0  assess_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  progression_%logit_1.0 -_%logit_3.0 free_%logit_3.0  survival_%logit_1.0  and_%logit_3.0  survival_%logit_1.0  in_%logit_0.0  these_%logit_3.0  individuals_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_0.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  prog_%logit_3.0 est_%logit_3.0 ogen_%logit_0.0  as_%logit_3.0  a_%logit_3.0  substitute_%logit_0.0  for_%logit_0.0  o_%logit_0.0 ocyte_%logit_3.0  retrieval_%logit_1.0  in_%logit_3.0  pre_%logit_3.0 clinical_%logit_0.0  pregnancy_%logit_1.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_1.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0  and_%logit_0.0  duration_%logit_1.0  of_%logit_0.0  prog_%logit_1.0 ester_%logit_0.0 one_%logit_1.0  as_%logit_3.0  a_%logit_3.0  complement_%logit_0.0  to_%logit_0.0  o_%logit_0.0 ocyte_%logit_3.0  retri_%logit_1.0 ev_%logit_3.0 als_%logit_1.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  prog_%logit_2.0 est_%logit_3.0 ogens_%logit_0.0  with_%logit_1.0  o_%logit_3.0 ocyte_%logit_3.0  extraction_%logit_1.0  as_%logit_3.0  an_%logit_3.0  adj_%logit_1.0 u_%logit_0.0 vant_%logit_1.0  strategy_%logit_1.0 ._%logit_0.0  Finally_%logit_0.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_1.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  meta_%logit_1.0 -_%logit_2.0 analysis_%logit_0.0  of_%logit_0.0  data_%logit_2.0  on_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  prog_%logit_3.0 esta_%logit_0.0  gel_%logit_1.0  as_%logit_1.0  a_%logit_2.0  replacement_%logit_1.0  for_%logit_0.0  o_%logit_0.0 ocytes_%logit_3.0  retrieval_%logit_1.0  as_%logit_1.0  part_%logit_1.0  of_%logit_1.0  the_%logit_1.0  standard_%logit_1.0  protocol_%logit_1.0  for_%logit_0.0  pre_%logit_0.0 clinical_%logit_1.0  pregnancies_%logit_2.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_3.0  of_%logit_3.0  any_%logit_3.0  particular_%logit_3.0  type_%logit_0.0  of_%logit_1.0  pad_%logit_0.0  test_%logit_3.0  in_%logit_0.0  the_%logit_0.0  treatment_%logit_0.0  of_%logit_0.0  urinary_%logit_1.0  exc_%logit_3.0 retion_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  pad_%logit_3.0  test_%logit_0.0  for_%logit_1.0  this_%logit_1.0  purpose_%logit_3.0  and_%logit_2.0  to_%logit_2.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_3.0  types_%logit_3.0  of_%logit_3.0  pad_%logit_1.0  tests_%logit_1.0  in_%logit_1.0  terms_%logit_1.0  of_%logit_3.0  accuracy_%logit_0.0 ,_%logit_3.0  reliability_%logit_3.0 ,_%logit_3.0  accuracy_%logit_1.0 ,_%logit_3.0  accuracy_%logit_1.0  and_%logit_3.0  reliability_%logit_1.0  of_%logit_3.0  results_%logit_3.0 ._%logit_0.0  Finally_%logit_1.0 ,_%logit_0.0  future_%logit_0.0  research_%logit_0.0  should_%logit_2.0  focus_%logit_0.0  on_%logit_2.0  assessing_%logit_3.0  the_%logit_3.0  effects_%logit_3.0  of_%logit_3.0  different_%logit_1.0  types_%logit_3.0  of_%logit_0.0  pads_%logit_1.0  on_%logit_3.0  quality_%logit_1.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  quantity_%logit_0.0  of_%logit_0.0  urine_%logit_3.0  exc_%logit_3.0 retion_%logit_0.0 ,_%logit_3.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  assessing_%logit_2.0  the_%logit_0.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_3.0  of_%logit_3.0  the_%logit_3.0  pads_%logit_3.0 ,_%logit_0.0  and_%logit_1.0  also_%logit_0.0  on_%logit_3.0  the_%logit_3.0  durability_%logit_3.0  of_%logit_3.0  urine_%logit_3.0  retention_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  T_%logit_1.0 ICH_%logit_3.0  as_%logit_0.0  a_%logit_1.0  diagnostic_%logit_0.0  tool_%logit_0.0  in_%logit_1.0  the_%logit_0.0  treatment_%logit_0.0  of_%logit_0.0  th_%logit_1.0 rom_%logit_3.0 bo_%logit_1.0 emb_%logit_2.0 olic_%logit_1.0  complications_%logit_2.0  in_%logit_3.0  cy_%logit_3.0 stic_%logit_3.0  fib_%logit_3.0 rosis_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_2.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  best_%logit_3.0  way_%logit_3.0  to_%logit_1.0  implement_%logit_1.0  T_%logit_2.0 ICH_%logit_1.0 ._%logit_0.0  The_%logit_1.0  results_%logit_0.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  should_%logit_2.0  be_%logit_2.0  interpreted_%logit_2.0  with_%logit_0.0  caution_%logit_1.0 ,_%logit_3.0  however_%logit_2.0 ,_%logit_2.0  because_%logit_0.0  of_%logit_2.0  the_%logit_3.0  rarity_%logit_3.0  of_%logit_3.0  the_%logit_3.0  cases_%logit_1.0  and_%logit_0.0  the_%logit_1.0  lack_%logit_3.0  of_%logit_3.0  reporting_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0  in_%logit_3.0  most_%logit_1.0  of_%logit_1.0  the_%logit_3.0  included_%logit_0.0  studies_%logit_0.0 ,_%logit_0.0  and_%logit_2.0  the_%logit_3.0  fact_%logit_0.0  that_%logit_3.0  the_%logit_1.0  majority_%logit_3.0  of_%logit_0.0  the_%logit_0.0  published_%logit_0.0  reports_%logit_0.0  were_%logit_0.0  published_%logit_2.0  in_%logit_0.0  the_%logit_3.0  United_%logit_0.0  Kingdom_%logit_3.0 ,_%logit_1.0  the_%logit_0.0  results_%logit_3.0  should_%logit_3.0  be_%logit_2.0  viewed_%logit_2.0  with_%logit_3.0  caution_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  dietary_%logit_3.0  lip_%logit_3.0 oly_%logit_3.0 sis_%logit_0.0  for_%logit_1.0  weight_%logit_3.0  loss_%logit_3.0  in_%logit_1.0  patients_%logit_3.0  with_%logit_3.0  cancer_%logit_1.0 ._%logit_0.0  Further_%logit_3.0  randomized_%logit_0.0  controlled_%logit_3.0  trials_%logit_3.0  are_%logit_0.0  needed_%logit_2.0  to_%logit_1.0  determine_%logit_3.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  lipid_%logit_1.0 oly_%logit_1.0 sis_%logit_1.0  on_%logit_2.0  quality_%logit_3.0  of_%logit_3.0  life_%logit_3.0  and_%logit_0.0  survival_%logit_3.0 ._%logit_3.0  Such_%logit_3.0  trials_%logit_0.0  are_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  assess_%logit_1.0  the_%logit_2.0  effects_%logit_3.0  on_%logit_3.0  other_%logit_1.0  important_%logit_3.0  outcomes_%logit_3.0 ,_%logit_3.0  such_%logit_1.0  as_%logit_3.0  progression_%logit_1.0  to_%logit_3.0  terminal_%logit_3.0  cancer_%logit_1.0 ,_%logit_1.0  progression_%logit_3.0  to_%logit_3.0  sen_%logit_3.0 or_%logit_3.0 rh_%logit_1.0 oe_%logit_1.0 a_%logit_1.0 ,_%logit_1.0  and_%logit_3.0  progression_%logit_3.0  to_%logit_3.0  metast_%logit_3.0 atic_%logit_3.0  cancer_%logit_1.0 ._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  long_%logit_0.0 -_%logit_0.0 term_%logit_3.0  data_%logit_1.0  are_%logit_0.0  required_%logit_2.0  to_%logit_2.0  determine_%logit_2.0  whether_%logit_2.0  lipid_%logit_3.0 oly_%logit_1.0 tics_%logit_1.0  are_%logit_2.0  beneficial_%logit_1.0  or_%logit_0.0  harmful_%logit_3.0  for_%logit_1.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  cancer_%logit_1.0 -_%logit_3.0 related_%logit_3.0  complications_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  any_%logit_3.0  of_%logit_3.0  the_%logit_3.0  methods_%logit_0.0  used_%logit_0.0  in_%logit_1.0  this_%logit_1.0  review_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_3.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_3.0  of_%logit_3.0  various_%logit_3.0  methods_%logit_3.0  of_%logit_3.0  cleansing_%logit_1.0  ul_%logit_0.0 cer_%logit_3.0  tissue_%logit_1.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  various_%logit_1.0  types_%logit_3.0  of_%logit_3.0  cleansing_%logit_1.0  and_%logit_0.0  cleansing_%logit_3.0  agents_%logit_3.0 ,_%logit_3.0  as_%logit_1.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  assess_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  various_%logit_3.0  cleansing_%logit_3.0  agents_%logit_3.0  in_%logit_3.0  ul_%logit_1.0 cer_%logit_3.0  areas_%logit_1.0 ._%logit_3.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_0.0  random_%logit_2.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  cleansing_%logit_1.0  agents_%logit_3.0  on_%logit_3.0  ul_%logit_1.0 cer_%logit_0.0  area_%logit_1.0  healing_%logit_3.0  and_%logit_0.0  healing_%logit_3.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  for_%logit_3.0  pain_%logit_1.0  relief_%logit_0.0  in_%logit_3.0  adults_%logit_3.0  undergoing_%logit_3.0  elect_%logit_1.0 ive_%logit_3.0  cervical_%logit_1.0  surgery_%logit_1.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_0.0  acupuncture_%logit_3.0 ,_%logit_1.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  acupuncture_%logit_2.0  with_%logit_3.0  other_%logit_3.0  analges_%logit_3.0 ics_%logit_3.0 ,_%logit_2.0  and_%logit_1.0  also_%logit_1.0  to_%logit_3.0  assess_%logit_3.0  the_%logit_2.0  efficacy_%logit_3.0  of_%logit_3.0  acupuncture_%logit_1.0  in_%logit_3.0  children_%logit_1.0 ._%logit_3.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_2.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  executed_%logit_2.0  random_%logit_2.0 ised_%logit_0.0  controlled_%logit_0.0  trial_%logit_0.0  comparing_%logit_0.0  acupuncture_%logit_2.0  to_%logit_3.0  other_%logit_1.0  analges_%logit_3.0 ic_%logit_3.0  treatments_%logit_2.0 ,_%logit_3.0  and_%logit_1.0  comparing_%logit_2.0  acupuncture_%logit_2.0  with_%logit_3.0  a_%logit_1.0  non_%logit_3.0 -_%logit_1.0 s_%logit_1.0 urgical_%logit_1.0  treatment_%logit_0.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  existence_%logit_3.0  of_%logit_3.0  a_%logit_3.0  mechanism_%logit_3.0  of_%logit_3.0  indirect_%logit_3.0  compensation_%logit_3.0  for_%logit_3.0  pain_%logit_3.0  relief_%logit_3.0  in_%logit_3.0  post_%logit_3.0 operative_%logit_3.0  pain_%logit_3.0  relief_%logit_3.0 ._%logit_3.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  identify_%logit_1.0  the_%logit_2.0  mechanism_%logit_3.0  by_%logit_3.0  which_%logit_3.0  indirect_%logit_1.0  compensation_%logit_3.0  relates_%logit_3.0  to_%logit_3.0  pain_%logit_3.0  relief_%logit_3.0 ,_%logit_3.0  function_%logit_3.0 ,_%logit_3.0  satisfaction_%logit_3.0 ,_%logit_1.0  satisfaction_%logit_1.0  with_%logit_3.0  pain_%logit_1.0  relief_%logit_3.0  and_%logit_3.0  satisfaction_%logit_1.0  with_%logit_0.0  treatment_%logit_3.0 ,_%logit_3.0  and_%logit_1.0  to_%logit_3.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  interventions_%logit_3.0  with_%logit_3.0  other_%logit_1.0  forms_%logit_3.0  of_%logit_3.0  pain_%logit_2.0  relief_%logit_3.0  (_%logit_3.0 such_%logit_1.0  as_%logit_1.0  relaxation_%logit_1.0 ,_%logit_3.0  relaxation_%logit_3.0 ,_%logit_3.0  rest_%logit_3.0 lessness_%logit_1.0 ,_%logit_3.0  relaxation_%logit_3.0 )._%logit_3.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_0.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_1.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_0.0  systematic_%logit_2.0  review_%logit_0.0  of_%logit_0.0  the_%logit_0.0  effectiveness_%logit_0.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  external_%logit_3.0  compensation_%logit_3.0  for_%logit_3.0  post_%logit_3.0 operative_%logit_3.0  discomfort_%logit_0.0 ._%logit_3.0  Such_%logit_1.0  a_%logit_0.0  review_%logit_0.0  is_%logit_0.0  warranted_%logit_0.0 ._%logit_0.0
 Knowledge_%logit_0.0  of_%logit_0.0  language_%logit_2.0  skills_%logit_0.0  is_%logit_0.0  a_%logit_3.0  valuable_%logit_3.0  tool_%logit_3.0  in_%logit_2.0  the_%logit_0.0  development_%logit_0.0  of_%logit_1.0  interpersonal_%logit_1.0  skills_%logit_0.0 ._%logit_0.0  However_%logit_1.0 ,_%logit_1.0  there_%logit_0.0  is_%logit_1.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  recommend_%logit_2.0  the_%logit_2.0  use_%logit_1.0  of_%logit_3.0  this_%logit_1.0  tool_%logit_1.0  as_%logit_1.0  a_%logit_2.0  standalone_%logit_1.0  tool_%logit_1.0  for_%logit_0.0  interpersonal_%logit_0.0  skills_%logit_0.0  training_%logit_1.0 ._%logit_1.0  Further_%logit_1.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  assess_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  this_%logit_1.0  intervention_%logit_1.0  in_%logit_1.0  relation_%logit_1.0  to_%logit_0.0  language_%logit_3.0  skills_%logit_3.0  training_%logit_1.0  and_%logit_1.0  interpersonal_%logit_1.0  skills_%logit_3.0  skills_%logit_1.0  training_%logit_1.0 ,_%logit_1.0  as_%logit_1.0  well_%logit_1.0  as_%logit_1.0  to_%logit_2.0  assess_%logit_3.0  its_%logit_3.0  effectiveness_%logit_3.0  in_%logit_3.0  the_%logit_1.0  treatment_%logit_0.0  of_%logit_3.0  coercive_%logit_3.0  behaviours_%logit_3.0 ._%logit_3.0  Future_%logit_1.0  research_%logit_0.0  should_%logit_0.0  focus_%logit_2.0  on_%logit_2.0  improving_%logit_3.0  the_%logit_3.0  quality_%logit_1.0  and_%logit_3.0  consistency_%logit_3.0  of_%logit_0.0  knowledge_%logit_3.0  and_%logit_1.0  skills_%logit_1.0  training_%logit_0.0  exercises_%logit_1.0 ._%logit_1.0  Research_%logit_1.0  is_%logit_0.0  also_%logit_2.0  needed_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  reliability_%logit_1.0  of_%logit_3.0  verbal_%logit_1.0  skills_%logit_1.0  training_%logit_1.0  as_%logit_1.0  a_%logit_1.0  component_%logit_1.0  of_%logit_0.0  workplace_%logit_0.0  skills_%logit_1.0  training_%logit_1.0  programmes_%logit_1.0 ._%logit_1.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  SP_%logit_3.0  mon_%logit_3.0 otherapy_%logit_1.0  for_%logit_0.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  P_%logit_3.0 ._%logit_0.0  fal_%logit_1.0 c_%logit_0.0 ip_%logit_0.0 ar_%logit_0.0 um_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  mon_%logit_3.0 otherapy_%logit_2.0 ,_%logit_0.0  the_%logit_1.0  optimal_%logit_0.0  dose_%logit_0.0 ,_%logit_0.0  and_%logit_1.0  the_%logit_0.0  optimal_%logit_3.0  duration_%logit_0.0  of_%logit_0.0  treatment_%logit_1.0 ._%logit_1.0  Finally_%logit_1.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_0.0  the_%logit_3.0  efficacy_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  PR_%logit_3.0  mon_%logit_0.0 otherapy_%logit_1.0  in_%logit_2.0  reducing_%logit_1.0  the_%logit_0.0  risk_%logit_3.0  of_%logit_3.0  relapse_%logit_1.0  and_%logit_0.0  relapse_%logit_1.0  in_%logit_3.0  patients_%logit_3.0  with_%logit_0.0  malaria_%logit_1.0 ,_%logit_0.0  as_%logit_2.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  compare_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  SP_%logit_3.0  and_%logit_3.0  SP_%logit_1.0  mon_%logit_0.0 other_%logit_1.0 ap_%logit_2.0 ies_%logit_1.0  in_%logit_0.0  reducing_%logit_1.0  relapse_%logit_0.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_3.0  urinary_%logit_3.0  inc_%logit_3.0 ont_%logit_3.0 inence_%logit_3.0 ._%logit_1.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_3.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotic_%logit_3.0  treatment_%logit_3.0  in_%logit_3.0  the_%logit_3.0  management_%logit_0.0  of_%logit_3.0  UT_%logit_3.0 I_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  antibiotic_%logit_2.0  treatment_%logit_3.0  with_%logit_3.0  no_%logit_3.0  treatment_%logit_3.0  or_%logit_3.0  no_%logit_1.0  treatment_%logit_3.0 ._%logit_2.0  Finally_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_0.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  a_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0 ,_%logit_2.0  well_%logit_0.0 -_%logit_2.0 conduct_%logit_2.0 ed_%logit_2.0  and_%logit_2.0  reported_%logit_0.0  randomized_%logit_2.0  controlled_%logit_2.0  trial_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotics_%logit_3.0  for_%logit_3.0  UT_%logit_3.0 I_%logit_3.0  in_%logit_1.0  humans_%logit_3.0  with_%logit_0.0  antibiotic_%logit_3.0 -_%logit_3.0 resistant_%logit_3.0  bacteria_%logit_2.0 ,_%logit_3.0  and_%logit_3.0  also_%logit_3.0  to_%logit_0.0  compare_%logit_0.0  antibiotics_%logit_2.0  with_%logit_3.0  antibiotic_%logit_3.0  treatment_%logit_3.0 ._%logit_3.0
 Reduced_%logit_0.0  sodium_%logit_1.0  intake_%logit_3.0  is_%logit_1.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  blood_%logit_0.0  pressure_%logit_3.0  and_%logit_0.0  blood_%logit_3.0  pressure_%logit_3.0 ,_%logit_0.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  no_%logit_2.0  evidence_%logit_3.0  of_%logit_3.0  an_%logit_3.0  effect_%logit_3.0  on_%logit_3.0  mortality_%logit_3.0  or_%logit_3.0  cardiovascular_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ._%logit_0.0  Reduction_%logit_3.0  in_%logit_0.0  sodium_%logit_3.0  intake_%logit_3.0  does_%logit_0.0  not_%logit_3.0  appear_%logit_3.0  to_%logit_2.0  have_%logit_1.0  a_%logit_3.0  significant_%logit_3.0  effect_%logit_2.0  on_%logit_2.0  blood_%logit_2.0  pressure_%logit_3.0  or_%logit_0.0  blood_%logit_3.0  pressure_%logit_3.0 ._%logit_0.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_3.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  well_%logit_1.0 -_%logit_2.0 designed_%logit_1.0  randomized_%logit_2.0  controlled_%logit_2.0  trials_%logit_0.0  to_%logit_0.0  evaluate_%logit_2.0  the_%logit_2.0  effects_%logit_3.0  of_%logit_3.0  reducing_%logit_1.0  sodium_%logit_3.0  intake_%logit_3.0  on_%logit_0.0  mortality_%logit_3.0  and_%logit_3.0  cardiovascular_%logit_3.0  morbid_%logit_3.0 ities_%logit_3.0  and_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0 ,_%logit_0.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_3.0  sodium_%logit_2.0  intake_%logit_3.0  with_%logit_3.0  sodium_%logit_3.0  intake_%logit_3.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  a_%logit_0.0  randomized_%logit_1.0  controlled_%logit_2.0  trial_%logit_0.0  of_%logit_0.0  sodium_%logit_2.0  intake_%logit_3.0  versus_%logit_3.0  sodium_%logit_3.0  intake_%logit_3.0  will_%logit_0.0  be_%logit_3.0  needed_%logit_2.0  to_%logit_0.0  determine_%logit_2.0  whether_%logit_2.0  sodium_%logit_3.0  intake_%logit_3.0  affects_%logit_3.0  mortality_%logit_3.0  or_%logit_3.0  morbid_%logit_3.0 ity_%logit_3.0  and_%logit_3.0  mortality_%logit_3.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_1.0  the_%logit_0.0  existence_%logit_1.0  of_%logit_0.0  a_%logit_3.0  correlation_%logit_0.0  between_%logit_3.0  surgical_%logit_3.0  site_%logit_0.0  infection_%logit_0.0  rates_%logit_0.0  and_%logit_3.0  surgical_%logit_1.0  site_%logit_3.0  infections_%logit_0.0 ._%logit_0.0  Further_%logit_3.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  surgical_%logit_3.0  site_%logit_1.0  disinfect_%logit_3.0 ion_%logit_3.0  and_%logit_3.0  disinfect_%logit_3.0 ion_%logit_3.0  in_%logit_3.0  terms_%logit_3.0  of_%logit_0.0  reducing_%logit_0.0  the_%logit_3.0  incidence_%logit_0.0  of_%logit_0.0  post_%logit_0.0 -_%logit_0.0 operative_%logit_0.0  infections_%logit_0.0  and_%logit_0.0  the_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  infection_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  to_%logit_3.0  compare_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  effectiveness_%logit_3.0  of_%logit_3.0  disinfect_%logit_3.0 ion_%logit_3.0  with_%logit_3.0  other_%logit_3.0  types_%logit_3.0  of_%logit_3.0  surgical_%logit_1.0  sites_%logit_0.0  disinfect_%logit_3.0 ion_%logit_1.0  or_%logit_1.0  disinfect_%logit_3.0 ion_%logit_3.0 ,_%logit_3.0  and_%logit_3.0  also_%logit_2.0  to_%logit_3.0  compare_%logit_3.0  disinfect_%logit_2.0 ion_%logit_3.0  versus_%logit_3.0  disinfect_%logit_3.0 ion_%logit_3.0  alone_%logit_3.0  or_%logit_3.0  in_%logit_3.0  combination_%logit_1.0 ._%logit_3.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_0.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  effectiveness_%logit_3.0  of_%logit_3.0  nicotine_%logit_3.0  replacement_%logit_3.0  therapy_%logit_3.0  for_%logit_3.0  the_%logit_1.0  treatment_%logit_3.0  of_%logit_3.0  nicotine_%logit_1.0  dependence_%logit_3.0  in_%logit_1.0  people_%logit_3.0  with_%logit_0.0  a_%logit_2.0  history_%logit_3.0  of_%logit_3.0  smoking_%logit_3.0  cessation_%logit_3.0 ._%logit_3.0  Nicotine_%logit_3.0  replacement_%logit_2.0  therapy_%logit_3.0  appears_%logit_3.0  to_%logit_3.0  be_%logit_3.0  effective_%logit_3.0  in_%logit_3.0  reducing_%logit_3.0  nicotine_%logit_3.0  dependence_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  its_%logit_3.0  effectiveness_%logit_3.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0  in_%logit_1.0  patients_%logit_2.0  who_%logit_3.0  are_%logit_2.0  already_%logit_2.0  taking_%logit_2.0  it_%logit_2.0 ._%logit_3.0  The_%logit_2.0  results_%logit_2.0  of_%logit_0.0  this_%logit_2.0  review_%logit_0.0  suggest_%logit_2.0  that_%logit_2.0  nicotine_%logit_1.0  replacement_%logit_2.0  may_%logit_0.0  be_%logit_3.0  a_%logit_3.0  viable_%logit_0.0  option_%logit_0.0  for_%logit_2.0  those_%logit_2.0  smokers_%logit_0.0  who_%logit_3.0  are_%logit_2.0  willing_%logit_2.0  to_%logit_2.0  take_%logit_2.0  it_%logit_2.0 ._%logit_3.0  However_%logit_2.0 ,_%logit_2.0  this_%logit_2.0  conclusion_%logit_2.0  is_%logit_2.0  based_%logit_2.0  on_%logit_0.0  a_%logit_0.0  small_%logit_3.0  number_%logit_3.0  of_%logit_0.0  studies_%logit_0.0  with_%logit_0.0  a_%logit_1.0  high_%logit_1.0  risk_%logit_1.0  of_%logit_0.0  bias_%logit_0.0  and_%logit_0.0  a_%logit_2.0  lack_%logit_3.0  of_%logit_3.0  reporting_%logit_3.0  of_%logit_3.0  adverse_%logit_3.0  events_%logit_3.0 ._%logit_3.0  Further_%logit_2.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  this_%logit_3.0  treatment_%logit_2.0 ._%logit_0.0
 There_%logit_0.0  is_%logit_0.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_2.0  support_%logit_2.0  or_%logit_2.0  refute_%logit_3.0  the_%logit_0.0  use_%logit_3.0  of_%logit_3.0  s_%logit_3.0 ul_%logit_3.0 ph_%logit_1.0 osph_%logit_2.0 on_%logit_1.0 ates_%logit_2.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  people_%logit_3.0  with_%logit_3.0  a_%logit_3.0  poly_%logit_3.0 p_%logit_3.0 -_%logit_1.0 bearing_%logit_1.0  poly_%logit_0.0 p_%logit_0.0 ._%logit_1.0  Further_%logit_0.0  research_%logit_0.0  is_%logit_2.0  needed_%logit_3.0  to_%logit_1.0  determine_%logit_2.0  the_%logit_2.0  optimal_%logit_3.0  dose_%logit_3.0 ,_%logit_0.0  duration_%logit_1.0  and_%logit_1.0  timing_%logit_1.0  of_%logit_3.0  treatment_%logit_1.0  and_%logit_1.0  to_%logit_1.0  assess_%logit_0.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  these_%logit_1.0  agents_%logit_3.0  in_%logit_3.0  reducing_%logit_2.0  the_%logit_0.0  incidence_%logit_3.0  of_%logit_3.0  poly_%logit_3.0 p_%logit_3.0 bearing_%logit_3.0  poly_%logit_0.0 ps_%logit_0.0 ._%logit_0.0  Finally_%logit_3.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_2.0  a_%logit_3.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_1.0  into_%logit_2.0  the_%logit_2.0  efficacy_%logit_3.0  and_%logit_3.0  safety_%logit_1.0  of_%logit_3.0  s_%logit_3.0 ut_%logit_3.0 uring_%logit_1.0  agents_%logit_0.0  in_%logit_3.0  poly_%logit_1.0 p_%logit_0.0  bearing_%logit_3.0  poly_%logit_3.0 ps_%logit_0.0 ,_%logit_1.0  as_%logit_3.0  well_%logit_3.0  as_%logit_0.0  to_%logit_2.0  evaluate_%logit_3.0  the_%logit_2.0  effectiveness_%logit_3.0  and_%logit_3.0  durability_%logit_1.0  of_%logit_3.0  s_%logit_3.0 uture_%logit_3.0  products_%logit_1.0 ._%logit_3.0
 Ant_%logit_0.0 ib_%logit_0.0 iotic_%logit_2.0  pro_%logit_2.0 ph_%logit_3.0 yl_%logit_0.0 axis_%logit_0.0  is_%logit_0.0  effective_%logit_3.0  in_%logit_0.0  reducing_%logit_3.0  the_%logit_3.0  incidence_%logit_3.0  and_%logit_3.0  severity_%logit_0.0  of_%logit_0.0  TP_%logit_0.0 B_%logit_3.0 ,_%logit_1.0  but_%logit_0.0  it_%logit_3.0  is_%logit_3.0  not_%logit_3.0  clear_%logit_3.0  whether_%logit_1.0  it_%logit_3.0  has_%logit_3.0  a_%logit_1.0  beneficial_%logit_3.0  effect_%logit_2.0  on_%logit_2.0  the_%logit_2.0  incidence_%logit_3.0  or_%logit_3.0  severity_%logit_3.0  of_%logit_0.0  infectious_%logit_3.0  complications_%logit_3.0 ,_%logit_3.0  or_%logit_1.0  on_%logit_3.0  the_%logit_3.0  severity_%logit_3.0  of_%logit_3.0  the_%logit_3.0  infection_%logit_3.0 ._%logit_3.0  Ant_%logit_1.0 ib_%logit_0.0 iotics_%logit_2.0  do_%logit_2.0  not_%logit_2.0  appear_%logit_3.0  to_%logit_2.0  have_%logit_1.0  a_%logit_2.0  significant_%logit_3.0  effect_%logit_2.0  on_%logit_2.0  incidence_%logit_2.0  of_%logit_3.0  bacterial_%logit_3.0  contamination_%logit_3.0 ,_%logit_3.0  but_%logit_3.0  they_%logit_3.0  do_%logit_3.0  appear_%logit_2.0  to_%logit_3.0  be_%logit_3.0  beneficial_%logit_3.0  in_%logit_3.0  reducing_%logit_3.0  bacterial_%logit_3.0  contamination_%logit_3.0  in_%logit_3.0  the_%logit_3.0  urine_%logit_3.0  and_%logit_3.0  blood_%logit_2.0  stream_%logit_3.0 ._%logit_0.0  However_%logit_2.0 ,_%logit_0.0  there_%logit_0.0  is_%logit_3.0  a_%logit_2.0  need_%logit_3.0  for_%logit_3.0  further_%logit_1.0  research_%logit_2.0  into_%logit_2.0  the_%logit_2.0  effectiveness_%logit_3.0  of_%logit_3.0  antibiotics_%logit_1.0  in_%logit_3.0  TP_%logit_3.0 B_%logit_3.0  and_%logit_2.0  in_%logit_2.0  the_%logit_3.0  treatment_%logit_3.0  of_%logit_3.0  infectious_%logit_3.0  conditions_%logit_3.0 ._%logit_3.0
 Dietary_%logit_0.0  carbohydrate_%logit_1.0  intake_%logit_3.0  during_%logit_3.0  pregnancy_%logit_3.0  is_%logit_0.0  associated_%logit_3.0  with_%logit_3.0  a_%logit_3.0  reduction_%logit_3.0  in_%logit_3.0  maternal_%logit_0.0  weight_%logit_3.0  gain_%logit_0.0 ,_%logit_3.0  a_%logit_3.0  decrease_%logit_3.0  in_%logit_3.0  maternal_%logit_1.0  hunger_%logit_3.0  and_%logit_1.0  a_%logit_3.0  decrease_%logit_3.0  of_%logit_3.0  maternal_%logit_1.0  hunger_%logit_3.0 ._%logit_1.0  However_%logit_3.0 ,_%logit_0.0  there_%logit_3.0  is_%logit_3.0  no_%logit_2.0  clear_%logit_3.0  evidence_%logit_3.0  of_%logit_3.0  an_%logit_3.0  effect_%logit_3.0  on_%logit_3.0  maternal_%logit_1.0  hunger_%logit_3.0  or_%logit_3.0  maternal_%logit_3.0  hunger_%logit_3.0  on_%logit_3.0  maternal_%logit_3.0  wellbeing_%logit_3.0  or_%logit_3.0  maternal_%logit_3.0  wellbeing_%logit_3.0 ._%logit_3.0  Dietary_%logit_3.0  carbohydrate_%logit_0.0  intakes_%logit_3.0  are_%logit_3.0  associated_%logit_1.0  with_%logit_3.0  an_%logit_3.0  increased_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  developing_%logit_0.0  hyp_%logit_3.0 ogly_%logit_3.0 ca_%logit_1.0 emia_%logit_0.0 ,_%logit_1.0  a_%logit_3.0  decreased_%logit_3.0  risk_%logit_3.0  of_%logit_0.0  cardiovascular_%logit_1.0  morbid_%logit_3.0 ity_%logit_3.0  and_%logit_0.0  mortality_%logit_3.0 ,_%logit_1.0  and_%logit_3.0  an_%logit_1.0  increase_%logit_3.0  in_%logit_0.0  maternal_%logit_1.0  thirst_%logit_3.0  and_%logit_3.0  thirst_%logit_3.0 ._%logit_3.0  Dietary_%logit_3.0  carbohydrates_%logit_0.0  are_%logit_3.0  also_%logit_3.0  associated_%logit_0.0  with_%logit_1.0  decreased_%logit_3.0  maternal_%logit_3.0  hunger_%logit_1.0 ,_%logit_3.0  but_%logit_3.0  there_%logit_3.0  is_%logit_3.0  insufficient_%logit_2.0  evidence_%logit_3.0  to_%logit_3.0  recommend_%logit_2.0  dietary_%logit_2.0  carbohydrate_%logit_1.0  intake_%logit_3.0  as_%logit_3.0  a_%logit_3.0  substitute_%logit_1.0  for_%logit_0.0  dietary_%logit_0.0  fibre_%logit_3.0  intake_%logit_3.0 ._%logit_3.0  Dietary_%logit_3.0  fiber_%logit_0.0  intake_%logit_3.0  should_%logit_0.0  be_%logit_3.0  considered_%logit_3.0  as_%logit_1.0  an_%logit_3.0  adjunct_%logit_3.0  to_%logit_0.0  dietary_%logit_0.0  fiber_%logit_3.0  intake_%logit_3.0  in_%logit_3.0  the_%logit_3.0  treatment_%logit_0.0  of_%logit_0.0  pre_%logit_1.0 -_%logit_3.0 part_%logit_1.0 um_%logit_1.0  weight_%logit_0.0  gain_%logit_3.0 ._%logit_3.0